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ABSTRACT
The possibility that consumption of aged whole milk powders containing significant 
levels of cholesterol oxides may be detrimental to health has stimulated extensive 
research. In this study, the effects of feeding regimen and processing technology on the 
oxidative stability of lipids and cholesterol in whole milk powders were evaluated. 
Animal feeding regimen had a significant effect (p < 0.05) on the levels of total protein, 
true protein, casein protein and whey protein in standardised milk over the experimental 
period. Levels of peroxides, thiobarbituric acid reactive substances and cholesterol 
oxidation products were used as indices of lipid oxidation occurring in whole milk 
powders. Lipid and cholesterol oxidation increased significantly (p < 0.01) after 12 
months storage, the predominant oxysterols being 7-ketocholesterol, cholesterol-a-and 
(3-epoxides, 25-hydroxycholesterol and cholestanetriol. A  positive correlation was 
found between the levels of thiobarbituric acid reactive substances and cholesterol 
oxidation products. Significant decreases in lipid oxidation were observed as a result of 
high pre-heat treatment of milk prior to processing (p < 0.001), vacuum packing of 
powders in laminated foil bags prior to storage (p < 0.05), and storing powders at 
reduced temperatures (15° C) (p < 0.05). Levels of free sulphydryl groups, which 
possess antioxidant activity in whole milk powders, increased significantly (p < 0.05) as 
a result of a grass plus concentrate-fed diet and the application of high pre-heat 
treatment of milk. The toxicity of these oxysterols was evaluted using primary cultures 
of porcine ovarian granulosa cells. The activities of catalase and superoxide dismutase, 
two antioxidant defense enzymes, were increased significantly (p < 0.01) following 24 
hour exposure to 2.5 (iM concentrations of both cholestanetriol and 25- 
hydroxycholesterol. Levels of thiobarbituric acid reactive substances remained 
unchanged under these conditions. Administration of a-tocopherol to the culture 
medium significantly (p < 0.01) improved cell viability and restored catalase and 
superoxide dismutase activities to control levels. These studies suggest that oxysterols, 
at levels found in whole milk powders were non cytotoxic.
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C H A P T E R  1
LITERATURE REVIEW
The production of whole milk powder in Ireland amounts to approximately 36,000 
metric tonnes per annum (Irish Dairy Board Annual Report, 1995), making a 
significant contribution to Ireland’s £100 billion food industry. The importance of 
milk and it’s various dairy products in the diet of people in Western countries is 
indicated by the fact that the average consumption of milk (in all it’s forms) per 
person in the EC is approximately 1 litre per day (Mepham, 1987).
Lipid oxidation products are ubiquitous in foods, although much variation exists in 
the levels present. Although these levels are generally low, the problem of lipid 
oxidation severely compromises the quality of stored foods and limits their shelf life. 
Lipid oxidation represents a key barrier in the development of new food products, 
especially convenience items and processes required in their manufacture. 
Deleterious changes in foods caused by lipid oxidation include loss of flavour, 
development of off-flavours, loss of colour, reduction of nutrient value and 
functionality and the accumulation of compounds which may be detrimental to 
health. All foods that contain lipids are susceptible to oxidative deterioration, but 
especially affected are dehydrated foods and those subjected to high temperatures 
prior to storage, e.g spray-dried whole milk powders, eggs, cheeses and foods fried 
in frying oils. Specific examples of compounds which are of concern to health 
include lipid peroxides and the free radicals involved in their formation/propagation 
as well as several cholesterol oxidation products (COPs) (Addis and Warner, 1992). 
Given the powerful array of antioxidants available and the recent advances in 
processing technology, identification of the steps that will reduce or control levels of 
oxidation products in foods is a major goal for the food industry and regulatory 
bodies.
The aim of this chapter is to define the composition of milk, to review the 
manufacture and properties of whole milk powder and to present a state of the art 
review of the development, control and biological effects of lipid and cholesterol
oxidation.
2
1.1 DEFINITION OF M ILK
Milk is defined in the Milk Ordinance and Code recommended by the United States 
Public Health Service as ‘the lacteal secretion, practically free from colostrum, 
obtained by the complete milking of one or more healthy cows, which contains not 
less than 8.25 %  of milk-solids-not-fat and not less than 3.25 %  of milkfat’ (Webb 
and Johnson, 1974). The distinctive feature of milk as a food lies in the balanced 
content of essential nutrients which it contains. This has been appreciated for 
thousands of years and led to the early domestication of docile, herbivorous 
ruminants, including cows, goats and camels (Mepham, 1987).
1.2 GROSS COMPOSITION OF MILK
The constituents of cows’ milk are derived from two sources. Several major 
components including fat, lactose and proteins and numerous minor components, 
including a variety of enzymes and sugar derivatives are synthesised within the 
mammary gland from materials present in the blood plasma, whereas other 
components such as water, minerals and vitamins are transferred directly from the 
blood plasma to milk (Kurtz, 1974). The composition of milk determines it’s 
nutritive quality, it’s value as a raw material for making food products and it’s 
physical, chemical and functional properties. The principal constituents of milk are 
shown in Table 1.1.
Table 1.1 Approximate Composition of Bovine Milk.
Component Average Content 
Percentage (w/w)
Water 87.3
Fat 3.9
Protein 3.2
Lactose 4.6
Ash 0.7
(Walstra and Jenness, 1984)
1.2.1 M ilkfat
Milk lipids provide a major source of energy and essential structural components for 
the cell membranes of the newborn in all mammalian species (Christie, 1994). They 
confer distinctive properties on dairy foods that affect processing. In consequence, 
the composition, structure and chemistry of milk lipids have probably been studied 
more intensively than those from any other natural source. Bovine milk lipids have 
received most attention because of their commercial importance. The content and 
composition of lipids from milks of different species vary with such factors as diet, 
stage of lactation, number of lactations, breed and season (Hawke and Taylor, 1994).
1.2.1.1 Com position of M ilkfat
In the milks of all species studied to date, triglycerides are by far the major lipid 
class, accounting for 97-98 %  of total lipids (Table 1.2). The triglycerides are 
accompanied by small amounts of di- and monoglycerides, free cholesterol and 
cholesteryl esters (commonly in the ratio 10:1), free fatty acids and phospholipids. 
In addition to these, a number of minor simple lipids and glycolipids have been 
found (Kurtz, 1974; Christie, 1994). Triglycerides consist of a molecule of glycerol 
to which is esterified three fatty acids, thus the major components of triglycerides 
are fatty acids, which in milkfat account for over 85 %  of the total weight. 
Monoglycerides and diglycerides contain one and two fatty acids, respectively. 
Triglycerides in milk are in themselves exceedingly complex, with different types of 
fatty acid esterified to glycerol and the position at which fatty acids are attached also 
varying (Fox, 1991). Phospholipids account for about 1 %  of total lipid in milkfat. 
The phospholipids of milkfat consist of several classes (Sonntag, 1979), the major 
ones being phosphatidylcholine or lecithin, phosphatidylethanolamine, 
phosphatidylinositol, phosphatidylserine, sphingomyelin and plasmalogens. The 
phospholipids of milk and dairy products are concentrated either in the milkfat 
globule membrane (MFGM) itself or in other membranous material that is probably 
derived from the M F G M  (Christie, 1994). During processing of milk, the M F G M  
may be disrupted and the phospholipids are then found in association with the water 
phase (Mulder and Walstra, 1974). Although they are only a small proportion of the
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total lipids in milk, the phospholipids act as detergents and are capable of covering a 
large surface area, so their content may be of considerable relevance during milk 
processing. Cholesterol is the principal sterol found in milkfat although lanosterol 
and small quantities of dihydrolanosterol and p-sitosterol (phytosterols) have also 
been found (Sonntag, 1979). Approximately 10-15 %  of the total cholesterol in milk 
is believed to be esterified to fatty acids. Linoleic acid has been reported to account 
for 27 %  of total fatty acids in milkfat cholesteryl esters (Patton and McCarthy, 
1963). Fresh milk contains free fatty acids (FFA) which increase during storage of 
raw milk as a result of hydrolysis of the ester linkage by lipase enzymes secreted by 
psychrotrophic bacteria. Factors affecting FFA levels in milk include animal 
nutrition, stage of lactation, storage temperature, time of milking and extent of 
foaming or agitation occurring during milking and milk assembly (Rajeh and 
Burgess, 1991).
Table 1.2 Composition of individual simple lipids and total phospholipids in milks
from various species.
Lipid Class Cow Buffalo Human Pig
(wt % of total lipid)
Triglycerides 97.50 98.60 98.20 96.80
Diglycerides 0.36 - 0.70 0.70
Monoglycerides 0.03 - trace 0.10
Cholesteryl esters trace 0.10 trace 0.06
Cholesterol 0.31 0.30 0.25 0.60
Free fatty acids 0.03 0.50 0.40 0.20
Phospholipids 0.60 0.50 0.26 1.60
(Christie, 1994)
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1.2.1.2 Factors affecting milkfat levels and composition
Bovine milk typically contains approximately 3.5 %  fat but the level varies widely 
depending on several factors including breed, stage of lactation, season, nutritional
status, type of feed, health and age of the animal and interval between milking (Fox,
1991).
A  wide diversity of cow breeds exist contributing to the commercial milk pool, from 
Holstein and Friesian to the Kerry cow. This has led to a wide variety in milk yield 
and to a somewhat lesser extent, composition (Walstra and Jenness, 1984). Milkfat 
composition is influenced strongly by stage of lactation (Palmquist et al., 1993). 
The proportion of short chain fatty acids (de novo synthesis) are low initially, and 
increase gradually until at least week 8 to 10 into lactation (Palmquist et al., 1993). 
For any particular population, the milkfat content is highest in winter and lowest in 
summer. In Ireland, lactational, seasonal, and possibly nutritional effects coincide 
and the seasonal changes in fat content (and of protein and lactose) are much greater 
than in other European countries (Fox, 1991). The quality and quantity of animal 
feed also affects milkfat yield and composition with milkfat composition being 
readily modified by the feeding regimen (Sutton, 1989; Grummer, 1991; Murphy et 
al., 1995). The most significant changes in milkfat quality relate to rheological 
properties, which influence numerous aspects of character and quality of 
manufactured dairy products (Palmquist et al., 1993). The composition of milkfat 
depends on the route from which it is derived (Early, 1992). The fat content of milk 
is also affected by interval of milking, with milkfat increasing continuously 
throughout the milking process. If a cow is incompletely milked, the fat content of 
the milk will be reduced and the entrapped fat will be expressed in the subsequent 
milking, giving an artificially high value for fat content (Fox, 1991).
1.2.1.3 M ilkfat globule membrane (MFGM)
Milkfat is secreted as individual globules, each encapsulated within a membrane, the 
presence of which prevents coalescence of the fat (Fig. 1.1). The fat globule is 
excreted from the secretary cell in the mammary gland by being ‘pushed’ through
6
milk
Fig. 1.1 Photomicrograph of milk.
(A) Magnified x 5. Uniform liquid.
(B) Magnified x 500. Spherical droplets consisting of fat. These globules float in a 
liquid plasma. This is still turbid.
(C) Magnified x 50,000. The plasma contains proteinaceous particles (casein 
micelles).
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the apical cell membrane and becoming surrounded with the membrane in the 
process. This excretion process has been confirmed by many investigators, although 
the complete mechanism has still not been fully explained (Brunner, 1974; Keenan 
et al., 1983). The M F G M  serves as a barrier separating aqueous compartments with 
different solute composition but also serves as the structural base to which certain 
enzymes and transport systems are bound. Although there is considerable variation 
(with cell type, species and nutritional status), the typical composition of membranes 
is approximately 40 %  lipid and approximately 60 %  protein. The lipids are mostly 
apolar, composed principally of phospholipids and cholesterol in varying 
proportions. The phospholipid component of the membrane is particularly rich in 
polyunsaturated fatty acids, which are liable to undergo oxidation thereby giving rise 
to ‘off-flavours’ (Keenan et al., 1983). The lipid molecules appear to be arranged in 
a bi-layer structure with a total thickness of 7-9 nm (Fox, 1991). The membrane is 
very sensitive to damage by abrasion. It’s whole or partial removal causes the fat 
globules to coalesce and renders them much more sensitive to lipoprotein lipase, the 
natural lipase present in raw milk. Lipoprotein action leads to the hydrolysis of 
milkfat and the liberation of FFA, resulting in the development of an unacceptable 
rancid flavour and odour. For these reasons, milk must be carefully handled during 
all stages of transit and storage. To retain the membrane on the globule, the most 
important single point is to avoid abrasive processes in handling milk. Positive 
pumping is therefore to be recommended and areas of turbulence are to be avoided 
(Rajeh and Burgess, 1991).
1.2.1.4 Milkfat Synthesis
Triglycerides comprise approximately 97-98 %  of milkfat and fatty acids are the 
primary constituent. Fatty acids are derived from two sources: (i) de novo synthesis 
in the mammary gland, and (ii) uptake from the circulating blood (Fig. 1.2). The 
composition of the fatty acids from these two sources is usually very different, e.g. 
endogenously produced fatty acids are of carbon length C4 to C ]6, while a proportion 
of C 16, and virtually all the C 18 fatty acids arise from blood (Hawke and Taylor, 
1994). Estimates of the contribution of blood lipids to milk lipids in the cow vary
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from about 35 %  to as high as 85 %  (Bishop et al., 1969; Annison et al., 1967). 
Under normal dietary conditions the triglyceride of very low density lipoproteins 
(VLDLs) and low density lipoproteins (LDLs) appears to be important in providing 
fatty acids for bovine milkfat synthesis (Glascock and Welch, 1974). The uptake of 
VLDL triglycerides by mammary tissue involves hydrolysis of the triglycerides by 
lipoprotein lipase. The lipase appears to be bound to the luminal surface of the 
endothelium of the blood capillaries and hydrolysis of triglycerides is regarded as a 
pre-requisite to the uptake of lipid by mammary epithelial cells. Bishop et al. (1969) 
estimated that approximately 30 %  of palmitate (C16:0) is synthesised de novo by 
the mammary gland. There is extensive desaturation of stearic acid (Cl 8:0) to oleate 
(Cl8:1) on entry into the mammary gland by a desaturase located in the microsomes 
(Annison et al., 1967). Thus, despite the high 18:0 to 18:1 ratios in triglycerides 
circulating in the blood of ruminants arising from extensive biohydrogenation of 
dietary fat in the rumen, desaturation of 18:0 in mammary tissue results in the 
production of milkfat not markedly dissimilar in 18:1 content to the milkfat of non­
ruminants. In general, the nature of the fatty acids taken up from the blood and 
utilized for milkfat synthesis reflects the composition of the circulating triglycerides. 
Biohydrogenation and other microbial reactions concerned with lipid metabolism in 
the rumen ensure a measure of consistency in the nature and level of the fatty acids 
absorbed in the lower gut, irrespective of the dietary lipid (Hawke and Taylor, 
1994).
The significance of feed in influencing fatty acid composition of milkfat is evident 
in the altered physical and chemical characteristics of milkfat that accompany 
dietary change (Cullinane et al., 1984; Grummer, 1991). Recent feeding studies 
(Murphy et al., 1990; 1995) have shown that it is possible to alter the fatty acid 
composition of milkfat by including ground fullfat soyabeans or ground fullfat 
rapeseed in the concentrate mixture fed to lactating cows at pasture. The unsaturated 
Cl8 fatty acids in these oilseeds are hydrogenated in the rumen to C18:0, which is 
then absorbed from the intestine and is converted to Cl8:1 in the mammary gland by 
a stearic acid desaturase. Murphy et al. (1990; 1995) found that increasing the
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supply of stearic acid to the mammary gland resulted in an increase in Cl8:1 in the 
milkfat, resulting in a softer fat.
Essential to fatty acid biosynthesis in the mammary gland is the provision of a 
carbon source in the form of acetyl-CoA and the availability of large quantities of 
reducing equivalents, such as NADPH. Folley and French (1950) showed that 
ruminant mammary tissue utilised acetate and not glucose for fatty acid synthesis, 
whereas glucose represented the major carbon source for fatty acid synthesis de novo 
in non-ruminant mammary tissue. Large amounts of acetate, propionate and 
butyrate, produced by the fermentation of dietary carbohydrates in the rumen are 
absorbed through the ruminal wall. The utilisation of blood acetate, rather than 
blood glucose by ruminants as a carbon source in lipogenesis, represented a unique 
metabolic adaptation of ruminants to ensure that glucose and glucogenic compounds 
are conserved for body processes for which these substances are essential.
1.2.2 Protein and m inor nitrogenous fractions
Milk protein is widely consumed as a human food, particularly in developed 
countries. The long history of it’s inclusion in the human diet and the relative ease 
with which the major proteins can be purified from raw milk have contributed to it’s 
early and extensive characterisation by scientists. Consequently, milk proteins are 
probably the best characterised of all food proteins (Swaisgood, 1992). Milk 
proteins are of two distinct types, whey proteins (serum proteins) and caseins. 
Caseins constitute over 80 %  of the total protein of bovine milk although the 
proportion of whey proteins to caseins varies according to a number of factors, 
including the stage of lactation (Vamam and Sutherland, 1994).
1.2.2.1 Casein proteins
In milk, caseins are organised into particles with an average size of about 100 nm. 
The caseins of milk may be subdivided into five main classes, asl, as2, P-, y-, and k- 
casein (Table 1.3). Various contrasting models have been proposed for the structure 
of casein micelles (Banks et al., 1981), but there are some common features. It is 
recognised that the micellar framework comprises a network of as-casein complexed
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with calcium phosphate. There is evidence that the serine phosphate ester groups are 
inherent in the structure of the micellar calcium phosphate. Within the framework of 
as-caseins both the (3- and K-caseins are accommodated. The relative proportions of 
a, (3- and y-caseins are subject to genetic variation within individual herds and there 
can be significant differences in casein composition of milk from different cows. 
The casein composition of bulk milk, however, varies very little at any stage in 
lactation (Walstra and Jenness, 1984; Swaisgood, 1992; Vamam and Sutherland, 
1994).
Table 1.3 The Caseins of milk.
Fraction Phosphoserine residues
Alpha sl 7 - 9
Alpha s2 10 -13
Beta 5
Gamma 0 - 1
Kappa 1
(Vamam and Sutherland, 1994)
1.2.2.1.1 Structure o f individual casein proteins
The primary structure of the caseins is completely defined (Eigel et al., 1984). 
Caseins exist in milk in the form of supramolecular aggregates, imparting 
opalescence to skim milk. Caseins are not present in milk as individual molecular 
structures, but rather as large protein complexes that also incorporate milk salts, 
particularly calcium salts (Schmidt, 1980). The ‘native’ structure is actually a 
protein complex resulting from interaction of all the individual caseins (Swaisgood, 
1992). Because of this property, they cannot be denatured by heating (Early, 1992). 
The a- and (3-caseins are phosphoproteins containing between 5 and 13 
phosphoserine groups. These phosphoserine residues are the key to the unique 
properties of casein. They account for the calcium sensitivity of milk protein. When 
calcium is added to casein solutions, the casein promptly coagulates as inter-
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molecular calcium bridges are formed. Clusters of phosphoserine residues are 
responsible for the highly charged hydrophilic areas leading to the presence of 
hydrophilic and hydrophobic domains in a single molecule that allows the proteins 
to act as highly effective surface active agents, and consequently they have found 
widespread use as emulsifier agents (Coupland and Me Clements, 1996). y-Caseins 
are the result of post-secretory hydrolysis of p-casein. In good quality milk, y- 
caseins constitute a very low proportion (less than 5 %) of the total casein fraction in 
milk. K-Casein differs from the other caseins, in that it is insensitive to the addition 
of calcium, as it has one serine phosphate ester group and contains a charged 
carbohydrate moiety (Early, 1992).
1.2.2.2 W hey proteins
Whey can be defined in a very general sense as the liquid remaining after removal of 
casein from milk (Mulvihill and Donovan, 1987). The whey, or serum proteins are 
compact gobular proteins and include four gene products; (5-lactoglobulin, a- 
lactalbumin, lactoglobulins (immunoglobulins) and bovine serum albumin (Table 
1.4).
Table 1.4 The Whey Proteins of Milk.
Fraction Molecular W eight (kDa)
Beta-lactoglobulin 18.3
Alpha-lactalbumin 14.2
Serum albumin 63.0
Immunoglobulins up to 1000
(Vamam and Sutherland, 1994) 
1.2.2.2.1 ß-Lactoglobulin
The major protein constituent of whey is (3-lactoglobulin, which is present to the 
extent of approximately 50 %  of the total whey protein of milk and approximately 
14 %  of the total protein of bovine milk. However, it is absent from human milk. 
Structurally, it consists of a single polypeptide chain ( MW 18.3 kDa) containing 162
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amino-acid residues and is usually present as a stable dimer between pH 5.5 and 7.5 
(Me Kenzie, 1971). Thermal dénaturation of bovine P-lactoglobulin causing the 
dimer to dissociate to momomer has been shown in vitro when the temperature was 
increased from 30 to 55° C (Me Kenzie, 1971). Dénaturants include alkali, heat, 
organic compounds and heavy metal ions (Hambling et al., 1992). A  major 
consequence of dénaturation is a reduction in protein solubility, which has been 
exploited to monitor the heat processing history of milk products. Quantitation of 
whey protein dénaturation by measurement of loss of solubility on saturation with 
NaCl is used as an index of the heat treatment of milk products (Harland and 
Ashworth, 1947; Leighton, 1962). Another manifestation of whey protein 
dénaturation is increased side-chain reactivity of the sulphydryl groups of 0- 
lactoglobulin which is reported to be responsible for cooked flavour development 
(Kinsella, 1985) and antioxidant properties (Taylor and Richardson, 1980).
1.2.2.2.2 a-Lactalbum in
a-Lactalbumin is the second most abundant of the whey proteins in bovine milk and 
has been physically and chemically characterised (Swaisgood, 1992) (Table 1.4). It 
is the regulatory component of the enzyme lactose synthetase (Brew and Grobler,
1992). It has been postulated that the secretion of a-lactalbumin in the mammary 
gland controls the levels of lactose synthesis, and a high correlation has been found 
between the lactose and a-lactalbumin contents of milks of a number of species. 
Since lactose is the principal osmotic regulator of milk, its synthesis must be rigidly 
controlled, and this is probably the physiological role of a-lactalbumin (Morrissey, 
1985). It is monomeric, existing as a highly compact, virtually spherical shaped 
protein with a greater heat stability than that of p-lacto globulin (Vamam and 
Sutherland, 1994).
1.2.2.2.3 Im m unoglobulins
Immunoglobulins are glycoproteins having high molecular weights and possessing 
antibody activity (Mulvihill and Donovan, 1987). They occur in only small amounts 
in normal milk, but in much higher concentration in colostrum. Four distinct classes 
of immunoglobulins occur in bovine milk, IgM, IgA, IgE and IgG. As a group, the
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immunoglobulins are either monomers or polymers of a four-chain molecule 
consisting of two light ( MW 22 kDa) and two heavy ( MW 50-70 kDa) chains (Eigel 
et al., 1984).
1.2.2.2.4 Bovine Serum  Albumin
Bovine serum albumin (BSA) prepared from milk is physically and 
immunologically identical to blood serum albumin. BSA contains 582 residues, has 
17 intra-molecular disulphide bonds and one free thiol group, which occurs at 
residue 34. In the model produced by Brown (1977), the BSA molecule is visualised 
as having three major domains, each consisting of two large double loops and a 
small double loop and appears to be in the shape of 3:1 ellipsoid.
1.2.2.3 Economic value o f milk protein
Protein accounts for approximately 25 %  of the total solids in milk and both its 
absolute concentration and its concentration relative to the concentration of fat and 
lactose are important in the manufacture of dairy products (Murphy and O ’ Mara,
1993). Recently, it has been shown that the presence of genetic variants of k-casein 
and (3-lactoglobulin are associated with increased total protein and casein 
concentrations and with increased cheese yields (Van den Berg et a l, 1991). 
Therefore, selective breeding may offer more opportunities in this regard. Low 
protein concentrations cause problems for the processor in terms of the efficiency of 
product manufacture and in meeting certain minimum protein standards for dairy 
products. Irish data have shown that Cheddar cheese yield decreased 15 %  when 
milk protein concentration decreased 18 %  from 35.5g/kg in October to 29g/kg in 
February (Murphy and O ’ Mara, 1993). Low milk protein can also be problematic 
in the manufacture of dairy products. For example, there are minimum protein 
concentrations set for the demineralised whey protein used in infant feed 
formulations while some countries specify a minimum protein for whole milk 
powder.
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Bovine milk contains approximately 60 enzymes, which originate from the 
mammary gland tissue cells, blood plasma and blood leucocytes. Certain flavour 
and stability problems in dairy products have stimulated considerable research on 
enzymes such as lipase, xanthine oxidase and protease (Kitchen, 1985). Plasmin is 
the major proteinase in milk whose concentration varies according to the extent of 
leakage of blood components into the milk, being high, for example, in very early or 
very late lactation milk. High concentrations of plasmin also arise as a result of 
mastitis (Politis et al., 1992). Milk lipase has received considerable attention in the 
dairy industry owing to it’s potential to produce free fatty acids (FFA) from milk 
triglycerides, thus causing off-flavours. Lipoprotein lipase (LPL) is the principal 
lipolytic enzyme in milk (Kitchen, 1985). The enzyme is present in large quantities 
in fresh milk, but the protective effect of the M F G M  means that significant lipolysis 
due to LPL is rare. However, spontaneous lipolysis involving rapid production of 
FFA and associated rancid flavour can occasionally occur. The causes are not well 
understood but probably arise from a combination of factors including diet and stage 
of lactation (Astrup et al., 1980). A  number of oxidoreductase enzymes are also 
present in milk, including catalase, lactoperoxidase and xanthine oxidase (Kanner 
and Kinsella, 1983; Spencer and Simon, 1960). Lactoperoxidase catalyses the 
transfer of oxygen from hydrogen peroxide to other substances such as thiocyanate 
and is present in high concentrations in milk. Lactoperoxidase has the potential to 
catalyse oxidation of unsaturated fatty acids leading to the development of oxidised 
flavours. On the other hand, lactoperoxidase can also act as a powerful bacteriocide 
which can kill coliforms, Salmonella and Pseudomonads (Early, 1992). Xanthine 
oxidase can cause ‘off-flavour’ production through catalysis of oxidation, but this is 
not thought to be of importance in most circumstances (Kitchen, 1985). The level of 
catalase in bovine milk varies with somatic cell count, and thus a measure of it’s 
activity has been used to detect mastitis. Catalase, being a haem-containing protein, 
may also be involved in lipid oxidation in a manner similar to that of 
lactoperoxidase. Superoxide dismutase is a common constituent of all microbial, 
plant and animal cells and has the ability to convert superoxide anions into oxygen
1.2.3 Enzymes o f bovine milk
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and hydrogen peroxide (Halliwell, 1994). It is located wholly in the skim milk 
fraction of milk. Alkaline phosphatase is another enzyme present in milk and 
although it is of no importance with respect to milk stability, it is widely used as an 
index of adequate heat treatment due to it’s inactivation by pasteurisation (Vamam 
and Sutherland, 1994).
1.2.4 Lactose and other carbohydrates
Lactose is the major carbohydrate in the milk of most mammals and it is generally 
accepted that non-mammalian sources of lactose are very rare. The lactose content 
of normal bovine milk is generally in the range 4.4 - 5.2 %, whereas it is higher, 
approximately 7 % in human milk (Vamam and Sutherland, 1994). Lactose is the 
major constituent of dried milk, constituting 37 % (w/w), thus at least some of the 
properties of lactose will be reflected in the behaviour of dried milk particles (Early, 
1992). For example, owing to the high hygroscopicity of lactose, dried milk 
particles readily adsorb moisture from the surrounding atmosphere. When this 
happens, the concentration of lactose is diluted so that it’s molecules acquire 
sufficient mobility and space to orientate themselves into a crystal lattice, which 
leads to clumping and caking. Lactose is used extensively in the food industry in 
infant foods, dietetic foods, fruit, vegetable and dairy products. It is also added to 
bakery products such as biscuits to impart a controlled degree of Maillard browning, 
a reaction considered favourable in certain food products (Vamam and Sutherland,
1994). Adverse reactions may occur in lactase-deficient individuals after ingestion 
of foods containing lactose (Morrissey, 1985). Ingested lactose is hydrolysed by the 
enzyme lactase which is found within the brush border of the microvillous area of 
the jejunal mucosa. If intestinal lactase activity is low, the ingested lactose may not 
be fully hydrolysed, leading to it’s transfer to the intestinal lumen causing abdominal 
distention, cramps and increased peristalsis (Paige and Davis, 1985).
1.2.5 M inerals
Milk contains all the mineral elements of nutritional significance for the growing 
young of the species (Table 1.5). Cow’s milk is characterised by a high calcium 
content, three or four times that of human milk and by a very low content of iron
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Table 1.5 Mineral and Vitamin Composition o f  Cow’s M ilk (Cremin and Power, 1985).
Vitamin Mean/1 Minerals Mean/1 Minerals Mean/1
A  (pg) 1000 Sodium (mg) 150 Chromium (pg) 40
D  (IU) 400 Potassium (mg) 600 Molybdenum
(f-ig)
8
E(pg) 10, 000 Chloride (mg) 430 Nickel (pg) 25
K(pg) 50 Calcium (mg) 350 Silicon (pg) 700
B i (pg) 450 Magnesium (mg) 28 Vanadium (pg) 7
B 2 (l^g) 1750 Phosphorus (mg) 145 Selenium (pg) 1270
Niacin (pg) 900 Iron (pg) 760 Vanadium (pg) 7
B 6(^ g) 500 Zinc (pg) 2950 Arsenic (pg) 50
Pantothenic acid (pg) 3500 Copper (pg) 390
Biotin (pg) 35 Manganese (pg) 12
Folic acid (pg) 55 Iodine (pg) 70
B 12 (Pg) 4.5 Fluoride (pg) 77
C (mg) 20 Selenium (pg) 14
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(Early, 1992). Various nutritional aspects of essential minerals in bovine and/or 
human milk have been reviewed in recent years (Flynn and Power, 1985; 
Hambraeus, 1992). The essential minerals are classified into two groups, i.e. the 
minerals and trace elements. The macrominerals (sodium, potassium, chloride, 
calcium, magnesium, phosphorus and sulphur) are present in the body in amounts 
greater than 0.01 %  by weight while the trace elements (the remaining 15 essential 
minerals) occur in the body at much lower levels and are required in the diet in 
amounts less than about 100 mg/day (Flynn and Power, 1985). The mineral 
composition of human and bovine milk is not constant but is influenced by a number 
of factors including stage of lactation, nutritional status of the mother, environmental 
and genetic factors. The total mineral content of bovine milk (7.3 g/1) is 
considerably higher than that of mature human milk (2.0 g/1). This is mainly due to 
the higher concentrations of sodium, potassium, chloride, calcium, phosphorus and 
magnesium in cows milk (Table 1.5) (Flynn and Power, 1985). A  60 g weight of 
dried skim milk can provide the recommended dietary allowance (RDA) for calcium 
and 75 %  of the R D A  for phosphorus. Whilst dietary calcium has been widely 
recognised as a key nutritional factor in determining healthy bone development in 
growing young, deficiency is only cause of osteoporosis in post-menopausal women 
(Heaney et al., 1982).
1.2.6 Vitamins
Vitamins are organic chemicals required in trace amounts for growth and 
maintenance of health (Cremin and Power, 1985). Vitamins can be sub-divided into 
two major groups: fat-soluble and water soluble. Vitamins A, D, E and K  are 
generally found in the lipid fraction of foods and are termed the fat-soluble vitamins. 
The water soluble vitamins include vitamin C and the vitamins of the B complex: 
thiamine, riboflavin, niacin, panthothenic acid, vitamin B 12, folic acid and biotin 
(Table 1.5). In metabolism, the water-soluble vitamins and vitamin K  function 
predominantly as coenzymes whereas the remaining fat-soluble vitamins have 
additional roles in the body. Vitamin A  is central to the visual process as a 
constituent of the visual pigment rhodopsin. Vitamin D is necessary for calcium
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absorption, while vitamin E has an antioxidant role. Milk and dairy products 
contribute significantly to the RDA for many o f these vitamins (Cremin and Power,
1985).
The vitamin content o f milk (Table 1.5) and dairy products is altered by many 
factors including animal diet quality, genetics, stage o f lactation, season and food 
processing. Bovine milk typically contains an average o f 20-50 ppm vitamin E, but 
animal diet quality can cause large variations in it’s content (McGillivay, 1956). 
Vitamin E occurs in cow’s milk exclusively as a-tocopherol. The concentration o f 
vitamin E in bovine milk exhibits a seasonal pattern reflecting variations in dietary 
vitamin E intake, with a maximum in April and a minimum in September (Early, 
1992; O’Shea 1996 personal communication). Vitamins C, riboflavin and vitamin A 
are all affected by light to varying degrees. The fat soluble vitamins are relatively 
stable to heat but the water soluble vitamin are less heat stable. Loss o f vitamin C is 
closely related to the oxygen content of the product and steps should be taken during 
milk processing to avoid excessive aeration. The nutritional value o f milk is often 
underestimated and arguments about the relative merits o f different fat types have 
tended to obscure the undoubted nutritional benefits associated with the 
consumption o f milk vitamins, minerals and proteins (Early, 1992).
1.3 M IL K  P O W D E R
Preservation o f the nutritive value o f milk, while at the same time maintaining it’s 
flavour quality and extending it’s shelf-life can be achieved through spray-drying of 
milk. By almost complete removal of water from milk, drying processes yield 
powders which are convenient to transport and use. Whole milk powder is the 
product obtained by dehydrating whole fluid milk.In countries where the indigenous 
milk supply is inadequate, whole milk powder is reconstituted for consumption as a 
substitute for fresh milk and for the manufacture o f dairy products. On the domestic 
European market, whole milk powder is utilised as an ingredient by the food 
industry for product manufacture (Tuohy, 1987).
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1.3.1 Whole M ilk  Powder Manufacture
Milk powder manufacture is an old process and it is known that the Mongolians 
produced milk powder by drying whole milk in the sun (Faldt and Bergenstahl
1995). In his writings, Marco Polo reports that in the 12th century, the Tartars 
produced a milk powder by exposing thin films o f  milk to the sun. However, it was 
only in 1875 that Grinwade patented a process for the manufacture o f milk powder 
in the U.K. This process was used in the U.S. by 1887 and in Canada and Europe by 
the early 1900s (Caric, 1994). From approximately 1930, the spray-drying process 
started to gain importance and great developments have taken place in recent years. 
Milk drying has become an essential part o f the long chain between the farm 
producer and the final domestic customer, and dried milk has grown into a large 
industry of considerable international importance. The diversification o f the dry 
milk industry has been described by Robinson (1986) who outlined the potential use 
in the food industry o f the non-fat milk solids and the whey proteins. The drying o f 
milk takes place in 5 stages; standardisation, heat treatment, evaporation, 
homogenisation and spray-drying as outlined below.
1.3.1.1 Standardisation
Standardisation, or correction o f the fat/non-fat solids ratio, is an adjunct step in the 
drying process. To achieve the desired ratio in the final product, these components 
are adjusted before evaporation. Standardisation o f milk may be achieved by the 
removal o f fat from whole milk and/or the addition o f liquid skimmed milk or cream 
to whole milk (Tuohy, 1987). For the production of milk powder, it is recommended 
that the fat/non-fat solids ratio be adjusted to 18-25 %. The fat and non-fat solid 
contents o f milk are analysed and on the basis o f these values and the desired ratio in 
the product, the value to which the fat content should be corrected is calculated by 
material balance. A mathematical formula called Pearson’s Square in used in the 
standardisation of milk. The Pearson Square method is a simple diagrammatic 
method of determining the amount o f skim milk required to standardise milk for 
whole milk powder manufacture.
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The whey proteins in milk are particularly sensitive to heat and can easily be denatured 
at temperatures above 65° C. Hence, whole milk may be given controlled heat 
treatments in the pre-heat section o f the evaporator to achieve desired levels o f whey 
protein denaturation. The degree o f whey protein denaturation influences the functional 
properties o f the resultant powder and it’s suitability for use in particular applications. 
Heat treatment is usually carried out at temperatures higher than pasteurization in 
continual heat exchangers o f a plate or tubular type (Caric, 1994). The goals are (i) to 
destroy all pathogenic bacteria and most o f the saprophytic micro-organisms, (ii) to 
inactivate enzymes, especially lipase, which could provoke lipolysis during storage, (iii) 
to activate sulphydryl groups o f p-lactoglobulin, thus increasing resistance o f the powder 
to oxidative changes during storage and (iv) to achieve a particular heat treatment class 
(Early, 1992). There are three general heat treatments used in the manufacture o f spray- 
dried whole milk powder. The different heat treatments can be differentiated by 
determining the undenatured whey protein nitrogen index (ADMI, 1971) (Table 1.6).
Table 1.6 The utilization o f low-, medium- and high-heat powder.
1.3.1.2 Heat Treatment
P roduct Pow der Type A ttributes
Cheese Low heat Rennetability
Reconstituted milk and milk Low/ medium heat High solubility,
drinks minimal cooked flavour
Ice cream Medium heat Emulsification, foaming,
water absorption
Recombined evaporated milk High heat Heat stability
(Modified from Vamam and Sutherland, 1994).
(i) Low heat pow der is produced by subjecting milk to between 70° C and 75° C, for 10 
seconds. The powder obtained, referred to as ‘low heat powder’, must contain a 
minimum amount o f undenatured whey proteins, that is, greater than or equal to 6.0 
mg/g milk powder. Low heat powder has relatively little protein denaturation or
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aggregation because it has received minimal heating during manufacture and therefore is 
ideal for reconstitution into beverages such as skim milk or, more usually, as 
recombined or filled pasteurised milk. It is also ideal for the manufacture o f ‘instant’ 
skim milk powder, milk placer formulations, cottage cheese and cultured milks (O’ 
Sullivan and O ’ Connor, 1971).
(ii) M edium  heat pow der is produced by subjecting milk to between 76.5° C and
85° C, for 15 to 30 minutes. Consequently, medium heat powder has a greater degree of 
protein denaturation as a result o f the more severe heat treatment than low heat powder. 
Medium heat powder contains between 1.5 and 6.0 mg o f undenatured whey proteins/g 
milk powder and is generally used in the manufacture o f recombined or filled evaporated 
milk and sweetened condensed milk, as this heat treatment classification is associated 
with heat stability (O ’ Sullivan and O ’ Connor, 1971).
(iii) High heat pow der is produced by subjecting milk to between 90° C and 120° C 
for 2 minutes and consequently possesses a higher degree of denaturation than powders 
o f lower heat classes. Heating at higher temperatures with shorter holding times 
produces a more soluble and better-tasting powder. High heat powder contains less than
1.5 mg of undenatured whey protcin/g of milk powder according to the WPNI index 
(ADMI, 1971) and is used for baking purposes because very severe heat treatment is 
necessary to denature the dough depressant factors native to milk (O’ Sullivan and O ’ 
Connor, 1971).
1.3.1.3 Evaporation
In the manufacture o f whole milk powder, the heat-treated milk is subsequently 
concentrated by evaporation. Concentration by evaporation using falling film 
evaporators is most commonly used although increasing use is being made of 
ultrafiltration and to a lesser extent reverse osmosis (Early, 1992). Evaporation is a 
compulsory step in powder processing for several reasons. Milk powder produced from 
evaporated milk has longer shelf-life and larger powder particles with a smaller amount 
o f occluded air (Pisecky, 1980). The omission of the concentration stage would not be
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economically justified because the drying process would be prolonged, the equipment 
would not be fully utilized and energy consumption would be markedly increased. 
Some 80 % of the water in milk is removed by evaporation to produce a concentrate of 
about 50 % total solids, suitable for spray-drying.
1.3.1.4 Homogenization
Homogenization is conducted after evaporation, or in partly concentrated milk. The 
main objective o f concentrate homogenisation is to reduce the average diameter o f the 
fat globule to < 1 pm (De Vilder et al., 1979) leading to a 4-6 fold increase in fat globule 
surface area. There is insufficient natural membrane to coat the newly formed surface 
fully and consequently the globules are coated with a new membrane which consists 
mostly o f casein. The membrane of homogenised milk contains 2.3 g protein/100 g fat 
which is considerably higher than the level of protein in the natural membrane (0.5-0.8 g 
protein/100 g fat) (Fox, 1991). Fat globules without protective membranes reduce milk 
powder solubility and increase susceptibility to oxidative rancidity (Caric, 1994).
1.3.1.5 Spray-Drying
The objective o f spray-drying is to convert a liquid into a dry material, thus providing a 
product with an extended shelf-life (Boersen, 1990). Fig. 1.2 depicts a conventional 
spray-dryer used in the manufacture o f whole milk powder. Spray-drying is an 
extremely complex process involving a number o f key steps. Milk concentrate is first 
converted into a fog-like mist (‘atomised’), whereby it is given a larger surface area. 
The atomization conditions are central to the spray-drying process, and play an 
important role in defining such powder properties as particle size, particle density and 
bulk density through their influence on droplet size (Bloore and Boag, 1982). The 
atomised liquid is exposed to a flow of hot air in a drying chamber. The air has the 
function o f supplying heat for the evaporation and, in addition, it acts as carrier for the 
vapour and the powder. When the atomised product is in contact with the hot air, the 
moisture evaporates quickly and the solids are recovered as a powder consisting o f fine, 
hollow, spherical particles with some occluded air. In single-stage drying the spray 
dryer is operated in such a way that the powder has reached the final moisture content 
when leaving the drying chamber whereas in the two-stage drying process, the primary
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Fig. 1.2 Schematic of a spray-dryer (Boersen, 1990).
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drying is carried out to about 2-10 % above the final moisture content. The excess 
moisture is evaporated in à fluid-bed or vibro-fluidizer, in which air is distributed over 
thè whole milk powder, thereby gently evaporating the rest o f the moisture (Boersen,
1990).
1.3.1.6 Packaging and storage of whole m ilk powder »,
Packing o f milk powder is especially important to retain optimum product quality during 
storage (Tuohy, 1984). The powder is packed in suitable containers designed to protect 
the powder from moisture, air, light, insects, and contamination. Wrappings typically 
used include paper, multilayer boxes or bags with a polyethylene layer inside, metal 
barrels with polyethylene bags inside and cans covered with aluminium foil on the 
contact surface. When the product is intended for long-term storage, the packing is 
performed in an atmosphere o f inert gas, mostly nitrogen, or in partial vacuum o f 4.0-5.3 
kPa, to avoid oxidative changes of fat and other milk components. Investigations o f the 
changes o f spray-dried milk powder during storage in an atmosphere o f nitrogen and in 
oxygen at 37° C have shown a decrease in levels o f lysine, folate, and ascorbate in the 
atmosphere o f oxygen, while in an atmosphere o f nitrogen there was no significant loss 
o f  any component (Carie, 1994).
1.3.2 Whole m ilk powder quality
Properties o f milk powders can be categorised as (i) chemical, (ii) microbiological,
(iii) physical, (iv) functional and (v) organoleptic (Early, 1992). The quality o f milk 
powders and other dried milk products is defined by quality specifications (ADMI, 
1971). Powders are manufactured to specifications which define, in particular, the 
chemical, microbiological and physical standards. Functional standards may also be 
cited, but for the most part will relate to performance characteristics o f the powder 
on reconstitution. Functional performance in a given application can be difficult to 
quantify in terms suitable for a specification. Organoleptic properties are probably 
the least precisely defined, as they relate only to a typical flavour or absence o f taint.
The distinction between the categories is not clear cut, e.g the degree o f denaturation 
o f  whey proteins is relevant to the chemical properties o f a powder, but it also 
influences the functional properties of the milk powder (Early, 1992).
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1.3.2.1 Chemical properties
The chemical properties o f a milk powder are dependent on the composition and 
quality o f the raw materials used in manufacture and can be influenced by the 
processing conditions during manufacture, e.g. heat-treatment which can result in 
Maillard reaction products (Lingnert and Hall, 1986) with consequent browning and 
flavour development.
1.3.2.2 Microbiological properties
Dried milk, because o f it’s low water activity, is a stable product and does not 
support the growth o f microorganisms in the dry state, but it can support growth of 
microorganisms following reconstitution. Any microorganisms present in the dried 
milk will subsequently multiply in the reconstituted product. The heat treatment 
given to milk during different stages o f drying is severe enough to destroy most 
pathogens in milk, though some thermophilic organisms can survive, e.g. 
thermophilic sporeformers. The microbiological properties o f a powder are defined 
in terms of (i) absence o f pathogenic organisms; (ii) absence of food spoilage 
organisms and (iii) a maxima o f plant hygiene indicators (Early, 1992).
1.3.2.3 Physical properties
The physical properties o f a milk powder are varied and important in influencing the 
shelf-life o f the powder and the handling characteristics. They include (i) moisture,
(ii) bulk density, (iii) insolubility index and (iv) scorched particles. Free moisture 
content is the most important physical property o f a powder, with an optimum of 3-4 
% being desirable in whole milk powder. Water can influence the chemical 
reactions in milk powder in various ways (Van Mil and Jans, 1991). It plays a role 
in controlling the oxidation in foods (Karel, 1980) and in the promotion of Maillard 
reactions (Lingnert and Hall, 1986). Bulk density is defined as the measure of a 
given volume o f powder, usually expressed as g/cm3 or kg/1. The importance o f 
bulk density is primarily one o f economics, since a high bulk density powder will 
give benefits in packing, storage and transport. The bulk density of powder is 
dependent on the interstitial air in the powder and the particle density. The more 
interstitial air in a powder, the lower the bulk density. By producing a powder with
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wide particle size distribution, smaller particles can pack between larger particles, 
such that the bulk density is increased. This can be achieved by drying from high 
solids o f the concentrate. High particle density is also important in achieving a high 
bulk density. To achieve a high particle density the incorporation o f air into the feed 
concentrate must be avoided by avoiding agitation of the concentrate prior to drying 
(Bloore and Boag, 1982). Bulk density should be taken into account when planning 
the quantity of wrapping used in storage o f whole milk powder (Tuohy, 1984). 
Solubility is important for most applications as milk powders are reconstituted in 
water and are therefore required to be highly soluble. However, even spray-dried 
powders will contain a small amount o f insoluble material, which may be expressed 
and measured in terms of an index (ADMI, 1971). Traditionally the term solubility 
index has been used but, since insoluble material is being measured, insolubility 
index is more accurate (Early, 1992). Scorched particles consist principally of 
burned powder deposits within the drying chamber, particularly around the atomiser 
and air dispenser. Scorched particles are undesirable in milk powders due to the 
‘burnt’ flavour and poor appearance.
1.3.2.4 Functional properties
Spray-dried products are manufactured for the consumer market or for further 
processing. Depending on their further application, they need to possess a number 
o f functional properties, such as wettability, flowability and whey protein nitrogen 
index (WPNI) (Boersen, 1990). The latter is one of the most important functional 
properties o f whole milk powder. Before 1967, milk powder manufactured in 
Ireland was o f an undefined heat treatment classification (O’Sullivan and O ’Connor, 
1971). Since then, however, the Irish milk powder industry has become more 
sophisticated in it’s manufacturing activities, and hence the need for various heat 
classifications o f milk powders. The heat-class of milk powders is defined by the 
extent o f  denaturation of the globular heat-labile whey proteins during the pre­
heating stage. Thus the degree o f heat treatment can be quantified by measuring 
suitable changes which occur on denaturation of these whey proteins. The standard
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method in use is the undenatured whey protein nitrogen index (WPNI) (ADMI, 
1971).
1.3.2.5 Organoleptic properties
A major aspect o f the quality of whole milk powder is its sensory quality, which 
may be defined as the colour and flavour o f the powder (Van Mil and Jans, 1991). 
The organoleptic properties o f a milk powder are dependent on the composition of 
the powder, the quality o f the raw materials and the effects o f processing such as 
heat treatment and storage. Storage has a significant impact on organoleptic quality 
and while whole milk powder containing milkfat may have a typically sweet milk 
flavour at the point o f production, after a period of storage rancid flavours may 
become predominant. The type o f packing and storage conditions significantly 
contribute to reduction/prevention o f the rate o f flavour changes in many powders 
(Tuohy, 1987; Van Mil and Jans, 1991; Chan et al, 1993). Additionally, milkfat and 
lactose may easily absorb and adsorb taints, respectively, from the environment, a 
characteristic which emphasises the importance o f impermeable packaging and clean 
hygienic storage conditions. Severe heat treatments, such as those employed in the 
manufacture o f high-heat powder and heat-stable skimmed milk powder will induce 
the production o f Maillard reaction products, resulting in typical cooked/carmelised 
flavours (Lingnert and Hall, 1986).
1.3.3 Fat in whole m ilk powder
Whole milk powder, having a legally defined minimum fat content o f 26-28 % is 
prone to oxidative deterioration and requires sophisticated drying and packing to 
minimise autoxidation of lipids during storage. Many researchers have observed 
that only part o f the fat in whole milk powder can be extracted by fat solvents under 
standardised conditions. This fat is usually termed ‘free fat’ or extractable fat 
(Buma, 1971a and b) and can be defined as non-globular fat (Fox, 1991). It is 
usually expressed as % weight o f the powder or as % o f total fat content. Roller- 
dried homogenised whole milk powder was reported to have a free fat content as 
high as 85-95 % of total fat, much o f the free fat being located on the surface o f the 
powder particles (Tuohy, 1987) whereas spray-dried homogenised whole milk
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powder had free fat levels of only 2.2-7.5 % total fat. Free fat has been reported to 
be more readily oxidisable than non-extractable fat (Chan, 1992). In milk powders, 
the lipid phase can be distributed differently in the powder particle; encapsulated 
inside the powder particles or spread at the particle surface (Buma, 1971 a). Granelli 
et al. (1996) investigated the influence of surface fat on cholesterol oxidation in 
stored model food systems. They used powders with 75 %, 50 % and 25 % surface 
fat, and found that the powder with the highest surface fat had the largest level of 
COPs after 6 months storage. In contrast, on storage, no correlation was found 
between free fat, defined as solvent extractable fat, and the amount of COPs formed. 
Although surface fat is a form o f free fat, Granelli et al. (1996) found no correlation 
between the actual surface coverage o f fat and the free fat. This is consistent with 
previous observations made by Buma (1971 b) where no correlation between free fat 
and the development of oxidation flavour in whole milk powder was observed.
1.4 L IPID  OXIDATION
Lipid oxidation leading to rancidity has long been recognised as a problem 
associated with the storage o f fats and oils (Gray and Monahan, 1992). Lipid 
oxidation refers to a series of basic chemical reactions involving polyunsaturated 
fatty acids and/or cholesterol that occur in bulk fats and oils generally resulting in a 
deterioration in quality. Lipid peroxidation is the equivalent term found in 
biochemical and medical literature to describe oxidative deterioration of unsaturated 
lipids as it occurs in cells and tissues in vivo (Halliwell and Chirico, 1993; Rice- 
Evans and Gopinanthan, 1995). The interest in lipid oxidation in the last 10-15 
years can be attributed in large to the accumulating evidence that free radicals and 
reactive oxygen species participate in tissue injuries and diseases (Halliwell and 
Chirico, 1993; Halliwell, 1994; Sevanian and Peterson, 1986).
1.4.1 M echanism  of Lipid Oxidation
Several reviews of the chemistry o f lipid oxidation have been published in the last 
decade (Chan, 1987; Grosch, 1987; Frankel, 1991; O ’ Connor and O ’Brien, 1994). 
It is essentially a free radical chain reaction involving initiation, propagation and 
termination stages.
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A free radical is simply defined as any species capable o f independent existence that 
contains one or more unpaired electrons (Halliwell and Chirico, 1993). Examples of 
free radicals are superoxide (0 2’ ), hydroxyl (’OH), singlet oxygen (' 0 2) and nitric 
oxide (NO’ ). High energy irradiation o f aqueous solutions produces highly reactive 
OH’ that can attack all biological molecules, including membrane lipids. The 
superoxide radical is not very reactive by itself, but its reactivity can be amplified by 
a number o f agents such as nitric oxide, or by interaction of hydrogen peroxide with 
haem proteins, transition metal ions or myeloperoxidase (Rice-Evans and 
Gopinathan, 1995). Ground state oxygen may be activated to singlet state oxygen 
by electron excitation. The oxygen activated to the singlet excited state reacts much 
more readily with unsaturated lipids than ground state oxygen.
Lipid oxidation is initiated by the abstraction of a hydrogen atom from a methylene 
group o f a polyunsaturated fatty acid.
-C H 2 - + ’OH ---------------------
methylene group hydroxyl radical
This initial H abstraction is defined as first chain initiation
Initiators in food systems may be UV light, transition metal ions and certain 
enzymes such as xanthine oxidase and lactoperoxidase. The abstraction of the 
hydrogen leaves behind an unpaired electron on the carbon. This alkyl radical tends 
to be stabilised by a molecular rearrangement to form a conjugated diene. While 
these may form cross links with eachother, by far their most likely fate under aerobic 
conditions is to combine with 0 2 to form a lipid peroxy radical (Kanner and 
Rosenthal, 1992):
—> -*C H - + H20  
carbon radical
'CH - + 0 2
carbon radical
■> - ’CHOO -
peroxy radical
This reaction with oxygen still remains the object o f much research and uncertainty. 
Some authors suggest that the oxygen must be in an excited singlet state to react 
readily with the lipid to produce a peroxy radical (ROO‘). Singlet oxygen may be 
generated by a number o f different pathways as proposed by Korycha-Dahl and 
Richardson (1980):
1. Chemical reaction between any residual hypochlorite (formed by 
myeloperoxidase) and hydrogen peroxide in milk.
H20 2 + ~OCl ----------------------------> !o 2 + H20  + Cl'
2. Chemical or peroxidase-catalysed reactions involving metalloproteins.
Peroxidase— OC1 + H20 2 -----------------------------> *02
3. Photochemical oxidation in the presence o f a sensitiser, e.g. riboflavin in milk.
4. Interaction between secondary peroxy radicals.
2 R- HCOO’----------------------------> 1Q2 + R-HC=0 + R-HCOH
5. Oxidation o f superoxide by selected oxidising agents.
Other reactive oxygen species together with active oxygen iron complexes can also 
react readily with the carbon radical to produce a peroxy radical. These peroxy 
radicals are capable o f abstracting H from another lipid molecule, i.e. an adjacent 
fatty acid side chain to form a lipid hydroperoxide and another alkyl radical.
-C H O O '-  + CH2  >  CHOOH + -* C H -
peroxy radical methylene group lipid hydroperoxide carbon radical
The latter can react with 0 2 to form another peroxy radical and so the chain reaction 
o f lipid peroxidation can continue. This is the propagation stage.
Lipid hydroperoxides are the primary products o f lipid oxidation. They are 
colorless, tasteless and odourless. They are relatively stable but decompose rapidly 
in the presence of heat or in the presence of transition metal ions, via the Fenton 
reaction, to yield a complex mixture of low molecular weight secondary breakdown
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products with distinctive odour and flavour characteristics, including alkanes, 
alkenes, aldehydes, ketones, alcohols, esters and acids. During the later stages o f 
lipid peroxidation polymerisation takes place resulting in termination:
-*CH -  + -  'C H - -----------------------------> -  C H -C H  -
2 carbon radicals cross link o f  fatty acid molecules
The chain is terminated by reactions o f free radicals to give non radical products.
An extremely important and useful route o f termination is the reaction o f free 
radicals with antioxidants (Karel, 1980), as outlined below in section 6.4.
1.4.2 Measurement of lipid oxidation products
A variety o f factors influence the relative amounts o f reaction products formed by 
lipid oxidation and a wide range o f tests, from organoleptic evaluation to physical 
and chemical methods o f various complexities have been suggested (Tuohy, 1987; 
Kanner and Rosenthal, 1992). Because sensory evaluation is subjective, chemical 
(e.g. peroxide value and thiobarbituric acid value) and physical (e.g 
spectrophotometric and chromatographic methods) measurements are also used to 
measure lipid oxidation (Rossell, 1991). The extent of lipid oxidation can be 
determined by measuring (i) losses o f unsaturated fatty acids, (ii) amounts o f 
primary oxidation products and (iii) levels of secondary oxidation products, such as 
carbonyls (Halliwell and Chirico, 1993).
1.4.2.1 Measurement of primary oxidation
Methods that measure primary changes may be classified as those that quantify the 
loss o f reactants (unsaturated fatty acids or oxygen) or the formation o f primary 
oxidation products (hydroperoxides) (Karel, 1980; Tuohy, 1987). The most widely 
used index monitor o f primary oxidation is the peroxide value (PV) test, which 
reflects the total concentration o f peroxides and hydroperoxides present in a fat 
sample (Kanner and Rosenthal, 1992). Lipid hydroperoxides do not themselves 
contribute to ‘off-flavour’ but are unstable intermediate compounds in the oxidation 
pathway. The most common method for measuring PV is based on iodometric
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titration (Loftus-Hills and Thiel, 1946) which measures the iodine produced from 
potassium iodide by peroxides present (Rossell, 1991) (Table 1.7). The PV is 
reported in units o f mEq 0 2/kg fat. Other methods such as high performance liquid 
chromatography (HPLC) may also be used for peroxide measurement (Halliwell and 
Chirico, 1993). The measurement o f peroxides is restricted by the chemical 
instability o f these compounds. Decay o f hydroperoxides can be accelerated by a 
number of factors such as increasing temperature and storage time (Gray, 1978; 
Kanner and Rosenthal, 1992).
1.4.2.2 Measurement of secondary oxidation
In situations where oxidation occurs at an accelerated rate and primary products 
rapidly decompose to stable secondary oxidation products, it may be more accurate 
to measure the secondary products as an index o f lipid oxidation which contribute to 
the rancid and other objectionable flavours (Gray and Monahan, 1992; Kanner and 
Rosenthal, 1992) (Table 1,7). One o f the most commonly applied assays is the 
thiobarbituric acid (TBA) test which is based on the reaction between secondary 
lipid oxidation products and TBA to form a pink chromagen (a [TBA]2 - 
malondialdehyde (MDA) adduct) which absorbs at 530-532 nm (Halliwell and 
Chirico, 1993). Much of the early data on the TBA test reported results in terms of 
parts per million o f malondialdehyde. However, it is more accurate to report in units 
of ‘thiobarbituric reactive substances’ (TBARS), because compounds other than 
malondialehyde also react with TBA. Csallany et al. (1984) noted that the TBA 
assay can greatly overestimate the malonadialdehyde present (as determined by size 
exclusion HPLC). The TBA or more correctly TBARS assay cannot differentiate 
between fatty acids and sterol hydroperoxides or detect many o f the secondary 
breakdown products, including all the commonly studied COPs and many o f the 
secondary and tertiary fatty acid breakdown products (Addis and Warner, 1992). In 
spite o f the many criticisms of it’s reproducibility and reliability, however the 
TBARS test remains one o f the most widely used assays for secondary lipid 
oxidation.
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Table 1.7Methods used to detect and measure lipid peroxidation.
Method Compound Detected Comments
Iodine liberation Lipid peroxides Lipid peroxides oxidise I" to I2 for titration with thiosulphate. Useful for bulk lipids (e.g. 
foodstuffs) (Loftus-Hills and Thiel, 1946).
Glutathione peroxidase (GPx) Lipid peroxides GPx reacts with H20 2 and hydroperoxides, oxidising GSH to GSSG. Addition of glutathione 
reductase and NADPH to reduce GSSG back to GSH results in consumption of NADPH, which 
can be related to peroxide content. GPx cannot measure peroxides within membranes (Guenzler 
et al., 1974).
GC-mass spectrometry Lipid peroxides and aldehydes Peroxidation products are extracted, reduced (e.g by borohydride) to alcohols, separated by GC 
and identified by MS (Halliwell and Chirico, 1993).
Spin trapping Intermediate radicals Spin traps (e.g phenyl t-butyl nitrone (PBN)) intercept radicals intermediate in the chain reaction 
(Schaich and Borg, 1980).
Light emission Excited carbonyls, singlet oxygen Self reaction of peroxyl radicals can produce excited state carbonyls and singlet oxygen: both 
species emit light as they decay to the ground state.
TBA test TBA-reactive material (TBARS) The test material is heated at low pH with TBA and the resulting pink chromagen is measured by 
absorbance at 532 nm. Most of the aldehydes that react with TBA are derived from peroxides 
and unsaturated fatty acids (Tarladgis et al., 1964).
Diene conjugation Conjugated diene structures Oxidation of unsaturated fatty acids is accompanied by an increase in UV absorbance at 230-235 
nm. Useful for bulk lipids and LDL .
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Feeding trials using oxidised fats and oils have provided ample evidence that lipid 
oxidation products pose significant biological effects (Peng and Taylor, 1984). In 
support of this, a wide spectrum of adverse health effects have been produced in 
animals fed highly oxidised oils. These include diarrhoea, loss o f appetite, growth 
retardation, cardiomyopathy and haemolytic anemia (Sanders, 1983). Severely 
processed oils contain more oxidised products (hydroperoxides and secondary 
products) than realistic frying conditions (Kubow, 1990). Thus, it is not surprising 
that the magnitude o f these symptoms may be influenced by the degree of 
processing and on the type o f oil and food used. Mildly oxidised oils have been 
reported to induce altered fatty acid composition o f tissue lipids (Yoshida and 
Kujimoto, 1989), elevated levels o f lipid peroxides in chylomicrons (Naruszewicz et 
al., 1987), inhibition of prostacylclin production (Ross, 1986), elevated rates of 
thromboxane A2 production by platelets and high thromboxane:prostacyclin ratios 
(Giani et al., 1985), suggesting a relationship between diets containing oxidised fats 
and conditions predisposing to atherosclerosis. Other studies were carried out which 
showed that linoleic acid hydroperoxide induced endothelial damage and accelerated 
the uptake o f LDL by cultured arterial smooth-muscle cells (Addis and Warner, 
1992). Fatty acid hydroperoxides have been shown to accelerate all three phases of 
atherosclerosis: (i) endothelial injury, (ii) accumulation o f plaque and (iii) 
thrombosis (Yagi, 1988). Higher serum levels of lipid peroxides were observed in 
animals and patients with atherosclerosis than in those with no clinical evidence of 
atherosclerosis (Kubow, 1990). Yagi (1988) investigated the possible atherogenic 
effects of fatty acid hydroperoxides. Using the TBA methodology, he reported that 
serum peroxide levels increased with age, and that levels in diabetic patients with 
angiopathy exceeded levels in diabetics without angiopathy. Malondialdehyde, a 
major secondary product of lipid peroxidation is present in many foods (Siu and 
Draper, 1978). Since it is a bifunctional aldehyde, it is a very reactive compound 
and has been found to take part in cross-linking with DNA and proteins (Addis,
1986). Chronic toxicity studies of orally administered malondialdehyde have
1.4.3 Biological significance of lipid oxidation products
35
revealed dose-dependent pathological changes in liver (Siu and Draper, 1978). The 
toxic effects o f oxidised lipids have been attributed to an imbalance between the 
oxidative deterioration o f ingested oils and the capacity o f the antioxidant defense 
system (Chow, 1979). Many o f these symptoms could be prevented by vitamin E or 
synthetic antioxidants (Kubow, 1990). Vitamin E is mainly involved in scavenging 
free radicals and stabilising cell membranes by protecting membrane 
polyunsaturated fatty acids (Rifici and Khachadurian, 1993).
An increased concentration of end products o f lipid peroxidation is the evidence 
most frequently reported for the involvement o f free radicals in human disease. 
However, such evidence is indirect because epidemiological studies that relate lipid 
oxidation to cancer or cardiovascular disease concern antioxidant status rather than 
lipid oxidation directly. For example, the World Health Organisation MONICA 
study (1985-1991), set up to monitor risk factors for coronary heart disease showed 
that antioxidant potential (plasma levels o f vitamin C, beta-carotene, vitamin A, 
vitamin E and selenium) was higher in areas of low coronary heart disease (CHD) 
mortality than in areas o f  high CHD mortality (Gey et al., 1991).
1.5 C H O LE S TE R O L O X ID A T IO N
Cholesterol, an unsaturated lipid, undergoes oxidation leading to chemically labile 
hydroperoxides. These peroxides are readily decomposed to form cholesterol 
oxidation products (COPs). Various food processing and storage treatments can lead 
to oxidation o f cholesterol in the presence o f oxygen, heat, light or radiation. 
Although more than 70 such oxidation products have been identified (Smith, 1981; 
Smith et al. 1981; Smith et al., 1982), only approximately eight have been detected 
in food (Sander et al., 1989; Paniangvait et al., 1995). Among the major COPs in 
foodstuffs are 25-hydroxycholesterol, cholestanetriol, hydroxycholesterol 
derivatives, a -  and p-epoxides and 7-ketocholesterol whose presence in the diet may 
have a number o f potentially negative health implications (Emanuel et al., 1991). 
Several studies have implicated COPs in the pathogenesis atherosclerosis, 
carcinogenesis, mutagenesis and cytotoxicity (Bosinger et al., 1993). Much of the
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research regarding cholesterol oxidation in foodstuffs has focused on eggs, cheese 
and dairy spreads (Tsai and Hudson, 1984; Morgan and Armstrong, 1992; Nielsen et 
al., 1995). Recently however, a number o f studies have reported levels o f COPs in 
whole milk powder (Nourooz-Zadeh and Appelqvist, 1988; Van de Bovenkamp et 
al., 1988; Sarantinos et al., 1993; Chan et al., 1993; Rose-Sallin et al., 1995). These 
studies have shown that while no detectable levels o f COPs are evident in freshly 
prepared milk powders, aged products contain varying amounts, the levels o f which 
are dependent on a number o f factors, including drying technology and storage 
conditions. The work o f Nourooz-Zadeh and Appelqvist (1988) has shown that 
while fresh milk powders prepared by spray-drying in a low-medium heat process 
exhibited no detectable levels o f COPs, high-heat powders contained higher levels
(2.8 ppm). Although systematic storage studies were not undertaken, results 
indicated that storage duration and conditions played a significant role in COPs 
development. While the oxidation o f fatty acids can be recognised by off-flavour, 
the oxidation o f cholesterol does not yield any flavour components. Thus, during 
storage, dry food products especially, such as milk, cheese and egg powders, may 
develop cholesterol oxides without incurring unacceptable sensory properties (Addis 
and Park, 1992).
1.5.1 Structure of cholesterol
The chemical structure of cholesterol is shown in Fig. 1.3. It has a polycyclic 
nucleus with four fused rings, a branched aliphatic side-chain attached to the D ring 
at C-17 and a hydroxyl group that is attached to C-3 of the A ring. O f relevance to 
autoxidation are the B ring unsaturation and positions allylic to it and the presence of 
two tertiary carbons (C-20 and C-25) in the side-chain (Smith, 1981).
Fig. 1.3 Structure o f Cholesterol (Adopted from Nourooz-Zadeh, 1988).
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1.5.2 Mechanism of cholesterol oxidation
Cholesterol is an unsaturated compound which readily undergoes autoxidation in the 
presence o f molecular oxygen, light and metal ions through a free radical reaction 
(Bergstrom and Samuelsson, 1961; Fioriti and Sims, 1967). The initiation process 
whereby cholesterol reacts with ground state oxygen remains unclear.
Two mechanisms have been proposed: intermolecular oxidation where hydrogen is 
abstracted from cholesterol by peroxy or oxy radicals o f oxidised neighbouring 
polyunsaturated fatty acids in membranes, or intramolecular oxidation where the 
oxidised fatty acyl portion attacks the cholesteryl portion o f the same cholesteryl 
ester molecule (Maerker, 1987). In view of the trace amounts o f cholesteryl esters in 
milk lipids, it is probable that the former system pathway predominates during 
cholesterol oxidation in milk.
Cholesterol oxidation may be initiated by hydrogen abstraction by peroxy or oxy 
radicals o f  oxidised neighbouring polyunsaturated fatty acids (Smith, 1987). This is 
followed by reaction with ground state oxygen ( 0 2) and the formation of peroxy 
radicals as described in Fig 1.4. The abstraction of the H atom predominantly occurs 
at position C-7. The attack at C-4 seldom takes place due to the influence o f the 
hydroxyl group at C-3 and trialkyl substituted C-5 (Smith, 1980; Maerker, 1987). 
Subsequently, the chain reaction proceeds when the 7-peroxy radical is stabilised to 
yield the epimeric cholesterol hydroperoxides. The epimeric cholesterol 7- 
hydroperoxides are decomposed to the 7a- and (3-hydroxycholesterols, respectively 
(Smith, 1980). Thermal degradation o f the epimeric cholesterol 7-hydroperoxides 
leads to the formation o f 7-ketocholesterol.
The cholesterol epoxides are secondary products and are formed from the interaction 
o f cholesterol with sterol hydroperoxides and other oxidising agents (Nourooz- 
Zadeh, 1988). The ratio o f cholesterol-p-epoxide to cholesterol-epoxide formed in 
solvent and dispersions is governed by the oxidising agent and pH (Smith, 1981).
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Hydration o f either o f the cholesterol epoxides results in formation of 
cholestanetriol.
Hydrogen abstraction can also take place at the two tertiary carbons in the side- 
chain, namely at C-20 and C-25 in solid-phase or crystalline cholesterol but is not 
observed in autoxidations carried out in solution or in aqueous dispersions (Maerker,
1987). Thermal decomposition o f the side-chain hydroxyperoxides leads to the 
corresponding 20a- hydroxy and 25-hydroxycholesterol.
Varying oxidation products o f cholesterol are formed, depending on the oxidising 
agent used. In the presence o f the hydroxyl radical ( OH), cholesterol undergoes 
autoxidation through a non-peroxidic reaction yielding certain oxides, namely the 
isomeric epoxycholesterols, the epimeric hydroxycholesterols and 7-ketocholesterol 
as the major products (Ansari and Smith, 1979).
Reaction o f cholesterol with singlet oxygen ( '0 2) occurs via a cyclic ene reaction 
mechanism with cholesterol a-hydroperoxide as the major product, which is rapidly 
decomposed to the corresponding hydroxycholesterol (Smith et al., 1973). Table 1.8 
summarises the major COPs found in food by both their common and systematic 
names.
1.5.3 Measurement of COPs
The presence o f COPs (oxysterols) in food has been of interest during the last 
decade as a result o f an increasing concern about a possible role for oxysterols in the 
initiation o f atherosclerosis (Peng and Taylor, 1984; Steinberg et al., 1989) and 
cancer (Addis and Warner, 1992; Rice-Evans, 1994). Based on a number o f studies 
(Nourooz-Zadeh and Appelqvist, 1988; Van de Bovenkamp et al., 1988; Sarantinos 
et al., 1993; Chan et al., 1993; Rose-Sallin et al., 1995) the most abundant COPs 
found in aged whole milk powder are the 7-hydroxy derivatives, the 7-keto 
derivatives and the epoxides. There are, however, large discrepancies among the 
reported values for COPs in these products (Table 1.9). Variations in temperature,
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light and oxygen availability during sample handling may contribute to artefact 
formation (Smith, 1981).
Table 1.8 Common and Systematic Names of Common Oxysterols Found in Food.
Common Name Systematic Name
Cholesterol Cholest-5-en-3p-ol
7a-hydroxycholesterol Cholest-5-ene-3 p-7a-diol
7p-hydroxycholesterol Cholest-5-ene-3p-7P-diol
19-hydroxycholesterol Cholest-5-ene-3 P-19-diol
2 5 -hydroxycholesterol Cholest-5-ene-3 P-25-diol
Cholestanetriol Cholestane-3 P-5a-6 p-triol
Cholesterol-a-epoxide 5,6-a-epoxy-5a-cholestane-3 P-ol
Cholesterol-p-epoxide 5,6-P-epoxy-5a-cholestane-3p-ol
7-Ketocholesterol 3P-hydroxy-cholest-5-en-7-one
Table 1.9 Typical levels o f COPs found in a variety o f milk powders.
Pow der Type H eat Analytical Total COPs Reference
Class M ethod (ppm)
Whole milk High GC-MS* 2.8 Nourooz-Zadeh
powder (fresh) and Appelqvist, 
(1988)
Skim milk Low GC-MS N.D. Nourooz-Zadeh
powder (fresh) and Appelqvist, 
(1988)
Whole milk Low GC-FID** 200 ppm Chan et al. (1993)
powder (stored)
Full fat cream Unknown GC-MS 4 ppm Rose-S allin et al.
powder (stored) (1995)
* GC-MS: Gas Chromatography with Mass Spectrum Detection 
**GC-FID: Gas Chromatography with Flame Ionisation Detection
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Fig. 1.4 Autoxidation pathways of cholesterol (Paniangvait et al., 1995)
Cholesterol
Cholestaneiriol
7-Hydroperoxide
In addition, stability o f COPs is greatly influenced by pH (Kim and Nawar, 1991). 
A variety of analytical methods are in use including HPLC with UV detection 
(Ansari and Smith, 1979; Sallin et al., 1993) and capillary GC (Park and Addis, 
1985a), which in conjunction with GC/MS is a powerful approach for 
identification/confirmation (Rose-Sallin et al., 1995) at low limits o f detection with 
high specificity (Nielsen et al., 1995). In view of the potential negative health 
impact o f  oxysterols from foods, any discrepancies in the levels o f COPs reported in 
food arising from methodology is o f major concern with regard to consumer health. 
A standardized method for quantification o f oxysterols has yet to be established 
(Appelqvist, 1996).
1.5.4 Biological significance of COPs
There is growing interest and concern regarding the potential health implications of 
COPs in the diet. The effects in humans o f chronic ingestion o f normal dietary 
levels o f these products are not known (Emanuel et al., 1991; Addis and Warner, 
1992). Research on possible postprandial absorption o f many specific lipid 
oxidation products is extremely limited. Bascoul et al. (1986) reported that dietary 
cholesterol a-epoxide was absorbed by the rat and Emanuel et al. (1991) has found 
COPs in human plasma after ingestion o f COPs. However, several studies 
performed both in animal models (Erickson et al., 1977; Jurgens et al., 1987) and in 
isolated cellular systems (Kandutch and Chen, 1977; Baranowski et al., 1982; Clare 
et al., 1995) have demonstrated the potential of COPs to produce adverse effects. 
Several studies have implicated COPs, in particular 25-hydroxycholesterol and 
cholestanetriol, as the cause o f atherosclerotic lesions (Imai et al., 1976; Taylor et 
al., 1979). a -  Epoxycholesterol has been reported to be mutagenic and cytotoxic in 
vitro (Sevanian and Peterson, 1986) and has been detected in UV- induced skin 
tumours in experimental animals (Black and Douglas, 1973). COPs have direct 
toxic effects on membrane structure and function by their ability to displace 
cholesterol (Peng et al., 1979) and thereby alter membrane fluidity (Santillan et al., 
1982). Recent studies on smooth muscle cells in vitro have shown that 
cholestanetriol can displace cholesterol from the cell membrane which may explain
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it’s cytotoxic nature (Mahfouz et al., 1995). Because atherosclerosis has long been 
directly related to cholesterol (Steinberg et al., 1989), the rest o f this section will 
discuss the current status of the involvement of oxysterols in atherosclerosis. 
Studies implicating toxicological activities of oxysterols will be discussed in 
Chapter 6.
1.5.4.1 Effects of COPs on atherosclerosis
Literature on atherosclerosis is dominated by two compelling hypotheses: the 
‘response to injury hypothesis’ and the ‘lipid hypothesis’ (Addis and Warner, 1992). 
The response to injury hypothesis proposes that the disease is essentially a response 
o f the vessel wall to injury and although it plays an important role in lesion 
progression, the deposition of lipid is a secondary phenomenon (Addis and Park
1989). The lipid hypothesis, on the other hand, suggests that atherosclerosis is 
caused by hypercholesterolaemia-induced deposition of lipid in vessel walls. It 
implicates cholesterol and not oxidised cholesterol or other oxidised lipids. The 
atherogenicity o f cholesterol is believed to be due to the contaminating COPs and 
not cholesterol per se. Pure cholesterol, in spite o f being able to induce 
hypercholesterolaemia has not been found to be atherogenic or angiotoxic, even in a 
sensitive animal such as the rabbit (Taylor et al, 1979) or in in vitro model systems 
(Clare et al., 1995). On the other hand, small amounts (10-250 ppm) of COPs have 
shown significant toxicity to many cell lines including vascular endothelial and 
smooth muscle cells (Peng et al., 1978; 1979). Although dietary cholesterol has 
long been considered a contributory factor to atherosclerosis in humans (Addis and 
Park, 1989), more recent studies have indicated a possible role o f COPs in the 
initiation o f atherosclerotic plaque formation (Kumar and Singhal, 1991).
Several possibilities exist with regard to the mechanism of oxysterol-induced arterial 
endothelial damage. Firstly COPs are far more inhibitory to cholesterol biosynthesis 
than cholesterol itself (Kandutch and Chen 1977, Clare et al., 1995). Inhibition of 
the rate-limiting enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl 
coenzyme A (HMG-CoA) reductase, may render cells deficient in cholesterol, a key
43
cellular component (Smith and Johnson, 1989), thereby exerting cellular injury 
(Addis and Park, 1989). Other biological activities of COPs possibly relevant to 
atherosclerosis include the ability of COPs to inhibit 5’-nucleotidase activity (Peng 
et al., 1985), thereby inhibiting the ability o f endothelial cells to replicate and enable 
cell repair.
Epidemiological evidence also exists showing that oxidised cholesterol may be 
related to coronary heart disease. Jacobson (1987) noted that Indian immigrants in 
London and Trinidad had a 1.5-2.0 times higher rate of CHD than average, a rate 
which cannot be explained on the basis o f accepted risk factors. Both populations 
consume clarified butter oil (‘ghee’) in cooking. Jacobson (1987) noted there were 
substantial amounts o f COPs in ghee, but not in fresh butter. A number o f studies 
have been reported that give support to the concept that COPs (in particular triol, 
epoxide, 25-OH and 7-hydroxyderivatives) are injurious agents capable o f initiating 
atherosclerosis. Calcium accumulation in the aorta o f white cameau pigeons has 
been reported to be involved in the pathogenesis o f atherosclerosis (Jacobson et al.,
1985). Calcium can accumulate as a result o f induced membrane disruption by 
COPs which disturbs normal ionic homeostasis. Krut (1982) demonstrated that 7a-, 
7p- and 25-hydroxycholesterol were effective in solubilizing cholesterol, indicating 
a possible role for oxysterols in inhibiting atherosclerosis by preventing the 
crystallisation o f cholesterol in tissues. However, the majority of studies in this area 
o f research suggest that COPs are more atherogenic than their native sterol 
counterpart.
Carpenter et al. (1993) analysed lipids and oxidised lipids in samples o f human 
atheroma (necrotic gruel from the interior o f advanced atherosclerotic plaques in the 
aorta) and normal human aorta by GC and GC-MS, and detected significantly higher 
amounts o f 26-hydroxycholesterol and 7a-hydroxycholesterol in all atheroma 
relative to normal aorta. It is well established that LDL plays a pivotal role in the 
progression of atherosclerosis, primarily by promoting the accumulation o f lipid in 
the lesion (Steinberg et al., 1989). LDLs are a metabolic end point for apo B-
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containing lipoproteins and circulate within the vascular compartment, including the 
sub endothelial space until removed by high affinity apo B receptor mediated 
endocytosis. Despite the association between hypercholesterolaemia and
atherosclerosis, rarely have researchers identified the involvement o f pure 
cholesterol in the etiological process. Rather, oxidised cholesterol, principally in 
LDL has been implicated in the etiology of atherosclerosis (Steinberg et al., 1989; 
Regnstrom et al., 1992). Oxidised cholesterol in LDL may be dietary in origin, or as 
a result o f in vivo metabolism and/or radical-induced peroxidation. Dietary sources 
o f COPs may include ingestion of aged whole milk powder (Nourooz-Zadah and 
Appelquist, 1988; Rose-Salin et al., 1995), dried egg powder (Chan et al., 1993) and 
deep-fat fried foods (Nourooz-Zadeh, 1988). In vivo metabolism may also result in 
COPs, for example, the 7cc-hydroxycholesterol formed in and secreted from liver (in 
bile acid biosynthesis) may also be formed in human plasma by leucocytes which 
possess a cholesterol 7a-hydroxylase (Sobel, 1953). COPs may also arise due to 
peroxidation in vivo by reactive oxygen species (Halliwell and Chirico, 1993). 
Exposure of LDL to reactive oxygen species chemically damages LDL creating lipid 
peroxides and ultimately protein adducts o f apo B. Oxidative modification o f apo B 
alters its ligand properties (specifically the lysine residue) and marks it for removal 
by scavenger receptors. Moreover compelling evidence gathered by Walzem et al. 
(1995) that older plasma lipoproteins are more susceptible to oxidation provides a 
linking mechanism for the lipid and oxidation theories o f atherosclerosis. Although 
the precise mechanism o f LDL oxidation in the arterial wall is not known, there is 
abundant in vitro evidence for oxidation of LDL by cells present in the vasculature 
such as endothelial cells, smooth muscle cells and monocyte/macrophages. A recent 
study carried out by Chisolm et al. (1994) using MS and NMR identified the 
principal toxin in oxidised LDL from human atherosclerotic lesions as 7P- 
hydroperoxycholest-5-en-3p-ol. It has been shown to be an intermediate in the non- 
enzymatic oxidation of cholesterol that leads to the formation o f 70- 
hydroxycholesterol, 7a-hydroxycholesterol and 7-ketocholesterol. This molecule 
accounted for approximately 90 % o f the cytotoxicity o f the lipids o f oxidised LDL.
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1.5.4.2 In vitro cytotoxicity
Cytotoxicity o f COPs to arterial smooth muscle cells and endothelial cells appear to 
have significant implications since these two cell types play major roles in the 
development o f atherosclerotic lesions. Imai et al. (1976) studied the effects of 
autoxidation products o f cholesterol which were identified and separated from 
U.S.P. (United States Pharmaceutical) grade cholesterol which had been stored at 
room temperature in the presence o f air for 5 years. The cytoxicity o f these 
autoxidation products was tested using rabbits as model systems. Aortic 
examination after 24 hours showed significant increases o f degenerative and necrotic 
arterial smooth muscle cells, whilst the aortas o f the animals fed purified cholesterol 
showed no significant differences from the controls. The minimum concentration in 
culture medium o f the most toxic compounds required to induce aortic smooth 
muscle cell death within 24 h was reported to be between 0.5 - 1 mg/dl which is 
approximately one two-hundredth o f the normal human serum cholesterol 
concentration o f 150-200 mg/dl (Peng and Taylor, 1984) suggesting that, i f  only 0.5 
% of the serum cholesterol is found to be oxidised, the aortic smooth muscle cells 
could be injured within 24 hours (Peng and Taylor, 1984). Increased acid 
phosphatase activity, indicative of cell damage, was observed when human aortic 
smooth muscle cells were incubated with different concentrations o f 25- 
hydroxycholesterol, cholesterol 5,6-epoxide or 7-ketocholesterol. Since acid 
phosphatase is a lysosomal enzyme, it’s presence is indicative o f cell damage 
(Wolinsky et al., 1975). The most toxic COP, 25-hydroxycholesterol, resulted in the 
greatest release o f acid phosphatase, and the least toxic, 7-ketocholesterol, showed 
statistically significant release at only the highest level examined (10 p-g/ml). It has 
been demonstrated both histochemically and biochemically that acid phosphatase 
activity is significantly increased in atherosclerotic lesions in humans and animal 
models (Wolinsky et al., 1975). Clare et al. (1995) found altered mitochondrial 
membrane integrity and inhibition o f HMG-CoA reductase in cultured human 
monocyte-macrophages on administration o f COPs. They found that cholesterol 
was not toxic and actually inhibited the toxicity o f 25-hydroxycholesterol. Lizard et 
al. (1996) found necrosis o f bovine aortic endothelial cells as a result o f exposure to
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COPs. It was shown that 7-ketocholesterol was the most toxic by inducing 
apoptosis in the endothelial cells treated.
1.6 P R E V E N T IO N  OF L IP ID  O X ID A T IO N
Lipid oxidation is o f great concern to the food industry because it leads to the 
development o f undesirable ‘off flavours’ and potentially toxic reaction products. 
Food manufacturers are therefore concerned with the development o f methods for 
preventing and/or retarding lipid oxidation in foods. To do this effectively, it is 
necessary to have a thorough understanding o f the mechanisms o f lipid oxidation 
(Coupland and McClements, 1996). Prevention o f both cholesterol and lipid 
oxidation in food (Pangiavait et al., 1995) can be achieved by control o f dietary, 
processing and storage conditions. Methods that have been employed to this end 
include feeding antioxidants to live animals before processing (Wahle et al., 1993; 
Monahan et al, 1990; Li et al., 1996), incorporation o f antioxidants prior to 
processing (Huber et al., 1995), low temperature or minimum temperature 
processing (Tuohy and Kelly, 1989; Chan et al, 1993), packaging with exclusion of 
0 2 (Chan et al, 1993) and low temperature and exclusion o f light during storage 
(Luby et al., 1986).
In view of the many uses for whole milk powder in the manufacture o f food products 
and it’s value as an export commodity, it is imperative that the oxidative stability of 
milk lipids is preserved during manufacturing and storage processes. A number of 
studies have shown that the process o f autoxidation in milk can be minimised or 
excluded by the use o f antioxidants, controlled processing, packing under nitrogen 
and controlled storage conditions as discussed below.
1.6.1 Processing effects
Storage stability o f dried milk is influenced by the pre-heating conditions used 
(Baldwin and Ackland, 1991; Van Mil and Jans, 1991) with higher pre-heating 
conditions leading to improved storage stability. Sulphydryl (SH) and disulphide 
(SS) groups have been widely implicated as important functional groups in many
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food proteins (Beveridge et al., 1974). Reactive or free SH groups increase with 
increased temperature and pre-heating time (Taylor and Richardson, 1980). The 
production o f SH groups, primarily from P-lactoglobulin is o f particular importance 
in whole milk powder as it has been shown to decrease the rate o f autoxidation o f fat 
by reaction with free radicals o f the unsaturated fatty acids (Van Mil and Jans, 
1991). Heat treatment of milk has been shown to increase antioxidant activity with 
increased ‘reactive’ sulphydryl groups but decreased ‘total’ sulphydryl content 
(Taylor and Richardson, 1980). The antioxidant activity o f milk has been shown to 
reside in both whey and casein proteins with the casein fraction providing the larger 
portion o f antioxidant activity, even though it contains no sulphydryl groups. Thus 
the sulphydryl groups are apparently responsible for only part of the antioxidant 
activity o f milk (Taylor and Richardson, 1980). Caseins have been reported to be 
the major protein in milk possessing antioxidant activity (Allen and Wrieden, 1982; 
Coupland and McClements, 1996). This antioxidant activity may be related in part 
to their hydrophobic nature and orientation o f side chains o f constituent amino acids 
at the lipid interface (Taylor and Richardson, 1980, Ericksson, 1982). Allen and 
Wrieden (1982) reported that the antioxidant activity of casein derives from its 
ability to bind metals to its phosphoseryl residues. The binding of metals generally 
inhibits their catalytic effect on autoxidation.
The rate o f lipid autoxidation in air is highly temperature-dependent, the reaction 
rate has been shown to double with a 10° C rise in temperature (Walstra and Jenness, 
1984; Tuohy, 1987; Chan et al., 1993). In parallel, higher temperatures also favour 
the Maillard reaction, some products o f which have antioxidant activity (Lingnert 
and Hall, 1986; Vamam and Sutherland, 1994). Various Maillard products formed 
through the interaction o f proteins and carbohydrates during the heat-processing of 
foods are reported to retard the development o f rancidity (Baldwin and Ackland,
1991). The formation of brown pigments was first observed by the French chemist, 
Louis Maillard (1912), following the heating of a solution o f glucose and lysine. 
This reaction was subsequently referred to as the Maillard reaction and essentially 
covers all those reactions involving compounds with amino groups and carbonyl
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groups present in foods. These include amines, amino acids, and proteins interacting 
with sugars, aldehydes, and ketones, as well as the products of lipid oxidation
(Eskin, 1990).
1.6.2 Control of oxygen
Lipid oxidation reactions can be retarded by reducing the concentration o f oxygen in 
the food, for example by packing foods under vacuum or nitrogen. Tamsma et al. 
(1961) reported a statistically significant (p < 0.05) improvement in storage stability 
of whole milk powders packed in inert gases containing 0.1 % oxygen compared 
with those packed at 1 % oxygen level and that oxygen was depleted to less than 
0.001 % within 24 hours in packed milk powder using a scavenging system of 95 % 
N2, 5 % H2 and a platinum catalyst (Tamsma et al., 1967). Abbot and Waite (1962) 
reported that a mixture o f 90 % N2 and 10 % H2 in the presence o f palladium 
catalysed the formation of water from the H2 and residual oxygen to produce an 
almost oxygen-free atmosphere in the pack. Chan et al. (1993) observed that oxygen 
absorbers effectively controlled lipid and cholesterol oxidation over 6 months 
storage at 20° C.
1.6.3 Control of Storage Temperature
Higher storage temperatures have led to increased levels o f oxidation in milk 
powders (Tuohy, 1987; Chan et al., 1993, Huber et al., 1995). Boon (1976) 
subjected whole milk powders to storage temperatures o f 22° C and 37° C and found 
that a significantly greater oxidative deterioration was noted at 37° C compared with 
22° C. Tuohy and Kelly (1981) found only a very slight decrease in the quality of 
whole milk powder stored at 20° C compared to 12° C, whereas they observed 
significantly greater TBARS values after 24 weeks of storage at 37° C compared to 
12° C. Similarly Chan et al. (1993) found a marked increase in TBARS and COPs 
levels in whole milk powder when stored at 40° C compared to storage at 20° C.
1.6.4 Antioxidants
Antioxidants are defined by the United States (U.S.) Food and Drug Administration 
(FDA) as substances used to preserve food by retarding deterioration, rancidity, or
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discoloration due to oxidation (Dziezak, 1986). Their inhibitory effect has been 
attributed to their donation o f electrons or hydrogen to a fat containing a free radical 
and to the formation o f a complex between the antioxidant and the fat molecule 
(Stuckey, 1972). No single antioxidant offers the definitive answer to oxidative 
deterioration for all food products. The selection of the appropriate antioxidant 
appears to be determined by compatibility with and resulting effectiveness in certain 
fats, i.e. it’s solubility in the fat or water phase o f the product, good dispersibility 
throughout the food and it’s ‘carry through’ potential post processing (Dziezak,
1986). Important antioxidants used in foods include the tocopherols, as well as the 
synthetic antioxidants, butylated hydroxy anisol (BHA), butylated hydroxy toluene 
(BHT), propyl gallate (PG) and tert-butylhydroquinone (TBHQ) (Karel, 1980). 
However, addition o f antioxidants to whole milk during processing is not permitted 
in Ireland (O’ Shea, 1996, personal communication). Therefore the most favourable 
way o f increasing antioxidants in food is by dietary means. This has previously 
been carried out in milk (Dunkley et al., 1967; King, 1968); pork (Monahan et al., 
1990; 1992) and eggs (Li et al., 1996).
1.6.4.1 Vitam in C
Vitamin C (ascorbic acid) occurs widely in plant tissues. The role o f vitamin C in 
mammalian physiology and biochemistry is far from fully understood (Coultate, 
1984). It has been implicated in a number o f reactions, particularly in the formation 
o f hydroxylysine from the parent amino acids after their incorporation into the 
polypeptide chain o f collagen (Coultate, 1984). Vitamin C, being a strong reducing 
agent, also functions as a free radical scavenger and in the regeneration o f a - 
tocopherol (Halliwell, 1994). In fruit and vegetable products, notably dehydrated 
potato, it is used as an antioxidant to prevent the browning reactions that would be 
catalysed by phenolase. In cured meat products, it is used as a reducing agent to 
lower the concentration o f nitrite needed and is also used as a flour improver 
(Coultate, 1984).
Vitamin E, the generic term for a group o f eight soluble substances, four tocopherols 
and four tocotrienols was discovered by Evans and Bishop (1922). The name 
‘tocopherol’ comes from the Greek word ‘tocos’ meaning childbirth and the Greek 
verb ‘phero’ meaning to bring forth (Shukla, 1990). The members o f each o f the 
tocopherols and tocotrienols are designated a , (3, y and 8, depending on the number 
and position o f the methyl groups attached to the chromanol ring. Fig 1.5 shows the 
structure and properties o f the tocopherols and tocotrienols. The side chain is 
saturated in the tocols and unsaturated in the tocotrienols (Schuler, 1990). The 
chromanol rings o f a-tocopherol and a-tocotrienol molecules fit like pieces o f a 
jigsaw into cell membranes, leaving the phytol chains free. Tocols with differently 
methylated chromanol rings do not fit into the available space. Hence only a -  
tocopherol and a-tocotrienol molecules have antioxidant properties in vivo (Rice and 
McMurray, 1983). The most important structural feature o f  a-tocopherol is the 
hydroxyl group and three methyl groups on the chromanol ring which confer on the 
molecule its activity as a biological antioxidant by allowing it to fit into the cell 
membrane (Rice and Kennedy, 1986). Use of the rat fetal resorption assay for 
vitamin E has established that the relative order of bioactivity o f the tocopherols is a  
>P > y > 8 (Bunyan et al., 1961). The tocotrienols are much less abundant and, of 
these, only the a -  and P- tocotrienols have been tested for antioxidant properties. 
The a -  form is the most active, but it is substantially less active than it’s tocopherol 
counterpart (Burton, 1994). The structure of the a-tocopherol molecule renders it a 
highly effective chain breaking antioxidant that readily donates the hydrogen atom 
from the hydroxyl group to free radicals which then become unreactive.
1.6.4.2 Vitamin E
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Fig. 1.5 Structure and properties o f Tocols and Tocotricnols (Adopted from 
Schuler, 1990).
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1
a-Tocopherol (AH2) functions as a chain-breaking antioxidant. The antioxidant 
activity o f  a-tocopherol is mainly based on the ‘tocopherol-tocopherylquinone redox 
system’(Fig. 1.6).
1.6.4.2.1 Mechanism of action
HjO 2[H]
 L .
•n r~ r
H20  2(H]
or-tocophero l
o o  c I6h „
H
aM o co p h e ry lq u in o n e
(stab le)
Fig. 1.6 a-Tocopherol-tocopherylquinone redox system (Adopted from Schuler, 
1990).
a-Tocopherol (AH2) transfers its H  atom to a lipid peroxy radical (R"), converting it 
to a regenerated molecule (RH). The reaction of a-tocopherol with a peroxy radical 
is faster than the reaction o f a peroxy radical with another polyunsaturated fatty acid
group. Thus a small amount o f a-tocopherol can protect a large amount o f
polyunsaturated lipid (Burton, 1994).
R ' + AH2 ------------------- > RH + AH ’
peroxy radical regenerated lipid
Eventually, the tocopheryl semiquinone radical (AH’) may react with another 
tocopheryl semiquinone radical to form one molecule o f tocopherylquinone (A) and 
a regenerated molecule o f tocopherol (AH2).
A H '+ A H '------------------- > A + AH2
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Each molecule o f a-tocopherol can scavenge only two radicals before undergoing 
regeneration. Therefore, at times o f high oxidative stress, the local supply may be 
exhausted. Fortunately, the radicals are readily reduced to a-tocopherol by ascorbic 
acid (vitamin C) or other aqueous oxidants (Karel, 1980; Duthie, 1991) as shown 
below in Fig. 1.7.
L O O - - T o c o p h e r o l Y
L O O H  v  t f - T o c o p h e r o l '
G S -  — >  G S S G  
A s c o r b i c  a c i d  ■
G S H
A s c o r b i c  a c i d
Fig. 1.7 Regeneration o f a-Tocopherol by Ascorbic acid (Adopted from Schuler,
1990).
1.7 C O NC LUSIO NS
Evidence has emerged in recent years that dietary lipid oxidation products (lipid 
peroxides, malondialdehyde and COPs) may be quite injurious to health. The aim of 
the work outlined in this thesis was to determine the influence of animal feeding 
regimen and processing on lipid and cholesterol oxidation in stored whole milk 
powders. In particular, the effects o f pre-heating, packing and storage conditions on 
primary and secondary oxidation products of lipid and cholesterol were investigated 
in whole milk powder derived from dietary restricted and supplemented animals. In 
addition, an in vitro system was set up to monitor the effects of COPs on biomarkers 
o f cell function and integrity. This thesis contains four main sections as follows: 
the first section investigates the development of a method for COPs analysis in 
whole milk powders (Chapter 2); the second and third sections deal with the 
nutritional and processing factors that affect lipid and cholesterol oxidation in whole
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milk powders (Chapters 3 and 4) and the fourth section of the study describes the 
effects o f COPs found in cell culture studies (Chapter 5).
1.8 AIMS
To evaluate the effects of animal feeding regimen and processing technology on the 
oxidative stability o f lipids and cholesterol in fresh and stored whole milk powders. 
The second stage o f this work was to evaluate the effects of COPs on biomarkers of 
cell function and integrity.
1.9 O B JECTIVES
• To establish and validate a GC method for the accurate detection and 
quantification o f cholesterol oxidation products (COPs) in whole milk powder.
• To evaluate the effect of supplementary concentrate feeding on lipid oxidation in 
whole milk powder.
• To assess the effects of processing, packing and storage conditions and the use of 
natural antioxidants on lipid and cholesterol oxidation and on the flavour 
stability o f whole milk powder during storage.
• To investigate the toxicity of COPs found in whole milk powder and the 
protective effect o f a-tocopherol in porcine ovarian granulosa cells.
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CH APTER 2
V A L ID A T IO N  OF A GAS C H R O M A T O G R A P H IC  M E T H O D  
FO R COPS D E T E R M IN A T IO N  IN  M IL K  PO W D ER
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COPs share very similar chemical structures, a property which requires that the 
analytical methods used for their detection possess a high resolving power. The 
presence o f COPs at trace levels also demands that the methods be capable of 
sensitive detection (Park and Addis, 1992). Various methods have been developed 
for the analysis of COPs, from thin layer chromatography (TLC) to high- 
performance liquid chromatography (HPLC) or capillary gas chromatography (GC). 
A nuclear magnetic resonance technique (NMR) was also recently employed for this 
analysis in spray-dried egg powder (Fontana et al., 1992, 1993). Trace analysis is 
complicated by interference from a diversity o f other lipid components in food, in 
particular triglycerides, cholesterol and phospholipids (Schmarr et al., 1996). Many 
of the problems that have been encountered in COPs analysis include loss of COPs 
during sample preparation (Csallany et al., 1989), production of artefacts during 
handling (Rose-Sallin et al., 1995), poor resolution or instability during sample 
preparation work-up and mis-identification (Table 2.1). In addition, quite 
considerable variation in fat content o f powdered milk samples between different 
laboratories have been reported, suggesting a need to study different extraction 
methods (Appelqvist, 1996).
In view of the potential health impact of oxysterols in food, any discrepancies in 
results being reported, due to the use of different methods, may lead to consumer 
concern. In addition, the precise quantification of the oxysterols remains a 
challenging task, especially in foods containing low levels o f these compounds 
(Rose-Sallin et al., 1995). For COPs analysis, therefore, it is obvious that a 
dependable, reliable, robust and sensitive analytical method that will minimise the 
generation o f artefacts is highly desirable. This chapter will provide an in depth 
review o f the established methodology for COPs analysis and investigate the setting 
up and validation of a GC method for COPs detection. Table 2.2 lists various 
different methodologies that have been used in the analysis of COPs in
2.1 INTRODUCTION
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Table 2.1 Problems encountered in the chromatographic analysis o f COPs.
Type Example
Loss o f COPs cholesterol-a-epoxide during hot saponification
Production o f artefacts 7-ketocholesterol to 3,5-cholestadiene-7-one.
Mis-identification No use o f Mass Spectrometry
Insolubility in non-polar solvent Cholestanetriol is insoluble in petroleum
ether
Poor resolution Thin layer chromatography
Instability during lengthy procedures Thin layer chromatography
Instability during gas chromatography Production o f dehydration products o f COPs at high column
temperatures
Poor detection by HPLC-UV detectors cholesterol-a- and (3- epoxides and their triol hydrolysis products
(Park and Addis, 1992)
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Table 2.2 Qualitative and quantitative methods developed between 1985 and 1996 for analysis o f COPs.
Reference Analytical Procedure COPs Analysed
Fisher et al. (1985) Saponification/Al20 3/Si- 
acid/GC
Isomeric cholesterol-epoxides, epimeric 7-hydroxycholesterols & 
2 5 -hydroxycholestero 1
Cleveland & Harris 
(1987)
Saponification/TLC cholesterol-a-epoxide, 7-ketocholesterol, epimeric 
hydroxycholesterols and 25-hydroxycholesterol
Nourooz-Zadeh & 
Appelqvist (1988)
HIPextraction/Saponification/ 
Sep-Pak/TEAP Lipidex/GC- 
MS
Epimeric hydroxycholesterols and cholesterol-epoxides and 
25-hydroxycholesterol
Sander et al. (1989) Folch extraction/ 
Saponification/GC
Epimeric hydroxycholesterols and cholesterol-epoxides, 
7-ketocholesterol, 25-hydroxycholesterol and cholestanetriol.
Chan et al. (1993) Folch extraction/LC-Si Sep-
Pak /GC
Epimeric hydroxycholesterols and cholesterol-epoxides and 
7-ketocholesterol
Rose-Sallin 
etal. (1995)
Saponification/ Sep-Pak/ 
GC-MS
Epimeric hydroxycholesterols, 7-ketocholesterol, 25- 
hydroxycholesterol and cholestanetriol.
Nielsen et al., 
(1996)
Folch extraction/ Sep-Pak/ 
HPLC/ GC-MS
Epimeric hydroxycholesterols and cholesterol-epoxides, 
7-ketocholesterol, 25-hydroxycholesterol and cholestanetriol.
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food during the past decade. All of the analytical methods used for COPs detection 
may be viewed as consisting of a series of stepwise procedures to accomplish the 
following goals (i) extraction of total lipids, (ii) enrichment of COPs, (iii) separation 
and detection o f COPs and (iv) confirmation o f structural identity (Park and Addis,
1992). Monitoring o f artefacts, though also an important step within the analytical 
procedure is not always carried out, leading to possible overestimations of the risk of 
exposure to COPs.
(/) Extraction o f  total lipids
Milk contains 2 mg/g cholesterol (Nielsen et al., 1995) representing approximately 
0.3 % of total lipids, the remaining 99.70 % of milk lipids being mainly 
triglycerides. The preparation of sterol samples as cleanly as possible is obviously a 
crucial factor for the successful analysis of COPs in food and biological samples. 
The first step towards analysis can be achieved by extracting total lipids from 
samples with organic solvents in which cholesterol and its oxides are co-extracted. 
The strength o f the extracting solvent is important to ensure a good extraction yield 
of COPs, whose polarities range widely from very non-polar to polar (Park and 
Addis, 1992). The most popular method over the past 4 decades has been the cold 
extraction procedure o f Folch et al. (1957), in which samples are homogenized in a 
mixture of chloroform:methanol (2:1, v/v) as the extracting solvents. The ratio of 
sample to extracting solvent is usually 1:20 (w/v). The homogenates are filtered and 
the filtrates containing lipid extracts are washed with distilled water or salt solution 
to remove non-lipid material. The efficiency of various organic solvents to extract 
lipids and cholesterol has been studied (Kaneda et al., 1980). O f the solvents tested, 
which included chloroform : methanol, benzene, acetone and diethyl ether, 
chloroform : methanol (2:1, v/v) was shown to be the most suitable solvent system 
to extract both lipids and cholesterol thoroughly. Other extraction systems have also 
been used: the modified Maxwell method (Maxwell et al., 1987) is based on the 
principle that non-lipid components are absorbed on a mixture of celite and 
anhydrous sulphate while lipids that are not absorbed are eluted with a mixture of 
dichloromethane : methanol and determined gravimetrically. The modified Radin
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method (Radin, 1981) employs a hexane : isopropanol (3:2 v/v) mixture to extract 
lipids for the analysis o f COPs in butterfat, non-fat dry milk and heated butter.
(if) Enrichment o f  COPs
The total lipid extract obtained from whole milk powder is a crude preparation, the 
major portion consisting o f triglycerides and phospholipids while sterols are only a 
very minor component. Cholesterol oxides are present in milk powder at trace 
levels, if  present at all (Nielsen et al., 1995). The trace nature o f COPs requires their 
enrichment from the bulk o f the accompanying lipids in the total lipid extract. 
Following enrichment, COPs can be analysed with less interference and 
concentrated to above the detection limit. This enrichment is commonly carried out 
by either saponification or chromatographic means.
The basic principle o f saponification (Fischer et al., 1985; Cleveland and Harris,
1987) is to hydrolyse the ester bonds o f trigylcerides and phospholipids in alkaline 
media such as methanolic or ethanolic KOH, converting them to water-soluble 
derivatives. To facilitate ester bond hydrolysis, the usual practice is to reflux the 
reaction mixture. After addition of water to the saponified mixture, COPs are 
extracted with suitable organic solvents (usually deperoxidised diethyl ether) into the 
non-saponifiable fraction. Variations in temperature and time of saponification exist; 
some workers saponify at 30° C for 2 h (Chicoye et al., 1968), others saponify at 
room temperature for 2 h (Bascoul et al., 1986) or overnight (Pie et al., 1990). In 
addition, direct saponification o f milk powders has been employed (Rose-Sallin et 
al., 1995), although it is not very common. Nevertheless, a comparison of both 
direct saponification (where COPs are extracted from milk powders shaken for 18 h 
with 1M KOH in methanol) and indirect saponification (i.e. after lipid extraction) 
yielded no difference in the levels of COPs analysed (Appelqvist, 1996). Hot 
saponification is limiting because both 7-ketocholesterol and a-cpoxide are unstable 
(Van de Bovenkamp et al., 1988; Rose-Sallin et al., 1995).
Column chromatography is another useful means of achieving enrichment of sterols 
from total lipid extracts (Schmarr et al., 1996). Bond-Elut systems for extraction of
61
lipids may be based on diol, silica or aminopropyl sorbents. The interaction between 
lipid components and the adsorbent in the column for a given solvent or solvent
system is the key factor determining the efficiency of isolating COPs or of 
eliminating other interfering substances. A schematic diagram of the solid-phase 
extraction apparatus used in enrichment of COPs is shown in Fig. 2.1.
A number o f solid-phases can be used, though the use of aminopropyl has been 
recommended by a number of workers (Morgan and Armstrong, 1987; Chan et al., 
1993; Rose-Sallin et al., 1995; Appelqvist, 1996). An aminopropyl sorbent takes 
advantage o f the ionic character of fatty acids and phospholipids. The initial elution 
o f neutral lipids leaves fatty acids and phospholipids on the NH2 sorbent. The COPs 
are the least polar of the isolates and can be selectively eluted with acetone.
Although silicic acid column chromatography has been used for the separation of 
different lipid classes, only a few researchers have employed this method as a 
purification procedure in place o f saponification prior to COPs analysis. Park and 
Addis (1985b) developed a procedure to analyze most of the more common COPs. 
After irrigating different lipid classes on silica gel plates with different developing 
solvents, they found that cholesterol and its oxides rarely migrated on silica gel 
plates using 10 % and 20 % ethyl acetate in hexane, whereas esterified cholesterol 
and triglycerides migrated rapidly. With acetone as the developing solvent, sterol 
fractions ranging from cholesterol to cholestanetriol migrated almost with the same 
mobilities but phospholipids remained at the origin due to their insolubility in 
acetone. Based on those observations, column chromatographic purification 
procedures were optimised (Smith, 1981): two consecutive washings with 28 ml 
hexane : ethyl acetate (9:1 v/v) and 20 ml hexane : ethyl acetate (8:2, v/v) through 4 
g silica gel columns removed triglycerides and much of the cholesterol. Subsequent 
elution with 45 ml acetone released the COPs fraction free from phospholipid 
contamination. This purification procedure was later improved by De Vore (1988) 
who used commercially available disposable columns for the analysis o f 7- 
ketocholesterol. With 2.8 ml volume silica columns, solvent consumption was
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interest through the Sep-Pak cartridge.
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reduced to 2 ml for each washing and elution (De Vore, 1988).
(/«) Separation and detection o f  COPs
The chromatographic analysis of COPs began in the 1960s with thin layer 
chromatography (TLC) (Fioriti and Sims, 1967; Chicoye et al., 1968) as the 
pioneering chromatographic method. Smith (1981) developed the method and 
reported R f values for COPs after developing a mixture of oxides in heptane:ethyl 
acetate (1:1 v/v), spraying with 50 % H2S 0 4 and heating cautiously to 110-120° C. 
The brilliant colours that developed ranged from magenta for cholesterol through 
blues for diols and epoxides to yellow for triols. However, resolution with TLC can 
be poor, particularly for 7-ketocholesterol and the epimeric cholesterol a -  and p- 
epoxides. In addition, it is not the method o f choice today because it allows 
exposure of the samples to potential oxidation as a result of its large surface area and 
low loading capacity (Cleveland and Harris, 1987). The advent o f High
Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) saw 
their subsequent use as analytical tools in COPs analysis.
Both reverse phase (Park and Addis, 1985b; Csallany et al, 1989) and normal phase 
(Maerker 1986; Tsai et al, 1980) HPLC systems have been used for COPs analysis. 
Good separations have been achieved with hexane : isopropanol combinations in 
which the hexane phase comprised 90-99 %. In spite of very significant advances 
during the past ten years, HPLC techniques have not reached the point where they 
are useful in the separation and quantification of complex mixtures o f COPs 
(Maerker, 1986). Problems that have been encountered include excessive retention 
times for cholestanetriol (Maerker, 1986), poor sensitivity (Tsai et al, 1980) and 
inability to detect cholestanetriol by HPLC-UV detection.
Application of GC methods has been somewhat more successful despite problems of 
incomplete derivatisation and peak resolution. Both packed column GC (Tsai and 
Hudson, 1984) and capillary column GC (Park and Addis, 1985a ; Missler et al, 
1985; Nourooz-Zadeh and Appelqvist, 1987) have been used in COPs detection. 
Capillary GC, especially in combination with direct on-column injection, has
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increased the popularity o f GC as a powerful tool (Maerker and Unrah, 1986). 
Nourooz-Zadeh and Appelqvist (1988) described a GC method for quantification o f 
COPs in milk powders which was found suitable for quantifying the most abundant 
COPs in whole milk powders. In recent years, newer and more powerful 
chromatographic methods combined with MS (Nielsen et al., 1995, 1996; Rose- 
Sallin et al., 1995; Schmarr et al., 1996) and NMR (Fontana et al., 1992; 1993) have 
facilitated the definitive identification and quantification of cholesterol oxidation 
end products in foods and biological tissues.
GC accomplishes separation o f components by partitioning the components o f a 
chemical mixture between a mobile gas phase and a stationary phase held on a solid 
support (Willard et al., 1988). Some sensitive compounds undergo partial thermal 
decomposition in the GC. Derivatisation may be employed to yield a more stable 
product and thereby improve chromatographic performance and peak shape (Kim 
and Nawar, 1991). Derivatisation also serves to accentuate the differences in the 
sample compounds to facilitate their chromatographic separation. The derivatisation 
most commonly used in the analysis o f lipids is silylation. Silylation significantly 
increases volatility, especially in compounds with multiple polar groups. Silyl 
derivatives are formed by replacement of active hydrogen on OH, SH and NH 
groups (Willard et al., 1988). Although silyl derivatives have the undesirable effect 
o f fouling flame ionisation detectors (FID) with silica deposits, especially when 
samples are injected in excess reagent, these deposits may be reduced by use of 
fluorine containing reagents such as N ,0-bis (trimethylsilyl) trifluoracetamide 
(BSTFA).
The instrument modules o f a GC are shown systematically, in Fig 2.2. A GC 
consists o f several basic modules joined together to (i) provide a constant flow of 
carrier (mobile phase) gas, (ii) permit the introduction o f sample vapours into the 
flowing gas stream, (iii) contain the appropriate length of stationary phase, (iv) 
maintain the column at the appropriate temperature (or temperature programmed 
sequence), (v) detect the sample components as they elute from the column, and (vi)
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provide a readable signal proportional in magnitude to the amount of each 
component. The columns on which the components are separated are the key to 
good analysis, and are responsible for much of the versatility o f gas 
chromatography. Temperature programming is another useful facility on many 
instruments. If the sample to be analysed contains components differing widely in 
volatility, it is advantageous to start the analysis with the column at low temperature 
so that the more volatile components are separated as single coherent peaks and then 
to raise the temperature at a fixed reproducible rate so that the less volatile 
components are eluted in a reasonable time. The sample emerges from the column 
into the detector, which is maintained, by a separate temperature control, at a slightly 
higher temperature than that reached by the column, so ensuring that there is no 
change in the response o f the detector during temperature programming. FID is 
chosen most frequently for lipid analysis. Eluted components are burned in a flame 
o f hydrogen and air and form ions that are detected and measured by an electrical 
system. Although the mechanism o f the ionisation process is not fully understood, 
this detector is very sensitive, has good signal-to-noise ratio, is rugged and does not 
deteriorate significantly with prolonged use (Christie, 1982).
Quantitative GC demands that all compounds of interest in the samples injected 
produce reproducible peaks for integration. Accordingly, one needs to control 
possible sources of error such as sampling error, column performance and detector 
performance. Variability in the injection amounts can be compensated for by the use 
o f the internal standard (IS) instead o f the absolute analyte response. The IS should 
not be an original constituent o f the analyte, should be separable from the analyte 
peaks and should have a chemical structure similar to that of the analytes. The use 
o f such an IS will compensate for any losses incurred throughout the procedure, 
since the concentration ratio of the analytes to the IS can be reasonably assumed to 
remain constant (Willard et al., 1988; Park and Addis, 1992). The most commonly 
used IS is 19-hydroxycholesterol (Sander et al., 1989; Pie et al., 1990; Rose-Sallin et 
al., 1995; Appelqvist, 1996), though others such as 5a-cholestane (Nourooz-Zadeh 
and Appelqvist, 1988), 6-ketocholesterol (Chan et al, 1993; Lai et al., 1995a) and
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deuterium-labeled oxides (Rose-Sallin et al., 1995) have also been used for the 
analysis o f COPs in whole milk powder, egg powder, cake mixes and meat products.
(iv) Confirmation o f  structural identity
The presence o f COPs can be confirmed using mass spectrometry (MS). Indeed, for 
quantification o f low concentrations o f oxysterols or for the analysis of samples with 
a high matrix background, verification of peak assignment by GC-MS is mandatory 
(Schmarr et al., 1996). In GC analysis o f COPs, identification o f COPs is based 
upon comparing the retention time o f a separated peak with that of an authentic 
standard. Because o f the possibility that more than one compound can elute with a 
retention time the same or very close to that of the target compound, identity 
confirmation o f a chromatographically separated peak needs to be performed in a 
more stringent manner, i.e. by means other than retention time comparisons. Nielsen 
et al. (1995) reported that oxidised monoacylglycerols and other compounds 
coeluting with the oxysterols can result in an overestimation o f the level of 
oxysterols when analysed using GC-FID, but not when using the MS selected ion 
monitoring technique. MS is commonly used and provides far more precise 
information on chemical identity of COPs (Rose-Sallin et al., 1995; Nielsen et al., 
1995).
In MS analysis, analytes are introduced into the ionization chamber either via the 
chromatographic inlet or by a direct insertion probe. The stream of molecules 
introduced in an ionization chamber is bombarded by high-energy electrons emitted 
from a heated filament, with a voltage o f approximately 70 eV. As a result, very 
small amounts o f molecules are ionized and the ionized molecules may remain as 
such or undergo characteristic fragmentation producing a variety o f ions. These ion 
beams are separated through a mass analyser according to their mass/charge (m/z) 
ratio. The molecular ion (m+) is a radical cation formed from the ionization of an 
analyte molecule with the loss o f one electron. The molecular ion therefore, appears 
at an m/z value numerically equal to the nominal molecular weight o f the compound. 
The most intense peak in the mass spectrum is called the base peak, against which 
the relative intensities of all other ions are normalized (Park and Addis, 1992).
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The critical step in the analysis of COPs is the clean-up procedure which should be 
designed to minimise the generation o f artefacts (Rose-Sallin et al., 1995). The 
formation of COPs by autoxidation o f cholesterol and their subsequent instability 
require a very mild analytical method to prevent artefact formation. The presence of 
air, light, peroxides in solvents or heat treatment during the clean-up procedure can 
promote artefact formation. The activity of some adsorbing agents such as silica gel 
is another possible reason for artefact formation, due to the interaction of cholesterol 
with silicic acid in the presence o f air. Moreover, the pH o f the media can influence 
the stability of several COPs (Kim and Nawar, 1993) in particular 7-ketocholesterol, 
which is very sensitive to hydrolysis in hot alkaline media (Chicoye et al., 1968). 
Deuterium-labelled cholesterol has been used for spiking samples prior to analysis 
(Rose-Sallin et al., 1995). The extent o f oxidation occurring during the clean-up 
procedures can be easily determined from the deuterated COPs formed. The 
difference between unlabelled COPs and deuterated COPs allowed determination of 
artefact-free COPs content of a sample. Artefact formation during milk powder 
analysis has been reported to be approximately 2 % (Rose-Sallin et al., 1995), which 
underlines the importance o f a mild analytical procedure for COPs analysis.
2.2 A IM S
To set up and optimise a GC method for COPs determination in milk powders
2.3 O BJECTIVES
• Evaluation of the performance characteristics o f a capillary GC column for 
separation and resolution o f a number of COPs.
• Confirmation o f the identity of COPs using GC. MS.
• Use o f the established method for screening a variety o f milk powders produced 
under low-, medium- and high-heat treatments.
(v) M onitoring o f  artefact form ation
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2.4 EXPERIM ENTAL
2.4.1 REAGENTS
Cholest-5-ene-3[3-ol (cholesterol), 3p-hydroxychoIest-5-en-7-one (7- 
ketocholesterol), cholest-5-ene-3p,25-diol (25-hydroxycholesterol), cholesterol- 
5a,6a-epoxide (cholesterol-a-epoxide), cholest-5-en-3p,19-diol (19- 
hydroxycholesterol), cholestane-3p, 5a, 6P-triol (cholestanetriol), all o f > 99 % 
purity, N ,0-bis (trimethylsilyl) trifluoracetamide (BSTFA) and cysteine were 
purchased from Sigma (Poole, Dorset, U.K.) and cholesterol 5p,6p-epoxide 
(cholesterol-P-epoxide) was purchased from Steraloids Inc. (Wilton, NH, USA). 
Malondialdehyde bis diethylacetal (MDA) was purchased from Merck-Schwchardt, 
Darmstadt, Repubic o f Germany. The cholesterol kit (Cat. No. 139 050) was 
purchased from Boehringer Mannheim (Mannheim, Germany). Ellman’s reagent (5, 
5 dithiobis-(2-nitrobenzoic acid)) was purchased from Aldrich-Chemie (Steinheim, 
Germany).
2.4.2 Standard Preparation
2.4.2.1 Preparation of standard solution of cholesterol and cholesterol oxides
A standard solution (standard mix I) containing approximately 10 mg of cholesterol, 
cholesterol-P-epoxide, cholesterol-a-epoxide, 7-ketocholesterol and cholestanetriol 
and 5 mg 25-hydroxycholesterol was prepared in a 20ml volumetric flask . The 
multistandard solution was made up to the 20 ml volume mark with chloroform. 
The final concentration of each oxide, except 25-hydroxycholesterol, was 500 jig/g. 
The concentration o f 25-hydroxycholesterol in the multistandard solution was 250 
pg/g. This standard mix was used to spike whole milk powder samples to monitor 
% recovery.
A second standard mix (standard mix II) was prepared for GC.MS analysis. A 1000 
pg/g standard mix was prepared by adding exactly 10 mg of cholesterol, cholesterol- 
a-epoxide, 7-ketocholesterol, 25-hydroxycholesterol and cholestanetriol into a 10 ml 
volumetric flask and making up to the volume with chloroform. A 100 pg/g and 10
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(ig/g solution was then made by serial dilution of the 1000 j.ig/g standard mix. 
These were then used to spike whole milk powder samples to monitor the 
repeatability and reproducibility o f the method.
2.4.2.2 Preparation of internal standard solution
Into a 20 ml volumetric flask 10 mg 19-hydroxycholesterol was weighed and made 
up to the volume with chloroform.
2.4.3 Determination of cholesterol in whole m ilk powder
The Boehringer Mannheim cholesterol assay kit (Cat. No. 139 050) was used to 
measure total cholesterol in milk powders. Approximately 10 g whole milk powder 
was weighed into a 250 ml round-bottomed flask and 50 ml freshly prepared 
methanolic 2 M KOH solution was added. The solution was heated for 30 min 
under reflux. The warm solution was transferred with 100 ml distilled water into a 
1000 ml separatory funnel. After cooling to room temperature, the solution was 
shaken with 100 ml ether/petroleum ether. The clearly separated bottom phase was 
carefully drained off into a saponification flask and the organic phase transferred 
into a 500 ml round bottomed flask. This extraction was repeated twice. The 
combined ether/petroleum ether phases were evaporated under a rotatory evaporator 
at 35° C and the residue was dissolved in isopropanol and transferred into a 50 ml 
volumetric flask, filtered and the clear solution then used for the cholesterol 
determination. The assay was performed by adding 2.5 ml o f the sample solution to 
0.02 ml o f cholesterol reagent solution (95 ml ammonium acetate, 2.6 M methanol, 
222,000 U catalase, 0.05M acetylacetone, 0.03M methanol) and incubating at 37° C 
for 60 min. The solution was then cooled at room temperature and the absorbance 
read at 405 nm. The fat was determined using the Rose-Gottlieb procedure and 
results were expressed in mg cholesterol/g fat.
2.4.4 Folch Extraction and derivatisation of COPs
For COPs analysis, 0.05 mg 19-hydroxycholesterol was used as an internal standard 
and was added to 1 g o f milk powder to monitor recoveries and correct for losses 
during sample preparation. The method o f Folch et al.(\951), as modified by Sander 
et al. (1989) was employed for extraction of lipids for COPs analysis. 1 g milk
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powder was added to 10 ml chloroform : methanol (2:1 v/v) and homogenised with a 
Polytron homogeniser for 2 min. A further 15 ml chloroform : methanol (2:1 v/v) 
was added and the mixture was homogenised again for 2 min. The homogenate was 
filtered through a Whatman no. 42 filter paper into a 50 ml centrifuge tube and 5 ml 
distilled water then added. The tube was centrifuged at 1000 g for 20 min, and the 
organic phase (lower) transferred into a 100 ml round bottomed flask. The organic 
phase was evaporated to dryness in a rotary evaporator at 30° C and dissolved in 5 
ml hexane. This lipid extract was then applied to a Sep-Pak silica cartridge (Waters 
Associates, Milford, MA, USA) which had been previously equilibrated with 5 ml 
hexane. The solid phase extraction column was then washed successively with 10 
ml hexane/diethyl ether (95:5 v/v), 25 ml hexane/diethyl ether (90:10 v/v) and 15 ml 
hexane/diethyl ether (80:20 v/v). The COPs fraction was eluted with 10 ml acetone 
and dried under nitrogen as described by Morgan and Armstrong (1989). The COPs 
were converted to trimethylsilyl ethers by addition of 250 pi BSTFA and silylation 
was completed by heating at 120° C for 30 min.
2.4.5 Measurement of COPs by Gas Chromatography
Separation o f COPS was performed using a Varian 3500 gas liquid chromatograph 
(Varian, CA, USA) fitted with a flame ionization detector (FID) as described by Pie 
et al. (1990). Separation was performed on a DB-5 capillary column (J & W 
Scientific, Folson, CA) (30 m x 0.32 mm i.d., 0.25 mm film thickness). Samples 
were injected onto the column using an on-column injector (SPI), using He as carrier 
gas and N2 as make-up gas and a flow-rate of 5 ml/min. Injector temperature was 
100° C increasing to a final temperature o f 300° C at a rate o f 30° C/min. Initial 
column temperature was 100° C with a hold time of 40 min, after which it increased 
to 300° C at a rate o f 10° C/min. The detector was at 300° C. Total COPs were 
detected in whole milk powder and then expressed as a fraction o f the lipid content, 
which was determined using the Rose-Gottlieb procedure. COPs were expressed in 
i-Lg/g fat.
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2.4.6 Confirmation of identity by Gas Chromatography / Mass Spectrometry
The structures o f COPs were confirmed by GC/MS, using a Varian Saturn 4D 
GC/MS (Varian, Harbor City, CA, USA). The conditions used were as previously 
outlined (Rose-Sallin et al., 1995). Separation was performed on a DB-5 fused silica 
capillary column (J & W Scientific, Folson, CA, USA) (30 m x 0.32 mm i.d., 0.25 
mm film thickness), following on-column injection, using He as carrier gas at 0.7 
bar. The initial oven temperature was 60° C with a hold time of 1 min. This was 
increased at a rate o f 30° C/min to 200° C which was then increased to 300° C at 5° 
C/min and held for 5 min. The mass spectrometer was operated under electron 
ionisation conditions with an electron energy o f 70 eV.
2.4.7 Optimisation of the analytical procedure
The optimisation o f the method required the following experiments:
(i) Determination o f the optimum volume o f BSTFA and derivatisation time for 
silylation o f COPs by BSTFA.
(ii) Determination o f the theoretical 100 % recovery of internal standard by direct 
injection of derivatised 50 pg 19-hydroxy cholesterol.
(iii) Optimisation o f the extraction of lipid extract for sample clean-up.
(iii) Establishment o f the optimum procedure for Sep-Pak clean-up. A vacuum 
apparatus was set up with a controlled flow-rate and this was compared with 
uncontrolled vacuum elution of solvent.
2.4.8 Validation of G C method for COPs analysis
2.4.8.1 Linearity
Calibration curves were constructed for cholesterol, cholesterol-a-epoxide and 
cholesterol-p-epoxide, 7-ketocholesterol, 25-hydroxycholesterol and cholestanetriol 
in the range 0-600 pg/g on a DB-5 column using a Varian 3500 GC.FID (National 
Dairy Products Centre, Moorepark, Fermoy, Co. Cork). Calibration curves were 
also constructed in the range 0-1000 pg/g using the Varian Saturn 4D GC.MS 
(Tralee Regional Technical College, Tralee, Co, Kerry).
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2.4.8.2 Response factors
The response factors were calculated relative to the IS. Relative response factors 
were calculated as described by Van de Bovenkamp et al. (1988) as follows: 
Response Factor = (Wn/An)/(Wjs/Ais)
Wn and Wis are weights of the nth COP and IS, respectively 
An and Ajs are peak areas of nth COP and IS, respectively 
Peak height can also be used in lieu of peak area. After the GC run o f samples, the 
concentration o f each oxide (|ig/g) was calculated using the following equation: 
Concentration = (Aj / Ais) RF (Wjs / Wj)
A, and W, refer to the peak area and weight of sample.
2.4.8.3 Recovery
To evaluate the recoveries o f the different oxides, 1 g of fresh whole milk powder 
(containing no COPs) was spiked with 500 |ri o f standard mix solution (standard 
mix I) containing cholesterol and COPs. The samples were taken through the entire 
procedure and analysed by GC. Recoveries were calculated by expressing recovered 
amounts o f individual oxides as a percentage of the original spiked amounts 
(standard mix I).
2.4.8.4 Precision
Precision o f the method was established by determining the repeatability and 
reproducibility o f the method. Fresh whole milk powder (containing undetectable 
levels of COPs) was spiked with 500 p.1 of 10, 100 and 1000 pg/g standard mixture 
o f COPs in triplicate on the same day (repeatability) and on three consecutive days 
(reproducibility). The coefficient of variation (% CV) was calculated to measure the 
degree of precision obtained.
2.4.8.5 L im it of Detection
The limit o f detection (LOD) was determined by firstly establishing the base noise 
level by running a number o f solvent blanks. The LOD was determined as the 
concentration whose signal height is three time that of the noise.
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2.4.9 Powder Sampling
Milk powder samples were received from a number of Co-operatives in Ireland. The 
milk powders were divided into varying heat classes. Low-heat powders received a 
heat treatment o f less than 75°C for 10 sec; medium-heat powders received a heat 
treatment of between 76.5-85°C for 15-30 min and high-heat powders received a 
heat treatment o f greater than 110 °C for 2 min. All samples were analysed on 
receipt with fresh milk powders being analysed within a week o f manufacture. 
Stored milkpowders refer to powders stored for longer than 12 months. Different 
batches were analysed for each category and the results pooled for statistical 
analysis.
2.4.10 Statistical Methods
The Mann-Whitney test was used to determine the statistical significance of the 
differences in COPs levels between low-heat, medium-heat and high-heat powders, 
using the GENSTAT package (The Numerical Algorithims Group Ltd., Oxford, 
UK).
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Prior to commencing the study to determine total and individual levels o f COPs in 
milk powders, it was necessary to characterise all stages of the method. Thus, 
optimisation o f the extraction and clean-up stages before GC analysis; precision of 
GC separation method; confirmation o f the identity of COPs; evaluation of the 
linearity and recovery of each oxide were evaluated in order to validate a method to 
measure COPs in milk powders. The accuracy o f the entire procedure was assessed 
by spiking milk powders with varying amounts of each oxide and assessing 
recoveries, reproducibility and repeatability o f the method.
2.5.1. Retention times and relative response factors
Using the parameters described in section 2.4.5, the complete separation of COPs 
was achieved by non-polar capillary column (DB-5) (Fig. 2.3). Retention times and 
response factors relative to 19-hydroxycholesterol are shown in Table 2.3. Response 
factors (RF) ranged from 0.70 ±  0.02 to 1.38 ± 0.03. Cholesterol had the shortest 
retention time (26.7 min) and cholestanetriol the longest (37.1 min). The COPs 
eluted in the following order: 19-hydroxycholesterol, cholesterol-(3-epoxide, 
cholesterol-a-epoxide, 25-hydroxycholesterol, 7-ketocholesterol and cholestanetriol.
Mass spectrometric detection o f the compounds was achieved after electron impact 
(El) ionisation. Fig 2.4 to 2.6 are mass spectra for TMS ethers of 7-ketocholesterol 
25-hydroxycholesterol cholesterol, 19-hydroxycholesterol, cholestanetriol, 
cholesterol-a-epoxide, and. The molecular ions for each of the oxides are also 
outlined in Table 2.3. Mass spectrum analysis of 7-ketocholesterol resulted in ions 
at m/z 174 (base peak) and at m/z 159 and 456 while that of 25-hydroxycholesterol 
resulted in a base peak at m/z 131. The m/z ions of interest were m/z 143 and 445 in 
the mass spectrum of cholestanetriol, the only COPs among those studied to have 
three hydroxyl groups. The mass spectrum of cholesterol was dominated by the ion 
of m/z 129 which is the base peak. The m/z 129 originates from the A-ring 
fragmentation between C l-10 and C3-4 (Park and Addis, 1992). Other distinguished 
fragment ions were at m/z 253 and 351.
2.5 RESULTS
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1.2
Retention Time (Mins)
Fig. 2.3. Chromatogram of COPs standard mix, with 19 hydroxycholesterol as the 
internal standard (IS). (1) Cholesterol; (2) cholesterol-p-epoxide; (3) cholesterol-a- 
epoxide; (4) 25-hydroxycholesterol; (5) 7-ketocholesterol and (6) cholestanetriol.
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Table 2.3. Retention times, relative response factors and molecular ions for 
cholesterol and COPs of interest.
COPs Retention Time 
(min)
Relative Response 
F a c to ra
Mass Spectrum  
Ions (m/z)
Cholesterol 26.70 0.79 ±0.012 129;253;351
19-hydroxycholesterol 27.33 1.00 ±0.022 145;197;353
cholesterol-P-epoxide 28.71 1.21 ±0.018 NA
cholesterol-a-epoxide 29.60 0.98 ± 0.008 135;366
25-hydroxycholesterol 31.11 0.70 ± 0.016 131
7-ketocholesterol 33.39 1.02 ±0.026 174; 159; 456
Cholestanetriol 37.08 1.38 ±0.032 143; 445
J n (number o f  analysis)=6  
N A  =  Not Available
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Fig. 2.4 Mass spectra of (a) 7-ketocholesterol and (b) 25-hydroxycholesterol TMS
ethers.
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The mass spectrum of 19-hydroxycholesterol was dominated by ions at m/z at 145, 
197 and 353. Mass spectrometric analysis of a-epoxide resulted in extensive 
fragmentation, leaving a limited number o f ions in the high m/z region with the 
major ions at m/z 135 and 366.
2.5.2 Recovery of 19-hydroxycholesterol after extraction and enrichment
The GC parameters employed in this work for analysis of COPs in whole milk 
powder are described in Table 2.3. The entire analytical procedure for COPs 
quantification from extraction to derivatisation was optimised before milk powders 
were analysed for their COPs content. 19-hydroxycholesterol was used to monitor 
the procedure. The theoretical 100 % recovery was first established by injecting 
derivatised 19-hydroxycholesterol directly onto GC and recording the peak area. Its 
recovery was then assessed after (i) extraction, (ii) clean-up on a Sep-Pak cartridge 
and (iii) derivatisation. BSTFA was used under different volume-time conditions; 
the optimal volume o f BSTFA was observed to be 250 fil and optimal length of 
incubation time required for derivatising 19-hydroxycholesterol (0.05 mg) into its 
trimethylsilyl (TMS) derivative was 30 min at 120° C (Fig 2.7). 50 f.ig 19-
hydroxycholesterol (corresponding to 562310 peak area units) was added to milk 
powder and the lipid extracted with 25 ml chloroform : methanol (2 : 1 v/v) and 
dissolved in a single 5 ml aliquot of hexane. After drying down under N 2 and 
derivatisating with 250p,l BSTFA for 30 min, 456,813 peak units was obtained, 
resulting in approximate 81 % recovery (Table 2.4). When a second wash with 5 ml 
hexane was included, the recovery improved from 81 % to 93 %. Approximately 60 
% of added internal standard was recovered after application of the lipid extract to 
the Sep-Pak cartridge with its elution under uncontrolled conditions (application of 
high pressure to accelerate flow-rate). However, using a controlled flow-rate and 
double hexane wash, recovery o f internal standard was approximately 77 %. 
Though an approximate 23 % loss o f 19-hydroxycholesterol occurred after the clean 
up stage, it was nevertheless considered necessary to continue with the solid-phase 
extraction as it considerably cleaned up the lipid extract prior to its injection on the 
GC column. Fig 2.8 shows a GC chromatogram of a whole milk powder sample 
before and after clean up.
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Fig 2.7(a) The optimal volume of BSTFA required for derivatisation o f 19- 
hydroxycholesterol and (b) time course assay for the derivatisation o f 19- 
hydroxycholesterol to its TMS ether. Error bar refer to mean values ± standard 
deviation (n=6).
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Table 2.4. % Recovery o f 19-hydroxycholesterol (a) before and (b) 
after optimisation.
(a)
Sample Peak A re a 3 Recovery
%
50 n g I S a 562,310 + 5699 100
Extraction and 456,813 ±6137 81,2
single hexane wash
Sep-Pak 337, 150 ±5129 59.9
(manual uncontrolled
flow-rate)
(b)
Sample Peak Area Recovery
%
50 ng IS a 562,310 ±5699 100
Extraction and 520,318 ±4933 92.5
double hexane wash
Sep-Pak 431,036 ±8973 76.7
(controlled flow-rate
at 5 psi)
an (number o f analysis)^
Data refer to mean ± standard deviation
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Fig. 2.8. Gas chromatogram of fresh (a) a low-heat whole milk powder sample 
without Sep-Pak clean-up and (b) having undergone a Sep-Pak clean up prior to 
injection
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Standard curves of COPs were constructed relating peak area to concentration (pg/g) 
of each oxide. Figs. 2.9-2.12 show the standard curves for cholesterol, 7- 
ketocholestcrol, cholesterol-a-epoxide, 25-hydroxycholesterol, cholestanetriol and 
cholesterol-P-epoxide in the range 0 to 600 pg/g. Varying peak areas were obtained 
for each oxide and relative response factors were calculated as ‘correction factors’ to 
be used in their subsequent quantification in milk powders. Correlation coefficients 
o f greater than 0.98 were obtained. The limit of detection was 0.1 pg/g lipid and 
was determined as three times the standard deviation o f the noise.
2.5.4 Recovery
Table 2.5 demonstrates the % recovery of cholesterol, cholesterol-a-and P-epoxides, 
25-hydroxycholesterol, 7-ketocholesterol and cholestanetriol following extraction 
from whole milk powder and subsequent analysis by GC. Fresh low-heat milk 
powder, containing no detectable COPs was spiked with a standard mix containing 
0.05 % w/v COPs and 0.025 % w/v 25-hydroxycholesterol and analysed for COPs. 
The resultant peak areas were compared with peak areas of the pure standard mix 
analysed directly by GC. Recovery of each COPs with the exception of 
cholestanetriol (59 %) was greater than 90 % and there were negligible differences 
in the amounts of each oxide recovered.
2.5.5 Precision
Precision of the method was determined by evaluating the intra-and inter-assay 
variations, respectively. Fresh low-heat whole milk powder was spiked with 500 pi 
o f 10, 100 and 1000 pg/g of a standard mix solution (standard mix II) of COPs in 
triplicate on the same day (intra assay) to determine the repeatability of the method. 
The coefficients of variation (% CV) (Table 2.6-2.10) were shown to range from 
3.23 to 5.29 % for powders spiked with 10 pg/g of each oxide.
2.5.3. Linearity  of response
86
(51)
4000000
C o n c e n t r a t i o n  ( ( . t g / 'g )
(b)
C o n c e n t r a t i o n  ( n g / g )
I*'ig. 2.9. Standard curves o f (,a) cholesterol and (h) cholesterol-a-epoxide.
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Table 2.5 Recovery o f  COPs from whole m ilk  p ow de rJ.
COPs Initial amounts 
(pg/g powder)
Recovered amounts 
(pg/g powder)
Recovery (%)
Cholesterol 2645 b 572.9 ±3.4 21.6
Cholesterol-P-epoxide 525 478 ± 20.5 91.1
Cholesterol-a-epoxide 525 482.4 ±31.9 91.9
25-hydroxycholesterol 265 244.4 ± 16.3 92.2
7-ketocholesterol 530 481.4 ±67.3 90.8
Cholestanetriol 575 338.9 ±24.0 58.9
a n (no of analysis) =  6.
b 2645 pg/g =  645 pg/g spiked cholesterol + 2000 pg/g endogenous milk powder 
cholesterol.
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% CV was lower when powder was spiked with 100 p.g/g (0.75 - 2.40 %) and 1000 
|j.g/g (0.65 - 1.98 %) (Table 2.6-2.10). Reproducibility of the assay was ascertained 
by triplicate analysis (on three consecutive days) of whole milk powder spiked with 
varying levels (10 - 1000 |0g/g) o f COPs. The coefficients of variation of inter-assay 
analysis are also shown in Tables 2.6-2.10. % CV for powders spiked with 10 jig/g 
COPs ranged between 4.72 - 8.33 %, while % CV ranged from 1.03 to 6.66 % for 
powders treated with 100 ppm and from 0.72-4.58 % when powders were spiked 
with 1000 ppm standard mix. The % CV for each oxide was higher when milk 
powders were spiked with 10 |u.g/g compared with 100 fig/g or 1000 jag/g of the 
standard mix. Willard et al. (1988) proposed that % CVs of less than 10 % are 
acceptable. The variations in % CV observed are likely to be due to analytical error, 
variations in GC response and/or day to day variations in sample preparation and 
analysis.
Table 2.6. Intra-assay and inter-assay variation following spiking of whole milk 
powder at 3 different concentrations of cholesterol.
Intra-assay variation Inter-assay variation
Concentration 
spiked (fJ-g/g)
Peak Area 
Mean ± S .D .a
C.V. (% ) Peak Area 
Mean ± S.D .a
C.V.(%)
10 28978 ±1140 3.93 31158 ±1941 6.22
100 253687 ± 1924 0.75 351292 ±2041 0.58
1000 1790367 ± 24110 1.34 1541505 + 11141 0.72
a n (number o f analysis) =3
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T a b le  2.7. Intra-assay and inter-assay varia tion  fo llo w in g  spiking o f  whole m ilk
pow der at 3 d ifferent concentrations o f  cholesterol-a-epoxide.
Intra-assay variation Inter-assay variation
Concentration 
spiked (pg/g)
Peak Area 
Mean ± S.D .a
C.V. (%) Peak Area 
Mean ± S.D .a
C.V. (%)
10 1267 ±41 3.23 1502 ± 64 4.26
100 10024 ±241 2.40 13983 ±471 3.36
1000 105260± 1141 1.08 121481 ±3614 2.97
a n (number o f analysis)=3
Table 2.8. Intra-assay and inter-assay variation following spiking of whole milk 
powder at 3 different concentrations o f 25-hydroxycholesterol.
Intra-assay variation Inter-assay variation
Concentration 
spiked (pg/g)
Peak Area 
Mean ± S.D .a
C.V. (%) Peak Area 
Mean ± S.D .a
C.V. (%)
10 7276 ± 367 5.04 8411 ±397 4.72
100 17724 ±841 4.74 15564 ±1041 6.66
1000 159878± 1041 0.65 183630 ±8411 4.58
a n (number o f analysis)=3
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Table 2.9. Intra-assay and inter-assay variation fo llo w in g  sp ik ing  o f whole m ilk
pow der at 3 d iffe ren t concentrations o f  7-ketocholesterol.
Intra-assay variation Inter-assay variation
Concentration 
spiked (p,g/g)
Peak Area 
M ean ±  S.D .a
C.V. (% ) Peak Area 
Mean ±  S .D .a
C.V. (%)
10 7266 ±313 4.3 5025 ± 419 8.33
100 17158 ± 4 4 7 2.60 19411 ±921 4.74
1000 133989 ±871 0.65 107348 ±1001 0.93
a n  (number o f analysis)-3
Table 2.10. Intra-assay and inter-assay variation following spiking of whole milk 
powder at 3 different concentrations of cholestanetriol.
Intra-assay variation Inter-assay variation
Concentration 
spiked (flg/g)
Peak Ar6a 
M ean ± S .D .a
C.V. (% ) Peak Area 
Mean ±  S .D .a
C.V. (%)
10 7823 ± 4 1 4 5.29 3542 ±  158 4.46
100 76729 ± 943 1.20 68448 ±711 1.03
1000 1065601 +Z1071 ■ 97 1172785 ±31009 2.64
an (number o f analysis)=3
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2.5.6 Comparison of present method with previous methods
Table 2.11 compares the present method with that of previous methods reported. 
The main difference is the absence o f a saponification step. The methods of Sander 
et al. (1989) and Chan et al. (1993) are similar to the present method in that they 
both use the folch extraction, indirect or no saponification and an NH2 Sep-Pak 
clean-up procedure. Rose-Sallin et al. (1995) does not extract lipids directly, but 
saponifies the milk powder (direct saponification) as opposed to saponification of 
the extracted lipids (indirect saponification). The present study used a DB-5 column 
in GC analysis which gave good resolution and short retention times. GC.FID and 
GC.MS was carried out as opposed to GC.FID only as was done by Sander et al. 
(1989) and Chan et al. (1993) to ensure accurate confirmation o f peaks.
Table 2.11 Comparison of methods of COPs determination
Extraction Saponification Clean-up GC analysis Confirmation
Present Study Folch No NH2 Sep-Pak DB-5 GC.FID and
Saponification GC.MS
Nielsen et al. Folch Indirect NH2 Sep- DB-1 GC.MS
(1996) Saponification Pak/HPLC
Rose-Sallin et al. None Direct NH2 Sep-Pak DB-1 GC.MS
(1995) Saponification
Chan et al. Folch No NH2 Sep-Pak DB-1 GC.FID
(1993) Saponification
Sander et al. Folch Indirect NH2 Sep-Pak DB-1 GC.FID
(1989) Saponification
Nourooz-Zadeh Hexane/Isopr Indirect C18- Sep-Pak DB-1 GC.MS
and Appelqvist opanol Saponification and Lipidex
(1988)
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A survey was carried out among a number o f Irish milk powder manufacturers to 
ascertain the levels o f COPs in a number o f commercial milk powders. A 
questionnaire was distributed to Dairy Co-Operatives to obtain details o f (a) type of 
milk powder (b) heat class (pre-heat temperature) (c) production date (d) storage 
temperature and (e) atomiser type (see appendix I). Table 2.12 demonstrates the 
levels o f five COPs: 7-ketocholesterol, cholesterol-a-and (3-epoxides, 25- 
hydroxycholesterol and cholestanetriol, expressed as jag/g in the spray-dried fresh 
milk powder products. COPs were not detected in low heat-treated cream, whole 
milk or skim milk powders. On the other hand, fresh (analysed within 1 week of 
manufacture) spray-dried powders from the high-heat class contained levels o f 7- 
ketocholesterol (full cream and whole milk powder) up to 1.25 p.g/g lipid, 
cholesterol-a-epoxide (whole milk powder) up to 1.23 (ig/g lipid and cholesterol-(3- 
epoxide (skim milk and whole milk powder) up to 1.78 (.ig/g lipid (Table 2.12).
Analysis o f stored spray-dried milk powder products was also carried out as part of 
the survey, results o f which are shown in Table 2.13. Stored low-heat treated whole 
milk powders contained higher levels o f 7-ketocholesterol (12.45 ± 0.89 (.ig/g lipid) 
than the corresponding fresh powders. Low-heat whole milk powder contained 
quantities o f P-epoxycholesterol up to 5.67 f_ig/g lipid. Low-heat treated full cream 
milk powders stored at hot room conditions (30° C) also contained increased level of 
7-ketocholesterol (39.10 jug/g lipid) and cholesterol-p-epoxide (4.32 ± 0.67 jj.g/g 
lipid) compared to fresh milk powders. Low-heat skim milk powder contained 
cholesterol-a-epoxide up to 3.51 (.tg/g lipid. The stored high-heat treated powders 
contained substantially less COPs than the low-heat treated powders (Table 2.13). 
The Mann Whitney test was used to analyse the significance of the results and it was 
found that there was a significant difference (p < 0.001) between low-heat and high- 
heat powders and no significant difference between medium-heat and high-heat 
powders in COPs levels. 25-hydroxycholesterol and cholestanetriol were not 
detected in any o f the fresh or stored powders samples.
2.5.7 Quantification of COPs in commercial milk powders
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Table 2.12 COPs in  spray-dried fresha m ilk  powder products. b
COPs (n-g/g lip id)c
Product Pre-heating
Temperature
7-keto -a-epoxide ß-epoxide 25-hydroxy Triol
WMP * High 0.89± 0.03 1.23+0.08 1.4510.06 ND ND
W M P* Med/high 1.11 ND 1.78+0.03 ND ND
W M P* Low ND ND ND ND ND
SMP ** High ND ND 1.05 ND ND
SMP ** Low ND ND ND ND ND
FCMP *** High 1.25± 0.05 ND ND ND ND
FCMP *** Low ND ND ND ND ND
a Analysed within 1 week o f manufacture
ND: Not detected, detection limit approx. 0.1(j.g/g.
b n (number of samples) = 7
c Means o f duplicate analysis (extraction, enrichment and GC analysis) 
*** FCMP: Full cream milk powder 
** SMP : Skim milk powder
* WMP : Whole milk powder.
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Tab le  2.13 COPs in  spray-dried stored3 m ilk  powder products.b
COPs (^g/g lipid)c
Product Pre­
heating
Temp.
Storage
Temp.
7-keto a-epoxide ß-epoxide 25-
hydroxy
Triol
WMP * High 0 n 0.43± 0.03 ND ND ND ND
WMP * Medium
uo
ND ND ND ND ND
WMP * Low 15° C 12.45± 0.89 ND 5.67+0.31 ND ND
SMP ** High 15° C ND ND ND ND ND
SMP ** Low L/1 O o 1.21+0.08 3.51+0.12 ND ND ND
FCMP *** Low 30° C 39.10+2.67 ND 4.32+ 0.67 ND ND
a 12 month old sample
ND: Not detected, detection limit approx. 0.1 (xg/g. 
b n (number of samples) = 7
c Means o f duplicate analysis (extraction, enrichment and GC analysis) 
*** FCMP: Full cream milk powder 
** SMP : Skim milk powder
* WMP : Whole milk powder.
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Retention times and relative response factors
In the present study, the complete separation o f all relevant COPs in milk powders 
was achieved by non-polar capillary GC using a DB-5 column while MS was used to 
confirm their presence in whole milk powders (Fig. 2.3). Identification o f COPs was 
achieved by comparison of retention times and by comparing mass spectra o f COPs 
peaks with those o f authentic standards (Table 2.3).
Mass spectrometric analysis of the compounds was achieved after electron impact 
(El) ionization and the mass spectra o f the TMS-derivatised compounds led to 
fragment ions that were predicted from their structure. The mass spectrum of 
cholesterol was characterised by a dominant ion at m/z 129 which is the base peak, 
and smaller ions at m/z 253 and 351. The base peak ion at m/z 129 originates from 
the A-ring fragmentation between C l-10 and C3-4 as previously reported (Park and 
Addis, 1992; Lai et al., 1995a) (Table 2,3). The base peak ion o f 19- 
hydroxycholesterol which enabled its confirmation was found at m/z 145 with 
smaller fragments at m/z 197 and 353. The ion at m/z 353 has previously been 
reported in mass spectra of 19-hydroxycholesterol (Rose-Sallin et al., 1995). 
Cholesterol-a-epoxide showed extensive fragmentation, leaving only a few ions in 
the high m/z region. The base peak ion was found at m/z 135 with another ion at 
m/z 366. While the base peak at m/z 135 has not been reported previously, the m/z 
at 366 was previously found (Pie et al., 1990; Rose-Sallin et al., 1995). A base peak 
at m/z 131 was found in the mass spectrum of 25-hydroxycholesterol, which is 
reported to originate from a-cleavage between C24 and 25 (Park and Addis, 1992; 
Rose-Sallin et al., 1995). No other ions were used in the confirmation o f 25- 
hydroxycholesterol. 7-Ketocholesterol was characterised by the base peak at m/z 
174 along with two further peaks at m/z 159 and 455. Finally, mass spectrometric 
analysis o f cholestanetriol, the only cholesterol oxide among those studied to have 
three hydroxy groups, resulted in a base peak at m/z 445, and an ion at m/z 143. 
While mass spectrometric detection was carried out by a number o f investigators 
(Nourooz-Zadeh and Appelqvist, 1988; Van de Bovenkamp et al., 1988; Pie et al.,
2.6 DISCUSSION
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1990; Rose-Sallin et a l 1995 and Lai et al., 1995a) only a few (Pie et a l 1990; 
Rose-Sallin et a l., 1995 and Lai et al., 1995a) actually reported details o f the mass 
spectra found, hence limiting comparisons with previous findings.
Incomplete separation of some COPs or overlapping pairs, such as those of the 
isomeric forms o f cholesterol a - and P-epoxides has been a major difficulty in the 
quantification of COPs by capillary GC (Fisher et al., 1985). However, in the 
present study, good resolution of a  and P-epoxides as well as cholestanetriol and 7- 
ketocholesterol was obtained. This was achieved by careful optimisation of the 
flow-rate o f the carrier gas to 5 ml/min in conjunction with temperature 
programming to ensure complete resolution of peaks. Because o f its higher 
concentration in samples, the bulk of cholesterol was separated from the oxysterols 
during solid-phase extraction. Cholesterol did not interfere with any o f the oxides, 
as 78 % of cholesterol in milk powder extract eluted with the hexane/di ethyl ether 
wash. This was ascertained by spiking a milk powder sample with cholesterol and 
monitoring its recovery. The amount spiked was 645 |_tg/g, and the level recovered 
was 572 jig/g. When the endogenous cholesterol in milk was taken into account, 
the recovery of cholesterol was 21.6 %. Since the cholesterol was not labelled, it 
was not possible to differentiate between spiked and basal cholesterol.
19-hydroxycholesterol was chosen as the IS since it has not been found in food 
products (Appelqvist, 1996) and it elutes close to the COPs investigated in the 
present study (Fig. 2.3). Relative response factors, defined as COPs response with 
respect to the internal standard ranged from 0.70 to 1.38 suggesting reproducible 
detector performance. Despite the critical role of response factors in quantitative 
analysis, they are seldom described in the literature. Nourooz-Zadeh and Appelqvist 
(1987) applied the same response factors, i.e. 1.0 to all COPs, citing Park and Addis 
(1985a), which may have resulted in over-estimation of the level of COPs present, 
since no correction factor (response factor) was used in their estimation.
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Recovery o f  cholesterol and cholesterol oxides
Given that the concentration of cholesterol in milk lipids is 2 mg/g and that less than 
1 ng/g of cholesterol is normally oxidised in milk (Nielsen et a l 1995), the large 
number o f steps in the analytical procedure for COPs hampers their successful 
analysis. Moreover, oxysterols have a polarity very similar to the polarity o f the 
triacylglycerides (Nielsen et al., 1995), which account for 97-98 % of the milk 
lipids. Separation and quantification of oxysterols in dairy products are therefore 
hampered by the combination o f low concentration and similarity in polarity with 
the lipid matrix. The very different levels o f oxysterols that have been reported for 
dairy products o f similar type from laboratories using different analytical methods 
may be traced to differences in these methods and may not reflect a real difference in 
the content o f oxysterols. This lack o f confidence in some o f the reported analytical 
results is further substantiated by the limited validation o f the methods employed 
(Nielsen et al., 1995).
Because of the low concentration o f COPs in foods, most attempts to measure these 
products require isolation and concentration steps to precede the actual 
determination. Previous workers have employed saponification of the extracted 
lipids with hot alkali as an important part o f the enrichment procedure. This step 
separates the bulk o f the lipids from the sterol residue and also converts esterified 
cholesterol to free cholesterol. However, some important COPs, notably 7- 
ketocholesterol have long been known to be unstable to hot, aqueous alkali (Chicoye 
et al., 1968; Finocchiaro and Richardson, 1983; Finocchiaro et al., 1984). A number 
o f investigators (Smith, 1981; Van de Bovenkamp et a l,  1988 and Appelqvist, 
1996) have reported the artefactual formation o f COPs during the course o f the 
saponification procedure. It has previously been reported that chromatographic 
techniques can be applied to separate COPs not only from each other but also from 
the large amounts o f interfering triglycerides, cholesterol, phospholipids and other 
matrix lipids present (Schmarr et al., 1996). The similarity between lipid class 
structures requires a highly selective extraction procedure. The lipid extract 
containing 50 (ig o f 19-hydroxycholesterol, was transferred to an NH2 Sep-Pak
100
cartridge. The column was then washed with 10 ml hexane and 15 ml hexane : 
diethyl ether (95 : 5 (v/v)) to elute most o f the trigylcerides from the column, thereby 
separating the COPs from the triacylglycerols. The remaining triglycerides and 
cholesterol were eluted by washing the column with 25 ml hexane : diethyl ether (90 
: 10 (v/v)) and 15 ml o f hexane : diethyl ether (80 : 20 (v/v)). The COPs were eluted 
off the column with 10 ml acetone and evaporated to dryness under nitrogen.
In the present study, the greatest loss was incurred at the clean-up stage o f the 
procedure (Table 2.4). This may have been due to incomplete solvation o f the 
sorbent bed; sample breakthrough; inadequate numbers of washes in the clean-up 
stage leading to increased potential for loss or inconsistent flow-rate through the 
column. Attempts made to improve the procedure involved the following 
precautionary steps: the use of nitrogen to retard oxidation, aluminium foil to 
eliminate light and oxygen; maintenance o f the temperature of the water in the 
evaporation stage at 35° C; maintenance o f a constant flow through the Sep-Pak 
cartridge, while not allowing the pressure to exceed 5-10 psi and finally performing 
all analyses on the same day. These precautionary steps reduced the losses incurred 
by approximately 10 %, resulting in recoveries o f approximately 90 %. Lai et al. 
(1995a) also used a vacuum manifold to maintain a constant flow-rate in Sep-Pak 
clean-up of samples. Whole milk powder which was not subjected to clean-up with 
a Sep-Pak column showed a number o f unidentified peaks at the start o f  the 
chromatogram, which may have been triglycerides and/or phospholipids. By 
contrast, these peaks were absent from powder samples which were subjected to the 
solid-phase extraction procedure (Fig. 2.8). These peaks masked the COPs of 
interest, and hence the solid-phase Sep-Pak extraction procedure was employed as a 
routine step in COPs analysis of whole milk powder. The Sep-Pak clean-up 
procedure may also have aided in prolonging the lifetime of the GC column used for 
COPs analysis, as the sample which did not undergo a clean-up could result in 
column overload. The advantages o f solid-phase extraction over traditional sample 
preparation methods include increased speed and simplicity, reduced solvent usage 
and disposal costs and improved selectivity. Analyte breakthrough is one o f the 
potential problems associated with solid-phase extractions. This occurs when the
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column is overloaded, when solvents have not been properly selected, when pores 
become blocked or when flow through the column is too fast. In the present study, a 
vacuum manifold was used to increase the speed o f elution and care was taken not to 
allow the pressure to exceed 5-10 psi. Care was also taken to ensure that Sep-Paks 
from the same batch were used for a given set o f samples, as batch-to-batch 
variability in commercial solid-phase extraction cartridges is frequently observed 
(Blevins et al., 1990). Differences have been reported in stationary phase loading 
due to the extent o f end-capping o f bonded phases from different sources (Blevins et 
al., 1990). These observed differences may be due to differences in manufacturing 
methods between vendors. One major disadvantage o f Sep-Pak columns is that 
separations on solid-phase extraction columns cannot be monitored, and hence 
method development can be difficult and lengthy. This could be alleviated by using 
TLC to confirm solid-phase extraction separation or to identify components in a 
given eluent.
TMS ether derivatives o f COPs were prepared by redissolving COPs in BSTFA. 
Derivatisation using BSTFA was necessary in order to prevent interaction of active 
hydrogens from the sterol oxides with metal wall surfaces or the stationary phase 
itself (Csallany et al., 1989). The BSTFA solution was heated at 120° C for 30 min, 
as these conditions were previously reported to result in reproducible derivatisation. 
Poor reproducibility resulted when COPs were heated at lower temperatures (80° C ) 
and for longer periods (2 h ) (Nawar et al., 1991).
Validation o f  cholesterol oxide analysis
Once the chromatographic procedure was optimised for separation of COPs, the 
entire method was validated prior to milk powder analysis. Linearity of a method is 
its ability to produce a response that is proportional to the concentration o f an 
analyte within a given range. The standard procedure is to analyse a set o f standards 
and subject the results to linear regression analysis. The correlation coefficient is 
then used as an estimate o f ‘best fit’. Linear responses were recorded for each 
COPs, with correlation coefficients of approximately 0.99 which indicates that the
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method was linear in the range 0-600 jj.g/g using GC.FID (Figs. 2.9-2.11) and 0- 
1000 jj,g/g using GC.MS (Appendix II).
To assess recovery, varying amounts o f COPs were added to whole milk powder 
which were processed through the entire procedure and finally analysed by GC. The 
amount recovered was compared with the COPs standards which had been 
derivatised and analysed directly by GC. By taking the areas o f the standards that 
were directly injected onto the column as 100 %, the recoveries o f COPs from milk 
powder samples after extraction, clean-up and derivatisation were calculated 
accordingly. The recoveries obtained were greater than 90 %, except for 
cholestanetriol (Table 2.5). Full recovery was not obtained possibly because o f the 
trace amounts o f COPs present in milk powders and also because o f possible 
interference from the bulk lipids in milk (Csallany et al., 1989). One reason for the 
low recovery o f cholestanetriol may be adsorption, since cholestanetriol has three 
hydroxyl groups which may adsorb to glass and other reactive substances (Granelli 
et al., 1996). Pie et al. (1990) suggested that poor recovery o f cholestanetriol was 
possibly due to the fact that it is poorly extracted from silica. Another reason for 
poor recovery is aging GC columns, with older columns reported to give rise to peak 
broadening, peak tailing, poor resolution and consequently poor recoveries 
(Appelqvist, 1996). Pie et al. (1990) demonstrated that 20-hydroxycholesterol and 
cholesterol epoxides were slightly overestimated possibly due to the fact that they 
were extracted more effectively from silica than the internal standard, 19- 
hydroxycholesterol. The percent recoveries of COPs reported in the literature range 
from 23.6 % (Higley et al., 1986) to close to 100 % (Nielsen et al., 1995; Rose- 
Sallin et al., 1995). Specific flow-rates of solvents have not been been reported in 
other studies in which solid-phase extraction was used to isolate COPs from other 
lipids and/or cholesterol (Lai et al., 1995a). Therefore, the large variations among 
the recoveries o f COPs reported in the literature may, in part at least, be attributed to 
inconsistent flow-rates (Lai et al., 1995a). The higher recoveries obtained in recent 
years may be a reflection of our better understanding of separation techniques in 
analytical chemistry.
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In the present study, repeatability o f the GC procedure for quantification of 
cholesterol and its oxides was achieved by triplicate injections of three 
concentrations of each o f the oxides on the same day (Tables 2.6-2.10). Coefficients 
of variation of less than 5.3 % were obtained indicating acceptable repeatability 
(Willard et al., 1988). The reproducibility of the present method was ascertained by 
running cholesterol and its oxides through the entire procedure on 3 successive days. 
The coefficient of variation were less than 8.33 %, which again indicated that this 
method was reproducible and suitable for analysis o f COPs in milk powders 
(Willard et al., 1988; Schmarr et al., 1996). Similar % CV values (2-7 %) were 
reported by Schmarr et al. (1996). Rose-Sallin et al. (1995) reported higher 
coefficients o f variation (up to 34 %) and attributed this to decomposition of oxides 
during the injection step and the closeness o f the level o f COPs found in the milk 
powders with the limit o f detection o f their method (10-100 ng/g).
The limit o f detection o f the method was found to be 0.1 ^g/g, defined as the least 
detectable concentration of sample or the concentration where the signal height is 
three times that o f the noise (Nielsen et al., 1995). Reported limits of detection for 
COPs range from 0.01 (Rose-Sallin et al., 1995) to 0.1 p.g/g (Van de Bovenkamp et 
al., 1988; Nourooz-Zadeh and Appelqvist, 1988). The variation in the levels 
reported may be due to the differences in the chromatographic methods used for 
COPs detection.
Quantification o f  COPs in commercial milk powders
In Ireland, there is an average o f 36,000 tonnes of whole milk powder produced 
every year by an average o f 12 spray-drying plants. In the analysis of freshly made 
commercial spray-dried whole milk, cream and skim milk powders, no COPs were 
detected at the limit o f detection (0.1 j-ig/g) for low- and medium-heat powders. On 
the other hand, fresh spray-dried whole and skim milk powders from the high-heat 
category showed quantifiable levels of 7-ketocholesterol and cholesterol-P-epoxide 
(Table 2.12). Analysis o f stored spray-dried milk powder products was also carried 
out as part of the survey, and increased levels were found in the stored powders
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(Table 2.13). The results o f the present survey compare favorably with those of 
Nourooz-Zadeh and Appelqvist (1988) who carried out a survey amongst the 14 
spray-drying plants and 2 roller-drying plants in Sweden. They found that in the 
analysis o f freshly produced spray-dried cream, whole milk and skim milk powder * 
products, no COPs were detected for low- and medium-heat powders and similarly 
fresh roller-dried whole milk powder contained no quantifiable amount o f COPs. 
They also found that fresh spray-dried whole and skim milk powders from the high- 
heat category showed quantifiable amounts o f the hydroxycholesterols, the epimeric 
epoxides and cholestanetriol.
2.7 CONCLUSIONS
A method was successfully established and validated for reliable quantification of 
COPs in whole milk powders. Lipid extracts o f milk powders were successfully 
analysed for their content o f 5 COPs using a Folch extraction and solid-phase 
extraction procedure. COPs were separated from triglycerides on an NH2 Sep-Pak 
cartridge by elution with hexane : diethyl ether (95:5 v/v; 90:10 v/v and 80: 20 v/v), 
and then separated from each other and identified using GC.FID. Confirmation of 
structural identity was carried out using GC.MS. The limit o f detection o f the 
method was 0.1 |J.g/g. The method was suitable for analysis o f COPs in milk 
powders with levels detected being consistent with those found previously.
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CH APTER 3
EFFECT OF ANIMAL FE E D IN G  REG IM EN ON WHOLE MILK 
COMPOSITION AND O X ID A TIV E STABILITY OF WHOLE MILK
POWDER
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It has frequently been reported that dairy product manufacturers in Ireland as well as 
in parts of Australia, New Zealand and the United Kingdom experience difficulty in 
producing high quality dairy products consistently thoughout the year. The problems 
are seasonal and believed to be related to changes in milk characteristics associated 
with stage o f lactation, level of feeding and diet quality (Cullinane et al., 1984; 
Grandison et al., 1984, O’Keefe, 1984; Kefford et al., 1995). Differences in 
husbandry practices and calving patterns within and between countries may also lead 
to variations in the composition o f milk supplied to processing units (Phelan et al., 
1982).
Major difficulties exist with the processability o f a seasonal milk supply (Phelan et 
al., 1982). Late-lactation milk, for example, has serious limitations as a raw material 
for processing. The efficiency of centrifugal separators is much reduced due to the 
greater proportion o f small fat globules (< 1 f.im) in late-lactation milk and this may 
present a difficulty in conforming with the EC limit of 1.25 % fat in skim milk 
powder for intervention (Commission Regulation, 1978). In addition, the low 
thoughput o f milk from cows in late-lactation poses efficiency problems for 
equipment that is designed to handle larger volumes associated with a peak supply. 
Increased susceptibility to agitation and air incorporation can lead to a greater 
disruption o f the fat globule membrane which is weaker in late-lactation. This 
disruption causes an increase in free-fat levels in milk. Furthermore, particles of the 
fat acquire a new protein membrane and form smaller globules which are difficult to 
separate (Phelan et al., 1982). A higher content of copper is also problematic as it 
contributes to the susceptibility of late-lactation milk to fat oxidation (Van Mils and 
Jans, 1991). In Ireland, milk for manufacturing purposes is produced exclusively by 
Spring calving herds. Thus, heat-stable milk powders can only be manufactured 
from March to October (Phelan et al., 1982). Although this practice takes maximum 
advantage o f grass as a cheap feed, it may nevertheless result in extremes of milk 
volume and composition as the digestibility and quantity of the herbage can vary 
considerably between March and October.
3.1 INTRODUCTION
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in view of the difficulties in relying on grass only as a feed source, intense efforts in 
recent times have been made to improve milk composition by altering the quality of 
the animal diet (Astrup et al., 1980, Palmquist et al., 1993, Grummer, 1991,Kefford 
et a l., 1995, Murphy et a l, 1995). Although the relationship between feed 
constituents and milk composition is complex, animal diet quality has been reported 
to exert a significant impact on milk composition (Sutton, 1989).
Milk composition varies in response to certain nutritional manipulations such as 
severe underfeeding (Sutton, 1989), concentrate supplementation (Rook, 1971; Rook 
et a l., 1992) and frequency of feeding (Grummer, 1991). The earliest experiment 
using animal diet as a method of manipulating milk composition was in 1937 when 
Powell found a direct correlation between roughage intake and the composition of 
milk (Powell, 1938). Powell (1938). also considered that there was a definite 
correlation between the activity of the microflora o f the rumen and the composition 
o f milk. Since then, many dietary components have been shown to be capable of 
altering the concentration of fat or protein in milk.
Most o f the attention paid to milk composition has focused on milkfat content as 
this is most sensitive to dietary influences and o f the thee major solids (fat, protein 
and lactose) in milk, it can be changed over the widest range (Sutton, 1989; 
Palmquist et a l., 1993). Many studies have shown that it is possible to alter the fatty 
acid composition o f milkfat by feeding different fats and oils (Banks et al., 1984; De 
Peters et al., 1985; Murphy et al., 1990, 1995). Feeding full fat soyabeans or 
rapeseeds containing unsaturated 18-carbon fatty acids, to lactating cows resulted in 
a softer fat (Murphy et al., 1995). The unsaturated fatty acids are hydrogenated by 
microflora in the rumen to stearic acid which is then absorbed from the intestine and 
converted to oleic acid in the mammary gland by an intramammary stearic acid 
desaturase (Palmquist et a l., 1993). Thus, increasing the supply of stearic acid to the 
mammary gland results in increased levels o f oleic acid in the milkfat thereby 
resulting in a softer fat (De Peters et al., 1985; Grummer, 1991; Murphy et al., 
1995).
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Effects of dietary protein on milkfat composition are less well documented 
(Palmquist et a l., 1993). Higher protein intake increased mobilization o f adipose 
tissue in early lactation (Oldham, 1984), which led to an increase in the proportion of 
long-chain fatty acids in milk. Energy intake influences milkfat composition in a 
number of ways. When an animal is in positive energy balance, increased synthesis 
o f short-chain fatty acids occurs. By contrast, when an animal is in negative energy 
balance the reduced dietary supply o f acetate and glucose reduces synthesis o f short- 
chain fatty acids causing a consequent increase in mobilization of fatty acids from 
adipose tisssue (Luick and Smith, 1963; Palmquist et al., 1993). Changes in milkfat 
composition are accompanied by other changes including decreased milk protein 
concentration and increased milk urea concentration (non-protein nitrogen) 
(Palmquist et a l,  1993). Milk protein accounts for approximately 25 % of total milk 
solids and is a more valuable component of milk than fat (Murphy and O’Mara, 
1993). Increasing the amino acid supply to the mammary gland is the basis for most 
dietary manipulations to increase protein concentration or yield. Dietary protein 
does not affect milk protein concentration (Butler et al., 1983; Hettinga, 1989). 
However, feeding higher levels o f concentrate supplement, thereby increasing the 
plane o f nutrition o f the cow, has been reported to increase both milk protein 
concentration and yield (Rook et al., 1992). The inclusion of lipid in either a rumen- 
protected or unprotected form has resulted in a decrease in milk protein 
concentration but not in protein yield except at high levels o f inclusion (Murphy and 
Morgan, 1983; Banks et al., 1984).
Few attempts have been made to segregate and quantify the relative influences of 
each o f these factors on product quality and performance. Recently, however, 
Kefford et al. (1995) showed separate effects of diet and stage o f lactation on protein 
and fat contents o f milk used for Cheddar cheese manufacture in Australia.
The absolute criterion for suitability o f milk for processing is stability during 
manufacture and storage, often over extended periods, o f high-quality dairy products 
(Phelan et al., 1982). A major aspect of the quality o f whole milk powder is its 
sensory quality which declines upon storage as a result o f ‘off-flavour’ development
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caused by autoxidation. While there have been a number o f systematic studies 
carried out on the influence of animal diet quality on lipid oxidation (Buckley and 
Connolly, 1980; Atwal et al., 1991; Monahan et al., 1990; 1992; Li et al., 1996) 
there have been no known studies reported on it’s influence on cholesterol oxidation 
in whole milk powder.
The second stage o f the research investigated the influence o f animal feed quality on 
whole milk powder performance during storage with particular regard to the 
appearance of cholesterol oxides in these powders. The term animal feeding regimen 
as used thoughout this thesis refers to the feeding regimes employed. Cows were fed 
either a restricted grass supply or an amount o f concentrate which supplemented the 
standard grassland management system. The concentrate furnished extra protein, oil, 
crude fibre, minerals and vitamins including a-tocopherol. The feeding regimens 
were compared with respect to their influence on lipid and cholesterol oxidation in 
whole milk powders. Milk from both herds was taken for powder production at 
intervals corresponding to early, middle and late-lactation. In order to segregate the 
effects o f processability from those o f animal feed quality and stage of lactation, all 
powders were manufactured using a low pre-heat treatment prior to spray-drying. 
The powders were sachet-packed in foil-lined paper bags and stored at 15° C for 12 
months. Peroxide values (PVs), thiobarbituric acid reactive substances (TBARS) 
and cholesterol oxidation products (COPs) were used as indices for monitoring 
oxidation occurring in the powders during storage.
3.2 AIMS
To investigate the influence of nutrition on the composition o f milk and resultant 
whole milk powders.
3.3 OBJECTIVES
• To investigate the influence o f animal feeding regimen on composition of milk 
and powder products
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• To determine the oxidative stability o f whole milk powder, when sachet-packed 
and stored at ambient temperature.
I l l
3.4 EXPERIM ENTAL
3.4.1 Reagents
DL -a-Tocopherol (E307) and Ronoxan D20 were received as gifts from Roche 
Products Limited, Hertfordshire, U.K. All other reagents, including thiobarbituric 
acid and ammonium thiocyanate, were Analar grade and were purchased from BDH 
(Poole, Dorset, UK). Chloroform and methanol were HPLC grade, while all other 
solvents were Analar grade and were purchased from Labscan Ltd. (Stillorgan, Co. 
Dublin). Kjeltabs (5 g Potassium Sulphate K2S 0 4j, 0.5 g Copper (II) Sulphate, 
C uS04) were purchased from Alkem, Little Island, Co. Cork.
3.4.2 Feeding regimen
Thirty two Spring-calving Friesian cows were allocated to two herds (n = 16) on the 
basis of calving date and milk yield one week before initiation of the experiment, until 
the end of the feeding experiment which lasted 26 weeks.
Dietary Treatments:
R =  Grass-fed.
S = Grass + concentrate-fed
Herds R and S were stocked at 4.0 cows/ha and 3.57 cows/ha, respectively. Herd S 
cows received 3 kg concentrate/cow/day. The herds were grazed separately with a 
residence time of 3 days/plot. The concentrate furnished 186 g/kg protein, 38 g/kg 
lipid, 100 g/kg crude fibre and 91 g/kg ash. The vitamin E concentration of the 
concentrate was 7,500 IU/ton and supplementation was therefore 22.5 IU vitamin 
E/cow/day.
Composition of the concentrate
375 kg/ton unmolassed sugar beet pulp 
494 kg/ton com gluten feed 
99 kg/ton rapeseed meal
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10 kg/ton tallow 
7 kg/ton salt
6 kg/ton limestone flavour
7 kg/ton dicalcium phosphate 
2 kg/ton calcined magnesite
10 kg/ton minerals and vitamins
Minerals and Vitamins
80 g/ton Manganese oxide M n03 
150 g/ton Copper Sulphate CuS04 
118 g/ton Zinc Oxide ZnO 
12 g/ton Potassium Iodide KI 
4 g/ton Sodium Sulphate Na2S 0 4 
12 g/ton Cobalt Sulphate CoS04 
7.5 mlU/ton Vitamin A
1.5mIU/ton Vitamin D3
7,500 IU/ton Vitamin E
The concentrate supplementation (kg/day) was as follows:
Herd Apr 1-Apr 30 May 1-Sept 14 Sept 15-Oct 31
R 0 0 0
S 4 3 4
The stocking rates (cow/ha) were as follows:
Herd Apr 1-June 20 June 21-Aug 20 Aug 21-Oct 31
R 0.40 0.50 0.80
S 0.45 0.55 0.90
The land allocation (ha) was as follows:
Herd Apr 1-June 20 June 21-Aug 20 Aug 21-Oct 31
R 2.62 3.33 5.33
S 3.00 3.60 6.00
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The target post-grazing sward heights (cm) were as follows:
Herd Height
R <5.0
S 6.0-8.0
3.4.3 Milk collection, storage and transport
Milk samples were pooled and bulk milk samples from the 2 herds were pumped 
directly into each o f two 680 litres insulated tanks. The tanks were cooled to 4° C 
by a chilled water system. Evening milk was pumped into each o f the 2 tanks and 
stored overnight, after which morning milk was then added. The milk was sampled 
on Tuesday evening and Wednesday morning for each week. Powder was made 
after standardisation o f the milks.
3.4.4 Manufacture and storage of whole milk powder
The whole milk powders used in this work were produced in the Moorepark pilot 
scale milk processing plant at intervals over a 12 month period. Milk powder 
manufacture required initial standardisation of milk, resulting in a powder containing 
26 % fat. Only the low-heat powders were used in this study.
3.4.4.1 Standardisation of milk
Pearson’s square was used to assess the amount o f skim milk which should be added 
to the whole milk to yield a powder with 26 % fat in dry matter (Phelan et al., 1982). 
The Pearson’s square method is a diagrammatic method o f reducing the risk o f error 
in the calculation o f proportions of 2 ingredients to be used to give a desired end- 
product (Vamam and Sutherland, 1994).
3.4.4.2 Spray-drying of whole milk powder
A flow-chart o f the manufacture o f whole milk powder is shown in Fig. 3.1. The 
standardised milk (250 L) was pre-heated, using an APV Paraflow plate heat 
exchanger (Type HX), fitted with a 15 s holding tube. The pre-heated milk was 
concentrated using a single-effect, recirculation type, Anhydro falling film 
evaporator (Type Lab. 3).
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Fig. 3.1 Flowchart o f low-heat and high-heat whole milk powder manufacture and 
storage in the present study.
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The concentrate was homogenised (two-stage) using an APV Manton Gaulin 
homogeniser (Type KF 3). The homogenised concentrate was spray-dried using an 
Anhydro single-stage drier (Type 1 KA) equipped with a centrifugal atomiser. The 
powder was collected in a stainless steel bin at the base of the powder recovery 
cyclone and transferred to foil sacks. It was then allowed to cool in the sealed sacks 
to ambient temperature before packing.
Processing conditions were as follows:
Milk pre-heated at 75° C for 10 sec (low-heat powder) and 110° C for 2 min (high- 
heat powder)
Total solids o f the concentrate was 40 - 42 %
Homogenisation pressure at 80/20 bar and temperature at 60° C 
Spray-diyer inlet air temperature 200° C 
Spray-dryer outlet air temperature 90° C
3.4.4.3 Packing of whole milk powders
Sachet packed powders were packed in aluminium-lined sachet bags and sachet 
sealed while the vacuum packed powders were packed into laminated aluminium 
bags and vacuum sealed using a Webomatic Vacuum Packer.
3.4.4.4 Storage of whole milk powders
Storage stability trials were carried out at 15° C and 30° C, for up to 12 months. 
Powders were stored in a walk-in room with artificial lighting, with temperature 
control to ± 2° C.
116
3.4.5 Compositional analysis of standard ised  milk
3.4.5.1 Compositional analysis
The prote in, fat and lactose contents o f  m ilks  were analysed as ou tlined  by Phelan et 
a l., (1982) using the fu l ly  automated M ilkoscan  In fa -R ed A na lyser (Foss E lec tric , 
D enm ark)
3.4.5.2 Determination of fat content in milk
The fat content o f fluid milk was analysed according to the Rose-Gottlieb method 
(IDF, 1987). A 1 ml aliquot of milk (35 - 40° C) was added to 2 ml ammonia (25 % 
w/v) in a Mojonnier fat extraction flask and mixed thoroughly. 10 ml ethanol (94 % 
v/v) and 2 drops Congo Red indicator dye were then added and mixed gently. 25 ml 
petroleum ether was added, and the mixture allowed to stand for 30 s before 
centrifugation at 600 g for 2 min. The supernatant was decanted into a previously 
weighed round bottomed flask to which 15 ml diethyl ether and 15 ml light 
petroleum ether were added. This extraction was repeated twice. The final 
supernatant was added to the round bottom flask and its entire contents were heated 
at 102 ± 2° C for 1 h, allowed to cool to room temperature and the weight recorded. 
The fat content, expressed as a % by weight, was recorded as the difference in 
weight between the final weight of the round bottomed flask and its initial weight.
3.4.5.3 Fatty acid analysis
3.4.5.3.1 Milkfat extraction
Milk was cooled to approximately 4° C and a 10 ml aliquot centrifuged at 1000 g 
for 10 min. The extracted cream was then heated to 60° C and centrifuged at 1000 g 
for a further 10 min.
3.4.5.3.2 Milkfat methylation
100 mg of extracted milkfat was dissolved in 5 ml n-heptane and 0.5 ml 2 M 
methanolic KOH added. After 5 min, the solution was centrifuged at 1000 g for 3 
min, and the supernatant removed for GC analysis.
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A 100 pi aliquot of supernatant was added to a 2 ml chomatography vial containing 
0.6 ml heptane, and 1 pi injected onto a Pye-Unicam 204 GC.FID. A packed glass 
column (10 % ethylene glycol adipate on a Q 10/120 mesh (Analabs, North Haven, 
CT, USA)) with dimensions o f 2.15 m x 2 mm i.d. was used for fatty acid analysis. 
The N2 carrier gas had a flow-rate o f 20 ml/min. The injector temperature was 200° 
C and the detector temperature 250° C. The column was temperature programmed 
from 60° C, with a hold time of 2 min, to a final temperature of 200° C with a hold 
time of 32 min, at a rate o f 16° C/min. Results were expressed as g fatty acids as 
methylester /100 g o f total milk fatty acid methyl esters (FAME).
3.4.5.4 Determination of nitrogen fractions of milk by Kjeldahl analysis
Samples were heated to approximately 40 ± 2° C for 30 min and then cooled to 20 ± 
2° C in an ice-bath.
3.4.5.5 Non protein nitrogen (NPN)
Protein was precipitated from 20 g of milk sample using 12 % (w/v) trichloroacetic 
acid (TCA) and the solution was then filtered though a Whatman No. 42 filter paper. 
The nitrogen content in 20 g o f the filtrate was analysed using the Kjeldahl method 
(IDF, 1993).
10 ml concentrated sulphuric acid and one catalyst tablet (0.5 g CuS04 and 5 g 
K2S 0 4) were added to each tube. The tubes were heated on a digestion block at a 
low initial temperature (180 - 230° C), to control foaming. After approximately 30 
min, the temperature o f the digestion block was increased to 400-430° C. Digestion 
was allowed to continue until the contents of the tubes were clear green, and then for 
a further 1.5 h. 50 ml distilled water was then added to the cooled digest, which was 
then distilled into boric acid.
A conical flask, containing 50 ml 4 % boric acid was placed in the distillation unit, 
and the digestion tube attached. 55 ml 50 % (w/v) sodium hydroxide (NaOH) was 
dispensed into the tube. The ammonia, liberated by the addition of NaOH, was then
3.4.5.3.3 Fatty acid analysis
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steam distilled and 200 ml distillate collected and titrated with 0.02 M HC1 to pH 
4.6.
3.4.5.6 Non casein nitrogen (NCN)
NCN was analysed according to the Kjeldahl method (IDF, 1993). 30 g of milk was 
added to 50 ml o f distilled water at 50° C and 3 ml 10 % (w/v) TCA was added. The 
solution was allowed to stand for 10 min at room temperature before 3 ml o f 1 M 
sodium-acetate was added and the solution made up to 100 ml with distilled water. 
This was then filtered though Whatman No. 42 filter paper.
3.4.5.7 Total nitrogen (TN)
Total Nitrogen was analysed in 2 g o f the milk sample using the Kjeldahl method 
(IDF, 1993) and 10 ml water used as a blank.
3.4.5.8 Calculations
Total Nitrogen
% TN = (1.4 x (vl - vO) x C)/W 
No protein content
% NPN= (1.4 x (vl - vO) x C x 0.988)/W 
No casein nitrogen content 
% N C N - (1.4 x (vl - vO) x C x 0.985)/W 
Where: v l = Sample titre (ml) 
vO - Blank titre (ml)
C = Molar concentration o f the acid used for titration (0.02 ± 0.0005 M) 
0.988 = Correction factor for 20 g of milk sample analysed (NPN).
0.985 = Correction factor for 30 g of milk sample analysed (NCN)
W= Weight o f milk sample taken (g)
Calculations o f crude total protein content 
% TP = % TN x 6.38 
Calculation o f casein protein 
% CP = ( % TN - % NCN) x 6.38 
Calculations o f casein number 
CN=(% Casein protein /% TP) x 100
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Calculations o f whey protein content
% WP=(% NCN - % NPN) x 6.38
3.4.6 Whole milk powder analysis
3.4.6.1 Moisture analysis
Whole milk powder samples were analysed for moisture content by drying to 120° C 
for 10 min in a Mettler LP 16 (Mason Technology, Switzerland).
3.4.6.2 Determination of fat content in whole milk powder
The fat content o f a 10 % (w/v) solution o f whole milk powder was determined 
according to the Rose-Gottlieb procedure, as outlined in section 3.4.5.2.
3.4.6.3 Determination of undenatured whey protein nitrogen
The undenatured whey protein nitrogen index was determined by the method 
outlined in ADMI (1971). Whole milk powder was first reconstituted (2.7 g/20 ml) 
and 8 g NaCl was then added and the mixture incubated at 37° C for 30 min. The 
mixture was shaken 8-10 times during the first 15 min, and then filtered, without 
cooling though Whatman No. 42 filter paper. To 1 ml of the filtrate was added 10 
ml o f saturated NaCl solution (1 kg/1) which was then acidified with 30 p.1 1 N HC1 
and the transmission recorded at 420 nm within 5 - 1 0  min. Undenatured whey 
protein was expressed as mg undenatured whey protein/g whole milk powder.
3.4.6.4 Determination of peroxide values in whole milk powder
The peroxide value (PV) of milkfat isolated from milk powder was determined using 
the ferric thiocyanate method, as outlined by (IDF, 1991). Milkfat was extracted as 
outlined by Murphy (1978): 35 ml o f reconstituted powder (13 g/90 ml water) and 11 
ml o f the de-emulsification reagent (30 g Triton X-100 and 70 g of sodium 
hexametaphosphate/1) were placed into narrow necked fat separation tubes (AGB 
Ltd., Dublin) and mixed thoroughly. The tubes were placed in a boiling water-bath 
and the contents were agitated after 5 and 10 min. The tubes were centrifuged in a 
Gerber centrifuge for 1 min. Sufficient de-emulsification reagent was then added to 
bring the fat column up the narrow neck of the tube and the sample was centrifuged
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again for 1 min. The fat was transferred from the tube using a Gilson pipette. If the 
fat solidified before being transferred, the tube was put back into the heated water- 
bath for a further 3 - 5  min to liquify the fat once again. 9.6 ml chloroform : 
methanol (70:30 v/v) and 0.05 ml 0.5 M ammonium thiocyanate were added to 0.3 g 
of the isolated milkfat samples and the resultant solutions vortexed. Subsequently, 
0.05 ml 3 M iron (II) chloride was added and the solution incubated for 10 min at 
room temperature. Iron (III) Chloride was used as a standard. Absorbance at 500nm 
was recorded and results expressed as mEq 0 2/kg fat.
3.4.6.5 Determination of thiobarbituric acid reactive substances in whole milk 
powder
Secondary lipid oxidation products were measured by the 2-thiobarbituric acid 
(TBA) method o f Tarladgis et al. (1960) using a Buchi steam distillation apparatus 
(Model VD 100). 7 ml 3 N HC1 were added to a dispersion of whole milk powder 
(15 g in 75 ml) in cold distilled water. 1 drop of silicone antifoam agent was added 
and the contents mixed and subsequently distilled to yield 50 ml distillate. A 20 ml 
aliquot of distillate was added to 2 ml 0.02 M TBA (in 90 % glacial acetic acid) and 
the mixture boiled for 35 min. The solution was then cooled to room temperature 
and TBA expressed as absorbance units at 530 nm, measured using a 1 cm path 
length cuvette. A conversion factor o f 6.2 (Crackel et al., 1988) was used to convert 
absorbance unit to mg malondialdehyde (MDA)/kg whole milk powder.
3.4.6.6 Measurement of free sulphydryl groups
The amount of free sulphydryl groups in milk powder was measured using the 
procedure outlined by Kalab (1970). Ellman’s reagent was prepared by dissolving 
20 mg 5,5’-dithiobis-(2-nitrobenzoic acid) in 10 ml 0.1 M phoshate buffer, pH 7. 5 
ml of the reconstituted milk powder (20 % (w/v)) was mixed with 0.1 ml Ellman’s 
reagent, 1 ml o f 0.2 M phosphate buffer, pH 8 and 4 ml distilled water. Cysteine 
was used as standard and absorbance at 412 nm was recorded. The concentration of 
free sulphydryl groups was expressed as ^imoles/g powder.
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3.4.6.7 Measurement of total sulphydryl groups
Total sulphydryl groups were measured using Ellman’s reagent according to an 
adapted method of Beveridge et al. (1974). To 10 ml of a 20 % (w/v) solution of 
whole milk powder was added 1 ml 10 M urea in Tris-Glycine buffer (0.09 M Tris, 
0.09 M glycine, pH 8.6 containing 4 mM EDTA) and 20 pi of 2-mercaptoethanol 
and the solution centrifuged at 5000 g for 10 min. The precipitate was washed twice 
with 5 ml 12 % (w/v) TCA and then dissolved in 3 ml 8 M urea in Tris-glycine 
buffer, pH 8.6 and 0.03 ml Ellman’s reagent was added. Absorbance at 412 nm was 
recorded and total reactive sulphydryl groups expressed as pmoles/g powder.
3.4.6.8 Measurement of Vitamin E content
Vitamin E concentration of milk powder was determined using the method of Buttriss 
and Diplock (1984). To 1 ml o f a 25 % (w/v) solution of whole milk powder was 
added 2 ml of a 1 % pyrogallol solution and 0.3 ml of a 50 % solution of KOH and the 
mixture saponified by shaking vigorously at 70° C for 30 min. The mixture was then 
allowed to cool on ice, after which 4 ml hexane containing 0.005 % butylated 
hydroxy toluene (BHT) and 1 ml water was added. The mixture was then 
centrifuged at 600 g for 10 min at 4° C. The upper layer was removed, dried under 
nitrogen and redissolved in 200 pi ethanol. Vitamin E was separated and quantified 
using a reverse phase HPLC with a nucleosil 100-5 C l8 column (Macherey Nagel 
Art. 720014). The mobile phase was 97 % methanol and UV detection was at 292 
nm. Results were expressed as pg/g powder.
3.4.6.9 Analysis o f COPs
Lipids were extracted as described by Sander et al. (1989) and as outlined in Chapter 
2, section 4.4. COPs were isolated from the twice hexane-washed lipid extract by 
solid phase extraction as described by Morgan and Armstrong (1989). COPs were 
then analysed by GC.FID using the method described in chapter 2, section 4.5. 
Results were expressed as pg/g lipid.
3.4.7 Statistical Methods
Whole milk powder was manufactured on 14 occasions. These occasions were 
grouped into three periods. The duration of each period was selected so that powders 
made during a specific period were manufactured from milk of similar composition,
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and thus could be used as replicates in the statistical analysis. Periods 1, 2 and 3 had 
5 (April 20-May 26; Trial number 1-5), 5 (June 16-July 21; Trial number 6-10) and 4 
(August 3-October 21; Trial number 11-14) occasions as replicates, respectively. 
For each period COPs, WPNI, PVs and TBARS were analysed as a randomised 
block design with diet and heat treatment as a factorial combination. COPs at 12 
months, PV and TBARS at 2, 4, 6 and 12 months were analysed as a split-plot 
design with diet and heat treatment combined factorially in the main plots and 
temperature and package type as the sub-plot factorial combination. Sulphydryl 
groups were analysed as a randomised block design with diet and heat treatment as 
the factors. Sulphydryl group analysis was done for a mid-lactation period with milk 
powder made on four separate occasions as replicates and for a late lactation period 
using thee separate occasions as replicates. Statistical analysis was completed using 
the GENSTAT package (The Numerical Algorithms Group Ltd., Oxford, UK).
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3.5 RESULTS
3.5.1 Effcct of animal feed quality on milkfat content
Animal feeding regimen had no significant effect on milkfat levels in the grass-fed 
herd (R) and grass plus concentrate-fed herd (S). Fig. 3.2 shows the fat levels in 
these milks, which ranged from 3.57 to 4.59 % for milk of herd R and from 3.77 to
5.05 % for the milk o f herd S. An increase in milkfat levels was observed in milk of 
the grass plus concentrate-fed herd in late-lactation, though it was not statistically 
significant. Similarly, animal feeding regimen had no significant effect on fatty acid 
composition o f milks obtained from these two herds. Table 3.2 shows the levels of 
fatty acids in milk from the grass-fed and grass plus concentrate-fed herds in early 
and mid-lactation. Milkfat content o f short chain saturated fatty acids (C4-C12) 
were in general, much lower than the levels of longer chain saturated fatty acids 
(C14 - C18), the exception being the C20:0 saturated fatty acid (arachidic acid) 
content which was present in low concentrations (Table 3.1). Levels o f even 
numbered saturated fatty acids (C4 - C l6) were similar in milkfat from both herds. 
No significant difference was observed between total C 18 fatty acids from the grass- 
fed herd (44.1 g FAME/100 g) and grass plus concentrate-fed herd (41.99 g 
FAME/1 OOg).
3.5.2 Effect of animal feed quality on milk protein content
Fig. 3.3 (a) shows the percentage total protein in standardised milk o f the grass-fed 
and grass plus concentrate-fed herds. Milk from the grass plus concentrate-fed herd 
(herd S) had significantly higher protein content (p < 0.001) than milk of the grass 
only-fed herd (herd R) thoughout the feeding study. Protein concentration was 
approximately 10 % lower in milk from herd R (2.96 to 3.66 %) than the herd S 
(3.34 to 4.02 %). Total protein levels increased in late-lactation (periods 11-14), 
though not significantly. Fig. 3.3 (b) shows the non-protein-nitrogen (NPN) in 
standardised milk o f grass-fed and grass plus concentrate-fed herds. NPN content of 
milk from the 2 herds was not significantly different thoughout the study. Fig. 3.4 
(a) shows data obtained for true protein content, defined as total protein less NPN in 
standardised milks from herds R and S. The pattern for true protein content followed
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Fig. 3.2. Fat levels (%) in standardised milk o f grass-fed herd (R) and grass plus 
concentrate-fed herd (S). Period 1 from April 20-May 26; Period 2 from June 16 to 
July 21 and Period 3 from August 3 to October 21. Error bars refer to mean ± 
standard deviation.
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Table 3.1 Fatty acid composition (g FA as methylester/100 g o f total FAME) o f raw 
milks from the grass-fed herd (R) and grass plus concentrate-fed herd (S) during 
early and mid lactation.
Fatty acid Ra S u
C4:0 3.34 ±  0.16 3.28 ±0.12
C6:0 2.17 ±  0.13 2.20 ± 0.09
C8:0 1.28 ±0.11 1.34 + 0.08
C10:0 2.70 ±0.33 2.98 ± 0.33
C12: 2.95 ±0.38 3.32 ±  0.40
C14:0 9.66 ± 0 .77 10.46 ±0.51
C14:l 1.06 ±0 .12 1.08 ±0 .06
C16:0 23.17 ±1 .06 23.80 ±0.68
C16:l 1.87 ±0 .12 1.73 + 0.12
C18:0 12.82 ± 0 .70 12.32 ± 0 .76
Cl 8:1 28.71 ±  1.82 26.94 ±1.38
C18:2 1.68 ±0 .39 1.96 ±0.13
C18:3 0.85 ±0.11 0.77 ±0.08
C20:0 0.16 ±0 .02 0.15 ±0 .04
a n= 9 periods
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Fig. 3.3. (a) Total protein and (b) non-protein nitrogen of standardised milks from 
grass-fed herd (R) and grass plus concentrate-fed herd (S). Grass-fed significantly 
higher than grass plus concentrate-fed over full experimental period *** (p < 0.001). 
Error bars refer to mean ± standard deviation.
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Fig. 3.4. (a) True protein and (b) whey protein o f standardised milks from grass-fed 
herd (R) and grass plus concentrate herd (S). Grass-fed significantly higher than 
grass plus concentrate-fed over full experimental period ** (p < 0.01), * (p < 0.05). 
Error bars refer to mean + standard deviation.
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that of total protein, indicating that milk o f herd R had significantly lower (p < 0.01) 
true-protein than that of the grass plus concentrate-fed herd. The level of true protein 
in milk from the grass plus concentrate-fed herd increased, though not significantly, 
in late-lactation. Whey protein was also significantly higher (p < 0.05) in milk of 
herd S than that o f herd S (Fig. 3.4 (b)) and increased in late-lactation for both herds. 
Fig. 3.5 (a) shows the casein protein levels in milk from both herds. Casein levels 
followed a similar trend to that o f protein content with milk of herd R showing 
significantly lower (p < 0.001) casein than milk of herd S. Similar to total protein 
and whey protein, casein increased markedly in the milk of herd S during late 
lactation. Animal feed quality had no significant effect on casein number (casein 
protein expressed as a percentage o f total protein) over the full experimental period 
(Fig. 3.5 (b)). Table 3.2 summarises the effect o f animal feed regimen and stage of 
lactation on protein composition (Figs. 3.3 - 3.5).
3.5.3 Effect of animal feed regimen on undenatured whey protein nitrogen 
index of whole milk powder
Whole milk powder was produced from milk o f grass-fed and grass plus concentrate- 
fed herds following low pre-heat treatment. The effects of animal feeding regimen 
on whey protein nitrogen index (WPNI) values of the whole milk powders were 
compared. The WPNI values obtained for the low-heat powders o f herds R and S 
were 6.9 ±  0.9 and 7.8 ±  1.1 mg/g powder, respectively. Animal feeding regimen 
significantly (p < 0.05) affected levels o f undenatured whey protein in whole milk 
powders only during period 1, but had no effect on powders produced in periods 2 
and 3 (Fig. 3.6).
3.5.4 Effect of animal feeding regimen on PV levels in whole milk powder
The primary oxidative stability of fresh and stored low-heat whole milk powders was 
assessed by measuring peroxide values (PV). Fig. 3.7 (a) shows the PV (mEq 0 2/kg 
fat) levels obtained in fresh milk powders manufactured thoughout the experimental 
period.
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Fig. 3.5. (a) Casein protein and (b) casein number o f standardised milks from grass- 
fed herd (R) and grass plus concentrate-fed herd (S). Grass-fed significantly higher 
than grass plus concentrate-fed over full experimental period *** (p < 0.001). Error 
bars refer to mean ± standard deviation.
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Tabic 3.2 Effect o f animal feed quality and period o f milking on protein fractions in 
milk. Values refer to probability levels.
Effect Total T rue Casein Casein Non Protein Whey
Protein Protein Protein Num ber Nitrogen Protein 
Animal Feeding 0.001 0.01 0.001 N.S. N.S. 0.05
Regimen
Stage o f lactation N.S.* N.S. N.S. N.S. N.S. N.S.
* N.S. : not statistically significant.
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Fig. 3.6 Undenatured whey protein nitrogen index (WPNI) o f low-heat powders 
from grass-fed herd (R) and grass plus concentrate-fed herd (S). Grass-fed 
significantly higher than grass plus concentrate-fed * (p < 0.05). Error bars refer to 
mean ± standard deviation.
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PV levels o f powders manufactured during periods 1 and 2 were significantly higher 
(p < 0.05) for the grass-fed herd than the grass plus concentrate-fed herd,while in PV 
levels o f powders manufactured during periods 1 and 2 were significantly higher (p < 
0.05) for the grass-fed herd than the grass plus concentrate-fed herd, while in PV 
levels o f powders manufactured during periods 1 and 2 were significantly higher (p < 
0.05) for the grass-fed herd than the grass plus concentrate-fed herd, while in fed 
herd showed higher PV levels (up to 0.5 mEq 0 2/kg) than the grass-fed herd herd 
(0.31 mEq 0 2/kg.). Fig. 3.7 (b) shows the changes in PV values obtained when 
powders were sachet-packed and stored for up to 12 months at 15° C. PV values 
increased in both powders reaching a maximum after 6 months storage at 15° C and 
declined thereafter. Maximum PV reached was 2.9 mEq 0 2/kg for powder o f the 
grass-fed herd and 2.7 mEq 0 2/kg for powders o f herd S after 6 months o f storage. 
In general, whole milk powders from the grass plus concentrate-fed herd that were 
sachet-packed and stored at 15° C had lower levels of lipid oxidation as indicated by 
lower PV compared with whole milk powder from the grass-fed herd. Concentrate 
feeding had a significant inhibitory (p < 0.05) effect on peroxide development in 
whole milk powder after 12 months storage at 15° C.
3.5.5 Effect of animal feeding regimen on TBARS in whole milk powder
Fig. 3.8 (a) shows the levels of TBARS (mg MDA/kg) obtained in fresh milk 
powders manufactured thoughout the experimental period. Animal feeding regimen 
had a significant (p < 0.05) effect on TBARS in fresh whole milk powders in periods 
1 and 2 only, though the effect was not in the same direction as for PV. As seen for 
PV levels, TBARS increased in powders from both herds when stored in foil-lined 
paper bags at 15° C for up to 12 months (Fig. 3.8 b). TBARS continued to increase 
steadily thoughout the entire 12 month storage period, increasing more rapidly in the 
second half o f the storage study, unlike PV levels which increased only during the 
first 6 months of the storage study (Fig. 3.7 b). This inverse relationship between PV 
and TBARS after 6 months storage may indicate progression of oxidation from a 
primary to a secondary state. TBARS in whole milk powder of the grass-fed herd
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Fig. 3.7. PV levels in (a) fresh and (b) sachet-packed whole milk powders stored at 
15° C from grass-fed herd (R) and grass plus concentrate-fed herd (S). Grass-fed 
significantly higher than grass plus concentrate-fed * (p < 0.05). Error bars refer to 
mean ± standard deviation.
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Fig. 3.8. TBARS levels in (a) fresh whole milk powder and (b) sachet-packed whole 
milk powders stored at 15° C from grass-fed herd (R) and grass plus concentrate-fed 
(S) herd. Grass-fed significantly higher than grass plus concentrate-fed * (p < 0.05) 
** (p < 0.01) was significantly higher (p < 0.01) than whole milk powder o f the 
concentrate-fed herd after 12 months. Error bars refer to mean ± standard deviation.
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3.5.6 Effect of animal feed quality on cholesterol oxidation in whole milk 
powder
The data obtained for total cholesterol oxidation products (COPs) expressed as pg/g 
lipid for fresh whole milk powders manufactured from both grass and grass plus 
concentrate-fed herds are shown in Fig. 3.9. Total COPs levels remained below 1 
pg/g for the duration of the study and were not significantly different in powders 
manufactured with milk of the grass-fed herd compared with the grass plus 
concentrate-fed herd. Storage o f whole milk powder from both herds yielded 
significantly higher (p < 0.001) levels of COPs relative to fresh whole milk powder 
and Table 3.3 shows the levels o f individual and total COPs (expressed as pg/g and 
as a % total cholesterol) when these powders were sachet-packed and stored for 12 
months at 15° C. Following storage, 7-ketocholesterol was the predominant 
cholesterol oxide detected in milk powders of both herds. 7-Ketocholesterol and 
cholesterol-P-epoxide were significantly higher (p < 0.05) in whole milk powder of 
the grass-fed herd compared with the grass plus concentrate-fed herd. Neither 25- 
hydroxycholesterol or cholestanetriol were detected in whole milk powders o f both 
herds, which were sachet-packed and stored at 15° C for 12 months. The level of 
total COPs in stored powders o f the grass-fed (5.50 ± 1.27 pg/g) herd was 
approximately 5-fold higher relative to fresh milk powders of the same herd. This 
represented 0.27 % of total cholesterol (2000 pg/g fat) in milk being oxidised during 
the storage period. The level of total COPs observed in stored powders of the grass 
plus concentrate-fed herd (3.89 ± 1.01 pg/g) was significantly lower (p < 0.05) than 
powders o f the grass-fed herd, and amounted to 0.19 % of total cholesterol being 
oxidised during the 12 months storage period (Table 3.3).
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Fig.3.9. COPs levels in fresh low-heat whole milk powders manufactured from 
milks o f grass-fed (R) and grass plus concentrate-fed (S) herds. Error bars refer to 
mean ± standard deviation.
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Table 3.3 Levels of COPs in 12 month old sachet-packed whole milk powders after storage at 15°C. Levels o f primary’ and secondary' 
oxidation products are shown as well as the total level o f COPs expressed as fig/g and as % total cholesterol.
Whole 7-Keto 25-OH a-epoxide ß-epoxide Triol Total Total
milk (jig/g lipid) (% total
powder cholesterol)
R 4.18 ±0.94 * 0.65 ±0.11 0.67 ± 0 .9 * 5.5 ± 1 .2 7 * 0.27 ± 0.063 *
S 3.42 ± 0.S9 0.47 ±0.08 - 3.89 ± 1.01 0.19 ±0.05
* Grass-fed herd (R) (p < 0.05) significantly higher than grass plus concentrate-fed herd (S).
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Tabic 3.4 demonstrates the levels o f free and total sulphydryl groups found in stored 
powders thoughout this study. Animal feed quality had a significant effect (p < 0.05) 
on free sulphydryl levels, with whole milk powder from the grass plus concentrate- 
fed herd containing higher levels o f free sulphydryl groups (0.11 ± 0.04 p.moles/g 
powder) than whole milk powder from the grass-fed herd (0.07 ± 0.02 pmoles/g 
powder). Whole milk powders from the grass plus concentrate-fed herd also had 
higher levels o f total sulphydryl groups (16.88 ± 0.03 |umoles/g powder) compared 
with those from the grass-fed herd (15.91 ± 0.03 /¿moles/g powder).
Table 3,4 Free sulphydryl and total sulphydryl group levels in whole milk powder 
o f grass-fed herd (R) and grass plus concentrate-fed herd (S).
3.5.6 Effect of animal feed quality on sulphydryl groups in whole milk powder
Herd Free Total
Sulphydryl Sulphydryl
|j.moles/g powdera pmoles/g pow der“
R 0.07 ± 0.02 15.91 ±0.03
S 0.11 ±0 .04* 16.88 ±0.03
a n (number o f samples analysed)=7
* Grass plus concentrate-fed herd significantly higher (p < 0.05) than grass-fed 
herd.
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Milk from both herds R and S was analysed for fat and protein contents prior to 
low-heat powder manufacture. The oxidative stability o f these low-heat powders 
was assessed during ‘normal’ commercial storage conditions (i.e. sachet-packed 
and stored at 15° C). In this way, the influence of animal feeding regimen on milk 
quality could be addressed. It should be emphasised at this stage however that only 
the relative effects o f dietary restriction and supplementation could be evaluated, as 
a control herd fed on the standard grassland and stocking management system was 
not included in the study. The grass only-fed herd differed from the standard 
grassland and stocking management system in having a lower land allocation, a 
lower stocking rate and no concentrate supplementation.
Effect o f  animal feeding regimen on milkfat content
The results presented in this chapter report the effects of grass feed only compared 
to grass plus concentrate feed on oxidative stability of whole milk powder in 
addition to the influence of stage o f lactation on fat and protein levels prior to 
whole milk powder manufacture. The milkfat levels analysed in the present study 
ranged from 3.78 - 5.05 % and the data suggests that the 2 dietary treatments did 
not significantly influence milkfat content. Previous reports o f fat levels in milk 
range from 2.14 to 4.49 % (Sutton, 1989) (Fig. 3.2). Variation in fat levels can be 
attributed to a number of factors including stage of lactation, dietary intake, breed, 
health o f animal and climate (Cullinane et al., 1984) Though not significant, an 
increase was observed in milkfat o f the grass plus concentrate-fed herd in period 3, 
coinciding with late lactation. Milkfat increases in late-lactation have been 
previously reported (Walstra and Jenness 1984; Early, 1992). Walstra and Jenness 
(1984) reported that the time elapsed after parturition (calving) considerably 
influenced milk composition, though the extent to which milk composition changed 
with lactation varied markedly among animals. It is difficult to establish the 
precise effect o f lactation stage as both season and feeding regimens change with 
advancing lactation.
3.6 DISCUSSION
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In the present study, milkfat levels increased slighty, though not significantly, in 
the grass plus concentrate-fed animals but not in the grass-fed herd, suggesting that 
milkfat content during late-lactation was influenced by animal feeding regimen, 
coinciding with the earlier study of McDowall (1962). Hence the absence o f a late- 
lactation effect on fat content that was observed in the grass-fed herd may be 
accounted for by the lower plane of nutrition.
Similarly, the two dietary regimens investigated had no significant effect on fatty 
acid composition o f milk, though there was a small trend towards increased levels 
o f total C18 unsaturated fatty acids in the grass-fed herd (Table 3.1). A state of 
negative energy balance during early to mid lactation has been reported to result in 
mobilisation o f adipose tissue reserves (Parodi, 1974; Palmquist et al., 1993), 
which have a high content of long chain fatty acids and may account for the slightly 
higher level o f total C l8 fatty acids in the milk from herd R up to and including 
mid-lactation. However, the uptake o f long chain fatty acids was not sufficiently 
high to inhibit de novo synthesis of short chain fatty acids by the mammary tissue 
since similar levels o f these short chain fatty acids were observed in milk from both 
herds. Luick and Smith (1963) reported a decrease in the proportions of fatty acids 
o f chain length C4 to C16 and an increase in C18:0 and C18:1 as a result o f the 
mobilisation of body reserves when cows are placed on a ‘restricted’ intake.
Effect o f  animal feeding regimen on milk protein content
Protein levels ranged from 2.96 to 4.02 % in the present study and concentrate 
feeding had a significant effect (p < 0.001) on milk protein content (Fig. 3.3 a). 
Previous studies have also shown that feeding higher levels o f concentrate 
supplement, thereby increasing the plane o f animal nutrition increases both milk 
protein concentration and yield (Rook, 1992; O ’ Mara, 1993). In the present study, 
milk obtained from the grass-fed herd had a total protein content o f less than 3.3 % 
between April and October. Though not significant, the total protein content 
increased from September to October, which may be attributable to a late-lactation 
effect. It has previously been reported that protein levels vary according to stage of
141
lactation (Rook, 1961; Rook, 1971; Faegan, 1979; De Peters and Cant, 1992; 
Murphy and O ’Mara, 1993). Rook (1971) reported that in days immediately before 
calving, milk secretion accumulates within the udder and during that time there is 
considerable resorption of lactose, but a negligible resorption of protein and hence 
the high level o f protein in early lactation milk. The relationship between protein 
and lactose synthesis is due to the role of a-lactalbumin in lactose synthesis in the 
mammary gland (Morrissey, 1985). The secretion o f a-lactalbumin controls the 
levels of o f lactose synthesis and a high correlation has been found between lactose 
and a-lactalbumin in milk (Morrissey, 1985).
The pattern for true protein content followed that o f total protein, where again, the 
grass-fed herd had significantly lower (p < 0.01) levels (Fig. 3.4 a). The casein 
levels followed similar trends to that of total protein in the present study (Fig. 3.5). 
In late-lactation milk, the casein content increased as total protein increased. This 
observation was reported also by De Peters and Cant (1992). In the present study, 
the casein number was similar for both herds thoughout lactation, showing that the 
ratio of casein to total protein was maintained, although the total protein was 
different at the two nutritional levels. The casein number declined slightly from 
September onwards for both herds. This may be due to the degradation o f P-casein 
in the mammary gland by the milk enzyme plasmin, which is a phenomenon o f late- 
lactation milk (Oltner et al., 1983).
The grass only diet had a negative impact on the whey protein content of milk, with 
milk of the grass-fed herd containing significantly lower (p < 0.05) levels than that 
of the grass plus concentrate-fed herd Fig. 3.4 b). This could have serious 
implications in the manufacture of whole milk powder from milk of grass-fed herd, 
as milk powder is classified on the basis of native whey protein in the powder after 
heat treatment. High-heat powder is classified as containing less than or equal to 1.5 
mg whey protein/g powder, whereas low-heat is classified as containing greater than 
or equal to 6.0 mg whey protein/g powder (ADMI, 1971). Therefore, if  the 
concentration o f whey protein is low in the raw milk, medium-heat powder
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subsequently manufactured could be incorrectly classified as high-heat powder, 
leading to problems in the production of consistent quality powder.
A recent study on the influence of diet on Cheddar cheese manufacture (Kefford et 
til., 1995) found that the plane o f nutrition also had a significant increase (p < 0.05) 
on casein and whey protein, as seen in the present study, and no significant effect on 
milkfat levels. However, direct comparisons cannot be made, as the concentrate 
used by Kefford et al. (1995) was different to that of the present study in that it 
contained only maize grain (as energy source) and sunflower meal (as protein 
source).
Effect o f  animal feeding regimen on undenatured whey protein nitrogen index o f  
whole milk powder
Animal feeding regimen had no overall effect on WPNI o f low-heat powder o f both 
the grass-fed herd R and the grass plus concentrate-fed herd S although whole milk 
powder of herd S had significantly higher WPNI values than that of herd S in period 
1 (p < 0.05). Though not significant over the entire experimental period, the WPNI 
of powders produced from the grass plus concentrate-fed herd showed a trend 
towards an increase, which may be accounted for by the significantly higher (p < 
0.05) whey protein content (Fig. 3.6).
Effect o f  animal feeding regimen on oxidative stability o f  whole milk powder
While animal feeding regimen had no overall significant effect on PV or TBARS in 
fresh whole milk powder, fresh milk powder from the grass-fed herd did show 
significantly elevated (p < 0.05) levels of PV and TBARS in periods 1 and 2. On the 
other hand, whole milk powders from the grass plus concentrate-fed herd, when 
sachet-packed and stored at 15° C for 12 months, had lower levels o f lipid oxidation 
as indicated by lower PV and TBARS values compared with whole milk powder 
from the grass-fed herd.
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When whole milk powders were sachet-packed and stored at 15° C for 12 months, 
total COPs levels were significantly lower (p < 0.05) for powders of the grass plus 
concentrate-fed herd compared with those o f the herd fed grass only (Fig. 3.9). 25- 
hydroxycholesterol and cholestanetriol were not detected and 7-ketocholesterol and 
cholesterol-P-epoxide were significantly lower (p < 0.05) in whole milk powder of 
the grass plus concentrate-fed herd than that o f the grass-fed herd. Though not 
significant, the grass-fed herd showed slightly higher levels o f  oleic, linoleic and 
linolenic acids and it has been reported that cholesterol in foods is oxidised when it 
exists together with unsaturated fats (Osada et al., 1993). This may have been a 
contributory factor to the increased presence o f cholesterol oxides in powders of the 
grass-fed herd.
The data from the present study indicated differences in cholesterol oxides in stored 
milk powders from both grass-fed and grass plus concentrate-fed herds, with the 
whole milk powder o f the grass-fed herd showing higher levels following 12 months 
storage (Table 3.4). 7-Ketocholesterol was found to be the predominant cholesterol 
oxide present, followed by the epimeric epoxides, coinciding with findings of Chan 
et al. (1993). 7-Ketocholesterol, a primary oxidation product, has been reported as a 
principal cholesterol oxide (Maerker, 1987) and has been used as a marker of 
cholesterol oxidation in ground beef (De Vore, 1988). Cholestanetriol, a secondary 
oxidation product, is a degradation product o f 7-ketocholesterol and is only found in 
extremely oxidised powders. The stored powders in the present study contained total 
COPs levels o f less than 6 jag/g, which is low relative to other foodstuffs. Dried egg 
powders have been shown to contain up to 300 jj,g/g total COPs (Nourooz-Zadeh and 
Appelqvist, 1987; Van de Bovenkamp et al., 1988).
The protective effect against oxidation offered by the milk o f the grass plus 
concentrate-fed herd would indicate that supplementary concentrate feeding was 
beneficial. A number of factors need to be considered in order to account for this 
effect. It has been previously reported that animals supplemented with vitamin E 
showed higher vitamin E content in milk compared with grazing animals (Atwal et 
al., 1991). The vitamin E concentration o f the concentrate supplement fed to the
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grass plus concentrate fed herd in this study was 22.5 IU vitamin E/ day. Analysis of 
vitamin E in whole milk powders from both herds did not show a significant 
difference, although the levels were slightly higher (14 ± 0.8 M-g/g), in the grass plus 
concentrate fed-herd compared to the grass-fed herd (11 ±0.5 |_ig/g). Herd R was fed 
on grass only, and the vitamin E in the milk powder would therefore have been 
furnished by grass intake, which has been reported to range from 9 fig/g (September) 
to 350 jj.g/g (April) Brown (1953). Bovine milk typically contains an average of 20- 
50 ng/g vitamin E (McGillivay, 1956; O’Shea, personal communication). The 
vitamin E level o f 14 ± 0.8 (ig/g in the milk powders o f the grass plus concentrate- 
fed herd may have been a result o f the extra vitamin E intake, as a result of 
concentrate feeding. The levels observed in these powders were consistent with 
those found in commercial powders (O’Shea, 1996 personal communication). This 
may have been due to losses incurred on processing and it has been reported 
(Dziezak, 1986) that vitamin E can be lost during refining and processing conditions. 
However, it is more likely that the similar vitamin E levels found may be due to the 
fact that the levels in the concentrate were too low to have any significant effect 
(Murphy 1996, personal communication). In the present study, the vitamin E levels 
in the concentrate were very low (22.5 IU/day) compared with other studies where 
levels ranging from 400 IU/day to 1 g/day (1 mg = 1.49 IU) were incorporated 
(Atwal et al., 1990; Ashes et al., 1992; Wahle et al., 1993). In addition, the transfer 
of vitamin E from feed has been reported to be as low as 2 % (King, 1968), hence the 
need for incorporation o f very high levels in feed to bring about a significant 
increase in the resultant milk. It is worth reiterating that the aim of the study was to 
investigate the protective effect o f concentrate feeding, rather than investigating dose 
responses o f a-tocopherol.
The increased intakes o f antioxidant minerals and vitamins in the concentrate, in 
addition to vitamin E may be expected to contribute to the increased oxidative 
stability offered by the milk of the concentrate-fed herd. Among the minerals and 
vitamins added, manganese, copper and zinc are essential in their functioning in the 
active site o f free radical scavenging enzymes such as the superoxide dismutases 
(Mn SOD and Cu Zn SOD) (Halliwell, 1994). A possible increased activity o f
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SOD in the milk o f the grass plus concentrate-fed herd may have accounted for the 
increased oxidative stability seen in whole milk powders manufactured, although 
this was not measured in the present study.
Tallow was incorporated as the lipid source in the concentrate feed. Effects of 
dietary fat on milkfat levels and composition have been studied more than any 
other factor (Claperton and Banks, 1985; Grummer, 1991, Palmquist et al., 1993). 
The effects o f dietary lipids on milkfat synthesis are complex (Sutton, 1989) and 
are mediated within the rumen, body and udder o f the cow (Storry, 1981). In the 
present study, however, supplemental lipids had no significant effect on the fatty 
acid profiles, though slightly higher levels o f unsaturated fatty acids were observed 
in milk o f the grass-fed herd.
Effects of dietary protein on milkfat composition are less well documented 
(Palmquist et al., 1993). The protein sources o f the concentrate-fed to the grass 
plus concentrate-fed herd were rapeseed meal and com gluten. High intakes of 
protein have been reported to result in mobilisation of adipose tissue in early 
lactation, which could increase the proportion o f long chain fatty acids in milk. 
Protein intake may also have subtle effects on milk fatty acids by providing 
precursors for synthesis of various branched-chain fatty acids though ruminal 
degradation o f dietary protein (Oldham, 1984). Again, the protein in the 
concentrate did not have a significant effect on the proportion of long chain fatty 
acids. However, a protein effect wasn’t specifically examined.
Previous reports suggest that a grass only-fed diet can result in the production of 
increased levels o f unsaturated C l8 fatty acids, which can result in increased 
autoxidation (Sidhu et al., 1976; Sutton, 1989). In the present study, however, the 
cows fed the grass only diet showed no significant differences in levels o f oleic, 
linoleic and linolenic acids compared to cows fed grass plus concentrate. A possible 
explanation for the increased oxidation in the whole milk powders o f the grass-fed 
herd may have been induction of lipolysis as Astrup et al. (1980) found that 
restricted feed intake induced lipolysis. However, the data presented in the present
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study did not indicate any evidence of increased lipase activity in milk of the grass- 
fed herd as the levels o f short chain fatty acids (C4 - CIO) were similar in milk 
obtained from both herds.
Since concentrate feeding had no significant effect on milkfat level or composition in 
the present study, it is likely that the increased protein levels in the milk of the grass 
plus concentrate-fed herd may have been responsible for the protective effect 
observed in milk powder manufactured from this milk. Both the elevated whey and 
casein fractions observed have been previously reported to have antioxidant activity 
(Taylor and Richardson, 1980; Allen and Wrieden., 1982). Free sulphydryl groups 
are known to result in increased oxidative stability o f whole milk powder by 
scavenging of free radicals (Beveridge et al., 1974; Taylor and Richardson, 1980; 
Van Mil and Jans, 1991). Whole milk powders from the grass plus concentrate-fed 
herd had higher levels o f reactive sulphydryl groups compared with those from the 
grass-fed herd (Table 3.4). This may be attributed to the increased whey protein 
levels in milk o f the grass plus concentrate-fed herd relative to that o f the grass-fed 
herd. However, Taylor and Richardson (1980) have demonstrated that sulphydryl 
groups are responsible for only part o f the antioxidant activity. They found that (3- 
lactoglobulin, which contains most of the sulphydryl groups of the milk (0.9 moles 
SH/mole protein (Femandez-Diez et al., 1964)), accounted for only a small portion 
o f the total antioxidant activity, whereas the caseins, which have few or no 
sulphydryl groups (Beveridge and Nakai, 1970), had significant antioxidant effect 
when heated. In support o f this finding, the casein content of the milk of the grass 
plus concentrate-fed herd was greater than that o f the herd which received a grass 
only diet. Caseins possess significant antioxidant activity which may be related to 
their hydrophobic nature (Taylor and Richardson, 1980) and orientation of potential 
antioxidant side-chains o f constituent amino acids at the lipid interface. Brunner 
(1974) reported a retardation of lipid oxidation in homogenized milk when milkfat 
droplets were resurfaced with casein. The antioxidant activity associated with casein 
almost certainly derives from it’s ability to bind metals to phosphoseryl residues and 
the binding of metals to phosphate appears generally to inhibit their catalytic effect 
on autoxidation (Allen and Wrieden, 1982).
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3.7 C O N C LU SIO N S
increased dietary intake (i.e. concentrate-feeding and increased stocking rates) 
offered protection against oxidation o f whole milk powder during storage expressed 
by reduced levels o f lipid peroxides, secondary oxidation products and cholesterol 
oxidation products. Such protection may have been attributed to the total antioxidant 
activity of the increased levels o f casein and whey proteins o f milk o f the grass plus 
concentrate-fed herd (although other factors may have also contributed). In addition, 
protection may have been offered by the increased minerals and vitamins in the 
concentrate feed thereby further contributing to the antioxidant intake of the grass 
plus concentrate-fed herd. Animal feeding regimen offers considerable potential for 
modifying milk composition and much progress has been made since Powell’s 
original observations that diet had a significant effect on milkfat levels (Powell, 
1938), but many areas of uncertainty remain. Research into nutritional manipulation 
o f milk is likely to be limited until the Dairy industry recognises the potential to 
make significant progress in improving milk quality though feeding practices, and 
until technologies are developed and implemented which provide incentive for 
producers to improve milk quality (Grummer, 1991).
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C H A P T E R  4
EFFECT OF PROCESSING, PACKING AND STORAGE ON 
OXIDATIVE STABILITY IN WHOLE MILK POWDER
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Whole milk powder production in Ireland today amounts to 3600 % o f our national 
requirements and constitutes the bulk o f the Irish milk powder export market. A 
major part o f this export is marketed in countries with a hot and often humid climate. 
This requires that whole milk powder have good shelf life (Ipsen and Hansen, 1988), 
which can be defined as the ability to retain a fresh and neutral flavour under given 
storage conditions. The storage stability o f a powder also includes its ability to be 
reconstituted (Ipsen and Hansen, 1988).
The manufacture o f spray-dried milk products includes a number of steps in addition 
to evaporation and spray-drying (Caric, 1994). These include pre-heat treatments, 
homogenisation, selection and modification o f the spray-drying conditions, such as 
inlet and outlet temperatures. By incorporating a number of additional steps such as 
lecithinisation, it is possible to influence the product properties to a great extent, so 
as to produce specialised products (Pisecky, 1980).
Research endeavours on whole milk powder can be broadly classed under two 
headings: (i) the effect o f age on the development o f ‘off-flavours’ in milk powder 
and (ii) the effect o f storage conditions on the solubility of whole milk powders 
(Tuohy, 1987; Nourooz-Zadeh and Appelqvist, 1988; Baldwin and Ackland, 1991). 
There is, however, a relative dearth o f information on the effect o f heat processing 
treatments during spray-drying on oxidative stability o f whole milk powders, in 
particular on oxidative stability of lipid components such as cholesterol. A greater 
understanding of the changes in whole milk powder during storage arising from 
changes in pre-heat treatment is required in order to allow selection o f optimum and 
appropriate conditions for manufacture o f good quality whole milk powders.
Fat in dried milk products can deteriorate chemically in two ways, (i) the 
triglycerides can be hydrolysed and the flavour of the product spoiled by excessive 
liberation o f the pungent short chain fatty acids (‘hydrolytic rancidity’) or (ii) the 
unsaturated fatty acid constituents of the fat can be oxidised by atmospheric oxygen 
with the formation o f peroxides and ultimately, o f aldehydes, acids of low molecular
4.1 IN T R O D U C T IO N
150
weight and other compounds of objectionable flavour (‘oxidative’ rancidity). Since 
pasteurisation inactivates most lipases associated with ‘hydrolytic rancidity’, the 
latter phenomenon is a major problem associated with the long-term storage of 
whole milk powders (Coulter et al., 1951; Lea, 1953; Shipstead and Tarassuk, 1953; 
Boon et al., 1976; Tuohy, 1987; Ipsen and Hansen, 1988). As organoleptic 
examination of milk samples is time-consuming, subjective and expensive, 
chemical indices o f  autoxidation are often used, the two most common being 
peroxide values (PV) and thiobarbituric acid (TBA) determinations (Tuohy, 1987).
Since whole milk powder is subject to oxidation during storage, it is most important 
that packing precautions are taken to eliminate as much oxygen as possible. There 
are many different forms of packing materials used for whole milk powder, from tin­
plate cans and foil-lined sachets to foil laminates, each with their own specific uses. 
Tin-plate cans are expensive and there have been developments in flexible film 
lamination technology (Tuohy, 1984) resulting in a more cost-effective alternative. 
The main advantages associated with this form of packing are (i) lower cost 
material, because the metal layer is only 9-12 jam thick, (ii) light weight material for 
transport and distribution, (iii) flexible construction, allowing a greater weight of 
powder to be packed per unit load volume. Aluminium foil packs can be made, 
filled, gas-flushed and sealed on a single machine, occupying a small floor area. 
Since packs are actually made in situ, pack size can be changed, within limits 
without major disruption. There are, however, some disadvantages associated with 
using aluminium foil laminates in packing of whole milk powder: (i) laminate packs 
do not have the mechanical strength and durability of rigid containers, (ii) there can 
be difficulty getting an airtight pack due to heat-seal failure if the heat area becomes 
contaminated with powder fines, (iii) as the thickness of the foil used is only 9-12 
um, there is the possibility of finding ‘pinholes’ in the foil layer. Also, during 
handling o f the laminate prior to or during sachet formation, there is a risk of 
damaging the foil layer and making the laminate permeable to oxygen (Tuohy, 
1984). Vacuum-packing reduces the oxygen content of packed whole milk powder 
by both evacuation o f the interstitial air (air between powder particles) and by 
compression of the powder, which results from vacuumisation (Van Mil and Jans,
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1991). Tuohy (1984) found that vacuum-packing in aluminium foil laminates was 
as effective as gas flushing at retarding lipid oxidation and comparable with canning 
under nitrogen. An added advantage o f vacuum-packing of whole milk powder is 
the volume reduction arising from the compression which is associated with 
vacuumisation. Reducing the oxygen content o f packed whole milk powder has 
been reported to significantly reduce oxidation (Tuohy, 1987; Van Mil and Jans, 
1991; Chan et al., 1993). De Vilder (1982) reported that when whole milk powder 
was packed in tins with an atmosphere o f nitrogen and carbon dioxide, the flavour 
score remained favourable for thee years. However, when packed in material which 
permitted the passage of moisture (paper lined bags) or gas entry (sachets), the 
organoleptic properties after a period of storage were significantly lower when 
compared with the initial values.
Autoxidation also depends on temperature: it has been demonstrated that if  the 
temperature is raised by 10° C, the oxidation reaction rate is doubled (Walstra and 
Jenness, 1984). Oxidation o f whole milk powder has been reported to significantly 
increase at high storage temperatures (Tuohy, 1984; Chan et al, 1993). However, an 
increase in temperature may also lead to an increase in Maillard reactions, resulting 
in a compensating antioxidative effect of the reaction products (Wyott and Day, 
1965; Eriksson, 1982).
Spray-dried, cholesterol-containing foods, subjected to air and heat during 
processing are susceptible to sterol oxidation during preparation and storage and 
therefore may benefit from antioxidant addition (Huber et al., 1995). Since 
cholesterol oxidation proceeds via a free radical mechanism, antioxidants used to 
inhibit ‘general’ lipid oxidation may also retard cholesterol oxidation (Smith, 1980; 
Huber et a l, 1995; Lai et al., 1995b). Consumer concerns regarding the safety of 
synthetic antioxidants, such as BHT has prompted investigations into the 
effectiveness o f naturally occurring compounds, such as the tocopherols 
(Resurrection and Reynolds, 1990; Huber et al., 1995; Wahle et al., 1993; Li et al., 
1996). Nonetheless, studies involving the application o f antioxidants to inhibit 
cholesterol oxidation have been limited. BHA, BHT and propyl gallate, common
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synthetic antioxidants, were only slightly effective in slowing hydrogen peroxide- 
induced cholesterol oxidation in egg yolk during spray-drying (Morgan and 
Armstrong, 1987). More recent evidence (Rankin and Pike, 1993; Huber et a l., 
1995) has shown that tocopherol isomers at concentrations of 0.02-0.2 % (w/w total 
lipid) proved effective in reducing cholesterol autoxidation in spray-dried egg 
powder. During storage, an inverse relationship between COP formation and a- 
tocopherol content was observed (Huber et al., 1995).
In Chapter 3, the effects o f animal feeding regimen on oxidative stability of whole 
milk powders were investigated. This chapter deals with an investigation of the 
effects o f pre-heat treatment on oxidative stability of whole milk powders. In 
addition, the effect o f vacuum-packing was compared with sachet-packing for long­
term storage o f whole milk powder at both ambient (15° C) and ‘hot-room’ (30° C) 
temperatures. Therefore, this chapter contains data that overlaps with chapter 3. 
Finally, a preliminary study was undertaken to investigate the antioxidative effects 
o f a-tocopherol addition to milk both prior to and after spray-drying.
4.2 AIMS
To assess the effects of pre-heat temperature, spray-drying, storage and packing 
conditions on oxidative stability of whole milk powder.
4.3 OBJECTIVES
• To investigate the effect of manufacture (processing) on the physical, functional 
and organoleptic properties o f whole milk powder.
• To investigate the effects o f low pre-heat and high pre-heat temperatures on lipid 
and cholesterol oxidation in whole milk powder during storage.
• To investigate the effectiveness o f reduced oxygen levels in retarding lipid and 
cholesterol oxidation in whole milk powder. The two packing conditions 
investigated were sachet-packing and vacuum-packing.
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• To investigate the role of storage temperatures on the extent o f lipid and 
cholesterol oxidation in whole milk powder.
• To evaluate the effectiveness of emulsified a-tocopherol in inhibiting lipid and 
cholesterol oxidation during storage o f spray-dried whole milk powder.
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4.4 E X PE R IM E N T A L
4.4.1 M anufacture of whole milk powder
Whole milk powder was manufactured from milk of the grass-fed herd and grass 
plus concentrate-fed herd in the Moorepark pilot plant as outlined in Chapter 3. 
Low-heat (75° C for 10 sec) and high-heat (110° C for 2 min) powders were 
manufactured, and subsequently sachet-packed in aluminium lined paper bags or 
vacuum-packed in foil laminates and stored at 15° C and 30° C in a walk-in room 
with artificial lighting and temperature control to ± 2° C.
4.4.2 M anufacture o f whole milk powder with a-tocopherol addition
A pilot study was performed in which the effect o f a-tocopherol addition on whole 
milk powder stability was investigated. The a-tocopherol was added to 2 o f the 
manufacturing trials ((3/8/94 (trial 11) and 18/8/94 (trial 12)). The effects o f a - 
tocopherol addition to milk both prior to and following spray-drying were assessed. 
Standardised milk o f the grass-fed herd was subjected to high pre-heat treatment and 
subdivided into 4 aliquots (50 litres); 1 aliquot was used as control, 2 aliquots for a- 
tocopherol addition prior to spray-drying and 1 aliquot for a-tocopherol addition 
after spray-drying. Emulsifed dl-a-tocopherol (oil form, Roche Products Ltd.) was 
added at two concentrations (500 jig/g lipid and 1000 jig/g lipid) to the milk 
concentrate on a fat basis prior to spray-drying. The concentrate was homogenised 
(two-stage) using an APV Manton Gaulin homogeniser (Type KF 3). The 
homogenised concentrate was spray-dried as outlined in Chapter 3. The powder was 
collected in a stainless steel bin at the base o f the powder recovery cyclone and 
transferred to foil-sacks. The powder was allowed to cool in the sealed sacks to 
ambient temperature before packing. Ronoxan D-20 (powder form, Roche Products 
Ltd.) (a mixture o f ascorbyl palmitate, dl-a-tocopherol and citric acid in the 
proportion 6:2:1, together with an anhydrous glucose and an emulsifier (glyceryl 
monostearate) was added to 1 aliquot (50 g) o f powder at a concentration of 1000 a - 
tocopherol (j.g/g on the powder basis for investigation of the effect o f a-tocopherol 
addition after spray-drying.
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4.4.3 Whole milk powder analysis
4.4.3.1 M oisture analysis
Samples were analysed for moisture as outlined in Chapter 3, section 3.4.6.1.
4.4.3.2 Determination o f fat content in whole milk powder
The fat content o f a solution o f whole milk powder (10 % w/v) was determined using 
the Rose-Gottlieb method as outlined in Chapter 3, section 3.4.6.2.
4.4.3.3 Determination o f bulk density in whole milk powder
The bulk density o f the whole milk powder manufactured in this study was 
determined according to the IDF (1995) procedure. 100 g whole milk powder was 
weighed into 250 ml graduated cylinder, which was then placed on the platform of 
the density tester and 100 jolts applied to the sample. The volume of powder was 
recorded from the graduated cylinder, and results were expressed in g/ml.
4.4.3.4 Determination o f insolubility index in whole milk powder
The insolubility index was determined as outlined in ADMI (1971). A solution of 
whole milk powder (13 g/100 ml), containing 2-3 drops o f antifoam agent was 
stirred for 90 sec at 24° C and allowed to stand at room temperature for 15 min. The 
sample was mixed thoroughly for 5 sec and a conical centrifuge tube immediately 
filled to the 50 ml mark and centrifuged for 5 min at 500 g. The supernatant was 
then siphoned off to within 5 ml of the surface o f the sediment level, taking care not 
to disturb the sediment layer. 25 ml distilled water at 24° C was added and the tube 
shaken gently to disperse the sediment, dislodging if necessary with a wire. The tube 
was again filled to the 50 ml mark with distilled water at 24° C, and inverted several 
times to mix the contents thoroughly and centrifuged again at 500 g for 5 min. The 
tube was held in a vertical position and the insolubility index measured to the nearest 
scale. Results were expressed in ml.
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4.4.3.5 Determination of undenatured whey protein nitrogen index
The undenatured whey protein nitrogen index (WPNI) was determined according to 
the method outlined by the ADMI (1971) as outlined in Chapter 3, section 3.4.6.3.
4.4.3.6 Determination of peroxide values in whole milk powder
The peroxide values (PV) o f the powders were assayed according to IDF (1991) as 
outlined in Chapter 3, section 3.4.6.4. PV values were expressed as mEq 0 2/kg fat.
4.4.3.7 Determination o f thiobarbituric acid reactive substances in whole milk 
powder
The thiobarbituric acid reactive substances (TBARS) were determined according to 
2-thiobarbituric acid method of Tarladgis et al. (1960) as outlined in Chapter 3, 
section 3.4.6.5. A conversion factor o f 6.2 (Crackel et al., 1988) was used to convert 
absorbance units to mg MDA/kg whole milk powder.
4.4.3.8 M easurement o f free sulphydryl groups
The level o f free sulphydryl groups was measured using the procedure described by 
Kalab (1970) and outlined in Chapter 3, section 3.4.6.6. Results were expressed as 
jimoles/g whole milk powder.
4.4.3.9 M easurem ent o f total sulphydryl groups
Total sulphydryl groups were measured using Ellman’s reagent as described by 
Beveridge et al. (1974) and outlined in Chapter 3, section 3.4.6.7. Results were 
expressed as (j,moles/g whole milk powder.
4.4.3.10 M easurem ent o f Vitamin E
Vitamin E concentration in milk powder was determined using the method of 
Buttriss and Diplock (1984) as outlined in Chapter 3, section 3.4.6.8. Results were 
expressed in (.ig/g powder.
4.4.3.11 Analysis o f COPs
COPs were analysed using the method outlined in Chapter 2, sections 2.4.4 and 2.4.5 
and results expressed as p.g/g lipid.
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Organoleptic assessment was carried out by The Borden’s Company Ltd. (see 
appendix III for detailed procedure) on a sub-sample of powders to investigate the 
effect o f pre-heat temperature, packing and storage conditions on organoleptic 
properties o f powders using an in-house method described as follows: 13 g whole 
milk powder was reconstituted by addition o f 90 ml demineralised water (25° C) and 
mixed in a blender for 90 sec. The reconstituted sample was allowed to stand for one 
h at room temperature before tasting. Panellists tasted the samples to which they 
assigned a score on their flavour score sheet (appendix III). The flavour score was 
reported by a numbering system as follows:
90: Perfect, slightly cooked flavour.
85: Good: no off-flavour, not quite as fresh tasting as 90.
80: Fair; no strong off-flavour, but less fresh tasting then 85.
75: Objectionable; some off-flavour.
‘Off flavours’ were identified as:
4.4.3.12 Organoleptic Assessment of whole milk powder
(i) Acid (vii) Metallic
(ii) Bitter (viii) Oxidised or tallowy
(iii) Chalky (ix) Rancid
(iv) Burnt (X) Salty
(v) Feed (xi) Stale
(vi) Flat (xii) Weedy
4.4.4 Statistical M ethods
Results were statistically analysed as outlined in Chapter 2, section 6, with 
correlation coefficients determined by Pearson’s Correlations using the SYS-STAT 
package.
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4.5 RESU LTS
4.5.1 Physical, chemical and functional characteristics of manufactured whole 
milk powder
Whole milk powder was manufactured on 14 different occasions thoughout the 
lactation period. All milks were heat treated prior to powder manufacture, equal 
volumes (50 litres) being subjected to low-heat (75° C for 10 sec) treatment and to 
high-heat (110° C for 2 min) treatment. The powders were analysed for physical, 
functional and organoleptic properties prior to and after storage for 12 months at 
‘ambient’ (15° C) temperature and ‘hot room’ (30° C) temperature. Table 4.1 
describes the chemical composition and physical, functional and organoleptic 
properties o f fresh and stored whole milk powders. Neither pre-heating nor storage 
had an effect on moisture content o f whole milk powders. There was no significant 
difference between the moisture contents o f freshly manufactured low-heat powders 
(2.01 ± 0.39 %) and high-heat powders (2.93 ± 0.80 %). Similarly, there was no 
significant difference stored low-heat (1.99 ± 0.45 %) and high-heat whole milk 
powders (2.78 ±  0.45 %). Bulk density of low- and high-heat whole milk powders 
ranged from 0.51 to 0.56 g/ml. No significant difference was observed in this 
parameter in fresh or stored powders.
A difference in the insolubility index, though not significant, was observed between 
low-heat and high-heat whole milk powders. Freshly manufactured low-heat 
powders had a mean insolubility index of 0.1 ± 0.23 ml compared to 0.4 ± 0.36 ml in 
fresh high-heat powders. Ambient temperature storage increased the insolubility 
index in both low-heat (approximately 3-fold) and high-heat powders (approximately 
1.5-fold). Storage at 30° C increased the insolubility index in low- and high-heat 
powders approximately 5-fold and 1.5-fold, respectively.
The fat content o f the powders (Table 4.1) was not affected by heat treatment or by 
storage. Freshly manufactured whole milk powders showed PV levels ranging from 
0.40 - 0.43 mEq 0 2/kg and TBARS levels ranging from 0.08 - 0.11 MDA/kg.
159
Table 4.1. Properties o f fresh and stored high-heat and low-heat whole milk powders" o f the grass-fed herd. All powders were sachet-packed 
and stored at 15 and 30° C for 12 months. Data refers to mean ± standard deviation.
W hole Milk Powder 
Characteristics
Fresh low-heat 
whole milk 
powder
Fresh high-heat 
whole milk 
powder
12 month old low- 
heat whole milk 
powder 
(15 °C)
12 month old 
low-heat whole 
milk powder
(30°C )
12 month old 
high-heat whole 
milk powder 
(15 °C)
12 month old 
high-heat whole 
m ilk powder
(30 °C)
Moisture (%) 2.01 ± 0.39a 2.93 ± 0.80a 1.99 ± 0.45a 2.02 + 0.45a 2.78 + 0.45a 2 .69+  0.45a
WPN index (mg/g) 6.90 ± 0.83 a 1.30 ± 0.20 a 6.60 ± 0 .65b 6.49 + 0.45 ° 1.10 + 0.45° 1.29+ 0.36°
Fat (%) 26.28 ± 0.26a 26.11+ 0.84 a 25.12 + 0.45° 25.99 + 0.41 b 25.99 + 0.65° 25.60+  1.05°
Bulk density (g/ml) 0.55 ± 0.34a 0.55 ± 0.52a 0.54 + 0.35° 0.54 + 0.45 0 0.56 + 0.46° 0.51 ± 0.09°
Insolubility index 
(ml)
0.10 ± 0.23 a 0.40 ± 0.36 a 0.30 + 0.54° 0.53 + 0.45 ° 0.60 + 0.32° 0 .58+  0.43°
Peroxide Value 
(mEq/kg fat)
0.43 + 0.14* 0.40 ± 0.09a 1.99 + 0 .6 0 a 2.72 + 0.95 a 1.17 + 0.73a 1.74+ 0.62 a
TBA (mg MDA/kg) 0.11 ± 0.04a 0.08 ± 0.02a 0.53 + 0 .15“ 1.59 + 0.45a 0.29 + 0.09a 0.44+  0 .09a
Flavour 85 ± 2.5° 85 ± 3 .7 ° 82 + 3 .2 ° 75 + 3.2° 90 + 4.1° 80 + 3.98°
“ n = 14 P n = 4
n= number o f samples analysed
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Storage for 12 months at 15° C resulted in a significant increase (p < 0.01) in PV 
values in low-heat powders (1.99 0 2/kg fat) and high-heat powders (1.17 mEq 0 2/kg 
fat), and a similarly significant (p <0.01) increase in PV levels was obtained at ‘hot 
room’ storage temperatures compared to storage at 15° C. TBARS were also 
significantly higher (p < 0.01) in low and high-heat whole milk powders at both 15 
and 30° C. Organoleptic evaluation o f  whole milk powder showed that freshly 
manufactured powders had a flavour score o f 85, which was classified by trained 
panellists as ‘good’. However, the flavour score deteriorated to 82 (‘slightly 
oxidised’) in stored low-heat powders and increased in the high-heat powders to 90 
( ‘perfect flavour’).
The effects o f animal feeding regimen and pre-heating temperatures on WPNI values 
o f whole milk powders are shown in Fig. 4.1. Animal feed regimen resulted in 
significantly higher levels o f undenatured whey protein during period 1 (p < 0.05) 
but had no significant effect on powders produced in periods 2 and 3. The low-heat 
powders o f the herds R and S had mean WPNI values o f 6.9 ± 0.8 and 7.8 ± 1.1 mg 
undenatured whey protein/g powder, respectively, compared to values of 1.3 ± 0.2 
and 1.1 ± 0.2 mg undenatured whey protein/g powder, respectively, for 
corresponding high-heat powders. All low-heat and high-heat powders 
manufactured thoughout the study fell within the limits o f each class according to the 
WPNI. As expected, the high pre-heating temperature (110° C) led to significantly 
more protein denaturation (Fig. 4.1) than the low pre-heating temperature (75° C).
The levels o f ‘free’ sulphydryl groups found in milk powder used in this study are 
compared in Table 4.2. High pre-heat treatment of milk from both herds resulted in 
increased levels o f ‘free’ sulphydryl groups (p < 0.05) compared with low pre-heat 
treatment. The ‘free’ sulphydryl content of powders manufactured from milk o f the 
grass plus concentrate-fed herd (S) were significantly (p < 0.05) higher than the 
grass-fed herd (R) at both low and high-pre-heat temperatures. High-heat powder 
o f the grass-fed herd yielded, on average, 0.28 ± 0.04 jamoles ‘free’ sulphydryl
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Fig. 4.1 WPNI o f low and high-heat whole milk powders o f grass- 
fed herd (R) and grass plus concentrate-fed herd (S).
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groups/g powder, while corresponding low-heat powders yielded only 0.07 ± 0.02 
l-imoles/g powder. The inverse was found for ‘total’ sulphydryl levels, which 
decreased as the pre-heat temperature increased. The level o f ‘total’ sulphydryl 
groups for low-heat powder o f the grass-fed herd was 15.9 ± 0.03 f.imoles/g 
compared to 0.14 ± 0.03 (j.moles/g for high-heat powder o f the same herd. Total 
sulphydryl levels in high-heat powders were, however, observed to be lower than the 
free sulphydryl content, suggesting that heat-treatment adversely affected the ability 
of mercaptoethanol to reduce disulphide groups in high-heat powders.
Table 4.2. Free and total sulphydryl group concentration in 12 month stored whole 
milk powder".
Herd Heat class Free Total
sulphydryl sulphydryl
|amoles/g powder l^moles/g powder
R low 0.07 ± 0.02 15.91 ±0.03
S low 0.11 ±0 .04  c 16.88 ±0.03
R high 0.28 ± 0.04 a 0.14 ±0.03
S high 0.46 ±0 .04  b’d 0.16 ±0.04
n (number o f samples analysed)^ 
a p < 0.05 relative to grass-fed grass-fed, low-heat class 
b p < 0.05 relative to grass plus concentrate-fed herd S, low heat class
c p < 0.05 relative to grass-fed grass-fed, low-heat class 
d p < 0.05 relative to grass-fed grass-fed, high heat class
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4.5.2 Effect o f pre-heat treatment on oxidative stability during storage o f whole 
milk powder.
The data from this study indicates that high pre-heating conditions led to improved 
oxidative stability in whole milk powders during subsequent storage compared to 
low pre-heat treatment. The PV values obtained for low-heat powders were 
significantly higher (p < 0.05) than those o f high-heat powders after 6 months 
storage at the temperatures examined (15° C and 30° C; Fig. 5.2 a-d, broken lines). 
While PVs increased 7-fold in low-heat powders, which were sachet-packed and 
stored at 15° C for 6 months, an increase o f only 3.5-fold was observed in high-heat 
powders under similar packaging and storage conditions (Fig. 5.2 a). Similarly, 
TBARS levels were significantly reduced (p < 0.01) in high-heat powders compared 
to low-heat powders during the 12-month storage period (Fig. 5.2 a-d solid lines). 
When PV levels were correlated with storage time, PV levels reached a maximum at 
6 months storage with correlation coefficients o f 0.92 ± 0.07. TBARS levels were 
found to reach a maximum at 12 months, with correlation coefficients o f 0.94 ± 0.05, 
when corrleated with time, indicating a progression from a primary to secondary 
oxidation state.
4.5.3 Effect o f packing on oxidative stability of whole milk powder.
Vacuum-packing o f  whole milk powder resulted in significantly lower PV and 
TBARS values compared to sachet-packing (p < 0.001) during subsequent storage at 
15° C and 30° C (Fig. 4.2 c-d). Vacuum-packing reduces the oxygen content of 
packed powders by both evacuation of the interstitial air and compression of the 
powder (Tuohy, 1984). In the present study, TBARS values of sachet-packed 
powders of the grass-fed herd increased 5-fold during storage for 12 months at 15°C 
(Fig. 4.2 a) and 15-fold during storage at 30° C (Fig. 4.2 b), while only 3 and 4-fold 
increases were observed when powders were vacuum-packed and stored at 15° C and 
30° C (Fig. 4.2 c-d), respectively.
4.5.4 Effect o f storage temperature on oxidative stability o f whole milk powder.
Storage temperature played a significant role in lipid oxidation o f milk powder in the 
present study, with higher storage temperatures leading to significantly increased PV
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Fig. 4.2 PV (— ) and TBARS (_) were monitored in high-heat (110° C for 2 min)
and low-heat (75° C for 10 sec) whole milk powders, manufactured from milk of
grass-fed herd (R) and grass plus concentrate-fed herd (S).
a. Sachet-packed and stored at 15° C; b. Sachet-packed and stored at 30° C; 
c. Vacuum-packed and stored at 15° C; d. Vacuum-packed and stored at 30° C.
R LO W  low -heat p o w d e r o f  th e  grass only-fed  herd 
R HIGH h igh -hea t p o w d e r o f  the grass only-fed  herd 
S LO W  low -heat p o w d e r o f  the  concen tra te  plus g rass-fed  herd  
S HIGH hlgh-lieat p o w d er o f  the concen trate  phis g rass-fed  herd
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levels (p < 0.001) and TBARS values (p < 0.001). Fig. 4.2 (a) illustrates the levels 
of PV (broken lines) and TBARS (solid lines) obtained from sachet-packed low-heat 
and high-heat whole milk powders o f the herds R and S and stored at 15° C for up to 
12 months, while Fig. 4.2 (b) shows similar powders, but stored at 30° C. PV levels 
increased at an accelerated rate compared to TBARS, reaching a maximum at 6 
months storage at 15° C and 30° C for all powders investigated, and declined 
thereafter (Fig. 4.2 a-d). An inverse relationship was observed between PV and 
TBARS after 6 months storage at both 15° C and 30° C, indicating progression of 
oxidation from a primary to a secondary state. While a 7-fold increase in PV values 
was observed due to storage of low-heat powders at 15° C for 6 months, storage at 
30° C resulted in a 10-fold increase in PV values (Fig. 4.2 b). A greater difference 
between storage temperatures was noted in low-heat (p < 0.001) than high-heat 
powders (p < 0.05), i.e. a significant interaction (p < 0.01) between pre-heat and 
storage temperature existed. Table 4. 3 summarises the interactions which occurred 
between treatments during this study. Significant interactions were found between 
packing conditions and animal feed quality (p < 0.05), storage temperature and 
animal feed quality (p < 0.05), packing conditions and pre-heat temperature (p <
0.01), storage temperature and pre-heat temperature (p < 0.05) and storage 
temperature and packing conditions (p < 0.001). This data indicates that the effect of 
any one o f these treatments on the oxidative stability of whole milk powder was 
increased when combined with another treatment, e.g. the effect o f sachet-packing on 
oxidative stability o f whole milk powder was greater at the higher storage 
temperature of 30° C than at the ambient storage temperature o f 15° C.
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Table 4.3 Interactions between animal feed quality, pre-heat temperature, packing 
and storage temperature. Values refer to probabilities.
Effect Animal Feeding 
Regimen
Pre-heat Packing Storage
Temperature
Anim al - N.S. 0.05 0.05
Feeding
Regimen
Pre-heat N.S. - 0.01 0.05
Packing 0.05 0.01 - 0.001
Storage 0.05 0.05 0.001 -
Tem perature
4.5.5 Effect of processing, packing and storage on organoleptic properties of 
whole milk powder.
Table 4.4 shows the data obtained by sensory evaluation o f the low and high-heat 
whole milk powders o f the grass-fed and grass plus concentrate-fed herd after 12 
months storage at 15 and 30° C. Low-heat whole milk powder stored at 30° C 
obtained the lowest flavour score (75), indicative of oxidised flavour. While storage 
o f low-heat and high-heat powders at 15° C resulted in slightly oxidised flavour 
score o f 80-82, the highest flavour score was obtained for high-heat vacuum-packed 
powders stored at 15° C which resulted in a flavour score of 90 and was deemed 
‘acceptable’ by taste panellists. Statistical analyses showed no significant 
differences between whole milk powders o f both herds. However, after 12 months 
storage at 15° C, vacuum-packed powders of the grass-fed herd resulted in a 
‘strongly oxidised’ flavour, while the corresponding powders from the grass plus 
concentrate-fed herd gave rise to an ‘oxidised’ flavour.
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'table 4. 4 Sensory evaluation o f  stored low and high whole milk powders.
Heat
Treatm ent
Animal feeding  
Regimen
Packing
type
Storage 
temp. (° C)
Flavour
score
Comments
Low-heat Grass only Sachet 15 82 Slightly oxidised
Grass plus concentrate Sachet 15 84 Slightly oxidised
Low-heat Grass only Sachet 30 75 Strongly oxidised
Grass plus concentrate Sachet 30 76 Strongly oxidised
Low-heat Grass only Vacuum 15 80 Oxidised
Grass plus concentrate Vacuum 15 82 Slightly oxidised
Low-heat Grass only Vacuum 30 75 Strongly oxidised
Grass plus concentrate Vacuum 30 80 Oxidised
High-heat Grass only Sachet 15 82 Slightly oxidised
Grass plus concentrate Sachet 15 83 Slightly oxidised
High-heat Grass only Sachet 30 80 Oxidised
Grass plus concentrate Sachet 30 80 Oxidised
High-heat Grass only Vacuum 15 90 Good
Grass plus concentrate Vacuum 15 90 Good
High-heat Grass only Vacuum 30 82 Slightly oxidised
Grass plus concentrate Vacuum 30 84 Slightly oxidised
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4.5.6 Effect o f  pre-heat, packing and storage temperature on cholesterol 
oxidation in whole milk powder of the grass-fed and grass plus concentrate-fed  
herds
In the present study, ‘total COPs’ refers to the quantification of 5 o f the most 
commonly found COPs in processed foods, which are the cholesterol-oc- and P- 
epoxides, 7-ketocholesterol, 25-hydroxycholesterol, and cholestanetriol. Fig. 4.3 
shows a chomatogram of stored sachet-packed whole milk powder from (a) grass 
only and (b) grass plus concentrate-fed herds. The most notable difference in these 
chomatograms is the presence of cholestanetriol in the powder o f the herd fed grass 
only, but not in the powder of the herd fed grass plus concentrate. Fig. 4.4 shows the 
levels o f total COPs in low- and high-heat whole milk powders manufactured from 
both herds. The histogram depicts the total COPs data obtained from fresh powders 
and vacuum and sachet-packed powders stored at 15° C and 30° C for 12 months.
In freshly prepared milk powders, high pre-heat treatment resulted in significantly 
higher levels (p < 0.001) o f COPs than low pre-heat treatment. The total COPs 
content o f fresh high-heat powders from the grass-fed herd was 1.6 ± 0.55 (ag/g lipid, 
compared with 0.66 ± 0.24 |_ig/g lipid for low-heat powders (Fig. 4.4). COPs levels 
o f the corresponding high-heat and low-heat powders of the grass plus concentrate- 
fed herd were 1.07 ± 0.60 and 0.43 ± 0.24 |ig/g lipid, respectively. Thus, the higher 
plane o f nutrition offered a protective effect against cholesterol oxidation during 
whole milk powder processing.
Low-heat powders from the grass-fed herd which were sachet-packed and stored at 
15° C had 1.9-fold higher COPs (5.5 ± 1 .3  f.ig/g lipid) than high-heat powders 
produced from the grass-fed herd and stored under the same conditions (2.9 ± 1.2 
(.ig/g lipid). In addition, low-heat powders o f the grass-fed herd had 1.4-fold higher 
COPs levels compared to similarly prepared powders from the grass plus 
concentrate-fed herd (3.9 ± 1.0 ¡.ig/g lipid). Under these conditions (i.e. sachet- 
packing and storage at 15° C), the lowest levels o f COPs were obtained in high-heat 
powders manufactured from the grass plus concentrate-fed herd (1.7 ± 0.7 (ig/g lipid) 
(Fig. 4.4).
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Fig. 4.3 Chomatogram of sachet-packed low-heat whole milk powder o f the (a) 
grass-fed herd (R) and (b) grass plus concentrate-fed herd (S) stored for 12 months at 
30° C. TS: internal standard; 2: cholesterol-P-epoxide; 3: cholesterol-a-epoxide; 5: 
7-ketocholesterol and 6 :cholestanetriol.
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Fig. 4.4 Total COPs in fresh and stored whole milk powder o f the (a) grass-fed herd 
(R) and (b) grass plus concentrate-fed herd (S), sachet and vacuum packed and stored 
at 15 and 30° C for 12 months.
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Low-heat powders from grass-fed that were sachet-packed and stored at 30° C for 12 
months had 3.2-fold higher COPs (37.2 ± 7.5 j_ig/g lipid) than sachet-packed high- 
heat powders produced from the same herd (11.5 ± 2.4 jig/g lipid) and stored at 30° 
C for 12 months. In addition, low-heat powders from the grass-fed herd had 1.4-fold 
higher COPs compared with similarly prepared powders from herd S (27.2 ± 6.7 
jag/g lipid) (Fig. 4.4). Under these conditions (i.e. sachet-packing and storage at 30° 
C), the lowest levels o f COPs was obtained in high-heat powders manufactured from 
the grass plus concentrate-fed herd (8.6 ± 3 .4  p.g/g lipid).
Low-heat powders from grass-fed that were vacuum-packed and stored at 15° C for 
12 months had 1.7-fold higher COPs (3.2 ± 0.8 |ig/g lipid) than similarly stored 
high-heat powders produced from the same herd (1.7 ± 0.6 p.g/g lipid). In addition, 
these low-heat powders from grass-fed had 1.7-fold higher COPs compared with 
similarly prepared powders from herd S (2.5 ± 0.7 |_ig/g lipid). Under these storage 
conditions (i.e. vacuum-packing and storage at 15° C), the lowest level o f COPs was 
obtained in high-heat powders manufactured from the grass plus concentrate-fed 
herd S (1.69 ± 0.61 jig/g lipid).
Low-heat powders from grass-fed, vacuum-packed and stored at 30° C for 12 months 
had 2.2-fold higher COPs levels (10.8 ± 3.8 (j,g/g lipid) than similarly packed and 
stored high-heat powders produced from the same herd (4.8 ± 1 .8  p,g/g lipid). In 
addition, these low-heat powders produced from grass-fed had 1.5-fold higher COPs 
compared with similarly prepared powders from herd S (7.2 ±1 .5  p.g/g lipid). Under 
these storage conditions (i.e. vacuum-packing and storage at 30° C), the lowest level 
o f COPs was observed in high-heat powders manufactured from the grass plus 
concentrate-fed herd S (3.7 ± 1.9 |jg/g lipid).
In the present study, cholestanetriol and 25-hydroxycholesterol were not detected in 
powders stored at 15° C (Table 4.5 and Table 4.7), but were detected in powders 
stored at 30° C (Table 4.6 and Table 4.8). 7-Ketocholesterol, cholesterol-a-epoxide 
and cholesterol-(3-epoxide were all significantly (p < 0.01) higher in powders stored 
at 30° C compared to storage at 15° C. Interestingly, all five COPs investigated were
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detected in measurable amounts only in sachet-packed low-heat powders 
manufactured from milk of the grass-fed grass-fed and stored for 12 months at 30° C. 
Under these conditions, the following oxides appeared in decreasing order: 7- 
ketocholesterol > cholesterol-P-epoxide > cholestereol-a-epoxide > 25-
hydroxycholesterol > cholestanetriol. 7-Ketocholesterol and cholesterol-P-epoxide 
were significantly (p < 0.05) higher in sachet-packed whole milk powder o f grass-fed 
compared to herd S stored at 15° C (Table 4.5). 7-Ketocholesterol, 25- 
hydroxycholesterol and cholesterol-P-epoxide were significantly (p < 0.05) higher in 
sachet-packed whole milk powder o f grass-fed and herd S stored at 30° C compared 
to sachet-packed powders stored at 15° C (Table 4.6). Cholesterol-a-epoxide was 
detected in vacuum-packed whole milk powder from the grass herd but not in that 
from the milk o f herd S stored at 15° C (Table 4.7). 7-Ketocholesterol, 25- 
hydroxycholesterol and cholesterol-P-epoxide were significantly (p < 0.05) higher in 
vacuum-packed whole milk powder of grass-fed compared to whole milk powders of 
herd S stored at 30° C (Table 4.8).
The concentration o f C7 oxidation products (primary oxidation products) represented 
greater than 50 % and 76 % of the COPs present in powders stored at 15° C and 30° 
C, respectively. This suggests that oxidation products at the allylic position of 
cholesterol, i.e. C7, are formed more abundantly than those at the double bond itself,
i.e. positions 5 and 6. Secondary oxidation products (the cholesterol a - and P- 
epoxides, 25-hydroxycholesterol and cholestanetriol) were present in greater 
amounts at the high storage temperature o f 30° C. Thus, the higher storage 
temperature appeared to accelerate cholesterol oxidation. A linear relationship was 
observed between lipid oxidation, quantified by the TBA method and cholesterol 
oxidation with correlation coefficients of 0.73 (p < 0.001) and 0.55 (p < 0.001) for 
sachet-packed and vacuum-packed powders, respectively (Fig. 4.5 a and b). This 
indicates that the oxidative rate o f cholesterol during storage o f whole milk powder 
coincides with TBARS and is more highly correlated for sachet-packed powders.
173
Table 4.5 COPs in sachet-packed low-heat and high-heat whole milk powders* of grass-fed herd (R) and grass plus concentrate-fed herd 
(S) stored at 15° C for 12 months.
Heat
Class
7-Keto 25-OH a-epoxy (3-epoxy Triol Total COPs 
(pg/g lipid)
Total COPs 
(% cholesterol)
Low R 4.18 ± 0 .9 4 a 0.65 ±0.11 0.67 ± 0 .9  b . 5.50 ± 1.27 a’b 0.27 ± 0.06a,b
Low S 3.42 ± 0 .8  d - 0.47 ± 0.08 d - - 3.89 ± 1.01 d 0.19 ± 0.10 d
High R 2.11± 0 .3 4 c 0.34 ± 0 .0 9 0.46 ± 0.1 l c 2.91 ± 1.18 c 0.15 ± 0.06 c
H ighS
a t-v .
1.46 ±0.21 0.25 ± 0 .13 1.71 ± 0 .6 9 0.09 ± 0 .0 4
15 P < 0.05 relative to high-heat powder from grass-fed grass-fed
bP < 0.05 relative to low-heat powder from grass plus concentrate-fed herd S 
c P < 0.05 relative to high-heat powder from grass plus concentrate-fed herd S 
d P < 0.01 relative to high-heat powder from grass plus concentrate-fed herd S 
* Mean ± SD of 14 samples
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Table 4.6 COPs in sachet-packed low-heat and high-heat whole milk powders* o f grass-fed herd (R) and grass plus concentrate-fed herd 
(S) stored at 30° C for 12 months.
Heat
Class
7-Keto 25-OH a-epoxide P-epoxide Triol Total COPs 
(M-g/g bpid)
Total COPs 
(%  cholesterol)
Low R 19.32 ± 4.10 a’b 1.32 ± 0 .64a 3.8 ± 0.50a,e 11.7 ±2 .40  a,b 0.98 ± 0.3 Ia’e 37.17 ± 7 54 a’e 1.86 ± 0.57a’e
Low S 15.43 + 1.84 d 1.92 ± 0.21 d 0.64 ± 0.41d 9.23 ± 0.29 d 27.22 ± 6.70 d 1.36 ±0.12 d
High R 7.88 ± 1.43 c 1.58 ±0.33 2.06 ±0.59 11.52 ± 2.35c 0.58 ± 0.12 c
HighS 5.13 ± 1.13 1.60 ± 0.41 1.87 ±0.41 8.60 ±3.40 0.43 ±0.17
a P < 0.05 relative to high-heat powder from grass-fed grass-fed
b P < 0.05 relative to low-heat powder from grass plus concentrate-fed herd S 
c P < 0.05 relative to high-heat powder from grass plus concentrate-fed herd S 
d P < 0.01 relative to high-heat powder from grass plus concentrate-fed herd S 
e P < 0.01 relative to low-heat powder from grass plus concentrate-fed herd S 
* Mean ± SD of 14 samples
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Table 4.7 COPs in vacuum-packed low-heat and high-heat whole milk powders* o f grass-fed herd (R) and grass plus concentrate-fed herd (S) 
stored at 15° C for 12 months.
Heat Class 7-Keto 25-OH a-epoxide (3-epoxide Triol Total COPs 
(Hg/g lipid)
Total COPs 
(% cholesterol)
Low R 2.92 ± 0.49 _ 0.27 ± 0.09a,b - _ 3.19 ± 0.85 a,b 0.16 ± 0 .0 4 a,b
Low S 2.49 ± 0.71 - - - 2.49 ±0.71 0.12 ±0.09
High R 1.90 ±0.38 1.90 ±0.38 0.10 ±0.03
HighS 1.69 ±0.61 1.69 ±0.61 0.09 ±0.03
a P < 0.05 relative to high-heat powder from grass-fed grass-fed
b P < 0.05 relative to low-heat powder from grass-fed grass-fed 
* Mean ± SD of 14 samples
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Table 4.8 COPs in vacuum-packed low-heat and high-heat whole milk powders* o f grass-fed herd (R) and grass plus concentrate fed herd (S) 
stored at 30° C for 12 months.
Heat Class 7-Keto 25-OH a-epoxide fi-epoxide Triol Total COPs 
(pg/g lipid)
Total COPs 
(% cholesterol)
Low R 6.2410.86 a’b 1.77 1 0.67 a’e 2.33 1 0.99a’b 0.441 0.08 a,e 10.7913.78 a,e 0.54 1 0.19 a,e
Low S 4.2110.99 0.69 1 0.54 d 1.32 10.84 7.22 1 1.55 d 0.36 1 0.17 d
High R 3.69 1 0.38c 1.1410.13 4.83 1 1.79 c 0.241 0.09 c
HighS
a t'»
2.81 10.29 0.92 10.19 3.73 11.88 0.19 10.09
a P < 0.05 relative to high-heat powder from grass-fed grass-fed
b P < 0.05 relative to low-heat powder from grass plus concentrate-fed herd S 
0 P < 0.05 relative to high-heat powder from grass plus concentrate-fed herd S 
d P < 0.01 relative to high-heat powder from grass plus concentrate-fed herd S 
e P < 0.01 relative to low-heat powder from grass plus concentrate-fed herd S 
* Mean ± SD o f 14 samples
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Fig. 4.6 shows the a-tocopherol levels in fresh and 12-month-old stored high-heat whole milk 
powder. Endogenous vitamin E levels o f control fresh milk powder (11.08 (-ig/g) to which no 
extra vitamin E was added was approximately 2-fold greater than in 12 month old powders (5.42 
(j.g/g). Fresh milk powders produced after addition of 500 jag/g a-tocopherol on a milk fat basis 
prior to spray-drying contained 150 p,g/g vitamin E, which decreased by 16 % upon storage for 
12 months. Fresh milk powders produced after addition o f 1000 |a.g/g a-tocopherol to the milk 
prior to spray-drying contained 324 |4.g/g vitamin E which did not appreciably decline after 
storage for 12 months (Fig. 4.6). This data indicates that when a-tocopherol (500 (j,g/g and 1000 
M-g/g) was added to milk prior to spray-drying approximately 70 % was lost as a result o f whole 
milk powder manufacture (Fig. 4.6). However, greater than 80 % of the vitamin E was retained 
in the milk powder over a 12 month storage period in sachet-packed powders stored at 15° C. 
When 1000 fig/g dried a-tocopherol was added to freshly manufactured whole milk powder on 
powder basis, the levels o f vitamin E detected were not significantly different from control 
powders to which no antioxidant was added (Fig. 4.6). This may have been due to localised 
mixing only or inadequate sampling.
4.5.7 Effect of a-tocopherol addition on oxidative stability of whole milk powder
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Fig. 4.5 Correlation between COPs and TBARS in stored (12 months) whole milk 
powders (a) sachet and (b) vacuum-packed at 15 and 30 °C.
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Fig. 4.6 Vitamin E levels in fresh (0 months) and stored (12 months) sachet-packed 
high-heat whole milk powders stored at 15° C. Data points refer to mean ± standard 
deviation (n= 4).
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Levels of TBARS were not significantly different in fresh whole milk powder 
manufactured using either low or high doses o f a-tocopherol supplemented milk 
compared to unsupplemented control (Fig. 4.7). However, a significant reduction in 
TBARS levels was seen in a-tocopherol supplemented sachet-packed whole milk 
powders stored at 15° C (Fig. 4.7) compared to unsupplemented controls. A 37.8 % 
reduction in TBARS was observed when 500 pg/g o f a-tocopherol was added to 
milk prior to spray-drying and a similar reduction in TBARS (36.2 %) was observed 
in powders into which 1000 jag/g a-tocopherol had been incorporated prior to 
manufacture. An approximate reduction in TBARS of 12 % was observed in 500 
pg/g lipid and 1000 lipid pg/g a-tocopherol supplemented sachet-packed whole milk 
powder stored at 30° C (Fig. 4.7). Hence, both levels o f a-tocopherol investigated 
(500 pg/g lipid and 1000 pg/g lipid) produced similar reductions in TBARS 
development in sachet-packed powders during storage.
However the extent o f lipid oxidation, as determined by TBARS, did appear to be 
dependent on a-tocopherol concentration in vacuum-packed powders stored at 15° C 
(Fig. 4.7). TBARS were reduced by 29.18 % and 52.63 % due to addition to the 
milk prior to spray-drying of 500 pg/g lipid and 1000 pg/g lipid doses o f a - 
tocopherol, respectively. Similarly, in vacuum-packed powders stored at 30° C, the 
higher level of a-tocopherol (1000 pg/g lipid) produced a greater inhibitory effect 
than the 500 pg/g lipid dose on TBARS development during storage. When a - 
tocopherol was added to the milk powder after spray-drying, no protective effect was 
found, with levels o f TBARS being similar to that o f the control whole milk powder, 
to which no extra a-tocopherol was added.
Fig. 4.8 shows the levels o f total COPs in fresh whole milk powders and in sachet 
and vacuum-packed powders stored at 15° C and 30° C, manufactured after addition 
o f a-tocopherol (500 and 1000 pg/g lipid) to the milk prior to spray-drying. While 
the 1000 pg/g dose o f a-tocopherol resulted in a 36.2 % reduction in TBARS in 
sachet-packed powders stored at 15° C (Fig. 4.7), this level of a-tocopherol had no
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Fig. 4.7 Levels o f TBARS in fresh and stored high-heat whole milk powders stored 
at 15° and 30° C for 12 months, sachet-packed (S) and vacuum-packed (V) after 
addition of a-tocopherol (500 (.ig/g lipid and 1000 fig/g lipid) to milk.
1000 (J.g/g pow dera refers to data obtained when a-tocopherol was added to spray- 
dried powder. Data points refer to mean ± standard deviation (n= 4).
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Fig. 4.8 Levels o f COPs in fresh and stored high-heat whole milk powders stored at 
15° C and 30° C for 12 months, sachet-packed (S) and vacuum-packed (V) after 
addition o f a-tocopherol (500 fig/g lipid and 1000 fxg/g lipid) to milk.
1000 (ig/g powder2 refers to data obtained when a-tocopherol was added to spray- 
dried powder. Data points refer to mean ± standard deviation (n= 4).
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appreciable effect on COPs in sachet-packed powder stored at 15° C (Fig. 4.8). 
Levels o f COPs found in control milk powder which were sachet-packed and stored 
at 15° C was 3.9 jag/g while levels of COPs in milk powders manufactured using 
milk to which was added 500 and 1000 jag/g a-tocopherol prior to spray-drying was 
3.78 (.Lg/g and 3.57 f-ig/g, respectively (Fig. 4.8). Storage at 30° C led to 
approximately 4-fold increases in COPs levels compared to storage at 15° C and 
addition o f a-tocopherol (500 and 1000 pg/g) to the milk prior to spray-drying 
resulted in a 15-16 % reduction in COPs levels in these milk powders stored at 30° 
C. Thus, under similar packing and storage conditions, a-tocopherol was less 
effective in inhibition o f COPs development than in the inhibition of lipid oxidation. 
These data demonstrate that mode o f addition of a-tocopherol and storage conditions 
may influence the effectiveness o f a-tocopherol in inhibiting oxidation o f fatty acids 
in stored milk powders, and that milk fatty acids appear to be more sensitive to 
antioxidant activity o f a-tocopherol than cholesterol oxidation.
a-Tocopherol appeared to have no effect on development o f COPs in vacuum- 
packed powders stored at 15 or 30° C (Fig. 4.8), compared to control milk powders, 
to which no extra a-tocopherol was added. Although the level o f total COPs 
increased when these vacuum-packed powders were stored at 30° C compared to 15° 
C, neither level of a-tocopherol in milk powder (500 or 1000 pg/g) resulted in any 
inhibitory effect on cholesterol oxidation.
In summary, addition o f 500 and 1000 pg/g a-tocopherol to milk prior to spray- 
drying had no effect on COPs content in freshly produced powders which ranged 
from 1.65 - 1.73 pg/g. While the addition of 500 and 1000 pg/g a-tocopherol to 
milk prior to whole milk powder manufacture resulted in up to 53 % reduction in 
TBARS, no significant reduction in COPs development in these powders was 
observed.
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The effects o f pre-heat treatment o f milk prior to evaporation and spray-drying on the 
physical, chemical, functional and organoleptic properties o f whole milk powders 
were investigated.
P h y s i c a l ,  c h e m i c a l  a n d  f u n c t i o n a l  c h a r a c t e r i s i t i c s  o f  m a n u f a c t u r e d  w h o l e  m i l k  
p o w d e r
A single-stage spray-dryer was used in the manufacture o f powders in the present 
study. One-stage drying is defined as the spray-drying process in which the product 
is dried to its final moisture content in the spray-drying chamber. This system 
allows control over moisture development at the exit from the drying chamber as 
well as influencing many other properties including insolubility index and bulk 
density. Organoleptic evaluation o f fresh powders indicated an acceptable flavour 
which deteriorated in low-heat stored whole milk powders and which improved in 
high-heat powders upon storage (Table 4.1).
Moisture content, one o f the most important physical properties o f a powder, was not 
significantly affected by pre-heat treatments or storage conditions. The moisture 
contents of powders used in this study were all < 4 %. In addition, insolubility index 
was not significantly affected by pre-heat or storage conditions although low-heat 
powders did have lower insolubility indices (higher solubility) (0.1 ml) than high- 
heat powders (0.4 ml) and there was a trend towards an increase during storage at 
15° C to 0.3 and 0.6 ml, respectively. Insolubility has been reported to increase if 
the storage temperature is high or if  the moisture is low (Kiesker and Clarke, 1984; 
Kudo et al., 1990). Although crystallisation of lactose (Saito and Taguchi, 1980) has 
been reported to be a possible cause for the increase in the insolubility index, Van 
Mil and Jans (1991) did not find any evidence of crystal formation. The term 
‘insolubility index’ instead o f ‘solubility index’ was introduced when the IDF 
modification of the original method was issued (Van Mil and Jans, 1991) and is 
determined as the volume of insoluble sediment remaining after reconstitution and 
centrifugation. It is often considered as one of the most important quality criteria of 
whole milk powders. The occurrence of insoluble sediment is undesirable, but to
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some extent unavoidable. The main factor causing solubility defects is the particle 
temperature during the water removal process (Pisecky, 1986).
It has been reported that the storage stability o f instant powder was maintained when 
the moisture content was < 4 % (Abbot and Waite, 1962) (Table 4.1). Van Mil and 
Jans (1991) studied the storage stability o f whole milk powder having thee different 
moisture contents (2.4, 2.7 and 3.0 %) in tins and sachets at thee different 
temperatures (20, 27 and 35° C) over a thee year period. They observed that the 
insolubility index increased during the storage period and was more pronounced at 
the higher temperature or if  the initial moisture content was high. The insolubility 
values found in this study were higher than those reported by Van Mil and Jans 
(1991), who reported values from 0.05-0.12 ml. This may have been due to 
differences in the pre-heating temperature; the powders of Van Mil and Jans (1991) 
being medium-heat powders, while low and high-heat powders were used in our 
study. In addition, there may have been differences in the inlet and outlet 
temperatures used in the spray-drying process. Both of these parameters affect the 
insolubility index o f whole milk powders. Increased pre-heat temperatures and 
holding times have been shown to increase the viscosity of skim milk concentrate 
(Bloore and Boag, 1982). Furthermore, it has been demonstrated that increased 
viscosity of concentrate, independent o f total solids can lead to increased insolubility 
index of resultant skim milk powder during the spray-drying process (Baldwin et al., 
1980). Therefore, the effect o f pre-heating on whole milk powder solubility most 
likely arises from the effect o f the pre-heat treatment on the concentrate viscosity.
The bulk density o f  the whole milk powders produced in the present study ranged 
from 0.51 to 0.56 g/ml. These values are similar to those previously reported by 
Van Mil and Jans (1991), who reported values from 0.53-0.57 g/ml. The bulk 
density of milk powders is economically, commercially and functionally an 
important property. When shipping powders over long distances, producers are 
interested in high bulk density to reduce shipping volume and to increase savings in 
packing.
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The effect o f pre-heat treatment on protein solubility of whole milk powder was 
determined by undenatured whey protein remaining in the powders after processing. 
The undenatured whey protein nitrogen index (WPNI) measures the proportion of 
undenatured protein remaining after a heat treatment. The low-heat powders had a 
mean WPNI value o f 6.9 ± 0.9 mg undenatured whey protein/g powder while the 
high-heat powders had a mean WPNI o f 1.2 ± 0.3 mg undenatured whey protein/g 
powder. As expected, high pre-heating temperatures (110° C) caused significantly (p 
< 0.001) more protein denaturation than low pre-heating temperature (75° C). These 
results were in agreement with previous data including Sanderson (1970) who 
reported values o f 8.38 and 1.27 mg undenatured whey protein/g powder for low and 
high-heat powders, respectively. Similarly, Van Mil and Jans (1991) reported WPNI 
values of 1.6 mg undenatured whey protein/g powder for high-heat powders.
A slight decrease in WPNI values was observed after 12 months storage in the 
present study. Fresh low and high-heat whole milk powders contained 6.9 and 1.2 
mg undenatured whey protein/g powder, respectively, which decreased to values of
6.6 and 1.1 mg undenatured whey protein/g, powder for corresponding stored 
powders respectively. This data indicating that the effect of storage on WPNI is 
negligible agrees with previous results (Baldwin & Ackland, 1991). Because the 
heat treatment classification is obtained indirectly by measuring the level o f residual 
undenatured whey proteins, the usefulness o f the undenatured WPN level as an index 
o f heating history is limited by the extent o f natural variation in the concentration of 
these proteins in raw milk. Whey protein was significantly higher (p < 0.05) in the 
standardised milk o f the grass plus concentrate-fed herd S than that o f the grass-fed 
herd, which may account for the higher WPNI in the resultant whole milk powder, 
but does not explain the seasonal effect. However, previous studies (Sanderson, 
1970) have shown a seasonal effect on WPNI, which may in part explain our 
findings. Sanderson (1970) suggested that the seasonal variation in WPNI values 
may be due to the variation in individual whey protein components during the 
season, especially P-lactoglobulin and a-lactalbumin. Since the individual whey 
proteins were not determined in the present study, it is not possible to make such 
comparisons with the data of Sanderson (1970).
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The average fat content o f the powder was 26 %, which coincides with specific 
grading requirements for whole milk powders according to ADMI (1971) (Table
4 .1). The raw milk was standardised to 3.2 % fat to produce a final fat content in the 
powder of 26 % according to Pearson’s Square (Vamam and Sutherland, 1994). The 
oxidative stability, measured by PV and TBARS, deteriorated substantially in the 
stored powders. The chemical changes induced in milkfat by the process of 
manufacturing whole milk powders was further examined under different pre-heat, 
packing and storage conditions.
E ffe c t o f p r e - h e a t  t r e a t m e n t  o n  o x i d a t i v e  s t a b i l i t y  d u r i n g  s t o r a g e  o f  w h o l e  m i l k  
p o w d e r
PV levels of fresh low-heat and high-heat powders in our study, which ranged from 
0.40 - 0.43 mEq 0 2/kg were high relative to the PV levels reported for anhydrous 
milkfat (Keogh and Higgins, 1982). The IDF standard for anhydrous milkfat (IDF 
67A : 1977) specifies a PV of less than 0.2 mEq 0 2/kg by the ferric ammonium 
thiocyanate method. Stine et al. (1954) reported PVs of 0.15 - 0.36 mEq 0 2/kg for 
fresh powders. The differences between the results of our study and others may be 
attributed to variations in processing technology and also in the methods used for PV 
assessment. The standardised IDF method was used in the present study, which 
differed from that employed by Stine et al. (1954) in that toluene replaced benzene 
in the fat extraction step. Numerous analytical methods exist for PV determination 
and the results of analysis depend upon the experimental conditions and upon the 
reducing agent used. Low-heat whole milk powders exhibited the highest levels of 
primary oxidation products assayed by PV.
Pre-heat temperature had no significant effect on secondary lipid oxidation products, 
in fresh milk powders, quantified by TBARS. The TBARS levels of whole milk 
powder samples obtained by low and high pre-heat treatment were 0.11 and 0.08 mg 
MDA/ kg, respectively. Stored low-heat whole milk powders, however, had 
significantly (p < 0.01) higher levels o f TBARS than stored high-heat powders.
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Chan (1992) reported values of 0.017 to 0.02 mg MDA7 kg in low-heat powders 
immediately after manufacture, which coincide with the results o f the present study. 
Mettler (1973) indicated that a TBARS value of 0.008 was representative of freshly 
produced whole milk powder. High pre-heat treatment of milk has previously been 
shown to result in significantly less oxidation in whole milk powder than low pre­
heat treatment, during subsequent storage (Boon, 1976; Tuohy and Kelly, 1981). In 
accordance with the results from the present study, Boon (1976) found that the 
highest level o f off-flavour at any given storage time was observed in the powder 
which had received the low intensity heat treatment. High-heat treatment resulted in 
powders which developed oxidised flavour at about half the rate o f the powders 
which had received a low pre-heat treatment. Tuohy and Kelly (1981) reported that 
a heat-treatment o f 120° C resulted in a better storage stability than one o f 80 or 90° 
C. Poulsen et al. (1971) stated that a heat-treatment o f 95° C or above should be 
used for the manufacture o f whole milk powder with good storage stability. One of 
the earliest studies on COPs in whole milk powder reported that after 12 months 
storage under ambient conditions, low-heat whole milk powder showed higher levels 
o f COPs (17 |j,g/g lipid) than high-heat whole milk powder (9 |_ig/g lipid) (Nourooz- 
Zadeh and Appelqvist, 1988).
Freshly manufactured high-heat powders had significantly higher (p < 0.05) levels of 
COPs than low-heat powders (Fig. 4.4). The level of COPs detected in fresh low- 
heat whole milk powder manufactured in the present study was negligible (0 - 0.66 
|j.g/g lipid). Previously, non-detectable levels of cholesterol oxides have been 
reported in fresh spray-dried milk powders, which were pre-heated at low and 
medium temperatures while levels o f 2.8 [4,g/g lipid COPs were reported in fresh 
high-heat powders (Nourooz-Zadeh and Appelqvist, 1988). In our study, COPs 
levels in all powders stored for 12 months increased significantly (p < 0.001). As 
previously described for primary and secondary oxidation products, low-heat 
powders contained the highest levels o f COPs after storage. Apart from 
cholestanetriol and 25-hydroxycholesterol, the high-heat powders used in this study 
contained similar cholesterol oxides to the low-heat powders, but the quantities 
recovered differed substantially between the two classes. The first detectable and
1S9
most prevalent oxide formed was 7-ketocholesterol, which confirms it’s usefulness 
as a marker o f cholesterol autoxidation (Maerker, 1987). Nourooz-Zadeh and 
Appelqvist (1988) and Chan et al. (1993) also reported that the predominant 
cholesterol oxide was 7-ketocholesterol. This oxide is of particular interest, from a 
biological point o f view, because it is one o f the products occurring in oxidatively 
modified low-density-lipoproteins (Addis and Warner, 1992), which play a role in 
the initiation o f atherosclerosis and has been shown to be absorbed to the greatest 
extent from the intestine (Emanuel et al., 1991).
The increased oxidative stability o f high-heat powders relative to low-heat powders, 
as indicated by the reduced levels o f PV, TBARS and COPs in high-heat powders 
after storage may be due to the increased levels o f ‘free’ sulphydryl groups in these 
powders. High pre-heat treatment o f milk increased ‘free’ sulphydryl groups (p <
0.05) in the resultant powders compared to low pre-heat treatment (Table 4.2). The 
observation that heat-treatment increased ‘free’ sulphydryl groups has been made 
previously (Harland et al., 1952; Taylor and Richardson, 1980; Baldwin and 
Ackland, 1991). Taylor and Richardson (1980) have demonstrated that sulphydryl 
groups are responsible for only part o f the anti-oxidant activity in milk. Exposure of 
reactive sulphydryl groups during pre-heating o f milk has previously been observed 
to result in increased oxidative stability in the resultant whole milk powder by 
scavenging o f free radicals (Harland et al., 1952). Baldwin and Ackland (1991) also 
found that sulphydryl groups increased with pre-heating temperature. They found 
that the sulphydryl group measurement became ‘saturated’ at the higher pre-heat 
temperatures and that pre-heat holding-time had little effect. Increasing the 
temperature to 125° C and the hold-time to 240 sec did not increase the SH group 
levels found. Other workers (Kisza and Rotkiewicz, 1974) have reported that 
addition o f heat-treated whey protein with a high content of sulphydryl groups 
improves the storage stability of whole milk powder. This is in accordance with 
Srinavasan and Singh (1974) who found that addition o f sulphydryl groups to 
condensed milk products improved the storage stability. Ipsen and Hansen (1988) 
reported an inhibition o f oxidation in whole milk powder with a high content of 
sulphydryl groups, but reported the inhibition to be the result of the total antioxidant
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ability of the powder and not only due to the presence of sulphydryl groups. In the 
present study, while the level o f ‘free’ sulphydryl groups increased as pre-heat 
treatment increased, the total sulphydryl groups decreased on heating. A similar 
observation has been previously reported (Taylor and Richardson, 1980) where skim 
milk which was heated for 30 min at 130° C showed greater antioxidant activity than 
raw milk. In addition, high-heat treated skim milk contained 48 % more reactive 
sulphydryl groups than raw milk, but 73 % fewer total sulphydryl groups (Taylor 
and Richardson, 1980). The exact reason for this phenomenon is not known.
Studies have shown that various Maillard products formed though the interaction of 
proteins and carbohydrates during high-heat-processing of foods exert antioxidant 
activity. Although Maillard reaction products were not measured in the present 
study, it is possible that their presence in high-heat powders may have contributed to 
the improved oxidative stability. The ability o f Maillard reaction products to retard 
the development o f rancidity in milk powders has been reported by a number of 
researchers (Wyott and Day, 1965; Erickson, 1982; Lingnert and Hall, 1986; 
Baldwin and Ackland, 1991).
E ffe c t o f p a c k i n g  o n  o x i d a t i v e  s t a b i l i t y  o f  w h o l e  m i l k  p o w d e r
Vacuum-packing reduces the oxygen content o f packed powder by both evacuation 
of the interstitial air and compression o f the powder (Tuohy, 1984). Packing type 
had a marked effect on extent of lipid oxidation in the present study, where a 
significant reduction (p < 0.05) was observed in PV levels in vacuum-packed 
powders compared to sachet-packed powders (Fig. 4.2). In addition, a significant (p 
< 0.01) interaction existed between pre-heat temperature and packing conditions,
i.e., the effect o f pre-heat temperature on the oxidative stability o f whole milk 
powder was more pronounced in sachet-packed powders than vacuum-packed 
powders. The present study also demonstrated that vacuum-packing resulted in 
significantly lower TBARS values (p <0.01) and COPs levels (p < 0.001) compared 
with sachet-packing over the full experimental period. It has been previously 
reported that oxidative stability of lipid and cholesterol in whole milk powder can be
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maintained for extended periods by exclusion of oxygen during subsequent storage 
(Chan et al., 1993). However, although oxidation was reduced by vacuum-packing 
in the present study, a complete retardation o f oxidation was not obtained. Residual 
oxygen may still cause lipid and cholesterol deterioration o f milk powder in 
enclosed vacuum-packed systems and Tamsma et al. (1961) noted that extremely 
low oxygen concentrations (0.1 %) are necessary to prevent oxidative flavours in 
reconstituted foam spray-dried powder. The level o f oxidation may have been 
reduced further if  an inert gas such as nitrogen or carbon dioxide had been used to 
flush the powder prior to vacuum-packing. Lea et al. (1943) concluded that the 
development o f oxidised flavours in spray-dried whole milk could be controlled by 
reducing the oxygen content in the free space o f the container to 1 to 3 %, whereas 
Coulter and Jenness (1945) concluded that less than 1 % oxygen in the packing gas 
was necessary to prevent oxidation in whole milk powder. Full cream milk powder 
which had been packed under an inert gas, contained only traces o f COPs (< 250 
ng/g powder), even after storage o f the unopened cans for 1 year (Rose-Sallin et al.,
1995). These authors also reported that the use o f tin cans for packaging protected 
against cholesterol oxidation to a greater extent than aluminium foil bags, with 
COPs levels o f 155 ng/g and 344 ng/g obtained for infant formula packed in tins and 
foil bags, respectively.
The variation in levels o f lipid and cholesterol oxidation products between our study 
and those of others may to a large extent be due to the different methods for COPs 
quantification used, thereby making any direct comparisons between the data from 
different studies difficult. We used a modified version of the method of Sander et al. 
(1989) and Pie et al. (1990) for COPs quantification by GC and obtained similar 
COPs data to those reported by Rose-Sallin et al. (1995) for milk powder stored at 
ambient temperature for a 12-month period. Differences in methodologies are 
accounted for by the use of different extraction procedures, exclusion of a 
saponification step, variation in choice o f internal standard, variation in choice o f 
clean-up procedure and variations in the GC column used for COPs detection. Chan 
et al. (1993) and Sander et al. (1989) both used the Folch procedure for lipid 
extraction unlike Nourooz-Zadeh and Appelqvist (1988) who employed a
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hexane/isopropanol extraction and saponification. Nourooz-Zadeh and Appelqvist 
(1988) used cholestane, Chan et al. (1993) 6-ketocholesterol and Rose-Sallin et al.
(1995) and Sander et al. (1989) 19-hydroxycholesterol as the internal standard. 
Sander et al. (1989) did not employ a clean-up procedure, whereas others (Morgan 
and Armstrong, 1989; Chan et al., 1993 and Rose-Sallin et al., 1995) incorporated 
an SPE clean-up step, as in the present study. There is significant variation in the 
standard mixes used for total COPs quantification (Nourooz-Zadeh and Appelqvist, 
1988; Morgan and Armstrong 1992; Sander et al., 1989; Chan et al., 1993; Rose- 
Sallin et al., 1995) which further contributes to the variations reported in ‘total’ 
COPs values.
E ffe c t o f s t o r a g e  t e m p e r a t u r e  o n  o x i d a t i v e  s t a b i l i t y  o f  w h o l e  m i l k  p o w d e r
In the present study, higher storage temperatures (30° C) resulted in increased PV, 
TBARS (Fig. 4.2) and COPs levels (Fig. 4.4) in whole milk powder compared to the 
lower storage temperature (15° C). Chan et al. (1993) reported that TBARS and 
COPS values o f powders stored at 40° C increased more rapidly (approximately 3- 
fold) than those stored at 20° C, while COPs levels were 12-fold higher at 40° C 
than 20° C. Huber et al. (1995) also reported that elevated storage temperature led 
to increased individual cholesterol oxide levels in spray-dried egg yolk. Lea et al. 
(1943) estimated an average temperature coefficient (Q10) of 2.2 for milkfat 
oxidation in whole milk powder based on oxygen absorption, PV development and 
development o f a tallowy flavour in powders stored at 37° C and 47° C. White et al. 
(1947) subsequently reported that there was a tendency for the Q 10 to be lower for 
low temperature pre-heated samples than for high temperature pre-heated samples. 
White et al. (1947) found a Q l0 of 1.6 for PV development in whole milk powder, 
measured over the temperature range 20-55° C, which is similar to those found by 
Tuohy (1987). Q 10, the average temperature coefficient, was not determined in this 
study, as only two temperatures were used, and a range o f temperatures is needed to 
calculate Q 10. However, estimations of the rates of increase of PV and TBARS were 
obtained by comparing their values in samples stored at 30° C and 15° C. Average 
factors o f 0.91 and 1.7 per 10° C were estimated for PV and TBARS development, 
respectively in sachet-packed powders stored over a 12 month period. The
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magnitude o f the increase in TBARS values illustrates the profound effect of storage 
temperature on lipid oxidation in whole milk powders.
Heat has been found to stimulate scission o f cholesterol 7-hydroperoxides (Fontana 
et al., 1993), and in our study both sachet and vacuum-packed low-heat and high- 
heat powders showed higher levels o f COPs development when stored at 30° C 
compared to storage at 15° C (Fig. 4.4). The storage temperature effect on COPs 
levels was more pronounced when powders were sachet-packed than vacuum-packed 
indicating a positive interaction between storage temperature and packing (p < 
0.001). This may have been due to the greater volume of headspace oxygen in 
sachet-packed powder, thus increasing the rate o f lipid and cholesterol autoxidation. 
A significant interaction was also found between storage temperature and pre-heat 
temperatures (p < 0.001), i.e., the effect o f pre-heat temperature was more 
pronounced at the higher storage temperature o f 30° C.
The quantities o f secondary cholesterol oxides increased at the higher storage 
temperature (Table 4.6). Secondary products o f cholesterol are breakdown products 
o f the primary oxidation products and hence are more highly oxidised. They have 
also been reported to be more cytotoxic and atherogenic than the primary oxidation 
products (Smith and Johnson, 1989). Because cholesterol-(3-epoxide, 25- 
hydroxycholesterol and cholestanetriol are secondary oxidation products of 
cholesterol, it is apparent that the elevated temperature accelerated the oxidative 
process. In general, cholesterol-p-epoxide was present in greater quantities in low- 
heat powders stored at 30° C than cholesterol-a-epoxide. This can be explained by 
the greater thermodynamic stability o f the equatorial over that o f the axial 
conformation (Smith, 1981). The latter also indicated that the exposure of 
cholesterol to high temperatures for a relatively long period of time in the presence 
of oxygen may initiate the allylic free radical reaction at C7. Following the 
formation o f C7 peroxy radicals, a series of free radical reactions take place which 
may result in the formation o f stable oxidative products. Storage o f samples at 30° C 
can lead to a more intense oxidative degradation of cholesterol than storage at 15° C.
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Chan et al. (L993) also reported significantly higher secondary oxidation products of 
cholesterol at 40° C compared to 20° C.
The rate o f increase of PV was greater than of TBARS during the first 6 months of 
storage. PV values reached a maximum at 6 months and decreased during the 
subsequent 6 months under all conditions o f storage (Fig. 4.2). That peroxide values 
are at best only a transitory measurement o f lipid oxidation (Tuohy, 1987) is seen 
from this study. The highest level o f peroxides were found after 6 months storage, 
in the sachet-packed low-heat powders stored at 30° C, after which they declined. 
Similar observations have been made by Lea et al. (1943) who reported that the PVs 
of spray-dried whole milk powders stored at 37° C reached a maximum between 
fifty and one hundred days which coincided with the point at which all the free 
oxygen in the storage can had been consumed. At this point, peroxide formation 
ceased and the PV decreased again as peroxide break-down proceeded. Similar 
patterns o f peroxide value development were reported by Pyenson and Tracy (1946) 
and White et al. (1947). Van Mil and Jans (1991) and Tuohy (1987) found that 
peroxide values reached a maximum in whole milk powders after 18 and 12 months, 
respectively. Van Mil and Jans (1991) concluded that due to the complex 
mechanism of autoxidation reactions, products can be formed after an extended time 
that do not contribute to the PV assay result but can lead to a recovery of the flavour 
score. This may be due the Maillard browning (a reaction between lysine groups of 
proteins and carbonyl groups o f lactose) that occurs during pre-heating and/or 
storage, which has a sweet taste and can lead to an improvement in flavour.
C o r r e l a t i o n  o f  C O P s  w i t h  l i p i d  o x i d a t i o n  p r o d u c t s
Previously, secondary oxidation products (TBARS) have been positively correlated 
with COPs production during storage in cooked pork (Monahan et al., 1992) and in 
whole milk powder (Chan et al., 1993). Recent observations by Nielsen et al.
(1996), however, suggests that COPs production in dairy spreads is linked to the 
early stages o f lipid oxidation. The difference may be due to a number o f reasons. 
Firstly, Nielsen et al. (1996) studied dairy spreads whose fat content is greater than
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that o f whole milk powder. In addition, the two different products makes it difficult 
to make direct comparisons. Also, the TBA acid distillation assay o f King (1962), 
employed by Nielsen et al. (1996) differed from that o f others (Monahan et al., 1992; 
Chan et al., 1993) making direct comparison o f TBARS levels in these studies 
difficult.
E ffe c t o f a - t o c o p h e r o l  a d d i t i o n  o n  o x i d a t i v e  s t a b i l i t y  o f  w h o l e  m i l k  p o w d e r
Since the transfer o f vitamin E from feed to milk by the dairy cow is relatively 
ineffective, with only 2 % secreted into the milk (King, 1968), it was of interest to 
investigate the effect o f direct addition to milk prior to processing. a-Tocopherol 
has been reported to be a more effective antioxidant than BHA (Rankin and Pike, 
1993), and hence its antioxidative properties were investigated in the present study. 
Also, it has been found that irrespective of the concentrations of the tocopherols in 
feedstuffs, only a-tocopherol is found in significant concentrations in the blood and 
tissues of pigs and cattle and therefore, only a-tocopherol was considered as 
biologically important (Rice and Kennedy, 1986). Loss o f a-tocopherol as a result 
o f whole milk powder manufacture was greater than 60 % (Fig. 4.6). Dziezak 
(1986) also reported that tocopherols can be generally lost during refining, 
deodorising and processing of food because o f their heat lability. Spontaneous milk 
oxidation was found to be inversely proportional to the a-tocopherol content 
(Dunkley et al., 1967) who also noted seasonal variations in a-tocopherol 
concentration in milk. The fact the a-tocopherol level is higher than that found in 
the whole milk powders produced in the present study may be due to dietary 
differences or seasonal variations between the studies.
A protective effect against lipid oxidation was found due to addition of a-tocopherol 
to the milk prior to spray-drying. The level o f oxidation was significantly higher in 
sachet-packed powders stored at 30° C compared to storage at 15° C. However, a -  
tocopherol incorporation did not offer a similar degree of protection against 
cholesterol oxidation as observed against lipid oxidation in our study (Fig. 4.8). 
Similar observations have been previously made, where no significant difference
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was observed in COPs development in spray-dried egg powders due to incorporation 
o f antioxidants (TBHQ and oleoresin rosemary), although a slight reduction was 
observed (Lai et al., 1995b). Similarly, Wahle et al. (1993) found that a-tocopherol 
levels o f approximately 500 pg/g resulted in some inhibition o f cholesterol 
oxidation, though not statistically significant. In the present study, a-tocopherol was 
incorporated into two o f the whole milk powder manufacturing trials (in duplicate), 
and hence only trends can be observed.
When a-tocopherol was added in a powder form to whole milk powder after the 
spray-drying process, the protective effect against lipid oxidation was not observed. 
The vitamin E concentration in the supplemented powder to which 1000 pg/g was 
added was only 11 pg/g lipid, compared to 9 pg/g lipid in the control powder to 
which no extra a-tocopherol was added. This may have been due to localised 
mixing of the a-tocopherol and poor inadequate mixing of the entire powder sample. 
The a-tocopherol added prior to spray-drying was emulsified (using glyceryl 
monostearate) in the concentrated milk prior to homogenisation and spray-drying. 
This was a pre-requisite, as a-tocopherol is immiscible with water. Emulsified 
tocopherol has previously been shown to be effective at concentrations o f 25-100 
pg/g lipid while non- emulsified forms of a-tocopherol were essentially ineffective 
in preventing oxidised flavour (King, 1968). Control of oxidised flavour by direct 
addition o f emulsified tocopherol to milk required less than 1/100 of the amount of 
vitamin E required by supplementing the diet (King, 1968). Although antioxidants 
did not completely retard lipid and cholesterol oxidation, the formation o f oxidation 
products was reduced to some extent and further work needs to be undertaken to 
ascertain the optimum levels required for reduction o f both lipid and cholesterol 
oxidation in whole milk powders.
E ffe ct o f processing, packing and storage on organoleptic properties o f whole m ilk  
powder
Little data is available on the relationship between TBARS value and flavour 
acceptability of whole milk powder. Biggs and Bryant (1953) reported TBARS 
values for a series o f powders with flavour descriptions ranging from ‘fresh’ to
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‘very oxidised’. ‘Fresh’ powders had a TBA value o f 0.04 mg MDA/kg, a ‘slightly 
oxidised’ powder had a TBA value o f 0.087 mg MDA/kg, the powders described as 
‘oxidised’ ranged in TBA value from 0.16 mg MDA/kg, to 0.24 mg MDA/kg, and 
two powders described as ‘very oxidised’ had TBA values o f 0.50 mg MDA/kg and
5.2 mg MDA/kg. However, the procedure used by Biggs and Byrant was based on 
the method o f Dunkley and Jennings (1951) while the method of Tarladgis et al. 
(1960), was used in the present study and therefore TBA values are not directly 
comparable between the two sets o f data. Tuohy (1987) concluded that the flavour 
o f  powders with a TBA value < 0 .19  mg MDA/kg would be regarded as stable and 
powders with a TBA value o f > 0.19 mg MDA/kg would be classified as spoiled. 
Based on Tuohy’s findings (1987), we can conclude that all powders manufactured 
in the present study were o f acceptable flavour when stored at 15° C for up to 4 
months and at 30° C up to 2 months (Fig. 4.2). However, on sensory analysis, high- 
heat vacuum packed powders o f milk from both herds which were stored for 12 
months were o f acceptable flavour, which may indicate a variation between sensory 
analysis and the TBA assay (Table 4.4). Ward (1985) reported that in some 
instances, good correlations between the TBA value and sensory results can be 
obtained but reliable and reproducible correlations are not achieved generally (Chan,
1993). Tuohy (1987) concluded that although the relationship between TBA 
development and sensory perception o f flavour acceptability may be empirical, it is 
clear that powders with a low TBA value have a high degree o f flavour acceptability. 
Thus, high-heat pre-heat treatment, vacuum-packing and ambient storage conditions 
resulted in reduced levels o f lipid oxidation and the most acceptable flavour score 
for stored whole milk powder.
4.7 CONCLUSIONS
In whole milk powders stored up to 12 months, primary oxidation products were 
dominant during the first 6 months while secondary oxidation dominated during the 
subsequent 6 months storage. Milk powders from the grass plus concentrate-fed 
herd S resulted in less protein denaturation in low-heat powders and higher levels o f 
‘free’ sulphydryl groups than those from grass-fed which received grass only. This 
may have contributed to the lower levels o f lipid and cholesterol oxidation found in
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fresh and stored powders from herd S. The elevated antioxidant status (a-tocopherol 
and sulphydryl groups) in whole milk powder from cows of herd S undoubtedly also 
contributed to reduced lipid and cholesterol oxidation. High pre-heat temperatures 
resulted in higher levels o f COPs in fresh whole milk powders, but led to a more 
stable product during subsequent storage. Both lipid and cholesterol oxidation 
increased under all storage conditions investigated, but these undesirable ageing 
effects could be further reduced by exclusion o f oxygen and reduced storage 
temperatures. Seventy percent o f added a-tocopherol was lost due to the whole milk 
powder manufacturing process. While the increased level o f antioxidant inhibited 
lipid oxidation during storage o f these powders at ambient temperatures, cholesterol 
oxidation was not inhibited to the same extent. This may be due to inability of the 
a-tocopherol added in the present study to inhibit cholesterol oxidation in addition 
to lipid oxidation.
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C H A PT E R  5
INVESTIGATIO N OF TOXICITY OF CHOLESTEROL  
OXIDATION PRODUCTS IN AN I N  V I T R O  M ODEL SYSTEM
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Several o f the oxidation products o f cholesterol have adverse biological activities 
and have been implicated in many diseases including cancer (Black and Douglas, 
1973; Petrakis et al., 1981; Smith and Johnson, 1989) and atherosclerosis (Imai et al., 
1976; Peng et al., 1979; Jacobson, 1987; Addis and Warner, 1992). Cholesterol 
oxides exhibit cytotoxicity toward a wide variety of cells leading to angiotoxic and 
atherogenic effects (Imai et al., 1976). They have been shown to alter prostaglandin 
synthesis (Weksler et al., 1977) and stimulate platelet aggregation (Ross, 1986). 
Evidence o f cytotoxicity have been obtained from indices of cytotoxicity from 
studies on cultured fibroblasts (Baranowski et al., 1982), smooth muscle cells 
(Hughes et al., 1994), endothelial cells (Hu et al., 1991), monocytes and 
macrophages (Baranowski et al., 1982), heart cells (Mersel et al., 1987), skin cells 
(Williams et al., 1987) and granulocytic progenitor cells of bone marrow (Hoffman 
et al., 1981). These studies showed an increased rate of cell death within hours of 
exposure to COPs, inhibition of cell growth, rounding up of cells and detachment 
from the surface o f cell culture flasks, decreased incorporation o f thymidine into 
DNA, suppression of cellular cholesterol biosynthesis, the appearance o f intracellular 
lipid droplets and accumulation of cholesteryl esters (Peng et al., 1992 a). In 
general, cytotoxicity o f individual cholesterol oxides appears to vary depending on 
the type o f cell line exposed and whether cells are in a proliferating or a quiescent 
state. The influence of duration of exposure to cholesterol oxides may vary 
depending on the nature of the compound and on the dose.
The exact mechanism of cholesterol oxide toxicity is unclear. Since many 
cholesterol oxides have been shown to be potent inhibitors of cholesterol 
biosynthesis (Kandutch and Chan, 1975; Erickson et al., 1977), a possible 
mechanism of action may be that they deplete the cellular cholesterol available for 
membrane synthesis, thereby affecting the molar ratio of cholesterol to phospholipid 
in membranes (Peng and Taylor, 1984; Peng et al., 1992 b). Furthermore, their 
similar molecular structure to cholesterol facilitates their direct insertion into cell 
membranes. The latter may be a separate mechanism for cytotoxicity since studies 
on mature red blood cells that do not synthesise cholesterol have shown that
5.1 IN TR O D U C T IO N
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c h o le s t e r o l  o x i d e s  c a n  g r e a t ly  a lte r  c e l l  s u r fa c e  s h a p e  a s  a  re s u lt  o f  th e ir  d ir e c t  
in s e r t io n  in to  m e m b r a n e s  ( S t r e u l i  et al., 1 9 8 1 ;  S a n t i l la n  et al., 1 9 8 2 ) .  A n a ly s i s  o f  
s u b c e l lu la r  d is t r ib u t io n  p r o f i le s  o f  in c o r p o r a t e d  c h o le s t e r o l  o x id e s  s h o w  th a t s o m e  
C O P s  s u c h  a s  2 5 - h y d r o x y c h o le s t e r o l  a re  e v e n ly  d is tr ib u te d  th o u g h o u t  th e  
m ito c h o n d r ia l  a n d  m ic r o s o m a l  f r a c t io n s ,  th e  p la s m a  m e m b r a n e -e n r ic h e d  f r a c t io n  a n d  
th e  n u c le a r  p e l le t s ,  w h i le  o th e rs  s u c h  a s  c h o le s t a n e t r io l  a re  lo c a l is e d  p r e fe r e n t ia l ly  in  
p la s m a  m e m b r a n e s  ( P e n g  et al., 1 9 8 5 ) .  T h e s e  m o d if ic a t io n s  in  c h o le s t e r o l  c o n te n t 
b y  C O P s  h a v e  b e e n  s h o w n  to b e  e x t e n s iv e  e n o u g h  to  a lte r  m e m b r a n e  f lu id i t y  a n d  
a f f e c t  a  n u m b e r  o f  m e m b r a n e  fu n c t io n s ,  in c lu d in g  p r o p e r t ie s  o f  m e m b r a n e -b o u n d  
e n z y m e s  ( D e  P ie r r e  a n d  K a m o v s k y ,  1 9 7 3 ) ,  r e c e p to r - m e d ia te d  e n d o c y t o s is  a n d  c e l l  
p r o l i fe r a t io n  ( P e n g  a n d  M o r in ,  1 9 9 2 ) .
A  n u m b e r  o f  m e c h a n is m s  e x is t  fo r  d e fe n c e  o f  t i s s u e s  a g a in s t  f r e e  r a d ic a l  d a m a g e  
( H a l l i w e l l  a n d  C h ir ic o ,  1 9 9 3 ;  R i c e - E v a n s ,  1 9 9 4 )  ( F i g  6 . 1 ) .  P r o te c t io n  a g a in s t  th e  
e f f e c t s  o f  C O P s  m a y  b e  a f fo r d e d  b y  th e  a n t io x id a n t  s ta tu s  o f  c e l l s  in vivo. T h e  a d u lt  
h u m a n  w it h  a  d a i l y  e n e r g y  r e q u ir e m e n t  o f  1 0 ,0 0 0  k J  ( 2 ,5 0 0  k c a l)  c o n s u m e s  
a p p r o x im a t e ly  6 6 0  g  o x y g e n / d a y .  I t  is  e s t im a te d  th a t a p p r o x im a t e ly  9 0 - 9 5  %  o f  th at 
o x y g e n  is  c o n v e r t e d  b y  m ito c h o n d r ia l  r e s p ir a t io n  to  h a r m le s s  w a t e r ,  w h e r e a s  th e  
r e m a in in g  5 - 1 0  %  o f  o x y g e n  u n d e r g o e s  u n iv a le n t  a n d  d iv a le n t  r e d u c t io n  y ie ld in g  
r e a c t iv e  s p e c ie s ,  s u c h  a s  s u p e r o x id e  r a d ic a ls ,  h y d r o g e n  p e r o x id e  a n d  h y d r o x y l  
r a d ic a ls  ( E s t e r b a u e r ,  1 9 9 3 ) .  E x t r a p o la t e d  to  th e  a v e r a g e  h u m a n  l i f e s p a n  o f  
a p p r o x im a t e ly  7 0  y e a r s ,  th e  h u m a n  b o d y  c o n s u m e s  a p p r o x im a t e ly  1 7 ,0 0 0  k g  o f  
o x y g e n ,  a n d  th is  r e s u lt s  in  th e  c o n c o m ita n t  p r o d u c t io n  o f  8 0 0 - 1 7 0 0  k g  o f  o x y g e n  
r a d ic a ls  ( E s t e r b a u e r ,  1 9 9 3 ) .  In  v i e w  o f  th e  p o t e n t ia l  d a m a g e  th at m a y  b e  c a u s e d  b y  
f r e e  r a d ic a ls  a n d  h y d r o p e r o x id e s ,  a n d  th e  p o s s ib le  d ir e c t  e f f e c t  o f  v a r io u s  o x id a n t s  o n  
th e  c e l lu la r  c o m p o n e n t s ,  it  is  im p o r ta n t  th a t th e  c e l l  c o n ta in s  a n t io x id a n t  d e fe n c e  
s y s t e m s  ( C h o w ,  1 9 7 9 ) .  A l l  o r g a n is m s  s u f f e r  e x p o s u r e  to  r a d ic a ls :  h y d r o x y l  r a d ic a ls  
a re  g e n e r a te d  b y  h o m o  ly t ic  f i s s io n  o f  O -H  b o n d s  in  w a t e r  (D u th ie , 1 9 9 1 ;  H a l l i w e l l ,
19 9 4 )  w h i le  a p p r o x im a t e ly  1 - 4  %  o f  th e  to ta l o x y g e n  u p ta k e  b y  m it o c h o n d r ia  is  u s e d  
in  s u p e r o x id e  f o r m a t io n  ( D u th ie , 1 9 9 1 ) .  A l t h o u g h  s u p e r o x id e  is  n o t  i t s e l f  
p a r t ic u la r ly  r e a c t iv e ,  in  th e  p r e s e n c e  o f  c o p p e r , iro n  a n d  o th e r  in it ia t o r s ,  a  m e ta l
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c a t a l y s e d  H a b e r - W e i s s  re ac t io n  m a y  o c c u r ,  r es u l t i ng  in the fo r m a t i o n  o f  t he  h i g h l y  
r e a c t iv e  h y d r o x y l  rad i ca l s .
L i v i n g  o r g a n is m s  h a v e  e v o lv e d  a n t io x id a n t  d e fe n c e s  to  r e m o v e  e x c e s s  s u p e r o x id e s  
a n d  h y d r o g e n  p e r o x id e  ( H a l l iw e l l ,  1 9 9 4 ;  R ic e - E v a n s  a n d  G o p in a t h a n , 1 9 9 5 )  ( F i g
6 . 1 ) .  T h e  f ir s t  l in e  o f  d e fe n c e  a g a in s t  s u c h  r a d ic a ls  is  th e  e n z y m e  s u p e r o x id e  
d is m u t a s e  ( S O D ) ,  w h ic h  d is m u te s  s u p e r o x id e  a n io n  r a d ic a l  to  h y d r o g e n  p e r o x id e .  
B e c a u s e  S O D  e n z y m e s  g e n e r a te  h y d r o g e n  p e r o x id e ,  th e y  w o r k  in  c o n c e r t  w ith  
h y d r o g e n  p e r o x id e - r e m o v in g  e n z y m e s ,  s u c h  a s  c a t a la s e  ( C A T )  a n d  g lu ta th io n e  
p e r o x id a s e  ( G P x )  ( H a l l iw e l l ,  1 9 9 4 ;  L a w l o r  a n d  O ’ B r ie n ,  1 9 9 4 ;  D e s c a m p ia u x  et al.,
1 9 9 6 ) .  C a t a la s e  r e d u c e s  h y d r o g e n  p e r o x id e  to  o x y g e n  a n d  w a t e r  ( C h o w , 1 9 7 9 ) .  T h e  
s e le n iu m  c o n t a in in g  e n z y m e , g lu t a th io n e  p e r o x id a s e  i s  o n e  o f  th e  m o s t  im p o rta n t  
h y d r o g e n  p e r o x id e - r e m o v in g  e n z y m e s  in  m a m m a lia n  c e l l s  ( C h o w , 1 9 7 9 ) .  A  
s e le n o c y s t e in e  r e s id u e , e s s e n t ia l  f o r  e n z y m e  a c t iv it y ,  is  p r e s e n t  at th e  a c t iv e  s ite  o f  
g lu t a th io n e  p e r o x id a s e  ( H a l l i w e l l  a n d  C h ir ic o ,  1 9 9 3 ) .  G P x  r e m o v e  h y d r o g e n  
p e r o x id e  b y  u s in g  it  to  o x id i s e  r e d u c e d  g lu ta th io n e  ( G S H ) .  G lu t a t h io n e  re d u c ta s e  
r e g e n e r a t e s  G S H  f r o m  G S S G ,  w it h  N A D P H  a s  a  s o u r c e  o f  r e d u c in g  p o w e r  
( H a l l i w e l l ,  1 9 9 4 ) .
a - T o c o p h e r o l  is  a  f r e e  r a d ic a l  s c a v e n g e r  th a t h a s  b e e n  re p o r te d  to  p ro te c t  a g a in s t  
o x i d a t iv e  s t r e s s  in vitro ( L a w lo r  a n d  O ’ B r ie n ,  19 9 4 )  a n d  in h ib it  l ip id  p e r o x id a t io n  
( B u r t o n  a n d  I n g o ld ,  1 9 8 1 )  th u s  m a in t a in in g  c e l l  m e m b r a n e  in t e g r it y  ( D ip lo c k ,  1 9 8 3 ) .  
In  a d d it io n  a - t o c o p h e r o l  h a s  b e e n  r e p o r te d  to  p ro te c t  a g a in s t  t o x ic i t y  o f  C O P s  in 
vitro ( H u g h e s  et al., 1 9 9 4 ;  W ils o n  et al., 1 9 9 5 )  at c o n c e n t r a t io n s  r a n g in g  f r o m  1 - 2  
(.iM . T h e r e  is  in c r e a s in g  e v id e n c e  th a t in  c e r ta in  c ir c u m s t a n c e s  th e  p r o t e c t iv e  
s y s t e m s  m a y  b e  o v e r w h e lm e d  a n d  th a t c e l l  d a m a g e  b y  o x y g e n  r a d ic a ls  a n d  l ip id  
p e r o x id a t io n  p la y  a  c r u c ia l  a n d  c a u s a t iv e  r o le  in  th e  p a t h o g e n e s is  o f  s e v e r a l  c h o n ic  
a n d  a c u te  d is e a s e s  s u c h  a s  c a n c e r  ( V a v a v i  et al., 1 9 9 4 ) ,  in f la m m a t io n , s h o c k , l i v e r  
in ju r y ,  r h e u m a to id  a r t h it is ,  a g e in g  a n d  a th e r o s c le r o s is  ( E s te r b a u e r ,  1 9 9 3 ) .  A s  
m e n t io n e d  e a r l ie r ,  th e  C O P s  m o s t  c o m m o n ly  fo u n d  in  fo o d  a re  th e  
h y d r o x y c h o le s t e r o l s  a n d  e p o x y c h o le s t e r o ls ,  7 - k e t o c h o le s t e r o l ,  c h o le s t a n e t r io l  a n d
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F i g .  5 . 1  T h e  a n t io x id a n t  d e f e n c e  s y s t e m  ( K u k u c k a  a n d  M is r a ,  1 9 9 3 ) .
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2 5 - h y d r o x y c h o l e s t e r o I  ( N o u r o o z - Z a d e h  a n d  A p p e l q v i s t ,  1988; P a n i a n g a v a i t  et al.,
1995).
T h e  p r e v io u s  c h a p te r s  in d ic a te d  th a t c h o le s t e r o l  o f  w h o le  m ilk  p o w d e r s  d e s t in e d  fo r  
d ie ta r y  u s e  c a n  r e a d i ly  a u to x id is e  in  th e  p r e s e n c e  o f  a ir  at h ig h  s t o r a g e  te m p e ra tu re s  
a n d  th at fo r m a t io n  c a n  b e  s ig n i f i c a n t ly  in f lu e n c e d  b y  th e  a n im a l f e e d  q u a l i t y  o f  th e  
m ilk  p r o d u c e r s ,  e x te n t  o f  p re -h e a t in g  d u r in g  m a n u fa c tu r e  a n d  th e  p r e s e n c e  o f  o x y g e n  
d u r in g  s to r a g e .  C h o le s t e r o l  o x id e s  c a n  a ls o  b e  e n d o g e n o u s ly  p r o d u c e d  in vivo, e ith e r  
v i a  f r e e  r a d ic a l - in d u c e d  c h a in  r e a c t io n s ,  s u c h  a s  l ip id  p e r o x id a t io n  ( S m it h ,  1 9 8 1 ;  
1 9 8 2 )  o r  b y  e n z y m e - c a t a ly s e d  r e a c t io n s ,  n o t a b ly  th o u g h  m ic r o s o m a l  a n d  
m it o c h o n d r ia l  c y t o c h o m e  P 450 s y s t e m s  ( S m it h  a n d  Jo h n s o n , 1 9 8 9 ) .  T h a t  c h o le s t e r o l  
o x id e s  t h e m s e lv e s  m ig h t  in f lu e n c e  c h o le s t e r o l  m e t a b o l is m  a n d /o r  c e l l  m o r p h o lo g y  
a n d  fu n c t io n  in  c e l l s  o th e r  th a n  l iv e r  a n d  v a s c u la r  t i s s u e s  n e e d s  fu r th e r  e x p lo r a t io n . 
B y  in f lu e n c in g  c e l l  a n d  t is s u e  v i a b i l i t y  t h e y  c o u ld  e v e n t u a l ly  b e  im p l ic a t e d  in  th e  
a e t io lo g y  o f  d i s e a s e  p r o c e s s e s  o th e r  th a n  a t h e r o s c le r o s is  a n d  c a n c e r .
T h is  c h a p t e r  r e p o r t s  o n  th e  e f fe c t s  o f  c h o le s t e r o l  o x id e s  o n  a  c e l l  m o d e l  k n o w n  to 
e x p r e s s  s ig n i f i c a n t  s te r o id o g e n ic  p o t e n t ia l .  P o r c in e  g r a n u lo s a  c e l l s  a re  fo u n d  l in in g  
th e  o v a r ia n  f o l l i c l e  a n d  a s  th e  o v a r y  in c r e a s e s  in  s iz e  d u r in g  th e  m e n s t r o u s  o r  
o e s tr o u s  c y c le ,  th e  g r a n u lo s a  c e l ls  m u l t ip ly  ( B a k e r ,  1 9 8 2 ) .  F i g .  5 .2  s h o w s  th e  s ta g e s  
o f  f o l l i c u l a r  g r o w t h . A t  b ir th , e a c h  o o c y t e  is  s u rr o u n d e d  b y  a  s in g le  l a y e r  o f  
f la t te n e d  e p it h e l ia l - d e r iv e d  g r a n u lo s a  c e l l s  a n d  th e  c o m b in e d  s tr u c tu re  i s  c a l le d  a 
p r im o r d ia l  f o l l i c l e  ( F i g .  5 .2 ) .  M o s t  p r im o r d ia l  f o l l i c l e s  re m a in  in  th e  a r re s te d  s ta te , 
w h ic h  m a y  la s t  u n t i l  p u b e r ty  o r  e v e n  m e n o p a u s e ,  i f  th e y  a re  n o t s e le c t e d  f o r  fu rth e r  
d i f fe r e n t ia t io n  a n d  d e v e lo p m e n t  ( H a d le y ,  1 9 9 2 ) .  W ith  th e  in i t ia t io n  o f  th e  
r e p r o d u c t iv e  c y c l e ,  th e  p r o c e s s  o f  f o l l i c u l a r  g r o w t h  c u lm in a te s  in  o v u la t io n  ( B a k e r ,  
1 9 8 2 ) .  W it h in  th e  e m b r y o n ic  o v a r y ,  th e  p r im o r d ia l  f o l l i c le s  b e g in  th e  r e p r o d u c t io n  
d iv i s io n  o f  m it o s i s  ( p r im a r y  f o l l i c le s ) ,  r e s u lt in g  in  an  in c r e a s e  in  s iz e  o f  th e  o o c y te  
a n d  a  c h a n g e  in  s h a p e  o f  th e  g r a n u lo s a  c e l l s  f r o m  f la t  to c u b o id a l  ( s e c o n d a r y  
f o l l i c le s )  ( F i g .  6 .2 )  ( B a k e r ,  1 9 8 2 ;  H a d le y ,  1 9 9 2 ) .  A lt h o u g h  a  n u m b e r  o f  p r im a r y  
f o l l i c l e s  m a y  b e  s e le c t e d  f o r  fu r th e r  d e v e lo p m e n t  in to  s e c o n d a r y  f o l l i c l e s  d u r in g  e a c h
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F i g .  5 . 2  S t a g e s  o f  f o l l i c u la r  g r o w t h  ( B a k e r ,  1 9 8 2 ) .
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m e n s tru a l c y c le ,  o n ly  o n e  is  u s u a l ly  d e s t in e d  to  d e v e lo p  in to  a  G r a f f i a n  f o l l ic le .  T h e  
o th e r s  b y  s o m e  u n k n o w n  p r o c e s s  b e c o m e  a tr e t ic  ( H a d le y ,  1 9 9 2 ) .T h e  g r a n u lo s a  c e l l s  
o f  f o l l i c le s  d e s t in e d  fo r  m a tu ra t io n  c o n t in u e  to  in c r e a s e  in  n u m b e r . A t  th e  s a m e  
t im e , in te r s t it ia l  t i s s u e  a d ja c e n t  to th e  f o l l i c le  a r r a n g e  a ro u n d  th e  f o l l i c le  to  fo r m  th e  
th e c a . T h e  c e l l s  a d ja c e n t  to  th e  f o l l ic le ,  th e  th e c a  in te rn a , a re  s u r r o u n d e d  b y  a n  
a d d it io n a l  o u te r  l a y e r  o f  in te r s t it ia l  c e l l s ,  th e  th e c a  e x te r n a . C o n t in u e d  p r o l i fe r a t io n  
o f  g r a n u lo s a  c e l l s  a n d  th e  in c o r p o r a t io n  o f  s u r r o u n d in g  in te r s t it ia l  c e l l s  in to  th e  th e c a  
a re  a c c o m p a n ie d  b y  th e  a c c u m u la t io n  o f  f lu id  in  s p a c e s  o r  c le f t s  w it h in  th e  g r a n u lo s a  
c e l l s .  A s  th e  f o l l i c l e  e n la r g e s ,  a  s in g le  la r g e  v e s i c l e  o r  a n tru m  is  fo r m e d . T h o s e  
g r a n u lo s a  c e l l s  th a t a re  a d ja c e n t  to  th e  o v u m  c o m p r is e  th e  ‘ c o r o n a l g r a n u lo s a ’ c e l l s ;  
th o s e  g r a n u lo s a  c e l l s  th a t r e m a in  in  c o n t a c t  w it h  th e  s u r r o u n d in g  th e c a  c e l l s  a re  
c a l le d  th e  ‘ m e m b r a n a  g r a n u lo s a ’ . A  b r id g e  o f  g r a n u lo s a  c e l l s  c o n n e c ts  th o s e  c e l l s  
a d ja c e n t  to  th e  o v u m  w it h  th e  ‘ m e m b r a n a  g r a n u lo s a ’ a n d  is  c a l le d  th e  ‘ c u m u lu s  
o o p h o r u s ’ . T h e  m a t u r e  f o l l i c l e  a t th is  s ta g e  o f  d e v e lo p m e n t  is  c a l le d  th e  ‘ G r a a f ia n  
f o l l i c l e ’ . D u r in g  o v u la t io n ,  th e  ‘ c u m u lu s  o o p h o r u s ’ is  s e v e r e d , a n d  th e  o v u m  is  
e je c te d . A f t e r  r u p tu re  o f  th e  G r a f f i a n  f o l l i c l e ,  th e  g r a n u lo s a  c e l l s  s ta rt  to  f i l l  u p , 
a c c u m u la t e  la r g e  q u a n t it ie s  o f  c h o le s t e r o l  a n d  th is  p r o c e s s  le a d s  to  th e  fo r m a t io n  o f  
th e  ‘ c o r p u s  lu t e u m ’ .
T h e  c o n tro l o f  o v a r ia n  s te r o id  s y n th e s is  a n d  s e c r e t io n  is  a  c o m p le x  p r o c e s s  in v o lv i n g  
th e  in t e r a c t io n  o f  th e  g r a n u lo s a  a n d  th e c a  c e l l s ,  a s  w e l l  a s  a  c o -o r d in a te d  s e q u e n c e  o f  
a c t io n s  b y  th e  p i t u i t a r y  g o n a d o tr o p h in s , lu t e in is in g  h o r m o n e  ( L H )  a n d  f o l l i c l e  
s t im u la t in g  h o r m o n e  ( F S H )  ( E r ic k s o n ,  1 9 8 3 ) .  G o n a d a l  t i s s u e s  a re  a c t i v e ly  
s t e r o id o g e n ic  u s in g  c h o le s t e r o l  a s  a  p r e c u r s o r . G r a n u lo s a  c e l l s  in  th e  o v a r ie s  a re  
r e s p o n s ib le  f o r  th e  p r o d u c t io n  o f  C 1 8  o e s t r o g e n s ,  w it h  th e  L e y d i g  c e l ls  o f  th e  te s te s  
b e in g  th e  e q u iv a le n t  c e l l  t y p e  in  th e  m a le  ( K u k u c k a  a n d  M is r a ,  1 9 9 3 ) .  T h e  C l 8 
o e s t r o g e n s  a re  p r o d u c e d  v i a  a n  a r o m a t is a t io n  c o n v e r s io n  o f  C 1 9  a n d r o g e n s ,  
d e l iv e r e d  to  th e  g r a n u lo s a  c e l l s  f r o m  th e  th e c a  c e l l s  w h e r e  th e y  fu n c t io n  in  o v u m  
m a t u r a t io n  ( H a d le y ,  1 9 9 2 ) .  T h e  a r o m a ta s e  s y s t e m  c o n s is t s  o f  th e e  e n z y m e s  lo c a t e d  
o n  th e  e n d o p la s m ic  r e t ic u lu m ; a  1 9 - h y d r o x y la s e  e n z y m e , a  19 - h y d r o x y s t e r o id  
d e h y d r o g e n a s e  a n d  a  1 0 ,  1 9 - l y a s e  e n z y m e  ( V a n c e ,  1 9 9 3 ) .  T h e  1 9 - h y d r o x y la s e  
e n z y m e , a  m ix e d  fu n c t io n  o x id a s e  h a v in g  c y t o c h o m e  P 450 a t th e  a c t iv e  s ite , is  fo u n d
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in  th e m ito c h o n d r ia  a n d  e n d o p la s m ic  re t ic u lu m  o f  s te r o id  p ro d u c in g  t i s s u e s  ( V a n c e ,
1 9 9 3 ) .  S t u d ie s  in  re c e n t  y e a r s  h a v e  s h o w n  th a t th e  a c t iv it ie s  o f  c y t o c h o m e  P 450 
h y d r o x y la s e  a n d  ly a s e  e n z y m e s  in  te s te s  L e y d i g  c e l l s  a re  d e c r e a s e d  in  th e  p r e s e n c e  
o f  0 2- g e n e r a t e d  f r e e  r a d ic a ls  ( K u k u c k a  a n d  M is r a ,  1 9 9 3 ) ,  e v e n  th o u g h  th e  
m e c h a n is m s  o f  o x y g e n  t o x ic i t y  h a v e  n o t b e e n  in v e s t ig a t e d  in  d e ta il .
A s  d is c u s s e d  e a r l ie r ,  d u r in g  n o r m a l o x id a t iv e  m e t a b o l is m , c e l ls  c o n t in u a l ly  c o n v e r t  
m o le c u la r  0 2 in to  s u p e r o x id e  r a d ic a l  a n d  h y d r o g e n  p e r o x id e  a n d  u n d e r  n o r m a l 
c o n d it io n s , m o s t  c e l l s  c o n ta in  a n t io x id a n t  d e fe n c e s  fo r  d e t o x i fy in g  a n d  e l im in a t in g  
th e s e  r e a c t iv e  s p e c ie s  o f  o x y g e n  ( F ig .  5 . 1 ) .  I f ,  h o w e v e r ,  th e  n o rm a l d e f e n c e s  a re  
w e a k  o r  th e re  is  a n  o v e r w h e lm in g  p r o d u c t io n  o f  f r e e  r a d ic a ls ,  m o r e  t o x ic  r e a c t iv e  
o x y g e n  s p e c ie s  a r e  fo r m e d  in c lu d in g  th e  p o te n t  h y d r o x y l  r a d ic a l  a n d  s in g le t  o x y g e n ,  
w h ic h  a re  c a p a b le  o f  e v o k in g  n u m e r o u s  p a t h o lo g ic a l  p h e n o m e n a  in c lu d in g  p r o t e in  
a lte r a t io n  a n d  c e l l  m e m b r a n e  d a m a g e  ( C la r e  et al. , 1 9 9 5 ) .
A b n o r m a l  a r o m a ta s e  a c t iv i t y  m a y  th e r e fo r e  a d v e r s e ly  a f f e c t  o e s t r o g e n  b io s y n t h e s i s  
a n d  th e r e b y  a f f e c t  o v u m  m a tu ra t io n . In  v i e w  o f  th e  a c t iv e  P 450 e n z y m e  s y s t e m  in  
g r a n u lo s a  c e l l s  a n d  i t ’ s  l ik e ly  d e p e n d e n c e  o n  th e  o x id a t iv e  s ta tu s  o f  c e l l s ,  it  w a s  o f  
in te re s t  to  in v e s t ig a t e  w h e t h e r  m e t a b o l is m  in  o v a r ia n  g r a n u lo s a  c e l l s  m ig h t  b e  
a d v e r s e ly  in f lu e n c e d  b y  c h o le s t e r o l  o x id e s  v i a  d a m a g e  to  c e l lu la r  a n d  s u b c e l lu la r  
e n d o p la s m ic  r e t ic u la r  m e m b r a n e s  a n d /o r a lte r e d  a n t io x id a n t  d e fe n c e  s y s te m  
fu n c t io n in g .
G r a n u lo s a  c e l l s  h a v e  m a n y  a d v a n ta g e s  fo r  c u ltu r e  s tu d ie s ,  b e in g  r e la t iv e ly  s im p le  to 
o b ta in  in  r e a s o n a b ly  p u r e  fo r m , in  la r g e  n u m b e r s  a n d  a t k n o w n  s ta g e s  o f  m a tu r a t io n  
( H a l l ,  19 9 4 ) .  In  f e m a le  m a m m a ls ,  a l l  g e r m  c e l l s  a r e  fo r m e d  in  th e  o v a r y  b e fo r e  
b ir th , m a n y  o f  w h ic h  b e c o m e  a tr e t ic , so  th a t b y  p u b e r t y  o n ly  h a l f  th e  in i t ia l  n u m b e r  
o f  o o c y t e s  re m a in . T h e r e f o r e ,  a n y  a g e n t  th a t d a m a g e s  th e  o o c y te  w i l l  a c c e le r a t e  th e  
d e p le t io n  o f  o o c y t e  n u m b e r , th e r e b y  r e d u c in g  fe r t i l i t y  ( G a r s id e  a n d  M c K ib b in ,
1 9 8 7 ) .  T h e  s u r v i v a l  o f  a  s p e c ie s  th e r e fo r e  d e p e n d s  o n  th e  in t e g r it y  o f  i t ’ s 
r e p r o d u c t iv e  s y s t e m  a n d  th e  p o s s ib le  to x ic  e f f e c t s  o f  o x y s t e r o ls  o n  th e  r e p r o d u c t iv e  
s y s t e m  is  a n  im p o r ta n t  h e a lth  is s u e .
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T h is  c h a p te r  in v e s t ig a t e s  th e  o x id a t iv e  s ta tu s  o f  g r a n u lo s a  c e l l s  w h e n  e x p o s e d  to 
s o m e  C O P s  p r e v io u s ly  fo u n d  to  e x i s t  in  w h o le  m ilk  p o w d e r s .  T h i s  e n ta i le d  s e t t in g  
up  an  in vitro m o d e l  s y s te m  in  w h ic h  a c t iv i t ie s  o f  a n t io x id a n t  d e fe n c e  e n z y m e s  w e r e  
d e t e r m in e d  in  c e l l s  e x p o s e d  to  a  r a n g e  o f  C O P s  in  th e  p r e s e n c e  a n d  a b s e n c e  o f  a- 
to c o p h e r o l .  T h e  c o n c e n t r a t io n  o f  e a c h  C O P  ( 2 .5  p ,M  in  th e  w e l l  w h ic h  is  e q u iv a le n t  
to  l | ig / m l)  th a t w a s  c h o s e n  fo r  th is  s t u d y  w a s  b a s e d  o n  th e  e v id e n c e  d e r iv e d  f r o m  a  
h u m a n  fe e d in g  s t u d y  c a r r ie d  o u t b y  E m a n u e l  et al. ( 1 9 9 1 ) .  It  w a s  e s t a b l is h e d  fro m  
th a t s t u d y  th a t th e  l e v e l s  o f  to ta l C O P s  in  p la s m a  r a n g e d  b e t w e e n  2 0 0 - 1 6 0 0  f-ig/dl 
( a v e r a g e  6 1 7  | ig / d l)  a ft e r  in g e s t io n  o f  a  te s t  m e a l  o f  p o w d e r e d  e g g s  c o n t a in in g  2 3 0  
| ig / g  l ip id  C O P s .  T h u s ,  th e  l e v e l s  o f  C O P s  fo u n d  in  s a c h e t - p a c k e d  w h o le  m i lk  
p o w d e r  s to r e d  at 3 0  ° C  fo r  1 2  m o n t h s  ( 3 7 . 1 7  ±  7 . 5 4  f ig / g  l ip id )  i s  e q u iv a le n t  to  1 
ja g /g  l ip id  in  p la s m a  a s s u m in g  a  l in e a r  d o s e  r e s p o n s e  o f  e a c h  C O P  a n d  s im i la r  
a b s o r p t io n  o f  e a c h  C O P .
5.2 A IM S
T o  in v e s t ig a t e  th e  t o x ic i t y  o f  a  n u m b e r  o f  C O P s  fo u n d  in  w h o le  m i lk  p o w d e r .
5.3 O B J E C T IV E S
T h e  o b je c t iv e s  o f  th is  s tu d y  w e r e :
•  T o  in v e s t ig a t e  th e  e f f e c t  o f  C O P s  o n  c e l l  g r o w t h  u s in g  p r im a r y  c u ltu r e s  o f
p o r c in e  o v a r ia n  g r a n u lo s a  c e l ls .
•  T o  d e t e r m in e  th e  e f f e c t  o f  C O P s  o n  d e v e lo p m e n t  o f  c e l lu la r  l ip id  p e r o x id a t io n .
•  T o  d e t e r m in e  th e  e f f e c t s  o f  C O P s  o n  th e  a n t io x id a t iv e  d e fe n c e  e n z y m e  s y s t e m s .
•  T o  d e t e r m in e  th e  e f f e c t  o f  a - t o c o p h e r o l  w h e n  a d m in is te r e d  s im u lt a n e o u s ly  w it h
C O P s  o n  th e  a n t io x id a n t  d e fe n c e  e n z y m e  s y s t e m s .
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5.4 EXPERIMENTAL
5.4.1 Reagents
N e w - b o r n  c a l f  s e r u m  ( N C S ) ,  n o n - e s s e n t ia l  a m in o  a c id s ,  p e n ic i l l in - s t r e p t o m y c in ,  L -  
g lu t a m in e , t r y p a n  b lu e , 3 - [ 4 ,5 - d im e t h y l t h ia z o l - 2 - y l ] - 2 ,5 - d ip h e n y l t e t r a z o l iu m  
b r o m id e  ( M T T ) ,  c y t o c h o m e  C ,  g lu t a th io n e  r e d u c ta s e , P - n ic o t in a m id e  a d e n in e  
d in u c le o t id e  p h o s p h a te  r e d u c e d  fo r m  ( P - N A D P ) ,  r e d u c e d  g lu t a th io n e , p y r u v i c  a c id , 
s u p e r o x id e  d is m u t a s e ,  te r t -b u ty l  h y d r o g e n  p e r o x id e ,  x a n th in e , x a n t h in e  o x id a s e  a n d  
m a lo n d ia ld e h y d e  ( M D A )  w e r e  a l l  p u r c h a s e d  fo r m  S ig m a  C h e m ic a l  C o . ( P o o le ,  
D o r s e t ,  U K ) .  D M E M  ( D u lb e c c o ’ s  m o d i f ie d  E a g le  m e d iu m )  a n d  m e d iu m  1 9 9  
w it h o u t  p h e n o l  r e d  w e r e  p u r c h a s e d  f r o m  G I B C O  ( P a is le y ,  S c o t la n d ) .
5.4.2 Recovery of granulosa cells from  porcine ovaries
P o r c in e  o v a r ie s  w e r e  ta k e n  fr o m  f r e s h ly  s la u g h te r e d  p ig s  at a  lo c a l  a b b a to ir  ( D e n n y s ,  
T r a le e ,  C o .  K e r r y )  a n d  p la c e d  in  ic e - c o ld  P B S  (8 g  N a C l ,  0 .2  g  K C 1 ,  2 .8 9  g  N a 2H P 0 4 
a n d  0 .0 2  g  K H 2P 0 4/1). E x c e s s  t i s s u e  w a s  r e m o v e d  fr o m  th e  o v a r ie s ,  w h ic h  w e r e  th e n  
w a s h e d  in  ic e - c o ld  P B S .  G r a n u lo s a  c e l l s  w e r e  c o l le c t e d  b y  a s p ir a t in g  a l l  f o l l i c le s  
u s in g  a  s y r in g e  a n d  21 - g a u g e  n e e d le  a n d  c e n t r i fu g e d  at 6 0 0  g  f o r  5  m in  a t 3 5 °  C . 
C e l l s  w e r e  c o u n te d  u s in g  a  h a e m o c y t o m e t e r  a n d  w e r e  s e e d e d  a t a  f in a l  c o n c e n tr a t io n  
o f  2  x  1 0 5 /m l in  c o m p le te  D M E M  c o n t a in in g  1 0  %  N C S ,  1  %  p e n ic i l l in -  
s t r e p t o m y c in  a n d  g lu t a m in e  a n d  c u ltu r e d  f o r  2 4  h  a t 3 7 °  C  in  a n  a tm o s p h e r e  
c o n t a in in g  9 5  %  0 2 a n d  5  %  C 0 2 in  2 4  w e l l  p la t e s .
5.4.3 Cell Treatment
T w e n t y - f o u r  w e l l  p la t e s  w e r e  u s e d  f o r  th e  b io a s s a y s ,  w it h  r a n d o m  n u m b e r  ta b le s  
u s e d  to  a s s ig n  tr e a tm e n ts  to  w e l l s .  T h e  tr e a tm e n ts  w e r e  a s  f o l lo w s :  c o n tro l c e l ls  
r e c e iv e d  20  p .1 a b s o lu t e  e th a n o l, a - t o c o p h e r o l  c o n tr o ls  r e c e iv e d  10 ( il  a b s o lu te  
e th a n o l a n d  1 0  jj.1 2 0 8  ( iM  a - t o c o p h e r o l ,  w h i le  c e l l s  tre a te d  w it h  C O P s  r e c e iv e d  2 0  
(.il 2 4 8  jj ,M  2 5 - h y d r o x y c h o le s t e r o l ,  c h o le s t a n e t r io l ,  7 - k e t o c h o le s t e r o l ,  c h o le s t e r o l - a -  
e p o x id e  o r  c h o le s t e r o l  a lo n e  (m a d e  u p  in  e th a n o l) . C e l l s  t r e a te d  w it h  C O P s  a n d  a -  
t o c o p h e r o l  s im u lt a n e o u s ly  r e c e iv e d  10 p.1 o f  2 0 8  p M  a - t o c o p h e r o l  a n d  e ith e r  10 p .1 
4 9 8  (J.M  2 5 - h y d r o x y c h o le s t e r o l  o r  c h o le s t a n e t r io l  d is s o lv e d  in  e th a n o l. T h e  f in a l
2 1 0
v o lu m e  in  th e w e l l  w a s  2 m l an d  th e f in a l c o n c e n t r a t io n s  o f  a - t o c o p h e r o l  a n d  C O P s  
in th e  w e l l  w e r e  a p p r o x im a t e ly  1 . 0  an d  2 .5  fa M , r e s p e c t iv e ly .
5.4.4 Cell V iability
5.4.4.1 Measurem ent of trypan blue exclusion by cells
G r a n u lo s a  c e l l  m o n o la y e r s  w e r e  d is s o c ia t e d  in  th e  c u ltu r e  w e l l s  u s in g  ( 0 .2 5  w / v )  
t r y p s in / E D T A  s o lu t io n  ( 1 0 0  m M  E D T A  in  P B S ,  p H  7 .4 ) .  T h e  c u ltu r e  m e d iu m  in  
e a c h  w e l l  w a s  f i r s t  r e m o v e d  b y  t r a n s fe r  p ip e t te  a n d  d is c a r d e d . In to  e a c h  w e l l ,  0 .5  m l 
o f  p r e -w a r m e d  P B S  ( 3 7 °  C )  w a s  a d d e d  to  w a s h  o u t  c e l l  d e b r is  an d  to  r e m o v e  a n y  
r e m a in in g  s e r u m  p r o t e in s  w h ic h  c o u ld  im p a ir  t r y p s in  a c t io n . T h e  P B S  w a s  a ls o  
r e m o v e d  b y  t r a n s fe r  p ip e t te  a n d  d is c a r d e d . T r y p s in / E D T A  s o lu t io n  (0 .5  m l)  w a s  
a d d e d  to  e a c h  w e l l .  T h e  c u ltu r e  p la t e s  w e r e  th e n  in c u b a t e d  at 3 7 °  C  in  th e  C 0 2 
in c u b a to r  u n t il  a l l  o f  th e  c e l l s  h a d  b e c o m e  d e t a c h e d  f r o m  th e  w e l l  f lo o r .  T o  in h ib it  
t r y p s in  a c t iv it y ,  0 .5  m l  c o m p le te  D M E M  ( c o n t a in in g  N C S )  w a s  a d d e d  to  e a c h  w e l l .  
T h e  c o n te n ts  o f  e a c h  w e l l  w e r e  r e p e a te d ly  a s p ir a te d  w it h  a  s te r i le  p a s t e u r  p ip e t te  to  
o b ta in  a n  e v e n  s u s p e n s io n  o f  c e l ls .  A n  a l iq u o t  o f  th e  c e l l  s u s p e n s io n  w a s  m ix e d  w it h  
a n  e q u a l  v o lu m e  o f  t r y p a n  b lu e  a n d  th e  c e l l s  o b s e r v e d  u n d e r  a  C a n o n  in v e r te d  
m ic r o s c o p e  a n d  c o u n te d  u s in g  a  h a e m o c y t o m e t e r .  U s in g  t r y p a n  b lu e  s ta in , d e a d  c e l l s  
w e r e  s ta in e d  b lu e .  R e s u l t s  w e r e  e x p r e s s e d  a s  %  v i a b i l i t y .
5.4.4.2 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay
C e l l  v i a b i l i t y  w a s  d e t e r m in e d  u s in g  th e  M T T  a s s a y  ( M o s m a n n , 1 9 8 3 ) :  th e  c u ltu r e  
m e d ia  in  e a c h  w e l l  w a s  f i r s t  d is c a r d e d  a n d  th e  c e l l s  w a s h e d  w it h  2  m is  P B S .  2 0 0  |il 
o f  1 0  %  M T T  ( in  M 1 9 9  m e d iu m )  w a s  a d d e d  a n d  in c u b a t e d  at 3 7 °  C  f o r  4  h . T h e  
m e d iu m  w a s  c a r e f u l l y  d is c a r d e d , ta k in g  c a r e  n o t  to  d is r u p t  th e  fo r m a z a n  c r y s t a ls .  
T h e  c r y s t a ls  w e r e  d i s s o l v e d  in  2  m l is o p r o p a n o l ,  th e  a b s o r b a n c e  re a d  at 5 7 0  a n d  6 9 0  
n m  a n d  th e  d i f f e r e n c e  c a lc u la t e d  a n d  e x p r e s s e d  a s  %  o f  c o n tro l c e l ls .
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5.4.5 Antioxidant Defence Bioassays
5.4.5.1 Superoxide Dismutase (SO D ) Assay
T o ta l  s u p e r o x id e  d is m u t a s e  ( S O D )  a c t iv i t y  in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  w a s  
d e te rm in e d  b y  th e  m e th o d  o f  G a l le a n o  et al. ( 1 9 9 4 ) .  T h is  a s s a y  d e p e n d s  o n  S O D  
a b i l i t y  to  in h ib it  c y t o c h o m e  C  r e d u c t io n  m e d ia t e d  b y  0 2 '  g e n e r a te d  fr o m  th e  
x a n th in e  o x id a s e  s y s t e m  ( L a w lo r  a n d  O ’ B r ie n ,  1 9 9 4 ) .  C e l l s  w e r e  s o n ic a t e d  a t  4 °  C  
f o r  2  m in  p r io r  to  a s s a y .  T h e  a s s a y  w a s  p e r fo r m e d  a t 2 5 °  C  in  2 .5  m l  0 .0 5  M  
p o t a s s iu m  p h o s p h a te  b u f fe r ,  p H  7 .8  to  w h ic h  w a s  a d d e d  0 .3  m l 5 0  p M  x a n th in e  
o x id a s e  a n d  0 .2  m l  2 0  p M  c y t o c h o m e  C  in  a  c u v e t t e  a n d  th e  in i t ia l  a b s o r b a n c e  
m o n ito r e d  at 5 5 0  n m  f o r  1  m in . 1 0 0  p i  o f  th e  c e l l  e x t r a c t  w a s  th e n  a d d e d , th e  c h a n g e  
in  a b s o r b a n c e / m in  w a s  r e c o r d e d  a n d  r e s u lts  w e r e  e x p r e s s e d  a s  a c t iv i t y  u n its / m g  
p ro te in . O n e  u n it  o f  S O D  a c t iv i t y  is  d e f in e d  a s  th e  a m o u n t o f  S O D  r e q u ir e d  to 
in h ib it  r a te  o f  c y t o c h o m e  C  r e d u c t io n  b y  5 0  % . T h e  le v e l  o f  p r o t e in  in  th e  c e l l  
e x t r a c t  w a s  d e t e r m in e d  a n d  th e  r e s u lt s  e x p r e s s e d  a s  u n its / m g  p ro te in .
5.4.5.2 Catalase (C A T )  Assay
C a t a la s e  ( C A T )  a c t iv i t y  w a s  m e a s u r e d  u s in g  th e  m e t h o d  o f  B a u d h u in  et al. ( 1 9 6 4 ) .  
C e l l s  w e r e  s o n ic a t e d  a t 4 °  C  fo r  2  m in  p r io r  to  a s s a y  a n d  d ilu te d  1 : 4  w it h  1 %  T r ito n  
X - 1 0 0 .  T h e  a s s a y  w a s  p e r fo r m e d  at 2 5 °  C  in  2 .9  m l  0 .0 1  M  p o t a s s iu m  p h o s p h a te  
b u f fe r ,  p H  7 .0  in  a  q u a r tz  c u v e t t e  to  w h ic h  w a s  a d d e d  1 0 0  p i  0 . 3  M  H 20 2 , a n d  th e  
in i t ia l  a b s o r b a n c e  m o n ito r e d  a t 2 4 0  n m . 1 0  p i  o f  th e  c e l l  e x tra c t  w a s  th e n  a d d e d  to  
th e  c u v e t te  a n d  th e  a b s o r b a n c e  m o n ito r e d  at 2 4 0  n m  o v e r  3 0  s e c . T h e  a m o u n t  o f  
H 20 7 r e d u c e d  w a s  d e t e r m in e d  b y  th e  B e e r  L a m b e r t  L a w  ( fo r  H 20 2 s  =  4 0  M ’1 c m '1). 
O n e  B e r g m e y e r  u n it  is  e q u iv a le n t  to  th e  a m o u n t  o f  C A T  re q u ir e d  to  d e c o m p o s e  1 .0  
p m o l  H 20 2 / m in / m l a t p H  7 .0  a t 2 5  0 C .  R e s u l t s  w e r e  e x p r e s s e d  a s  B e r g m e y e r  
u n its / m g  p r o te in . P r o t e in  w a s  d e te rm in e d  a c c o r d in g  to  th e  m e th o d  o f  B r a d f o r d  
( 1 9 7 6 ) .
5.4.5.3 Glutathione Peroxidase (G Px) Assay
G P x  a c t iv i t y  w a s  m e a s u r e d  a c c o r d in g  to  th e  m e th o d  o f  G u e n z le r  et al. ( 1 9 7 4 ) .  
R e d u c e d  g lu t a th io n e  is  o x id i s e d  b y  G P x  a n d  th is  r e a c t io n  is  c o u p le d  w it h  th e  
c o n v e r s io n  o f  N A D P H  to  N A D P  b y  g lu t a th io n e  re d u c ta s e  ( L a w lo r  a n d  O ’ B r ie n ,
2 1 2
1 9 9 4 ) .  T h e  f o l lo w in g  r e a g e n ts  w e r e  a d d e d  to a  s p e c t r o p h o to m e t r ic  c u v e t t e :  1 . 6 3  m l 
0 .0 1  M  p o t a s s iu m  p h o s p h a te  b u f fe r ,  p H  7 .7  c o n t a in in g  0 .0 0 1  M  E D T A ,  1 0 0  ja l 1 0  
m M  H 20 2 , 5 0  fal N 3N a , 3 0  ¡j.1 1 0  m M  N A D P H , 5 0  ^tl G S H  r e d u c ta s e  a n d  1 0 0  j.il 10 0  
m M  G S H .  T h e  a b s o r b a n c e  w a s  m o n ito r e d  at 3 4 0  n m  to  d e t e r m in e  th e  b a s e l in e .  T h is  
w a s  th e n  re p e a te d  a f t e r  a d d in g  5 0  fil c e l l  s a m p le  a n d  th e  N A D P H  c o n s u m p t io n  ra te  
r e c o r d e d . T h e  d i f fe r e n c e  in  N A D P H  c o n s u m p t io n  ra te  b e fo r e  a n d  a ft e r  a d d it io n  o f  
c e l l  s a m p le  w a s  c a lc u la t e d  u s in g  th e  B e e r  L a m b e r t  L a w  (e  =  6 .2  m M '1 c m ' 1) . O n e  
u n it  o f  G P x  a c t iv i t y  i s  d e f in e d  a s  1  ^ im o l o f  G S H  o x id is e d / m in  =  1  fxm o l N A D P H  
o x id is e d / m in . T h e  G P x  a c t iv i t y  w a s  e x p r e s s e d  a s  u n its / m g  p ro te in . P r o t e in  w a s  
d e t e r m in e d  a c c o r d in g  to  th e  m e t h o d  o f  B r a d f o r d  ( 1 9 7 6 ) .
5.4.6 Measurem ent o f lipid oxidation in cells using T B A R S  assay
T h e  l e v e l  o f  l ip id  p e r o x id a t io n  in  c e l l s  w a s  d e te r m in e d  b y  th e  m e th o d  o u t l in e d  b y  
E s t e r b a u e r  a n d  C h e e s e m a n  ( 1 9 9 0 ) .  A  1 0  m M  s to c k  s o lu t io n  o f  m a lo n d ia ld e h y d e  
( M D A )  w a s  p r e p a r e d  u s in g  m a lo n d ia ld e h y d e  b is m e t h y la c e t a l  in  1  %  s u lp h u r ic  a c id . 
T h i s  w a s  le f t  at r o o m  te m p e r a tu r e  f o r  2  h  to  a c h ie v e  c o m p le t e  h y d r o ly s is  a n d  w a s  
th e n  u s e d  in  th e  p r e p a r a t io n  o f  s ta n d a r d s  in  th e  r a n g e  0 . 1 -  1 0 0  ( im o l. C e l l  s a m p le  
w a s  s o n ic a t e d  o n  ic e  f o r  2 m in  a n d  1 m l  o f  th e  c e l l  e x t r a c t  w a s  m ix e d  w it h  2 m l o f  
ic e - c o ld  1 0  %  ( w / v )  T C A  to  p r e c ip it a t e  p ro te in . T h e  p r e c ip it a t e  w a s  p e l le t e d  b y  
c e n t r i fu g a t io n  a t 1 0 0 0  g  a n d  1  m l  s u p e rn a ta n t  re a c te d  w it h  a n  e q u a l v o lu m e  o f  0 .6 7  
%  w / v  T B A  in  a  b o i l in g  w a te r - b a th  f o r  1 0  m in . A f t e r  b o i l in g ,  a l l  s a m p le s  w e r e  le f t  to  
c o o l  a n d  th e  a b s o r b a n c e  w a s  re a d  a t 5 3 2  n m . T h e  a c tu a l c o n c e n t r a t io n  o f  M D A  w a s  
c a lc u la t e d  b a s e d  o n  a n  8 v a lu e  o f  1 5 3 , 0 0 0  M '1 c m '1 . R e s u lt s  w e r e  e x p r e s s e d  a s  n m o l 
M D A / m g  p ro te in . P r o t e in  w a s  d e t e r m in e d  a c c o r d in g  to  th e  m e th o d  o f  B r a d f o r d  
( 1 9 7 6 ) .
5.4.7 Determination of total cellular protein
P r o t e in  w a s  d e te r m in e d  a c c o r d in g  to  th e  B r a d f o r d  a s s a y  ( B r a d f o r d ,  1 9 7 6 ) .  M e d iu m  
w a s  d is c a r d e d  fr o m  w e l l s  a n d  c e l l s  w a s h e d  t w ic e  w it h  1  m l P B S .  C e l l s  w e r e  th e n  
s o n ic a t e d  fo r  3  m in  in  1 m l P B S ,  a n d  1 0 0  (.il c e l l  s a m p le  a d d e d  to  5  m l  B r a d f o r d  
r e a g e n t  ( 0 .0 1  %  C o o m a s s ie  B r i l l i a n t  B lu e ,  4 .7  %  e th a n o l a n d  8 .5  %  p h o s p h o r ic  
a c id ) ,  a l lo w e d  s ta n d  f o r  2  m in  a n d  a b s o r b a n c e  m o n ito r e d  at 5 9 5  n m . A  s ta n d a rd
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c u r v e  (0 - 100 ja g /m l ) w a s  c o n s t r u c te d  u s in g  b o v in e  s e r u m  a lb u m in  a n d  re s u lts  
e x p r e s s e d  a s  m g  p ro te in /m l.
5.4.8 Statistical Methods
S tu d e n t  t - te s ts  w e r e  u s e d  fo r  d e t e r m in in g  s t a t is t ic a l  s ig n i f i c a n c e  o f  t o x ic i t y  e f f e c t s  o f  
C O P s  u s in g  S ig m a s t a t  ( Ja n d e l  S c ie n t i f i c  S o f t w a r e ,  U S A ) .
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5.5 RESULTS
5.5.1 Porcine ovarian granulosa cell growth curve
F ig .  5 .3  s h o w s  a  t y p ic a l  g r o w t h  c u r v e  fo r  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  in vitro. 
T h e  v ia b le  c e l l  c o u n t  w a s  a s c e r ta in e d  u s in g  th e  t r y p a n  b lu e  e x c lu s io n  te st a s  o u t l in e d  
in  C h a p t e r  5 ,  s e c t io n  3 . 4 . 1 .  T h e  g r o w t h  c u r v e  in d ic a t e s  a n  in it ia l  1 6 . 5  %  m o r t a l i t y  
o v e r  th e  f i r s t  2 4  h  o f  c u ltu r e  b e fo r e  th e  o n s e t  o f  a n  e x p o n e n t ia l  p h a s e  o f  c e l l  d iv i s io n .  
A n a l y s i s  o f  th e  g r o w t h  c u r v e  in d ic a te d  th a t 2 4  h  a f t e r  p la t in g  w a s  a s u it a b le  t im e  fo r  
in it ia t io n  o f  e x p e r im e n t s  in v o lv in g  e x p o s u r e  o f  t h e s e  c e l l s  to  C O P s  ( F ig .  5 . 3 )  a s  th is  
in d ic a t e d  th e  s ta rt  o f  th e  e x p o n e n t ia l  p h a s e  o f  g r o w t h .
5.5.2 Investigation of toxicity of C O P s  on porcine ovarian granulosa cells
F i g .  5 .4  s h o w s  th e  e f f e c t s  o f  e x p o s u r e  to  2 .5  | tM  c h o le s t e r o l ,  t r io l ,  c h o le s t e r o l - a -  
e p o x id e ,  7 - k e t o c h o le s t e r o l  a n d  2 5 - h y d r o x y c h o le s t e r o l  fo r  2 4  h  o n  g r a n u lo s a  c e l l  
v i a b i l i t y .  C h o le s t e r o l  a n d  7 - k e t o c h o le s t e r o l  ( 2 .5  jx M )  h a d  n o  in h ib it o r y  e f f e c t  o n  
g r a n u lo s a  c e l l  v i a b i l i t y  f o l lo w i n g  2 4  h  e x p o s u r e  w i t h  re d u c t io n s  in  c e l l  v i a b i l i t y  o f  
o n ly  4  % . H o w e v e r ,  s ig n i f i c a n t  in h ib it io n  o c c u r r e d  in  th e  p r e s e n c e  o f  2 .5  |_iM 2 5 -  
h y d r o x y c h o le s t e r o l ,  c h o le s t a n e t r io l  (p  <  0 .001)  a n d  c h o le s t e r o l - a - e p o x id e  (p  <  0 .01) 
w h e r e  c e l l  v i a b i l i t y  w a s  r e d u c e d  b y  66 % ,  4 8  %  a n d  4 4  % , r e s p e c t iv e ly ,  f o l lo w i n g  
e x p o s u r e  o f  g r a n u lo s a  c e l l s  fo r  2 4  h.
5.5.3 Effect of extended incubation time with C O P s  on porcine ovarian 
granulosa cells
F i g .  5 .5  s h o w s  a  t im e  c o u r s e  b io a s s a y  o f  e x p o s u r e  to  2 .5  fJ.M  c h o le s t a n e t r io l  a n d  2 5 -  
h y d r o x y c h o le s t e r o l  o n  c e l l  v i a b i l i t y  a ft e r  2 4 ,  4 8  a n d  7 2  h  in c u b a t io n . C e l l  v i a b i l i t y  
w a s  s ig n i f i c a n t ly  (p  <  0 . 0 1 )  r e d u c e d  a t a l l  t im e s  o f  e x p o s u r e  to  C O P s  in v e s t ig a t e d  
th o u g h  n o  s ig n i f i c a n t  d i f fe r e n c e  w a s  fo u n d  b e t w e e n  th e  d if fe r e n t  t im e  p e r io d s  fo r  
b o th  o x id e s .  E x p o s u r e  o f  g r a n u lo s a  c e l l s  to  c h o le s t a n e t r io l  r e s u lte d  in  c e l l  n u m b e r  
re d u c t io n s  in  th e  r a n g e  4 2  - 5 2  %  o v e r  7 2  h , w h i le  e x p o s u r e  to  2 5 -  
h y d r o x y c h o le s t e r o l  r e s u lt e d  in  r e d u c t io n s  o f  66 % ,  7 1 %  a n d  4 6  %  in  c e l l  v i a b i l i t y  
a f t e r  2 4  h , 4 8  h  a n d  7 2  h  e x p o s u r e ,  r e s p e c t iv e ly .  A n  in c r e a s e  in  v i a b i l i t y  o f  2 5  % ,  
th o u g h  n o t s ig n i f i c a n t ,  w a s  o b s e r v e d  w h e n  2 5 -
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Fig. 5.3 G r o w t h  c u r v e  o f  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s .  D a t a  p o in ts  r e f e r  to  m e a n  
±  s ta n d a r d  d e v ia t io n .
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Fig. 5.4 P o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  w e r e  in c u b a t e d  w it h  2 .5  u M  c h o le s t e r o l ,  
c h o le s t a n e t r io l ,  c h o le s t e r o l - a - e p o x id e ,  7 - k e t o c h o le s t e r o l  a n d  2 5 - h y d r o x y c h o le s t e r o l  
a n d  in c u b a t e d  f o r  2 4  h . T r i o l :  C h o le s t a n e t r io l ;  7 - k e t o :  7 - K e t o c h o le s t e r o l ;  2 5 - O H : 
2 5 - H y d r o x y c h o l e s t e r o l ;  E p o x id e :  C h o le s t e r o l - a - e p o x id e .  V i a b l e  c e l l  c o u n t  w a s
th e n  c a r r ie d  o u t  u s in g  t r y p a n  b lu e  e x c l u s io n  d y e .  * *  (p  <  0 .01) , * * *  (p  <  0 .001) 
r e l a t i v e  to  c o n t r o l .  E r r o r  b a r s  r e f e r  to  s ta n d a rd  d e v ia t io n .
C ontro l C holestero l T rio l Epoxide 7-keto 25-OH
Treatm ent
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F i g .  5 . 5 .  T im e  c o u r s e  b io a s s a y  o f  2 .5  f i M  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l  
in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  in c u b a t e d  fo r  2 4 ,  4 8  a n d  7 2  h . T r io l :  
C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 - H y d r o x y c h o le s t e r o l .  C e l l  c o u n ts  w e r e  th e n  c a r r ie d  o u t 
a s  a  m e a s u r e  o f  c e l l  v i a b i l i t y  u s in g  t r y p a n  b lu e  e x c lu s io n  d y e .  * *  (p  <  0 .01) , * * *  (p  
<  0 . 0 0 1 )  r e la t iv e  to  c o n tr o l.  E r r o r  b a r s  r e f e r  to  s ta n d a rd  d e v ia t io n .
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h y d r o x y c h o le s t e r o l  w a s  in c u b a te d  fo r  7 2  h , in d ic a t in g  th at th e  c e l l s  m a y  h a v e  
‘ r e c o v e r e d ’ o r  a d a p te d  to  th e  p r e s e n c e  o f  2 5 - h y d r o x y c h o le s t e r o l  a f t e r  7 2  h  
in c u b a t io n . S in c e  n o  s ig n i f ic a n t  d i f f e r e n c e  in  c e l l  v i a b i l i t y  w a s  o b s e r v e d  b e tw e e n  
th e  th e e  in c u b a t io n  p e r io d s  in v e s t ig a t e d , th e  2 4  h  in c u b a t io n  p e r io d  w a s  e m p lo y e d  
fo r  a l l  fu r th e r  b io a s s a y s  in  th is  s tu d y .
5.5.4 Effect of 25-hydroxycholesterol and cholestanetriol on cell num ber and 
viability
F i g .  5 .6  s h o w s  th e  e f f e c t  o f  in c u b a t io n  o f  g r a n u lo s a  c e l l s  w it h  2 .5  p M  c h o le s t a n e t r io l  
a n d  2 .5  p M  2 5 - h y d r o x y c h o le s t e r o l  fo r  2 4  h  o n  c e l l  v i a b i l i t y ,  u s in g  b o th  th e  v ia b le  
c e l l  c o u n t  ( C h a p t e r  5 ,  s e c t io n  4 . 4 . 1 )  a n d  M T T  a s s a y  ( C h a p t e r  5 ,  s e c t io n  4 .4 .2 )  as  
in d ic a t o r s  o f  v i a b i l i t y .  T h e  re s u lts  in d ic a t e  th a t  w h e n  c e l l s  w e r e  e x p o s e d  to  e ith e r  
c h o le s t a n e t r io l  o r  2 5 - h y d r o x y c h o le s t e r o l  f o r  2 4  h , b o th  c e l l  v i a b i l i t y  an d  
m it o c h o n d r ia l  in t e g r i t y  w e r e  s ig n i f i c a n t ly  (p  <  0 .001) r e d u c e d  r e la t iv e  to  u n tre a te d  
c o n t r o ls .  W h e n  c e l l s  w e r e  e x p o s e d  to  2 .5  p M  c h o le s t a n e t r io l ,  m it o c h o n d r ia l  
in t e g r it y  w e r e  r e d u c e d  b y  2 6  % . S im i la r l y ,  w h e n  c e l l s  w e r e  e x p o s e d  to  2 .5  p M  2 5 -  
h y d r o x y c h o le s t e r o l ,  m ito c h o n d r ia l  in t e g r it y  w a s  r e d u c e d  b y  3 8  % . In  c o n t r a s t ,  a  
s im i la r  c o n c e n t r a t io n  o f  c h o le s t e r o l  h a d  l it t le  e f f e c t  o n  m ito c h o n d r ia l  in t e g r i t y  (11 %  
r e d u c t io n  in  m it o c h o n d r ia l  in te g r ity ) .
5.5.5 Effect of a-tocopherol addition on response to C O P s  administration
F i g .  5 .7  s h o w s  th e  e f f e c t s  o f  in c o r p o r a t io n  o f  a - t o c o p h e r o l  s im u lt a n e o u s ly  w i t h  2 5 -  
h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l  o n  c e l l  v i a b i l i t y  a n d  m ito c h o n d r ia l  in t e g r it y .  
W h e n  a - t o c o p h e r o l  ( 1 . 0  p M )  w a s  in c u b a t e d  w it h  c o n tro l c e l l s  f o r  2 4  h , i t  h a d  
n e g l ig b le  e f f e c t  o n  c e l l  v i a b i l i t y  o r  m it o c h o n d r ia l  in t e g r it y .  H o w e v e r ,  w h e n  a -  
to c o p h e r o l  w a s  in c o r p o r a t e d  s im u lt a n e o u s ly  w it h  c h o le s t a n e t r io l  f o r  2 4  h , c e l l  
v i a b i l i t y  a n d  m it o c h o n d r ia l  in t e g r it y  w e r e  1 . 4 - f o l d  a n d  1 . 2 - f o l d  g r e a t e r  th a n  in  th e  
a b s e n c e  o f  a - t o c o p h e r o l  ( 1 . 0  p M ) .  T h u s ,  t o x ic i t y  w a s  r e d u c e d  b y  2 0  %  a n d  1 6  % ,  a s  
m e a s u r e d  b y  t r y p a n  b lu e  e x c lu s io n  a n d  M T T  a s s a y s ,  r e s p e c t iv e ly .  W h e n  a -  
to c o p h e r o l  ( 1 . 0  p M )  w a s  in c o r p o r a te d  s im u lt a n e o u s ly  w it h  2 5 - h y d r o x y c h o le s t e r o l  
c e l l  v i a b i l i t y  a n d  m it o c h o n d r ia l  in t e g r it y  w e r e  1.8- fo ld  a n d  1.6- fo ld  g r e a t e r  th a n  in
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F i g .  5 .6  E f f e c t  o f  2 .5  (J.M  c h o le s t e r o l ,  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x c h o le s t e r o l  o n  
c e l l  v i a b i l i t y  a n d  m it o c h o n d r ia l  in t e g r i t y  in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  a f t e r  2 4  h  
in c u b a t io n . T r i o l :  C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 - H y d r o x y c h o le s t e r o l .  C e l l  v i a b i l i t y  
w a s  d e t e r m in e d  u s in g  t r y p a n  b lu e  e x c lu s io n  d y e  a n d  m it o c h o n d r ia l  r e le a s e  w a s  
d e t e r m in e d  u s in g  th e  M T T  a s s a y .  * * *  (p  <  0 . 0 0 1 )  r e la t iv e  to  c o n t r o l .  E r r o r  b a r s  
r e f e r  to  s ta n d a rd  d e v ia t io n .
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[ ■ Ce« Count j #
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l7io. 5 ,7 Ef fec t  o f  s i m u l t a n e o u s  r M o c o p h c r o l  (1 p M )  a d d i t i o n  w i t h  2.5 p.M 
c I u •> 11 * ^  i ; * 11 c t r i 111 atul 2 5 -h y d t o x y c h o l e ^ l i o l  nn  cell v iab i l i ty  and  m i t o c h o n d r i a l  in teg r i ty  
in p o r c i n e  o v a r i a n  g r a n u l o s a  ccl ls .  Tr io l :  C h o le s t a n e t r io l ;  2 5 -  O H :  25-
H y d i o w  c h o l e s t e r o l ;  tx-T: a - T o c o p h e r o l .  Ce l l  v i ab i l i t y  w a s  a s c e r t a i n e d  u s i n g  t r y p a n  
b l u e  am i  m i t o c h o n d r i a l  integr i ty  w a s  d e t e r m i n e d  u s i n g  the  M T T  as sa y .  * (p <  0 .05) ,  
*  ^ fp ) re la t iv e  to 25-011 .  Er ror  ba rs  re fe r  to s ta n d a rd  de v ia t i o n .
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th e  a b s e n c e  o f  a - t o c o p h e r o l  in d ic a t in g  th at a - t o c o p h e r o l  h a d  a  p r o t e c t iv e  e f f e c t  
a g a in s t  th e  t o x ic i t y  o f  C O P s  f o l lo w i n g  2 4  h  e x p o s u r e . T h u s ,  t o x ic i t y  w a s  re d u c e d  
b y  3 0  %  a n d  4 2  % ,  a s  m e a s u r e d  b y  t r y p a n  b lu e  e x c lu s io n  a n d  M T T  a s s a y s ,  
r e s p e c t iv e ly .
5.5.6 Effect of C O P s  on lipid peroxidation in porcine ovarian granulosa cells
F i g .  5 .8  s h o w s  th e  e f f e c t  o f  a d m in is t r a t io n  o f  2 .5  p M  c h o le s t a n e t r io l  a n d  2 5 -  
h y d r o x y c h o le s t e r o l  in  th e  p r e s e n c e  a n d  a b s e n c e  o f  1 . 0  p M  a - t o c o p h e r o l  o n  l ip id  
p e r o x id a t io n  a s  d e te rm in e d  b y  T B A R S .  C o n t r o l  c e l l s  s h o w e d  a  l e v e l  o f  T B A R S  
e q u iv a le n t  to  1 2 5  n m o l M D A /  m g  p r o t e in . In c u b a t io n  w it h  c h o le s t a n e t r io l  a n d  2 5 -  
h y d r o x y c h o le s t e r o l  a lo n e  s h o w e d  n o  s ig n i f i c a n t  e f f e c t  o n  T B A R S  l e v e l s  f o l lo w in g  
2 4  h  e x p o s u r e ,  c o m p a r e d  to  c o n t r o ls ,  b e in g  1 0 0  a n d  1 2 1  n m o l  M D A /  m g  p ro te in , 
r e s p e c t iv e ly .  H o w e v e r ,  w h e n  a - t o c o p h e r o l  w a s  in c u b a te d  in  c o m b in a t io n  w it h  2 5 -  
h y d r o x y c h o le s t e r o l ,  a  r e d u c t io n  o f  3 5  %  in  T B A R S  w a s  o b s e r v e d ,  th o u g h  n o t 
s t a t i s t ic a l ly  s ig n i f ic a n t .  A  n e g l ig ib le  r e d u c t io n  w a s  s e e n  o n  a - t o c o p h e r o l  in c u b a t io n  
w it h  c h o le s t a n e t r io l ,  th o u g h  n o t  s ig n i f i c a n t .
5.5.7 Effect of C O P s  on SO D , C A T  and G P x  activities in porcine ovarian 
granulosa cells
P o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  ( 2  x  1 0 5 / m l)  w e r e  in c u b a t e d  w it h  2 .5  p M  
c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l  f o r  2 4  h  to  d e te r m in e  th e ir  e f f e c t  o n  th e  
a c t iv i t i e s  o f  th e  a n t io x id a n t  e n z y m e s  S O D  ( F ig .  5 .9 ) ,  C A T  ( F i g .  5 . 1 0 )  a n d  G P x  ( F ig .  
5 . 1 1 )  in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s .  A  s ig n i f i c a n t  in c r e a s e  in  S O D  a c t iv i t y  w a s  
fo u n d  w h e n  th e s e  c e l l s  w e r e  in c u b a t e d  w it h  2 .5  p M  c h o le s t a n e t r io l  ( 0 .9 1  a c t iv i t y  
u n its / m g  p r o t e in )  (p  <  0 .0 5 )  a n d  2 5 - h y d r o x y c h o le s t e r o l  ( 2 . 1 3  a c t iv i t y  u n its / m g  
p r o t e in )  (p  <  0 . 0 1 )  r e la t iv e  to  c o n t r o l  c e l l s  ( 0 .4 7  a c t iv i t y  u n its / m g  p r o t e in )  ( F ig .  5 .9 ) .  
S im u lt a n e o u s  a d d it io n  o f  a - t o c o p h e r o l  h a d  n o  e f f e c t  o n  S O D  a c t iv i t y  in  c o n tro l c e l l s  
( 0 .4 7  a c t i v i t y  u n its / m g  p r o te in ) . W h e n  a - t o c o p h e r o l  w a s  a d m in is te r e d  
s im u lt a n e o u s ly  w it h  2 .5  p M  c h o le s t a n e t r io l  fo r  2 4  h , S O D  a c t iv i t y  w a s  s ig n i f i c a n t ly  
(P  <  0 . 0 0 1 )  r e d u c e d  to  th a t fo u n d  in  c o n t r o l  c e l l s  ( 0 .5 8  a c t iv i t y  u n its / m g  p ro te in ) . 
S O D  a c t iv i t y  o f  2 5 - h y d r o x y c h o le s t e r o l - t r e a t e d  c e l l s  w a s  4 - f o ld  h ig h e r  th a n  u n tre a te d
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Fig. 5.8 E f f e c t s  o f  2 .5  p ,M  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l ,  in  th e  
p r e s e n c e  a n d  a b s e n c e  o f  1.0 j i M  a - t o c o p h e r o l  o n  l ip id  p e r o x id a t io n ,  a s  d e te r m in e d  
b y  T B A R S ,  in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s .  T r io l :  C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 -  
H y d r o x y c h o le s t e r o l ;  a - T :  a - T o c o p h e r o l .  E r r o r  b a r s  r e f e r  to  s ta n d a r d  d e v ia t io n .
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F i g .  5 .9  E f f e c t s  o f  2 .5  (-iM c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l ,  in  th e  p r e s e n c e  
a n d  a b s e n c e  o f  1 . 0  f.iM  a - t o c o p h e r o l  o n  S O D  a c t iv i t y  a ft e r  2 4  h  in c u b a t io n .
T r io l :  C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 - H y d r o x y c h o le s t e r o l ;  a - T :  a - T o c o p h e r o l .
* * *  (p  <  0 . 0 0 1 )  r e la t iv e  to  2 5 - h y d r o x y c h o le s t e r o l .
* *  (p  <  0 .01) r e la t iv e  to  c o n tro l.
*  (p  <  0 .0 5 )  r e la t iv e  to  c o n tro l.
E r r o r  b a rs  r e f e r  to  s ta n d a rd  d e v ia t io n .
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Fig. 5.10 E f f e c t s  o f  2 .5  p M  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l  in  th e  
p r e s e n c e  a n d  a b s e n c e  o f  1 , 0  p M  a - t o c o p h e r o l  o n  C A T  a c t iv i t y  a f t e r  2 4  h  in c u b a t io n . 
T r i o l :  C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 - H y d r o x y c h o l e s t e r o l ;  a - T :  a - T o c o p h e r o l .
* *  (p  <  0 . 0 1 ) ,  * * *  (p  <  0 . 0 0 1 )  r e la t iv e  to  c o n t r o l .  E r r o r  b a r s  r e f e r  to  s ta n d a rd  
d e v ia t io n .
F i g .  5 . 1 1  E f f e c t s  o f  2 .5  ( iM  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o l e s t e r o l  in  th e  
p r e s e n c e  a n d  a b s e n c e  o f  1 . 0  |j.M  a - t o c o p h e r o l  o n  G P x  a c t iv i t y  a f t e r  2 4  h  in c u b a t io n . 
T r i o l :  C h o le s t a n e t r io l ;  2 5 -  O H : 2 5 - H y d r o x y c h o l e s t e r o l ;  a - T :  a - T o c o p h e r o l .
E r r o r  b a r s  r e f e r  to  s ta n d a r d  d e v ia t io n .
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c o n t r o ls ,  w h ic h  w a s  re tu rn e d  to c o n tro l l e v e l s  b y  s im u lta n e o u s  in c o r p o r a t io n  o f  1.0 
[ iM  a - t o c o p h e r o l  w it h  2 .5  | iM  2 5 - h y d r o x y c h o le s t e r o l .
F ig .  5 . 1 0  s h o w s  th e  e f f e c t  on  C A T  a c t iv i t y  o f  e x p o s u r e  o f  g r a n u lo s a  c e l l s  to  2 .5  (.iM  
c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l .  C o n t r o l  c e l l s  h a d  a le v e l  o f  C A T  a c t iv i t y  
e q u iv a le n t  to  8 3 3  B e r g m e y e r  u n its /m g  p r o t e in . A p p r o x im a t e ly  1 . 5 - f o l d  a n d  1 . 2 - f o l d  
in c r e a s e s  in  C A T  a c t iv i t y  w e r e  o b s e r v e d  w h e n  c e l l s  w e r e  tre a te d  w it h  c h o le s t a n e t r io l  
( 1 3 8 8  B e r g m e y e r  u n its / m g  p ro te in  (p  <  0 . 0 1 )  a n d  2 5 - h y d r o x y c h o le s t e r o l  (9 0 6  
B e r g m e y e r  u n it s / m g  p ro te in )  (p  <  0 . 0 0 1 )  r e la t iv e  to  th e  c o n t r o l  ( F i g .  5 . 1 2 ) .  a -  
T o c o p h e r o l  h a d  n o  e f f e c t  o n  C A T  a c t iv i t y  in  c o n t r o l c e l ls .  W h e n  a - t o c o p h e r o l  w a s  
in c o r p o r a t e d  s im u lt a n e o u s ly  w it h  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l ,  C A T  
a c t iv i t y  w a s  r e d u c e d  to  le v e ls  s im i la r  to  th o s e  o f  c o n t r o l  c e l ls .
F i g .  5 . 1 1  s h o w s  th e  e f f e c t  o n  G P x  a c t iv i t y  o f  e x p o s u r e  o f  g r a n u lo s a  c e l l s  to  2 .5  ( iM  
c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l .  C o n t r o l  c e l l s  h a d  G P x  a c t iv i t y  e q u iv a le n t  
to  2 7  u n its / m g  p ro te in . C e l l s  t r e a t e d  w it h  2 .5 fa M  c h o le s t a n e t r io l  a n d  2 5 -  
h y d r o x y c h o le s t e r o l  f o r  2 4  h  h a d  G P x  a c t iv i t i e s  s im ila r  to  th a t o f  c o n t r o l  c e l l s ,  a -  
T o c o p h e r o l  h a d  n o  e f f e c t  o n  G P x  a c t iv i t y  in  c o n tro l c e l ls .  R e d u c t io n s  o f  1 1  %  an d  
2 8  %  in  G P x  a c t iv i t y  w e r e  o b s e r v e d  w h e n  c e l l s  w e r e  in c u b a t e d  w it h  2 .5  |aM  
c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l  in  th e  p r e s e n c e  o f  1 . 0  |J,M  a - t o c o p h e r o l ,  
r e s p e c t i v e ly ,  c o m p a r e d  to  in c u b a t io n  w i t h  th e  c h o le s t e r o l  o x id e s  a lo n e . T h e s e  
r e d u c t io n s  w e r e  n o t , h o w e v e r ,  s t a t is t ic a l ly  s ig n i f i c a n t .
227
In  th e  p re s e n t  s t u d y ,  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  w e r e  in v e s t ig a te d  a s  a  m o d e l 
s y s te m  in w h ic h  to  s tu d y  th e  e f f e c t s  o f  C O P s . O th e r  m o d e l s y s t e m s  h a v e  in c lu d e d  
C h in e s e  H a m s te r  O v a r y  c e l ls  ( C H O )  ( E s t e r m a n  et al., 1 9 8 3 )  a n d  p o r c in e  a o r t ic  
s m o o th  m u s c le  c e l l s  ( S M C )  ( H u g h e s  et al., 1 9 9 4 ) .  T h e  la tte r  h a v e  b e e n  u s e d  a s  a 
m o d e l  s y s t e m  in  w h ic h  to  s tu d y  th e  t o x ic i t y  o f  C O P s  ( P e n g  et al., 1 9 7 8 ;  H u g h e s  et 
al., 1 9 9 4 )  at c o n c e n t r a t io n s  r a n g in g  f r o m  1 f ig / m l ( N a s e e m  an d  H e a ld ,  1 9 8 7 )  to  1 0 0  
(.ig/m l ( P e n g  et al., 1 9 8 5 ) .  2 5 - h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l  h a v e  b e e n  
r e p o r te d  to  b e  t o x ic  in vitro b y  a  n u m b e r  o f  in v e s t ig a t o r s  ( S m it h  a n d  Jo h n s o n ,  1 9 8 9 ;  
M a h f o u z  et al., 1 9 9 5 ) .  P e n g  a n d  T a y lo r  ( 1 9 8 4 )  in c u b a t e d  c u ltu r e d  a o r t ic  s m o o th  
m u s c le  c e l l s  w it h  a  n u m b e r  o f  C O P s  at l e v e l s  u p  to  1 0 0  t im e s  h ig h e r  ( 1 0 0  (.Lg/ml) 
th a n  in  th e  p r e s e n t  s t u d y  a n d  a f t e r  2 4  h  in c u b a t io n  fo u n d  th a t 2 5 - h y d r o x y c h o le s t e r o l  
a n d  c h o le s t a n e t r io l  w e r e  th e  m o s t  t o x ic .  T h e y  a s s e s s e d  c e l l  v i a b i l i t y  b y  m o r p h o lo g y  
a b e r r a t io n s ; v i a b le  c e l l s  w e r e  s p in d le  s h a p e d  w it h  d is t in c t  n u c le i  a n d  c y t o p la s m  a n d  
d y in g  c e l l s  w e r e  s m a l l ,  d a r k  ro u n d  b o d ie s  w it h  n o  n u c le a r  o r  c y t o p la s m ic  d e t a i l .  A  
m o r e  re c e n t  s t u d y  ( M a h f o u z  et al., 1 9 9 5 )  h a s  s h o w n  th a t c h o le s t a n e t r io l  ( 1 0  j-ig/m l) 
i s  c a p a b le  o f  d i s p la c in g  c h o le s t e r o l  f r o m  c e l l  m e m b r a n e s  o f  r a t - l iv e r  m ic r o s o m e s .  
C H O  c e l l s  a re  a  w e l l - e s t a b l is h e d  m o d e l  f o r  th e  s t u d y  o f  s te r o l s y n t h e s is  ( S in e n s k y  et 
a l,  1 9 8 0 ;  E s t e r m a n  et al., 1 9 8 3 ) ,  a n d  h e n c e  h a v e  b e e n  u s e d  to  in v e s t ig a t e  th e  e f f e c t  
o f  C O P s  in c u b a t io n  o n  H M G - C o A  re d u c ta s e . In h ib it io n  o f  H M G - C o A  r e d u c t a s e  h a s  
b e e n  re p o r te d  in  C H O  c e l l s  o n  in c u b a t io n  w it h  C O P s  a t c o n c e n tr a t io n s  r a n g in g  f r o m  
0 . 1  |ag/m l ( C h in  a n d  C h a n g , 1 9 8 1 )  to  1 . 5  |^g/m l ( S in e n s k y  a n d  M u e l le r ,  1 9 8 1 ;  
E s t e r m a n  et al., 1 9 8 3 ) .
Effect o f  COPs on cell viability
C h o le s t a n e t r io l ,  2 5 - h y d r o x y c h o le s t e r o l  a n d  c h o le s t e r o l - a - e p o x id e  w e r e  f o u n d  to  
s ig n i f i c a n t ly  (p  <  0 . 0 1 )  in h ib it  c e l l  v i a b i l i t y  w h i le  7 - k e t o c h o le s t e r o l  a n d  c h o le s t e r o l  
h a d  n o  in h ib it o r y  e f f e c t  o n  c e l l  v i a b i l i t y  ( F ig .  5 .4 ) .  T h e  tw o  m o s t  t o x ic  c h o le s t e r o l  
o x id e s  id e n t i f ie d  ( c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l )  w e r e  th e n  u s e d  f o r  a l l  
fu r th e r  b io a s s a y s .  I n  o u r  s tu d y , th e  g r a n u lo s a  c e l l s  m a y  h a v e  d e v e lo p e d  a  to le r a n c e  
to  7 - k e t o c h o le s t e r o l ,  w h ic h  h a s  p r e v io u s ly  b e e n  re p o r te d  in  h e p a t ic  c e l l s  ( E r i c k s o n  et
5.6 DISCUSSION
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al., 1 9 7 7 ) .  It h a s  b e e n  re p o rte d  th at 7 - k e t o c h o le s t e r o l  c a n  b e  m e t a b o l is e d  b y  
c y t o c h o m e  P 450 e n z y m e s ,  to  m o r e  p o la r  a n d  le s s  t o x ic  d e r iv a t iv e s  ( E r i c k s o n  et al., 
1 9 7 7 ) .  C y t o c h o m e  P 450 e n z y m e s  h a v e  b e e n  d e te c te d  in  p o r c in e  g r a n u lo s a  c e l l s  
( B e n o it  a n d  V e ld h iu s ,  19 9 6 ) ,  w h ic h  m a y  a c c o u n t  fo r  th e  n o n - t o x ic  e f f e c t  s e e n  in  th e  
p re s e n t  s tu d y . T h is  m a y  b e  im p o r ta n t  fo r  tw o  r e a s o n s . F i r s t ly ,  7 - k e t o c h o le s t e r o l  w a s  
fo u n d  to b e  th e  m o s t  a b u n d a n t  c h o le s t e r o l  o x id e  in  m ilk  p o w d e r s  in  th e  p r e s e n t  
s t u d y , a n d  b y  o th e r s  ( N o u r o o z - Z a d e h  a n d  A p p e lq v i s t ,  1 9 8 8 ;  C h a n  et al., 1 9 9 3 ) .  
H o w e v e r ,  i t ’ s  t o x ic  e f f e c t  in vivo ( E r i c k s o n  et al., 1 9 7 7 )  a n d  o n  o v a r ia n  g r a n u lo s a  
c e l l s  m a y  b e  m in im a l .  S e c o n d ly ,  it  h a s  b e e n  r e p o r t e d  th a t h u m a n s  c a n  s e le c t i v e ly  
a b s o r b  C O P s ,  w it h  7 - k e t o c h o le s t e r o l  b e in g  a b s o r b e d  to  th e  g r e a t e s t  e x te n t  ( E m a n u e l  
et al., 1 9 9 1 ) .  O th e r  s tu d ie s ,  h o w e v e r ,  h a v e  s h o w n  in h ib it o r y  e f f e c t s  o n  c e l l  v i a b i l i t y  
o f  7 - k e t o c h o le s t e r o l  in  c e l l  t y p e s  s u c h  a s  v a s c u la r  s m o o th  m u s c le  a n d  e n d o t h e lia l  
c e l l s  ( P e n g  et al., 1 9 7 8 ) ,  f ib r o b la s t s  ( S e v a n ia n  a n d  P e te r s o n , 1 9 8 6 ) ,  m a c r o p h a g e s  
( B a r a n o w s k i  et al., 1 9 8 2 )  a n d  C H O  c e l l s  ( E s t e r m a n  et al., 1 9 8 3 ) .
Mechanism o f  toxicity o f  COPs on porcine ovarian granulosa cells
G r o w t h  in h ib it io n  b y  c h o le s t a n e t r io l  a n d  2 5 - h y d r o x y c h o le s t e r o l  w a s  o b s e r v e d  u s in g  
t r y p a n  b lu e  a n d  M T T  a s s a y s  a s  v i a b i l i t y  in d ic e s  ( F ig .  5 .6 ) .  T h e  r e s u lt s  in d ic a t e  th a t 
w h e n  c e l l s  w e r e  e x p o s e d  to  e ith e r  c h o le s t a n e t r io l  o r  2 5 - h y d r o x y c h o le s t e r o l  f o r  2 4  h , 
b o th  p la s m a  m e m b r a n e  a n d  m ito c h o n d r ia l  m e m b r a n e  in t e g r it y  w e r e  s ig n i f i c a n t ly  (p  
<  0 . 0 0 1 )  r e d u c e d  ( 3 4  a n d  5 2  % ,  r e s p e c t iv e ly ) .  A  n u m b e r  o f  m e c h a n is m s  o f  C O P s  
t o x i c i t y  h a v e  b e e n  p r o p o s e d  ( S m it h  a n d  Jo h n s o n ,  1 9 8 9 ;  A d d is  a n d  W a rn e r , 1 9 9 2 ) .  
It  i s  p o s s ib le  th at th e  r e d u c e d  v i a b i l i t y  o b s e r v e d  w h e n  g r a n u lo s a  c e l l s  w e r e  tre a te d  
w it h  C O P s  in  th e  p r e s e n t  s tu d y  w a s  th e  r e s u lt  o f  s u b s t itu t io n  o f  c h o le s t e r o l  in  
m e m b r a n e s  b y  C O P s .  U p t a k e  o f  2 5 - h y d r o x y c h o le s t e r o l  h a s  p r e v io u s ly  b e e n  
r e p o r t e d , w h e r e  2 5 - h y d r o x y c h o le s t e r o l  r e p la c e d  7 5  %  o f  th e  c h o le s t e r o l  in  h u m a n  
f ib r o b la s t s  in vitro ( P e n g  a n d  T a y lo r ,  1 9 8 4 ) .  C h o le s t a n e t r io l  h a s  a ls o  b e e n  r e p o r t e d  
to  d is p la c e  f r e e  c h o le s t e r o l  f r o m  c e l l  m e m b r a n e  in  p o r c in e  k id n e y  c e l l s  ( M a h f o u z  et 
al., 1 9 9 5 ) .  T h e  in t r o d u c t io n  o f  m o r e  h y d r o p h i l ic  g r o u p s  in to  th e  b io lo g ic a l  
m e m b r a n e  m a y  a lte r  p h y s ic a l  c o n f ig u r a t io n  a s  w e l l  a s  fu n c t io n  o f  th e  m e m b r a n e  
( P e n g  a n d  T a y lo r ,  1 9 8 4 ) .  P la s m a  m e m b r a n e s  o f  c e l l s  e x p o s e d  to  C O P s  h a v e  b e e n
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re p o r te d  to  c o n t a in  a  s ig n i f i c a n t ly  d im in is h e d  c h o le s t e r o l/ p h o s p h o lip id  ra t io  ( P e n g  
a n d  M o r in ,  1 9 9 2 ) .  S u c h  a lte ra t io n s  c a n  re s u lt  in  c h a n g e s  in  th e  p e r m e a b i l i t y  o f  th e 
c e l l s  to  w a t e r  a n d  c a t io n s  an d  e v e n t u a l ly  in  a  p ro fo u n d  d is tu r b a n c e  o f  m e m b ra n e  
fu n c t io n s  r e s u lt in g  in  a c c u m u la t io n  o f  in t r a c e l lu la r  c a lc iu m  ( S e v a n i a n  a n d  P e te rs o n , 
1 9 8 6 ) ,  o s m o t ic  p e r m e a b i l i t y  a n d  c e l l  d e a th  ( S t r e u li  et al., 1 9 8 1 ) .  A n  in v e r s e  
r e la t io n s h ip  h a s  b e e n  o b s e r v e d  b e t w e e n  in s e r t io n  o f  c h o le s t e r o l  o x id e s  in to  
m e m b r a n e s  a n d  o s m o t ic  f r a g i l i t y  o f  th e  m e m b r a n e s  ( S t r e u li  et al., 1 9 8 1 ) .  P r o te in s  
th a t h a v e  im p o r ta n t  c e l lu la r  fu n c t io n s ,  s u c h  a s  tr a n s p o rte rs , r e c e p t o r s  a n d  e n z y m e s  
( D e P ie r r e  a n d  K a m o v s k y ,  1 9 7 3 )  a r e  e m b e d d e d  in  th e  c h o le s t e r o l- p h o s p h o l ip id  
b i l a y e r  o f  c e l l  m e m b r a n e s . C O P s  w h ic h  a lte r  m e m b ra n e  f lu id i t y  m a y ,  th e re fo re , 
a f f e c t  p o s i t io n in g  o f  m e m b r a n e  p r o t e in s  a n d  a lte r  m e m b r a n e - a s s o c ia t e d  fu n c t io n s  
( S t r e u l i  et al., 1 9 8 1 ;  P e n g  a n d  M o r in ,  1 9 9 2 ) .  O n e  su c h  p r o t e in  w h ic h  is  a f f e c t e d  is  
3 - h y d r o x y - 3 - m e t h y lg lu t a r y l  C o A  r e d u c t a s e  ( H M G - C o A  r e d u c t a s e ) ,  a n  im p o rta n t  
r a t e -  l im it in g  e n z y m e  in  c h o le s t e r o l  b io s y n t h e s i s  ( K a n d u t c h  a n d  C h a n , 1 9 7 7 ;  
E r i c k s o n  et al, 1 9 7 7 ;  C la r e  et al., 1 9 9 5 ) .  C o n s e q u e n t ly ,  c e l lu la r  c h o le s t e r o l  m a y  b e  
d e c r e a s e d  a n d  th e  c h o le s t e r o l  a v a i l a b le  f o r  m e m b r a n e  s y n t h e s is  m a y  b e  d e p le te d . 
G r a n u lo s a  c e l l s ,  w h i le  h a v in g  th e  c a p a c i t y  to  s y n th e s is e  c h o le s t e r o l  a t c e r ta in  s ta g e s  
in  th e ir  d e v e lo p m e n t ,  a ls o  u s e  L D L - d e r i v e d  c h o le s t e r o l  o r  th e c a  c e l l - d e r iv e d  
c h o le s t e r o l  a s  s u b s tr a t e s  fo r  th e ir  s te r o id  b io s y n th e t ic  a c t iv i t ie s .  F o r  th is  r e a s o n , 
s h o u ld  in h ib it io n  o f  H M G - C o A  r e d u c t a s e  in  g r a n u lo s a  c e l l s  o c c u r  a s  a  re s u lt  o f  
c h o le s t e r o l  o x id e  a d m in is t r a t io n , it s  e f f e c t  w o u ld  n o t g i v e  r i s e  to  th e  r e p o r te d  
c h a n g e s  in  c e l lu la r  c h a r a c t e r is t ic s ,  s u c h  a s  a lte re d  m ito c h o n d r ia l  in t e g r it y ,  c a lc iu m  
a c c u m u la t io n ,  c e l l  d e a th  a n d  o s m o t ic  f r a g i l i t y .  C O P s  h a v e  a ls o  b e e n  r e p o r t e d  to 
in h ib it  D N A  a n d  p r o t e in  s y n t h e s is  ( P e n g  a n d  T a y lo r ,  1 9 8 4 ) ,  w h ic h  m a y  h a v e  b e e n  a  
c a u s e  o f  th e  r e d u c t io n  in  c e l l  n u m b e r s  in  c h o le s t e r o l  o x id e - t r e a te d  c e l l s  in  th is  s tu d y .
Trypan blue assay and M T T  assay correlation
A  n o t a b le  d i f fe r e n c e  e x is t s  in  th e  r e s u lt s  b e tw e e n  th e  e f f e c t  d u e  to  C O P s  
a d m in is t r a t io n  a s  d e te r m in e d  b y  th e  t r y p a n  b lu e  e x c lu s io n  d y e  a s s a y  a n d  th e  M T T  
a s s a y .  T h e  M T T  a s s a y  an d  th e  v i a b le  c e l l  c o u n t  a s s a y  w e r e  e x p e c t e d  to  c o r r e la te  
( M o s m a n n , 1 9 8 3 ) ,  b u t  th e  M T T  a s s a y  a p p e a r e d  to  u n d e r e s t im a te  th e  g r o w t h
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in h ib it o r y  e f f e c t  o f  C O P s  c o m p a r e d  to  th e  v ia b le  c e l l  c o u n t  a s s a y .  T h e  M T T  a s s a y  
( M o s m a n n , 1 9 8 3 )  is  b a s e d  o n  th e  r e d u c t io n  o f  te t r a -z o liu m  s a lt  ( M T T )  to  a  c o lo u r e d  
fo r m a z a n  p r o d u c t  b y  r e d u c in g  e n z y m e s  p re s e n t  o n ly  in  m e t a b o l ic a l ly  a c t iv e  c e l ls .  
S u c c in a t e  d e h y d r o g e n a s e  is  r e p o r t e d  to  b e  in v o lv e d  in  th e  r e d u c t io n  ( J a b b a r  et al., 
1 9 8 9 ) .  T h e  t r y p a n  b lu e  a s s a y ,  o n  th e  o th e r  h a n d , is  b a s e d  o n  u p ta k e  o f  d y e  b y  c e l ls  
w h o s e  c e l l  m e m b r a n e s  a re  d a m a g e d , w it h  th e  v ia b le  c e l l s  ‘ e x c lu d in g ’ th e  d y e . 
S e v e r a l  f a c t o r s  m a y  h a v e  le d  to  th e  d i f f e r e n c e  in  th e  r e s u lts  o f  th e  t w o  a s s a y s .  I t  m a y  
b e  th a t c e l l  in ju r y  c a n  a c t u a l ly  in d u c e  m ito c h o n d r ia l  a c t iv it y .  T h is  h a s  p r e v io u s ly  
b e e n  r e p o r t e d  ( J a b b a r  et a l,  1 9 8 9 )  w h e r e  a  4 0  %  in c r e a s e  in  m ito c h o n d r ia l  a c t iv it y  
w a s  o b s e r v e d  a f t e r  t re a tm e n t o f  h u m a n  lu n g  c a n c e r  c e l l  l in e s  w it h  in te r fe ro n . In  
a d d it io n , n o  e v id e n c e  e x is t s  th a t m it o c h o n d r ia  a re  th e  o n ly  s ite  o f  M T T  r e d u c t io n  in  
th e  in t a c t  c e l l  ( J a b b a r  et a l,  19 8 9 ) .
Physiological concentrations o f  COPs
T h e  a b s o r p t io n  a n d  d e l i v e r y  o f  C O P s  th o u g h o u t  th e  b o d y  a r e  im p o rta n t  
c o n s id e r a t io n s .  T h e r e  a re , h o w e v e r ,  l im it e d  s tu d ie s  o n  th e  d ie t a r y  a b s o r p t io n  o f  
C O P s .  S t e in b e r g  et al. ( 1 9 5 8 )  r e p o r t e d  a  g r e a t e r  th a n  7 0  %  a b s o r p t io n  o f  c h o le s t -4 -  
e n e - 3 - o n e  in  ra t s , w h i le  K i k u c h i  et al. ( 1 9 6 8 )  s h o w e d  th a t th e  a b s o r p t io n  o f  
c h o le s t a n e t r io l  w a s  a p p r o x im a t e ly  7  %  a n d  w h e n  c h o le s t e r o l  w a s  a d m in is te r e d  
s im u lt a n e o u s ly ,  i t ’ s  a b s o r p t io n  ra te  c o u ld  b e  a lm o s t  d o u b le d . T h e  m o d e  o f  tra n s p o rt  
o f  C O P s  in  p la s m a  is  a ls o  o f  in te re s t ,  a n d  th e y  b e e n  re p o r te d  to  b e  lo c a l i s e d  in  lo w -  
d e n s i t y  l ip o p r o t e in s  ( L D L )  ( 5 6  % )  a n d  v e r y - lo w - d e n s i t y - l ip o p r o t e in s  ( V L D L )  ( 3 4  
% )  w h i l e  h ig h - d e n s it y - l ip o p r o t e in s  ( H D L )  c o n t a in e d  o n ly  1 0  %  ( P e n g  et al., 1 9 8 2 )  
t o t a l s  C O P s .  T h e  p r e fe r e n t ia l  t r a n s p o r t  o f  C O P s  in  L D L  a n d  V L D L  m a y  b e  th e  
b a s i s  f o r  th e  m o r e  p o te n t  a t h e r o g e n ic it y  o f  th e s e  l ip o p r o te in  s p e c ie s  ( C a r p e n te r  et al., 
1 9 9 3 ;  H u g h e s  et al., 1 9 9 4 ) .  H u g h e s  et al. ( 1 9 9 4 )  re p o r te d  th a t th e  m o s t  to x ic  
f r a c t io n  o f  o x - L D L  ( o x id i s e d  lo w  d e n s i t y  l ip o p r o te in s )  is  7 - k e t o c h o le s t e r o l .  P e n g  et 
al. ( 1 9 8 2 )  fo u n d  th a t 2 4  h  a f t e r  in g e s t io n , 2 5 - h y d r o x y c h o le s t e r o l  r e m a in e d  in  th e  
L D L  a n d  V L D L  f r a c t io n s ,  w h e r e a s  E m a n u e l  et al. ( 1 9 9 1 )  fo u n d  a  r e s id e n c e  t im e  o f  
a p p r o x im a t e ly  3  h  f o r  th e  i s o m e r ic  e p o x id e s ,  7 p - h y d r o x y c h o le s t e r o l  a n d  7 -  
k e t o c h o le s t e r o l  in  c h y lo m ic r o n s .  T h e  la t te r  a ttr ib u te d  th e  lo w  r e s id e n c e  t im e  to  th e
231
r e la t iv e ly  p o la r  n a tu re  o f  C O P s  c o m p a r e d  to s te ro l e s te r s  o r  t r ig ly c e r id e s  a n d  th e  
r e s id e n c e  o f  C O P s  w it h in  th e  s u r f a c e  m o n o la y e r  o f  p la s m a  l ip o p r o te in s . P o s t ­
p r a n d ia l  p la s m a  c o n c e n tr a t io n s  o f  to ta l C O P s  ( fe d  to  1 0  s u b je c t s  a t a  c o n c e n t r a t io n  o f  
2 3 0  jj.g/g  to ta l C O P s )  w e r e  a p p r o x im a t e ly  2 - 1 6  n g / m l a f t e r  3  h , a f t e r  w h ic h  th e y  
w e r e  c le a r e d . T h e  to ta l p la s m a  c o n c e n t r a t io n  o f  C O P s  w a s  a p p r o x im a t e ly  5  to  1 0 -  
fo ld  h ig h e r  th a n  th a t o f  c h y lo m ic r o n s ,  w h ic h  s u g g e s t e d  a  ra p id  t r a n s fe r  o f  C O P s  fr o m  
c h y lo m ic r o n s  to  o th e r  l ip o p r o t e in s  a n d /o r  p la s m a  ( E m a n u e l  et al., 1 9 9 1 ) .  I t  w a s  
a p p a r e n t  th a t p la s m a  c o n c e n t r a t io n  v a r ie d  a m o n g  s u b je c t s  f e d  th e  s a m e  q u a n t it y  o f  
C O P s ,  s u g g e s t in g  in d iv id u a l  d i f f e r e n c e s  in  a b s o r p t io n  ( E m a n u e l  et al., 1 9 9 1 ) .  B a s e d  
o n  d a ta  o b ta in e d  fro m  E m a n u e l  et al. ( 1 9 9 1 ) ,  c o n s u m p t io n  o f  a p p r o x im a t e ly  3 0 - 4 0  
H g/g  C O P s  m ig h t  b e  e x p e c t e d  to  y ie ld  a  1  (J.g/m l le v e l  in  th e  b lo o d . H e n c e ,  th e  le v e l  
in  th e  p r e s e n t  s tu d y  ( 2 .5  j.iM ) w a s  d e e m e d  to  b e  e q u iv a le n t  to  1  ( ig /m l in  p la s m a .
Effects o f  COPs on exogenous (a-tocopherol) and endogenous antioxidants (SOD, 
C AT and Gpx)
A  s ig n i f i c a n t  (p  <  0 .0 5 )  p r o t e c t iv e  e f f e c t  o f  a - t o c o p h e r o l  o n  c e l l  v i a b i l i t y  w a s  
o b s e r v e d  w h e n  a d m in is te r e d  s im u lt a n e o u s ly  w it h  b o th  c h o le s t a n e t r io l  a n d  2 5 -  
h y d r o x y c h o le s t e r o l  ( F ig .  5 .7 ) .  P r e v i o u s  re p o r ts  h a v e  d e m o n s t r a te d  a  p r o t e c t iv e  
p f f e c t  o n  c e l l  v i a b i l i t y  w h e n  a - t o c o p h e r o l  w a s  in c u b a te d  s im u lt a n e o u s ly  w it h  C O P s  
in vitro ( W e it b u r g  et al., 1 9 8 5 ;  W ils o n  et al., 1 9 9 5 ) .  It  h a s  b e e n  r e p o r t e d  th a t a -  
t o c o p h e r o l  fu n c t io n s  a s  a  p r o t e c t o r  a g a in s t  p e r o x id a t io n  in vivo. B e i n g  h y d r o p h o b ic ,  
it  t e n d s  to  a c c u m u la te  w it h in  th e  m e m b r a n e , s o  it c a n  b o th  q u e n c h  a n d  r e a c t  w it h  
s in g le t  o x y g e n ,  h y d r o x y l  a n d  s u p e r o x id e  r a d ic a ls  ( D e s c a m p ia u x  et al., 1 9 9 6 ) .  
H o w e v e r ,  its  m a jo r  a n t io x id a n t  a c t io n  in  b io lo g ic a l  m e m b r a n e s  i s  to  r e a c t  a s  a 
s c a v e n g e r  w it h  l ip id  p e r o x y  r a d ic a ls ,  d o n a t in g  h y d r o g e n  a n d  t h e r e b y  te r m in a t in g  th e  
c h a in - r e a c t io n  o f  p e r o x id a t io n  ( H a l l i w e l l  a n d  G u t te r id g e ,  1 9 8 9 ) .  W e it b u r g  et al.
( 1 9 8 5 )  r e p o r t e d  th a t w h e n  C H O  ( c h in e s e  h a m s te r  o v a r y )  c e l l s  w e r e  c u lt iv a t e d  w ith  
a - t o c o p h e r o l  a n d  th e n  e x p o s e d  to  a  c e l l - f r e e  o x id i s in g  s y s t e m , l it t le  c h o m o s o m a l  
d a m a g e  o c c u r r e d , th e r e b y  in d ic a t in g  th a t a - t o c o p h e r o l  is  m e m b r a n e  a s s o c ia t e d  to  
p r o v id e  p r o t e c t io n  a g a in s t  o x i d a t iv e  s t r e s s .  T y p ic a l  p la s m a  l e v e l s  o f  a - t o c o p h e r o l  in  
h u m a n s  h a v e  b e e n  r e p o r te d  to  r a n g e  f r o m  6.6 - 1 5 .0  (m e a n  9 .6 )  (ag/m l in  p la s m a  a n d
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fro m  0 .9 - 1 .8  (m e a n  1 .4 )  (J.g/m l in  re d  b lo o d  c e l l s  ( C h o w , 1 9 7 9 ;  L u c e s o l i  et al.,
1 9 9 4 ) .  W h ile  th e  le v e l  o f  a n t io x id a n t s  a d d e d  to  th e  m ilk  p r io r  to  s p r a y - d r y in g  w a s  
n o t s u f f i c ie n t  to  a b o l i s h  c h o le s t e r o l  o x id a t io n  a s  o u t lin e d  in  C h a p t e r  4 , th e  le v e l  o f  a -  
to c o p h e r o l  a d d e d  in  th e  in vitro s tu d ie s  a p p e a r e d  to  b e  s u f f ic ie n t  to  s c a v e n g e  th e  fre e  
r a d ic a ls  p r o d u c e d  a s  a  re s u lt  o f  c e l l  in ju r y  d u e  to  th e  p r e s e n c e  o f  C O P s .
T h e  le v e l  o f  l ip id  p e r o x id a t io n  in  o v a r ia n  g r a n u lo s a  c e l l s  in  th e  p r e s e n t  s tu d y  w a s  
a s s e s s e d  b y  th e  T B A R S  a s s a y  ( F ig .  5 .8 ) .  N o  s ig n i f i c a n t  in c r e a s e  in  T B A R S  w a s  
o b s e r v e d  a f t e r  C O P s  a d m in is t r a t io n  w i t h  r e s p e c t  to  th e  c o n tr o l.  T h e s e  re s u lts  
c o n tra s t  w it h  th o s e  o f  W ils o n  et al. ( 1 9 9 5 )  w h o  re p o r te d  a n  in c r e a s e  in  T B A R S  
le v e ls  w h e n  n e w b o r n  ra t  k id n e y  ( N R K )  c e l l s  w e r e  in c u b a te d  w it h  C O P s  ( 5 -  5 0  | iM )  
fo r  7 2  h . S in c e  th e  a n t io x id a n t  d e fe n c e  e n z y m e s  ( S O D  a n d  C A T )  w e r e  in c r e a s e d  o n  
e x p o s u r e  to  C O P s  in  th e  p re s e n t  m o d e l  s y s t e m , it  m a y  b e  th a t th e s e  a c t iv it ie s  
p r o t e c t e d  th e  g r a n u lo s a  c e l ls  f r o m  p e r o x id a t io n  d a m a g e . I t  m a y  a ls o  b e  th a t th e  
in c u b a t io n  p e r io d  w it h  C O P s  in  th e  p r e s e n t  s t u d y  w a s  n o t  s u f f i c ie n t ly  lo n g  to  re s u lt  
in  s ig n i f i c a n t  l ip id  p e r o x id a t io n .
In  p o r c in e  o v a r ia n  g r a n u lo s a  c e l ls ,  b o th  S O D  a n d  C A T  a c t iv i t ie s  w e r e  in c r e a s e d  
s ig n i f i c a n t ly  (p  <  0 . 0 1 )  ( F ig s .  5 . 9 - 5 . 1 0 )  w h e r e a s  a  s l ig h t  d e c r e a s e  w a s  s e e n  in  G P x  
a c t iv i t y  ( F i g .  6 . 1 1 )  w h e n  C O P s  w e r e  a d m in is t r a t e d  at a  c o n c e n t r a t io n  o f  2 .5  (J.M. 
W ils o n  et al. ( 1 9 9 5 )  fo u n d  th a t S O D  a n d  C A T  w e r e  a ls o  in d u c e d  in  c h ic k e n  e m b r y o  
f ib r o b la s t  c e l l s  o n  e x p o s u r e  to  5 -  5 0  |i.M  C O P s  ( 7 - k e t o c h o le s t e r o l ,  2 5 -  
h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l) .  S O D  a c t io n  r e s u lt s  in  th e  a c c u m u la t io n  o f  
h y d r o g e n  p e r o x id e ,  w h ic h  in  tu rn  is  r e m o v e d  b y  C A T  a n d  G P x .  S in c e  G P x  a c tu a l ly  
d e c r e a s e d  s l i g h t l y ,  th o u g h  n o t s ig n i f i c a n t ly ,  in  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  a fte r  
e x p o s u r e  to  C O P s ,  it  is  p o s s ib le  th a t a n y  h y d r o g e n  p e r o x id e  p r o d u c e d  m a y  h a v e  b e e n  
e l im in a t e d  f r o m  c e l l s  th o u g h  th e  a c t iv i t y  o f  C A T  a lo n e , a n d  th u s  th e  C O P s  d id  n o t 
in d u c e  th e  a c t i v i t y  o f  G P x  in  th e  g r a n u lo s a  c e l l s .  A  d e c r e a s e  in  G P x  a c t iv i t y  o n  
in c u b a t io n  w it h  t o x ic  p a r a q u a t  w a s  o b s e r v e d  b y  L a w l o r  a n d  O ’ B r i e n  ( 1 9 9 4 ) .  T h e y  
c o n c lu d e d  th a t  p a r a q u a t  d id  n o t a f f e c t  th e  th e e  a n t io x id a n t  e n z y m e s  in  a  c o n s is t e n t  
m a n n e r : it  in d u c e d  S O D  a n d  C A T  a n d  in a c t iv a t e d  G P x  a c t iv it y .  T h is  e f f e c t  h a s  a ls o  
b e e n  s e e n  in  h u m a n  h e p a to m a  H e p  3 B  c e l l s  t r e a te d  w ith  l in d a n e , a n  o r g a n o c h lo r id e
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in s e c t ic id e ,  w h ic h  is  k n o w n  to  e l ic i t  fre e  r a d ic a l  fo rm a tio n  d u r in g  i t ’ s m e t a b o l is m  in 
m a m m a lia n  o r g a n is m s  ( D e s c a m p ia u x  et a i ,  19 9 6 ) .
S in c e  a n t io x id a n t  e n z y m e  a c t iv it ie s  in  g r a n u lo s a  c e l ls  w e r e  in d u c e d  b y  C O P s  a n d  
re s to re d  to  c o n t r o l  le v e l s  in  th e  p r e s e n c e  o f  a - t o c o p h e r o l ,  th is  m o d e l  m a y  b e  u s e d  in  
th e  fu tu r e  f o r  s c r e e n in g  fo o d  e x t r a c t s  f o r  f a c t o r s  th a t e n h a n c e  o x i d a t iv e  s tr e s s  
to le r a n c e .
5.7 C O N C L U S IO N S
T h e  e f f e c t s  o f  a  n u m b e r  o f  C O P s  fo u n d  in  w h o le  m i lk  p o w d e r  o n  p o r c in e  o v a r ia n  
g r a n u lo s a  c e l l s  in vitro w e r e  in v e s t ig a t e d . 2 5 - h y d r o x y c h o le s t e r o l ,  c h o le s t e r o l - a -  
e p o x id e  a n d  c h o le s t a n e t r io l  ( 2 .5  f iM )  w e r e  f o u n d  to  b e  th e  m o s t  t o x ic ,  w h i l e  s im ila r  
c o n c e n t r a t io n s  o f  c h o le s t e r o l  a n d  7 - k e t o c h o le s t e r o l  h a d  n o  in h ib it o r y  e f f e c t  o n  c e l l  
v i a b i l i t y .  2 5 - h y d r o x y c h o le s t e r o l  s ig n i f i c a n t ly  in c r e a s e d  th e  a c t iv i t y  o f  S O D  (p <  
0 . 0 0 1 )  a n d  C A T  (p  <  0 .0 0 1 )  w h i le  c h o le s t a n e t r io l  in d u c e d  a  s ig n i f i c a n t  (p  <  0 . 0 1 )  
in c r e a s e  in  S O D  a c t iv i t y  o n ly .  G P x  a c t iv i t y  d e c r e a s e d  s l ig h t ly ,  th o u g h  n o t 
s ig n i f i c a n t ly ,  o n  e x p o s u r e  to  2 .5  f^M  2 5 - h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l .  T h e  
t o x ic i t ie s  o f  2 5 - h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l  w e r e  r e d u c e d  b y  
s im u lt a n e o u s  in c u b a t io n  w it h  1  p ,M  a - t o c o p h e r o l .  F i n a l l y ,  th e  la c k  o f  e v id e n c e  
im p lic a t in g  C O P s - in d u c e d  l ip id  p e r o x id a t io n  a s  th e  c a u s e  o f  c e l l  d e a th  in  th is  s tu d y  
is  in d ic a t iv e  o f  a  s u f f i c ie n t  a n t io x id a n t  d e fe n c e  s y s te m  in  p o r c in e  o v a r ia n  g r a n u lo s a  
c e l l s .
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D e s p it e  th e  c u r r e n t  s u r g e  o f  r e s e a r c h  o n  C O P s ,  th e  e x a c t  m e c h a n is m s  o f  c h o le s t e r o l  
o x id a t io n  r e m a in  u n c le a r . H o w e v e r ,  in  v i e w  o f  th e  w id e  r a n g e  o f  p r o c e s s in g  
o p e r a t io n s  e m p lo y e d  w it h in  th e  fo o d  in d u s t r y , it  is  o b v io u s  th a t th e  p o te n t ia l  fo r  
c h o le s t e r o l  o x i d e s  to  fo r m  in  c h o le s t e r o l- c o n t a in in g  fo o d s  is  v e r y  r e a l ,  w it h  s o m e  
f o o d s  b e in g  m o r e  s u s c e p t ib le  to  c h o le s t e r o l  o x id a t io n  th a n  o th e rs . C h o le s te r o l  
o x id a t io n  h a s  a  n u m b e r  o f  u n d e s ir a b le  b io lo g ic a l  e f f e c t s  a n d  h e n c e  it is  o f  c o n c e r n  to 
fo o d  s c ie n t is t s  a n d  c o n s u m e r s . R e s e a r c h  o n  th e  o c c u r r e n c e  o f  c h o le s t e r o l  o x id e s  is  
in  its  in f a n c y ,  a lth o u g h  th e re  h a v e  b e e n  v a s t  im p r o v e m e n t s  in  th e  m e t h o d o lo g ie s  
u s e d  in  th e ir  d e t e c t io n  o v e r  th e  p a s t  f e w  y e a r s .  T h e  d a i ly  fo o d  in ta k e  fo r  a n  a v e r a g e  
p e r s o n  is  a b o u t  5 0 0  g  ( V a n  d e  B o v e n k a m p  et al., 1 9 8 8 )  w it h  a  d a i ly  c h o le s t e r o l  
in t a k e  a v e r a g in g  2 8 0  m g / d a y  ( S a r a n t in o s  et al., 1 9 9 3 ) .  T h u s ,  th e  t y p ic a l  l e v e l  o f  
o x y s t e r o l s  in  th e  a v e r a g e  d ie t  is  at m o s t  a  f e w  m g  p e r  d a y  ( V a n  d e  B o v e n k a m p  et al.,
19 8 8 ) .  W h e th e r  s u c h  a m o u n ts  c o n tr ib u te  to  th e  d e v e lo p m e n t  o f  c h o n ic  d is e a s e s  is  at 
p r e s e n t  u n k n o w n . T h e  a im s  o f  th e  c u r r e n t  s tu d y  w e r e  4 - f o ld :  ( i)  to  e s t a b lis h  a  v a l id  
a n d  a c c u r a te  a n a ly t ic a l  m e th o d  f o r  d e te c t io n  o f  C O P s  in  w h o le  m i lk  p o w d e r s ,  ( i i)  to  
in v e s t ig a t e  th e  e f f e c t  o f  a n im a l f e e d in g  r e g im e n  o n  l e v e l s  o f  C O P s  in  w h o le  m i lk  
p o w d e r s  ( i i i )  to  d e t e r m in e  th e  e f f e c t  o f  p a r t ic u la r  p r o c e s s in g  c o n d it io n s  o n  l ip id  a n d  
c h o le s t e r o l  o x id a t io n  in  w h o le  m i lk  p o w d e r  a n d  ( iv )  to  a s c e r t a in  th e  in vitro e f f e c t s  
o f  C O P s  o n  c e l l  g r o w t h  a n d  o x id a t iv e  s ta tu s .
T h e  q u a n t i f ic a t io n  o f  c h o le s t e r o l  o x id e s  f r o m  b io l o g ic a l  m a t e r ia ls  a n d  fo o d s  is  
d i f f i c u l t  b e c a u s e  th e ir  is o la t io n  is  f r e q u e n t ly  im p e d e d  b y  la r g e  a m o u n ts  o f  in t e r fe r in g  
c h o le s t e r o l ,  t r ig ly c e r id e s ,  p h o s p h o l ip id s  a n d  o th e r  l ip id s .  W h o le  m i lk  p o w d e r s  
c o n t a in  a p p r o x im a t e ly  0 . 1  %  ( w / v )  c h o le s t e r o l  ( C h a n  et al., 1 9 9 3 ) .  C h o le s t e r o l  
o x id a t io n  in  w h o le  m i lk  p o w d e r s  h a s  n o t  b e e n  s tu d ie d  to  th e  s a m e  e x te n t  a s  in  e g g  
p r o d u c t s  ( M o r g a n  a n d  A r m s t r o n g ,  1 9 9 2 )  an d  a  w id e  v a r i e t y  o f  m e t h o d o lo g ie s  h a v e  
b e e n  u s e d  le a d in g  to  la r g e  d is c r e p a n c ie s  in  th e  r e s u lt s  re p o r te d . C O P s  le v e ls  
d i f f e r in g  b y  o v e r  a  1 0 0 0 - f o l d ,  f r o m  2 5 0  n g / g  ( R o s e - S a l l in  et al., 1 9 9 5 )  to  3 0 0  n g / g  
( C h a n  et al., 1 9 9 3 )  h a v e  b e e n  re p o r te d  in  s to re d  w h o le  m i lk  p o w d e r .  S u c h  v a r ia t io n  
p r e s e n t ly  g i v e s  r i s e  to  c o n t r o v e r s y ,  a n d  th e  p r e c i s e  q u a n t i f ic a t io n  o f  C O P s  r e m a in s  a  
c h a l le n g i n g  ta s k , e s p e c i a l ly  in  fo o d s  c o n t a in in g  lo w  l e v e l s  o f  th e s e  c o m p o u n d s . In  
th e  p r e s e n t  s tu d y , G C  w a s  u s e d  a s  th e  a n a ly t ic a l  m e th o d  f o r  C O P s  d e te c t io n  a n d
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m e a s u re m e n t . T h e  s e t t in g  up o f  a  v a l id  m e th o d  e n ta ile d  d e t e r m in in g  th e  r e c o v e r y ,  
p r e c is io n , l in e a r it y  a n d  r e p r o d u c ib i l i t y  o f  th e  m e th o d . S o l id  p h a s e  e x t r a c t io n  w a s  
u se d  p r io r  to  s a m p le  in je c t io n  a s  a  s a m p le  c le a n - u p  p r o c e d u r e , w h ic h  re s u lte d  in  
‘ c le a n e r ’ c h o m a t o g r a m s . M S  w a s  u s e d  f o r  c o n f ir m a t io n , s in c e  F I D  a lo n e  c a n n o t 
d is t in g u is h  b e t w e e n  c o - e lu t in g  p e a k s  w h ic h  c a n  p re se n t  p r o b le m s  in  c h o le s t e r o l  
o x id e  d e t e c t io n . T h e  s u r v e y  o f  c o m m e r c ia l  m i lk  p o w d e r s  s h o w e d  th a t  th e  l e v e l  a n d  
ty p e  o f  C O P s  fo u n d  in  w h o le  m ilk  p o w d e r  d u r in g  s to r a g e  m a y  b e  g r e a t ly  in f lu e n c e d  
b y  th e  fa t  c o n te n t  o f  m i lk  a n d  th e  e x te n t  o f  p r e - h e a t in g  o f  m i lk  p r io r  to  s p r a y - d r y in g .  
In  o r d e r  to  e s t a b l is h  a  v a l id  m e th o d  w o r ld w id e ,  th e  m e th o d  s h o u ld  b e  v a l id a t e d  v i a  
p a r t ic ip a t io n  in  a  ro u n d  ro b in  te st. T h i s  w o u ld  e s t a b l is h  th e  a c c u r a c y ,  r e c o v e r y  a n d  
r e p r o d u c ib i l i t y  o f  th e  m e th o d  a n d  p e r m it  a n y  m e t h o d o lo g y  e r ro rs  to  b e  m in im is e d  so  
th a t fo o d  s c ie n t is t s  a n d  t o x ic o lo g is t s  c o u ld  a c c u r a t e ly  e s t a b l is h  d ie t a r y  C O P s .
H a v in g  e s t a b l is h e d  a  m e th o d  fo r  r e l i a b l y  q u a n t i f y in g  c h o le s t e r o l  o x i d e s  in  w h o le  
m ilk  p o w d e r s ,  w e  s u b s e q u e n t ly  in v e s t ig a t e d  th e  e f f e c t s  o f  a n im a l f e e d  q u a l i t y  o n  th e  
e x te n t  o f  c h o le s t e r o l  a n d  l ip id  o x id a t io n  d u r in g  p r o c e s s in g  a n d  s t o r a g e  o f  w h o le  m ilk  
p o w d e r .
M i lk f a t  c o m p o s it io n  m a y  b e  r a p id ly  a lte r e d  b y  n u tr it io n a l m a n ip u la t io n  a n d  m a y  
th e r e fo r e  b e  a  m o r e  a p p r o p r ia te  m e a n s  o f  im p r o v in g  m i lk  a n d  d a i r y  p r o d u c t  q u a l i t y  
( S u tto n , 1 9 8 9 )  th a n  g e n e t ic  m e a n s . T h e r e f o r e ,  m o d if ic a t io n  o f  a n im a l f e e d in g  
r e g im e n  w a s  u s e d  in  th e  s e c o n d  s ta g e  o f  o u r  s tu d y  a s  a  m e a n s  to  in v e s t ig a t e  th e  r o le  
o f  n u tr it io n  in  o f f e r in g  p r o te c t io n  a g a in s t  o x id a t io n  o f  w h o le  m i lk  p o w d e r .  F e e d  
p r o v id e s  th e  n u tr ie n ts  th at a re  th e  p r e c u r s o r s ,  e ith e r  d ir e c t ly  o r  in d i r e c t ly ,  o f  th e  
p r in c ip a l  m i lk  s o l id s  a n d  p a r t ic u la r  d ie t s  m a y  re s u lt  in  th e  p r o d u c t io n  o f  g r e a t e r  
v o lu m e s  o f  m i lk  ( S u t t o n , 1 9 8 9 ) .  In  o u r  s tu d y , th e  g r a s s  p lu s  c o n c e n t r a t e - fe d  h e rd  ( S )  
r e c e iv e d  a  s ta n d a rd  c o n c e n t r a te - fe d  a t 3  k g / c o w / d a y ,  w h ic h  is  th e  s ta n d a rd  d o s a g e  
( M u r p h y ,  1 9 9 6  P e r s o n a l  C o m m u n ic a t io n ) .  T h e  c o n c e n tra te  f e d  to  th e  h e r d  S  
in c lu d e d  p r o t e in , c a r b o h y d r a t e ,  l ip id ,  c r u d e  f ib r e  a n d  m in e r a ls  a n d  v i t a m in s .  T h e  
g r a s s - f e d  h e r d  ( R )  w a s  fe d  th e  M o o r e p a r k  s ta n d a rd  g r a s s  s u p p ly  w it h o u t  a  
c o n c e n tra te . I t  h a s  p r e v io u s ly  b e e n  r e p o r t e d  th a t o f  th e  p r in c ip a l  s o l id  c o n s t itu e n ts  o f  
m i lk ,  th e  c o n c e n t r a t io n  o f  fa t  c a n  b e  a lte r e d  b y  a p p r o x im a t e ly  3  %  b y  n u tr it io n a l
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m e a n s  w h i le  p ro te in  c a n  b e  a lte re d  b y  o n ly  a p p r o x im a t e ly  0.6 %  a n d  la c t o s e  s c a r c e ly  
at a ll (S u t t o n , 1 9 8 9 ) .  In  th e  p re s e n t  s t u d y , h o w e v e r ,  n o  s ig n i f ic a n t  d i f f e r e n c e s  w e r e  
o b s e r v e d  in  th e  fa t  l e v e l s  o r  m i lk f a t  c o m p o s it io n ,  w h ile  a  s ig n i f i c a n t  (p  <  0 .0 5 )  
in c r e a s e  w a s  o b s e r v e d  in  th e  to ta l p r o t e in  l e v e l s ,  c a s e in  an d  w h e y  l e v e l s  in  m i lk  o f  
th e  g r a s s  p lu s  c o n c e n t r a te - fe d  h e rd  c o m p a r e d  to  th e  g r a s s  o n ly - fe d  h e rd . T h e  le v e ls  
o f  l ip id  a n d  c h o le s t e r o l  o x id a t io n  in  th e  r e s u lta n t  w h o le  m ilk  p o w d e r s  w e r e  lo w e r  in  
h ig h e r  q u a l i t y  c o n c e n t r a te - fe d  d ie t , in d ic a t in g  th a t a n im a l f e e d in g  r e g im e n  d o e s  h a v e  
a  p r o t e c t iv e  e f f e c t  o n  l ip id  a n d  c h o le s t e r o l  o x id a t io n  in  w h o le  m i l k  p o w d e r .  T h e  
im p r o v e d  l e v e l  o f  p r o te c t io n  a g a in s t  o x id a t io n  in  m i lk  p o w d e r  m a n u fa c t u r e  f r o m  
m ilk  o f  th e  g r a s s  p lu s  c o n c e n t r a te - fe d  h e r d  w a s  a ttr ib u te d  to  a  n u m b e r  o f  fa c t o r s . 
S in c e  b o th  w h e y  a n d  c a s e in  h a v e  r e p o r t e d  a n t io x id a n t  a c t iv i t y  ( T a y lo r  an d  
R ic h a r d s o n ,  1 9 8 0 ;  A l l e n  a n d  W r ie d e n , 1 9 8 2 ) ,  a n d  w e r e  e le v a t e d  in  th e  m i lk  o f  th e  
g r a s s  p lu s  c o n c e n t r a t e - fe d  h e rd , th e  p r o t e c t iv e  e f f e c t  o b s e r v e d  m a y  h a v e  b e e n  d u e  to  
th e  to ta l a n t io x id a n t  a c t iv i t y  o f  th e  c a s e in  a n d  w h e y  f r a c t io n s  o f  m i lk .  H ig h e r  l e v e l s  
o f  f r e e  s u lp h y d r y l  g r o u p s  w e r e  o b s e r v e d  in  w h o le  m i lk  p o w d e r  o f  th e  g r a s s  p lu s  
c o n c e n t r a t e - fe d  h e r d  w h ic h  m a y  h a v e ,  in  p a r t  a t le a s t , c o n tr ib u te d  to  th e  r e d u c e d  
l e v e l s  o f  l ip id  a n d  c h o le s t e r o l  o x id a t io n  o b s e r v e d .  a - T o c o p h e r o l  w a s  in c lu d e d  in  th e  
c o n c e n t r a te  a t  a  s ta n d a r d  le v e l  o f  2 2 . 5  I U / c o w / d a y  w h ic h  m a y  a ls o  h a v e  c o n tr ib u te d  
to  th e  p r o t e c t iv e  e f f e c t  in  th e  g r a s s  p lu s  c o n c e n t r a te - fe d  h e rd  m ilk .  A  s h o r t c o m in g  o f  
th is  s tu d y  w a s  th e  a b s e n c e  o f  w h o le  m i l k  p o w d e r s  p r o d u c e d  f r o m  a  c o n t r o l  h e r d  fe d  
th e  M o o r e p a r k  s ta n d a r d  g r a s s  s u p p ly .  T h e  g r a s s  o n ly - f e d  h e rd  d i f f e r e d  f r o m  th e  
s ta n d a rd  M o o r e p a r k  s ta n d a rd  g r a s s  m a n a g e m e n t  s y s te m  in  h a v in g  a  lo w e r  la n d  
a l lo c a t io n ,  a  lo w e r  s t o c k in g  ra te  a n d  n o  c o n c e n t r a te  s u p p le m e n ta t io n . T h e r e f o r e ,  a n y  
d i f f e r e n c e s  o b s e r v e d  b e tw e e n  th e  t w o  h e r d s  u s e d  in  th is  s tu d y , i .e .  g r a s s - f e d  an d  
g r a s s  p lu s  c o n c e n t r a t e - fe d  c o u ld  n o t  b e  r e la t e d  to  a  c o n tro l h e rd . F u t u r e  w o r k  in  th is  
a r e a  m ig h t  in v e s t ig a t e  th e  e f fe c t s  o f  in c r e a s in g  th e  le v e ls  o f  a - t o c o p h e r o l  in  th e  fe e d  
a n d /o r  in t r a p e r ito n e a l  in je c t io n  o f  v i t a m in  E ,  a n d  a s s e s s in g  th e  r e la t io n s h ip  b e tw e e n  
th e  r e s u lta n t  v i t a m in  E  le v e ls  in  th e  m i lk  a n d  th e  o x id a t iv e  s t a b i l i t y  o f  re s u lta n t  
w h o le  m i lk  p o w d e r .
It  w a s  p r e v io u s ly  r e p o r te d  th at fo r m a t io n  o f  C O P s  in  d r ie d  fo o d s  o f  a n im a l  o r ig in  
c a n  b e  m in im is e d  b y  d e v e lo p in g  im p r o v e d  m e th o d s  o f  p r o c e s s in g ,  p a c k in g  a n d
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s to r a g e  ( C h a n  et al., 1 9 9 3 ) .  T h e  th ird  s e c t io n  o f  th is  s t u d y  in v e s t ig a te d  th e  e f f e c t s  o f  
p re -h e a t  te m p e r a tu r e s , p a c k in g  c o n d it io n s  a n d  s t o r a g e  te m p e ra tu re s  o n  l ip id  a n d  
c h o le s t e r o l  o x id a t io n  in  w h o le  m ilk  p o w d e r .  A  n u m b e r  o f  p h y s ic o c h e m ic a l  a n d  
fu n c t io n a l p r o p e r t ie s  o f  w h o le  m ilk  p o w d e r  w e r e  in v e s t ig a t e d  in  f r e s h  a n d  s to re d  
p o w d e r s .  H ig h  p r e - h e a t  tre a tm e n t c a u s e d  s ig n i f i c a n t ly  (p  <  0 .0 0 1 )  g r e a t e r  p r o t e in  
d e n a tu ra t io n  th a n  lo w  p r e -h e a t  tre a tm e n t. O r g a n o le p t ic  p ro p e r t ie s  o f  th e  p o w d e r s  
w e r e  a ls o  m e a s u r e d  a n d  h ig h - h e a t  w h o le  m i lk  p o w d e r ,  v a c u u m - p a c k e d  a n d  s to r e d  at 
1 5 °  C  g a v e  th e  b e s t  f la v o u r  s c o r e  (9 0 ) . O v e r a l l ,  lo w - h e a t  w h o le  m i lk  p o w d e r  
r e s u lte d  in  r e d u c e d  o x id a t iv e  s t a b i l i t y  a f t e r  12 m o n t h s  s to r a g e  a s  in d ic a t e d  b y  
in c r e a s e d  P V ,  T B A R S  a n d  C O P s  in  th e s e  p o w d e r s .  V a c u u m - p a c k in g  m a r k e d ly  
r e d u c e d  l ip id  a n d  c h o le s t e r o l  o x id a t io n  c o m p a r e d  to  s a c h e t - p a c k in g  w h i le  s t o r a g e  at 
1 5 °  C  re s u lte d  in  r e d u c e d  l ip id  a n d  c h o le s t e r o l  o x id a t io n  c o m p a r e d  to  s t o r a g e  at 3 0 °  
C .  H o w e v e r ,  o x id a t io n  w a s  n o t  c o m p le t e ly  e l im in a t e d  in  v a c u u m - p a c k e d  p o w d e r s .  
F u r th e r  w o r k  o n  th e  e f f e c t  o f  f lu s h in g  w it h  a n  in e r t  g a s  s u c h  a s  n it r o g e n  p r io r  to  
p a c k in g  is  w a r r a n t e d  to  in v e s t ig a t e  it s  r o le  in  fu r th e r  p r o t e c t io n  a g a in s t  l ip id  a n d  
c h o le s t e r o l  o x id a t io n .
a - T o c o p h e r o l  (a d d e d  a t  5 0 0  | ig / g  l ip id  a n d  1 0 0 0  ^ g / g  l ip id )  in h ib ite d  l ip id  o x id a t io n  
at a m b ie n t  t e m p e r a t u r e s  ( 1 5 °  C ) ,  b u t  d id  n o t  s ig n i f i c a n t ly  r e d u c e  c h o le s t e r o l  
o x id a t io n  u n d e r  a n y  c o n d it io n s  in v e s t ig a t e d , s u g g e s t in g  th a t a  th e s h o ld  l im it  o f  
c h o le s t e r o l  o x id e s  f o r  p r o t e c t io n  b y  a - t o c o p h e r o l  m a y  e x is t .  a - T o c o p h e r o l  w a s  
a d d e d  b o th  to  m i lk  p r io r  to  s p r a y - d r y in g  a n d  to  p o w d e r  f o l lo w i n g  m a n u fa c tu r e  b u t 
o n ly  th e  fo r m e r  m o d e  o f  a d d it io n  w a s  fo u n d  to  b e  e f f e c t iv e  at r e d u c in g  l ip id  
o x id a t io n ,  e f f e c t i v e  a n t io x id a n t  a c t iv i t y  p r e s u m a b ly  a r is in g  f r o m  its  in c o r p o r a t io n  
in to  th e  m i lk  fa t  g lo b u le  m e m b ra n e . O th e r  s tu d ie s  h a v e  s h o w n  th a t a n t io x id a n t  
a d d it io n  r e d u c e d  l ip id  o x id a t io n  in  w h o le  m i lk  p o w d e r  ( T u o h y ,  1 9 8 7 ;  C h a n , 1 9 9 2 ) .  
F u r t h e r  r e s e a r c h  i s  n e e d e d  to  in v e s t ig a t e  th e  e f f e c t s  o f  v a r y in g  l e v e l s  o f  a -  
to c o p h e r o l ,  a n d  in d e e d  o th e r  n a tu ra l a n t io x id a n t s ,  o n  c h o le s t e r o l  a n d  l ip id  
r e ta r d a t io n . S in c e  a d d it io n  o f  a n t io x id a n t s  to  m i lk  d u r in g  p r o c e s s in g  i s  n o t  p e r m it te d  
in  I r e la n d  ( O ’ S h e a ,  1 9 9 6  P e r s o n a l  C o m m u n ic a t io n ) ,  fu r th e r  r e s e a r c h  is  n e e d e d  to  
in v e s t ig a t e  th e  p o t e n t ia l  f o r  in c r e a s in g  le v e ls  o f  o f  a n t io x id a n t s  in  m i lk  b y  d ie t a r y  
m e a n s . W h ile  a  lo t  o f  d a ta  e x is t s  o n  th e  le v e ls  o f  C O P s  in  fo o d  p ro d u c ts  s u c h  a s
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s p r a y - d r ie d  e g g  p r o d u c t s  ( T s a i  a n d  H u d s o n , 1 9 8 4 ) ,  m e a t  p ro d u c ts  ( H ig le y  et a i, 
1 9 8 6 ;  M o n a h a n  et a i ,  1 9 9 2 ;  B u c k le y  et al., 1 9 9 5 )  a n d  d a ir y  p ro d u c ts  ( C h a n  et al., 
1 9 9 3 ;  R o s e - S a l l in  et al., 1 9 9 5 ) ,  th e re  is  s t i l l  a  n e e d  to in v e s t ig a t e  o th e r  c h o le s t e r o l-  
c o n t a in in g  fo o d s t u f f s ,  s u c h  a s  in fa n t  fo r m u la e ,  c o n fe c t io n a r y  a n d  c o n v e n ie n c e  fo o d s . 
It  w o u ld  b e  o f  im m e n s e  b e n e f it  to  e s t a b l is h  a  d a ta  b a s e  o n  l e v e l s  o f  c h o le s t e r o l  
o x id a t io n  p r o d u c t s  in  I r is h  f o o d s t u f f s ,  a s  h a s  b e e n  d o n e  f o r  fo o d s t u f f s  in  S w e d e n  
( N o u r o o z - Z a d e h  a n d  A p p e lq v i s t ,  1 9 8 8 )  a n d  A u s t r a l i a  ( S a r a n t in o s  et al., 1 9 9 3 ) .
L ip id  a n d  c h o le s t e r o l  o x id a t io n  w e r e  p o s i t i v e l y  c o r r e la t e d  d u r in g  s t o r a g e  o f  w h o le  
m i lk  p o w d e r .  T h is  h a s  a l s o  b e e n  p r e v io u s ly  r e p o r te d  in  p o r k  (M o n a h a n  et al., 1 9 9 2 ) ,  
w h o le  m i lk  p o w d e r  ( C h a n  et al., 1 9 9 3 )  a n d  d a ir y  s p r e a d s  ( N ie ls e n  et al., 1 9 9 6 ) .  
H o w e v e r ,  th e  n a tu re  o f  th e  c o r r e la t io n  in  p o r k  a n d  w h o le  m i lk  p o w d e r  w a s  q u ite  
d i f fe r e n t  to  th a t o b s e r v e d  in  d a ir y  s p r e a d s .  In  th e  fo r m e r ,  c h o le s t e r o l  o x id a t io n  
m ir r o r e d  d e v e lo p m e n t  o f  s e c o n d a r y  o x id a t io n  w h i le  in  th e  la tte r  c h o le s t e r o l  
o x id a t io n  r e f le c t e d  p r im a r y  l ip id  o x id a t io n . In  v i e w  o f  th e  r e la t iv e ly  n o n - s p e c i f ic  
n a tu re  o f  th e  T B A  a s s a y ,  it  m a y  b e  c o n c lu d e d  th a t th e  C O P s  a s s a y  m ig h t  b e  a s  
a p p r o p r ia te , i f  n o t  m o r e  a p p r o p r ia te  th a n  a  m e a s u r e  o f  T B A R S  fo r  m o n it o r in g  l ip id  
o x id a t io n ,  in  p a r t ic u la r  fo o d s t u f f s  s u c h  a s  p o r k  a n d  m i lk  p o w d e r s .
S e v e r a l  c h o le s t e r o l  o x id a t io n  p r o d u c t s  h a v e  b e e n  im p lic a t e d  in  a  n u m b e r  o f  a d v e r s e  
b io lo g ic a l  e f f e c t s  in c lu d in g  a t h e r o g e n e s is ,  c y t o t o x ic i t y  a n d  c a r c in o g e n e s is  ( K u m a r  
a n d  S in g h a l ,  1 9 9 1 ) .  T h e r e  is ,  h o w e v e r ,  a  r e la t iv e  d e a r th  o f  in fo r m a t io n  o n  th e ir  
e f f e c t s  o n  m a jo r  s t e r o id o g e n ic  t i s s u e s  o th e r  th a n  l iv e r .  G o n a d a l  t i s s u e s  a re  a c t i v e ly  
s t e r o id o g e n ic  u s in g  c h o le s t e r o l  a s  p r e c u r s o r . G r a n u lo s a  c e l l s  in  th e  o v a r ie s  a re  
r e s p o n s ib le  f o r  th e  p r o d u c t io n  o f  C l  8 o e s t r o g e n s .  T h e  1 9 - h y d r o x y l a s e  is ,  l ik e  o th e r  
h y d r o x y l a s e s  fo u n d  in  m ito c h o n d r ia  a n d  e n d o p la s m ic  r e t ic u lu m  o f  s te r o id - p r o d u c in g  
t i s s u e s ,  a  m ix e d  fu n c t io n  o x id a s e  h a v in g  c y t o c h o m e  P 450 at th e  a c t iv e  s ite . In  v i e w  
o f  th e  a c t iv e  c y t o c h o m e  P 450 e n z y m e  s y s t e m  in  g r a n u lo s a  c e l l s ,  a n d  its  l i k e l y  
d e p e n d e n c e  o n  th e  o x i d a t iv e  s ta tu s  o f  c e l l s ,  it w a s  o f  in te re s t  to  in v e s t ig a t e  w h e t h e r  
v i a b i l i t y  o f  o v a r ia n  g r a n u lo s a  c e l l s  m ig h t  b e  a d v e r s e ly  in f lu e n c e d  b y  c h o le s t e r o l  
o x i d e s  v i a  d a m a g e  to  c e l lu la r  a n d  s u b c e l lu la r  e n d o p la s m ic  r e t ic u la r  m e m b r a n e s  
a n d /o r  v i a  a lte re d  fu n c t io n  o f  k e y  p r o t e in  e n z y m e s  in v o lv e d  in  a n t io x id a t iv e  d e fe n c e .  
P o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  w e r e  u s e d  a s  a  m o d e l  s y s t e m  to  a s s e s s  th e  b io lo g ic a l
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e f f e c t s  o f  th e  f o l lo w in g  c h o le s t e r o l  o x id a t io n  p ro d u c ts : 7 - k e t o c h o le s t e r o l ,  a - e p o x id e ,  
2 5 - h y d r o x y c h o le s t e r o l ,  c h o le s t a n e t r io l .  T h e  in vitro e f f e c t s  o f  p u r i f ie d  c h o le s t e r o l  
w e r e  a ls o  in v e s t ig a te d . 2 5 - h y d r o x y c h o le s t e r o l ,  a - e p o x id e  a n d  c h o le s t a n e t r io l  w e r e  
fo u n d  to  b e  th e  m o s t  t o x ic ,  w h i le  c h o le s t e r o l  a n d  7 - k e t o c h o le s t e r o l  h a d  n o  in h ib it o r y  
e f f e c t  o n  c e l l  g r o w t h . 2 5 -  h y d r o x y c h o le s t e r o l  in d u c e d  s ig n i f i c a n t  in c r e a s e s  in  S O D  
a c t iv i t y  (p  <  0 .0 0 1 )  a n d  C A T  a c t iv i t y  (p  <  0 .0 0 1 )  w h i le  c h o le s t a n e t r io l  in d u c e d  a  
s ig n i f i c a n t  (p  <  0 . 0 1 )  in c r e a s e  in  S O D  a c t iv i t y  o n ly .  G P x  a c t iv i t y  w a s  r e d u c e d  b y  
e x p o s u r e  to  C O P s .  T h e  d a ta  r e p o r t e d  in  C h a p t e r  5 s u g g e s t  th a t c h o le s t e r o l  o x id e s  
g e n e r a t e d  s u p e r o x id e  r a d ic a ls  a n d  h y d r o g e n  p e r o x id e  in  g r a n u lo s a  c e l l s  b u t  th a t th e  
c e l l s  w e r e ,  in  p a r t  a b le  to  a d a p t b y  in d u c in g  a n t io x id a n t  d e f e n c e  e n z y m e s .  T h a t  c e l l  
d e a th  o c c u r r e d , h o w e v e r ,  s u g g e s t s  s o m e  d e f ic ie n c y  in  th e  l e v e l s  o f  a n t io x id a n t  
d e f e n c e s .  T h e r e  w a s  n o  s ig n i f i c a n t  e f f e c t  o n  l ip id  p e r o x id a t io n  a s  in d ic a t e d  b y  
T B A R S  l e v e l s .  S in c e  a n t io x id a n t  e n z y m e  a c t iv it ie s  w e r e  in d u c e d  b y  C O P s  in  th e  
p r e s e n t  m o d e l  s y s te m , th is  m o d e l  s y s t e m  c o u ld  b e  u s e d  to  c o m p a r e  th e  r e la t iv e  
d e f e n s i v e  e f f e c t s  o f  a n  e x o g e n o u s  a n t io x id a n t ,  a - t o c o p h e r o l .  T h e  t o x ic i t y  o f  2 5 -  
h y d r o x y c h o le s t e r o l  a n d  c h o le s t a n e t r io l  w a s  r e d u c e d  b y  in c u b a t io n  w it h  a - t o c o p h e r o l  
( 1  (J.M ). R e l a t i v e l y  lo w  c o n c e n t r a t io n s  o f  C O P s  w e r e  u s e d  in  th e s e  c e l l  c u ltu r e  
s tu d ie s .  H o w e v e r ,  b a s e d  o n  e x t r a p o la t io n s  f r o m  th e  o n ly  h u m a n  fe e d in g  s tu d y  
c a r r ie d  o u t  b y  E m a n u e l  et al. ( 1 9 9 1 ) ,  th is  c o n c e n tra t io n  o f  C O P s  in  c e l l  c u ltu r e  ( 1  
p ,g /m l) w o u l d  b e  e x p e c te d  to  s im u la t e  th e  p la s m a  C O P s  l e v e l s  o b ta in e d  a ft e r  
in g e s t io n  o f  1  g  lo w -h e a t - t r e a t e d  m i l k  p o w d e r  s a c h e t - p a c k e d  a n d  s to r e d  a t 3 0 °  C . 
F u r t h e r  w o r k  in  th is  a r e a  c o u ld  f o c u s  o n  th e  e f f e c t  o f  C O P s  a t h ig h e r  c o n c e n tr a t io n s , 
to  d e t e r m in e  th e  L D 50 fo r  e a c h  o f  th e  C O P s  fo u n d  in  w h o le  m i lk  p o w d e r s .  T h e  
e x a c t  m e c h a n is m  o f  c e l l  t o x ic i t y  b y  C O P s  a d m in is t r a t io n  s t i l l  r e m a in s  u n c le a r . It 
m a y  b e  th a t c h o le s t e r o l  is  d is p la c e d  fr o m  th e  c e l l  m e m b r a n e  b y  C O P s ,  th u s  a lte r in g  
c e l lu la r  in t e g r i t y  a n d  fu n c t io n . I t  w o u ld  b e  o f  in te re s t  to  in v e s t ig a t e  l e v e l s  o f  H M G -  
C o A  r e d u c t a s e  in  th e  p o r c in e  o v a r ia n  g r a n u lo s a  c e l l s  to  d e t e r m in e  ra te  o f  c h o le s t e r o l  
b io s y n t h e s i s  a n d  w h e t h e r  in h ib it io n  o f  m e v a lo n a t e  a n d  c h o le s t e r o l  s y n t h e s is  m a y  
h a v e  le d  to  c e l l  d e a th  v i a  in t e r fe r e n c e  w it h  p r o g r e s s io n  th o u g h  G 1  
( m e m b r a n o g e n e s is )  a n d  S  p h a s e s  ( D N A  r e p lic a t io n )  o f  th e  c e l l  c y c le .  F u r th e r m o r e , 
a n a ly s i s  o f  th e  o x y s t e r o l  p r o f i l e  o f  c e l l s  e x p o s e d  to  c h o le s t e r o l  o x id e s  w o u ld  h a v e
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y ie ld e d  in fo r m a t io n  o n  th e  c a p a c i t y  o f  th e s e  c e l l s  n o t o n ly  to ta k e  u p  o x y s t e r o ls  b u t 
a ls o  to  g e n e r a te  o x y s t e r o l s  b y  s e c o n d a r y  o x id a t io n .
F u r th e r  b io c h e m ic a l  r e s e a r c h  i s  n e e d e d  to  e lu c id a te  th e  e x a c t  m e c h a n is m  o f  
c h o le s t e r o l  t o x ic i t y .  W ith  r e g a r d  to  th e  c u r r e n t  s tu d y  w h e r e  c e l l  n u m b e r  an d  
m it c h o n d r ia l  in t e g r i t y  w e r e  u s e d  a s  in d ic a t o r s  o f  c e l l  v i a b i l i t y ,  fu r th e r  w o r k  c o u ld  
fo c u s  o n  L D H  r e le a s e  to  v e r i f y  r e s u lt s  f r o m  tr y p a n  b lu e  a n d  M T T  a s s a y s .  In  
a d d it io n , in d ic e s  o f  c e l l  fu n c t io n  in c lu d in g  g e n e r a t io n  o f  A T P ,  m e a s u r e m e n t  o f  re d o x  
p o t e n t ia l ,  e x te n t  o f  3H  th y m id in e  in c o r p o r a t e d  in to  D N A  a n d  e x te n t  o f  14C  le u c in e  
in c o r p o r a t io n  in to  p r o t e in  c o u ld  b e  in v e s t ig a t e d .  V e r y  f e w  s t u d ie s  h a v e  b e e n  
p e r fo r m e d  to  in v e s t ig a t e  th e  e f f e c t  o f  C O P s  in vivo a n d  fu r th e r  r e s e a r c h  is  th e re fo re  
r e q u ir e d  to  a s c e r t a in  th e  le v e ls  o f  C O P s  in vivo a s  a  re s u lt  o f  in g e s t io n  o f  d ie ta r y  
C O P s .  C O P s  h a v e  b e e n  d e te c te d  in  a th e r o m a  s a m p le s  b u t  n o t  in  n o r m a l a o r ta  
(C a r p e n t e r  et al., 1 9 9 3 )  a n d  h e n c e  th e  p o s s ib i l i t y  o f  p h e n o t y p in g  s e r u m  l ip id s  fo r  
C O P s  m a y  b e  a  u s e fu l  d ia g n o s t ic  m a r k e r .  T h e  le v e ls  o f  C O P s  a d m in is t e r e d  to  c e l ls  
in  th e  p r e s e n t  s t u d y  (1 ja g /m l) w e r e  lo w e r  th a n  h a s  b e e n  r e p o r t e d  in  h u m a n  p la s m a  
( 2 - 1 6  ja g / m l)  ( E m a n u e l  et al., 1 9 9 1 )  a n d  n o  s ig n i f i c a n t  l ip id  p e r o x id a t io n  w a s  
o b s e r v e d  ( a s  in d ic a t e d  b y  T B A R S )  in  c u ltu r e d  p o r c in e  o v a r ia n  g r a n u lo s a  c e l ls .  T h is  
w o u ld  i m p l y  th a t th e  le v e l s  o f  C O P s  fo u n d  in  w h o le  m ilk  p o w d e r s  in  th is  s tu d y  m a y  
n o t c a u s e  a  s ig n i f i c a n t ly  t o x ic  e f f e c t  in vivo.
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A b b o t ,  J .  a n d  W a it e ,  R .  ( 1 9 6 2 ) .  T h e  e f f e c t  o f  a n t io x id a n t s  o n  th e  k e e p in g  q u a l i t y  o f  
w h o le  m ilk  p o w d e r  I. J .  D a i r y  R e s .  2 9 :  5 5 - 6 1 .
A d d i s ,  P .B .  a n d  P a r k ,  S .W . ( 1 9 8 9 ) .  R o le  o f  l ip id  o x id a t io n  p r o d u c t s  in  
a th e r o s c le r o s is .  In F o o d  T o x i c o lo g y .  A  P e r s p e c t iv e  o n  th e  R e la t iv e  R is k s .  E d s .  
T a y lo r ,  S . L .  a n d  S c a n la n ,  R .A .  M a r c e l  D e k k e r ,  N e w  Y o r k ,  p p  2 9 7 - 3 3 0 .
A d d i s ,  P . B .  a n d  P a r k ,  S .W . ( 1 9 9 2 ) .  C h o le s t e r o l  o x id e s  c o n te n t  o f  fo o d s .  In 
B i o l o g i c a l  E f f e c t s  o f  C h o le s t e r o l  O x id e s .  E d s .  P e n g ,  S . K .  a n d  M o r in ,  R . J .  C R C  
P r e s s ,  L o n d o n ,  U K .  p p 7 1 - 8 1 .
A d d i s ,  P .B .  a n d  W a r n e r ,  G . J .  ( 1 9 9 2 ) .  T h e  p o t e n t ia l  h e a lth  a s p e c ts  o f  l ip id  o x id a t io n  
p r o d u c t s  in  fo o d . In F r e e  R a d ic a ls  a n d  F o o d  A d d i t i v e s .  E l s e v i e r  A p p l ie d  S c ie n c e  
P u b l i s h e r s  L t d . ,  E s s e x ,  U . K .  E d s .  A r u o m a ,  O .I . a n d  H a l l iw e l l .  B .  p p  2 0 7 - 2 5 1 .
A D M I  ( A m e r ic a n  D r y  M i l k  In s t it iu te )  ( 1 9 7 1 ) .  In S ta n d a r d s  fo r  g r a d e s  o f  d r y  m ilk  
in c lu d in g  m e t h o d s  o f  a n la y s i s  ( 3 r d  E d it io n ) .  A m e r ic a n  D r y  M i l k  In s t it iu te , C h ic a g o ,  
I l l in o is ,  U . S .A .
A l le n ,  J . C .  a n d  W r ie d e n , W .L .  ( 1 9 8 2 ) .  I n f lu e n c e  o f  m i lk  p r o t e in s  o n  l ip id  o x id a t io n  
in  a q u e o u s  e m u ls io n . C a s e in ,  w h e y  p r o t e in  a n d  a - la c t a lb u m in .  J .  D a i r y  R e s .  4 9 : 
2 3 9 - 2 4 8 .
A n n is o n ,  E . F . ,  L in z e l l ,  J . L . ,  F a z a k e r le y ,  S .  a n d  N ic h o ls ,  B .W .  ( 1 9 6 7 ) .  T h e  
o x id a t io n  a n d  u t i l is a t io n  o f  p a lm it a t e , s te a ra te , o le a te  a n d  a c e ta te  b y  th e  m a m m a r y  
g la n d  o f  th e  f e d  g o a t  in  r e la t io n  to  th e ir  o v e r a l l  m e t a b o l is m , a n d  th e  r o le  o f  p la s m a  
p h o s p h o l ip id s  a n d  n e u tr a l  l ip id s  in  m ilk - fa t  s y n th e s is .  B io c h e m . J .  1 0 2 :  6 3 7 - 6 4 7 .
A n s a r i ,  G . A . S .  a n d  S m it h ,  L . L .  ( 1 9 7 9 ) .  H ig h  p e r fo r m a n c e  l iq u id  c h r o m a t o g r a p h y  o f  
c h o le s t e r o l  o x id a t io n  p r o d u c ts . J .  C h r o m a t o g . 1 7 5 : 3 0 7 - 3 1 5 .
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A p p e lq v i s t ,  L .A .  ( 1 9 9 6 ) .  H a r m o n iz a t io n  o f  m e th o d s  fo r  o x y s t e r o l  a n a ly s i s .  F ir s t  
re p o rt  f r o m  a  w o r k s h o p  in  L a u s a n n e , A u g u s t  2 9 - 2 9 ,  1 9 9 5 .  S w e d i s h  U n iv .  o f  A g r ic .  
S c i . ,  D e p t . F o o d  S c i . ,  U p p s a la ,  S w e d e n .
A s h e s ,  J . R . ,  S t . V in c e n t  W e lc h , P . ,  G u la t i ,  S .K . ,  S c o t t ,  T .W . a n d  B r o w n ,  G .H .
( 1 9 9 2 ) .  M a n ip u la t io n  o f  th e  fa t t y  a c id  c o m p o s it io n  o f  m ilk  b y  fe e d in g  p ro te c te d  
c a n o la  s e e d s .  J .  D a i r y  S c i .  7 5 : 1 0 9 0 - 1 0 9 5 .
A s t r u p ,  H .N . ,  B a e v r e ,  L . ,  V i k - M o ,  L .  a n d  E f e m ,  A .  ( 1 9 8 0 ) .  E f f e c t  o f  m i lk  l ip o ly s i s  
o f  r e s t r ic te d  fe e d in g  w it h  a n d  w it h o u t  s u p p le m e n ta t io n  w it h  p r o t e c t e d  r a p e  s e e d  o il. 
J .  D a i r y  R e s .  47: 2 8 7 - 2 9 4 .
A t w a l ,  A .  S . ,  H id ir o g lo u ,  M . ,  K r a m e r ,  J . K . G .  a n d  B in n s ,  M .R .  ( 1 9 9 0 ) .  E f f e c t s  o f  
f e e d in g  p r o t e c  a n d  a - t o c o p h e r o l  a n d  c a lc iu m  s a lt s  o f  fa t t y  A c i d s  o n  v i t a m in  E  a n d  
fa t t y  a c id  c o m p o s it io n  o f  c o w ’ s m ilk .  J .  D a i r y  S c i .  73: 2 8 3 2 - 2 8 4 1 .
A t w a l ,  A .  S . ,  H id ir o g lo u ,  M . a n d  K r a m e r ,  J . K . G .  ( 1 9 9 1 ) .  E f f e c t s  o f  f e e d in g  P r o te c  
a n d  a - T o c o p h e r o l  o n  fa t t y  a c id  c o m p o s it io n  a n d  o x id a t iv e  s t a b i l i t y  o f  c o w ’ s  m ilk . J .  
D a i r y  S c i .  7 4 :  1 4 0 - 1 4 5 .
B a k e r ,  T .G .  ( 1 9 8 2 ) .  O o g e n e s is  a n d  o v u la t io n . In R e p r o d u c t io n  in  m a m m a ls  I. E d s .  
A u s t in ,  C .R .  a n d  S h o r t ,  R . V .  C a m b r id g e  U n iv e r s i t y  P r e s s ,  N e w  Y o r k ,  p p  1 7 - 4 6 .
B a l d w i n ,  A . J .  a n d  A c k la n d ,  J .D .  ( 1 9 9 1 ) .  E f f e c t  o f  p re h e a t  t r e a tm e n t  a n d  s to r a g e  o n  
th e  p r o p e r t ie s  o f  w h o le  m i lk  p o w d e r .  C h a n g e s  in  p h y s ic a l  a n d  c h e m ic a l  p r o p e r t ie s . 
N e t h . D a i r y  J .  45: 1 6 9 - 1 8 1 .
B a l d w i n ,  A . J . ,  In n e s ,  S . K . ,  C o o k ,  W .R .  a n d  W in te r , G .A .  ( 1 9 8 0 ) .  K e e p i n g  q u a l i t y  o f  
w h o le  m i lk  p o w d e r .  B ie n n ia l  R e v .  ( A u g .  1 9 7 8 - J u l y  19 8 0 ) .  N e w  Z e a la n d  D a i r y  R e s .  
In st . ( N .Z .D .R . I . ) :  7 1 - 7 2
245
B a n k s ,  W ., C la p p e r to n , J . L . ,  G ir d le r ,  A . K .  a n d  S t e e le ,  W . ( 1 9 8 4 ) .  E f f e c t  o f  
in c lu s io n  o f  d i f fe r e n t  fo rm s  o f  d ie t a r y  fa t t y  a c id  o n  th e  y ie ld  a n d  c o m p o s it io n  o f  
c o w ’ s  m ilk .  J .  D a i r y  R e s .  52: 3 8 7 - 3 8 2 .
B a n k s ,  W ., D a lg le i s h ,  D .G .  a n d  R o o k ,  J . A . F .  ( 1 9 8 1 ) .  D a i r y  M ic r o b io lo g y  V o l .  1 .  
E d .  R o b in s o n ,  R . K .  E l s e v i e r  A p p l ie d  S c i e n c e ,  L o n d o n , U .K .
B a r a n o w s k i ,  A . ,  A d a m s ,  C .W . .M . ,  B a y l i s s  H ig h , O .B .  a n d  B o w y e r ,  D .B .  ( 1 9 8 2 ) .  
C o n n e c t iv e  t i s s u e  r e s p o n s e s  to  o x y s t e r o l s .  A t h e r o s c le r o s i s  4 1 :  2 5 5 - 2 5 8 .
B a s c o u l ,  J .  D o m e r g u e ,  N . ,  O lle , M .  a n d  d e  P a u le t ,  A .C .  ( 1 9 8 6 ) .  A u t o x id a t io n  o f  
c h o le s t e r o l  in  t a l lo w s  h e a te d  u n d e r  d r y in g  c o n d it io n s :  e v a lu a t io n  o f  s te r o ls  b y  G L C  
a n d  T L C - F I D ,  L ip i d s  2 1 :  3 8 3 - 3 8 7 .
B a u d h u in ,  P . ,  B e a u f a y ,  H .,  R a h m a n - L i ,  Y . ,  S e l l in g e r ,  O .Z . ,  W a t t ia u x ,  R . ,  J a c q u e s ,  P . 
a n d  d e D u v e ,  C .  ( 1 9 6 4 ) .  T is s u e  f r a c t io n a t io n  s tu d ie s . In t r a c e l lu la r  d is t r ib u t io n  o f  
m o n o a m in e  o x id a s e ,  a s p a r ta te  a m in o t r a n s fe r a s e ,  D - a m in o  a c id  o x id a s e  a n d  c a ta la s e  
in  ra t  l i v e r  t i s s u e .  B io c h e m . J .  9 2 :  1 7 9 - 1 8 4 .
B e n o it ,  A . M .  a n d  V e ld h iu s ,  J .D .  ( 1 9 9 6 ) .  D i f f e r e n t ia l  e f f e c t s  o f  p u ls a t i le  v e r s u s  
c o n t in u o u s  f o l l ic le - s t im u la t in g  h o r m o n e  d e l i v e r y  o n  th e  p r o d u c t io n  o f  c y c l ic  
a d e n o s in e  5 ’ - m o n o p h o s p h a te s  a n d  th e  a c c u m u la t io n  o f  c y t o c h r o m e  P 4 5 0  c h o le s t e r o l  
s id e - c h a in  c le a v a g e  e n z y m e  m R N A  in  p e r fu s e d  p o r c in e  g r a n u lo s a  c e l l s .  B io l .  
R e p r o d .  5 3 :  4 6 - 5 4 .
B e r g s t r o m , S .  a n d  S a m u e ls s o n ,  B .  ( 1 9 6 1 ) .  T h e  a u to x id a t io n  o f  c h o le s t e r o l .  In 
A u t o x id a t io n  a n d  A n t io x id a n t s .  W ile y - I n t e r s c ie n c e ,  C h ic h e s t e r ,  U .K .  p p  2 3 3 - 2 4 7 .
B e v e r i d g e ,  H . J .T .  a n d  N a k a i ,  S .  ( 1 9 7 0 ) .  E f f e c t s  o f  c h e m ic a l  m o d i f ic a t io n  w it h  2 -  
p h e n y l - l ,4 - d ib r o m o a c e t o in  o n  a s ,- c a s e in .  J .  D a i r y  S c i .  53: 1 5 3 2 - 1 5 3 4 .
246
B e v e r id g e ,  T . ,  T o m a ,  S .  T . ,  a n d  N a k a i ,  S .  ( 1 9 7 4 ) .  D e te r m in a t io n  o f  S H -  a n d  S S -  
g r o u p s  in  s o m e  fo o d  p r o te in s  u s in g  E l l m a n ’ s  r e a g e n t . J .  F o o d  S c i .  3 9 :  4 9 - 5 1 .
B ig g s ,  D .A .  a n d  B r y a n t ,  L .R .  ( 1 9 5 3 ) .  T h e  th io b a r b itu r ic  a c id  te s t  f o r  b u t te r fa t  
o x id a t io n . C a n .  J .  T e c h n o l .  3 1 :  1 3 8 - 1 4 5 .
B is h o p ,  C . ,  D a v i e s ,  T . ,  G la s c o c k ,  R . F .  a n d  W e lc h ,  V . A .  ( 1 9 6 9 ) .  S t u d ie s  o n  th e  
o r ig in  o f  M i l k  F a t .  B io c h e m . J .  1 1 3 :  6 2 9 - 6 3 4 .
B la c k ,  H .S .  a n d  D o u g la s ,  D .R .  ( 1 9 7 3 ) .  F o r m a t io n  o f  a  c a r c in o g e n  o f  n a tu r a l  o r ig in  
in  th e  e t io lo g y  o f  u l t r a v io le t  l ig h t - in d u c e d  c a r c in o g e n e s is .  C a n c e r  R e s .  3 3 :  2 0 9 4 -  
2 0 9 6 .
B le v i n s ,  D . B . ,  B u r k e ,  M .F . ,  G o o d , T . J . ,  H a r r is ,  P . A . ,  V a n  H o m e , K . C . ,  S im p s o n ,  N . 
a n d  Y a g o ,  L . S .  ( 1 9 9 0 ) .  S o r b e n t  E x t r a c t io n  T e c h n o lo g y .  E d .  S im p s o n ,  N .  a n d  V a n  
H o m e , K . C .  V a r i a n  S a m p le  P re p a r a t io n  P r o d u c t s ,  C A ,  U S A .
B lo o r e ,  C .G .  a n d  B o a g ,  I .F .  ( 1 9 8 2 ) .  S o m e  fa c t o r s  a f f e c t in g  th e  v i s c o s i t y  o f  
c o n c e n tr a te d  s k im  m ilk .  N . Z . J .  D a i r y  S c i .  T e c h n o l .  1 6 :  1 4 3 - 1 5 4 .
B o e r s e n ,  A . C .  ( 1 9 9 0 ) .  S p r a y - d r y in g  T e c h n o lo g y .  J .  S o c .  D a i r y  T e c h n o l .  1 :  5 - 7 .
B o o n ,  P .M .  ( 1 9 7 6 ) .  T h e  E f f e c t  o f  P r e - H e a t  T r e a tm e n t  o n  th e  s to r a g e  s t a b i l i t y  o f  
w h o le  m i lk  p o w d e r .  N . Z . J .  D a i r y  S c i .  T e c h .  1 1  : 2 7 8 - 2 8 0 .
B o o n ,  P .M . ,  K e e n ,  A . R .  a n d  W a lk e r ,  N . J .  ( 1 9 7 6 ) .  O f f - f l a v o u r  in  s to re d  w h o l e  m i lk  
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APPENDICES
APPENDIX I 
Questionnaire on Whole M ilk Powder Survey
Company name:
Contact person:
Please tick appropriate box and include necessary data:
Atomizer Type
Heat Stable Class Production Date Storage Temp. (Disc/Nozzle)
Low
Med.
High
Cho les te ro l  O x ida t ion  Products  (COPS) Quest ionna ire  on WiVlP
Standard  Curves of Cholesterol Oxidation Products (GC-MS)
APPENDIX II
Pe
ak
 
A
re
a
(a)
I2IHKII)
0  100 200 300 400 500 600 700 800 000 1000
C oncentration (|i|im |
(b)
Co net!n tra  I ion (p p in )
Standard curves o f (a) oc-epoxycholesterol and 25*1
Pea
k 
Ar
e»
(a)
2500000
(.'once u t ra t  io li (pp  nt)
(b)
160000 _
C o n ce n tra tio n  (p p m )
Standard curves o f (a) cholesterol and (b) 7-ketocholesterol.
APPENDIX III 
Procedure for  F lav o u r  Scoring in Whole Milk Powder
THE BORDEN COMPANY LIMITED
•ROCEDURE TITLE: PROCEDURE FOR FLAVOUR SCORING
>ROCEDURE NO : 1.8 REVISION NO : ROO PAGE 1 of 2
lPPROVED RY TITLE AUTHORISED BY TITLE
DATE: __________________
1.0 PURPOSE
.1 To determine and assign a flavour score for milk powder.
J.O Reagent
!. 1 Demineralized water.
t.O Equipment and Ancillaries
1.1 Analytical Scales.
!.2 Thermometer.
1.3 Glass beakers (200 ml).
1.4 Mixing Equipment: Instant Powder - Fork.
Regular - Blender.
.0 Procedure
-.1 Responsibility: Laboratory Assistant.
-.2 Take a min.of three samples per batch for Incoming Inspection (first, middle and last bin).
Take one can, twice per shift (a.m. and p.m.), for Final Inspection.
Take samples for storage as stated in Procedure No. 1.20.
.3 Pour 90 ±0. 5 ml of 25 ± 2 °C. demineralized water into the beaker.
.4 Weigh 13 ± 0.5g of powder on analytical scales.
.5 Put instant powder into the beaker and mix with a fork for 10 seconds.
Put regular powder into the blender and mix for 90 seconds.
. 6  Allow reconstituted sample to stand for 1 hour at room temperature before flavouring.
.7 Prepare a sample tray for each panelist by placing a 50ml beaker into each well
. 8  Sub-divide each reconstituted sample, according to the number of panelists participating, 
into respective 50ml beaker in the sample tray, i.e. sample 4 would be sub-diivided into 
number 4 well in each of the sample trays.
i . 9  Record date, time, code, powder type and sample number In Flavour Log Books before
flavour score sampling begins.These must be recorded for the Storage samples as well.
L10 Panelists will flavour the samples and assign them a score on their Flavour Score Sheet
(BML/S049), without consultation with any of the panelists.
1.11 Transfer results from Incoming > Laboratory Report Sheet
Final > Green Book
Storage > Storage Book
5.0 ASSIGNING SCORE
5.1 The flavour and odour should resemble closely that of freshly made milk sample and any 
variations should be indicated on Flavour Score Sheet (BNML/S049).
5.2 The value of the test lies in the ability of the panelist to recognise the normal flavour and 
odour characteristics of a good quality powder and to appreciate any variations that may 
occur.
5.3 The flavour score is reported by a numbering system as follows:
5.3.1 Perfect, slightly cooked flavour. 90
5.3.2 Good: no off flavour, not quite as fresh tasting as 90. 85
5.3.3 Fair; no strong off flavour, but less fresh tasting than 85. 80
5.3.4 Objectionable; some off flavour. 75
¡.4 An experienced, discerning taster will be capable of assigning some score values which 
lie within the above figures (8 8 , 83, etc.).
¡.5 Off flavours may be identified as:
5.5.1 Acid
5.5.2 Bitter
5.5.3 Chalky
5.5.4 Burnt
5.55 Feed
5.5.6 Flat
5.5.7 Metallic
5.5.8 Oxidized or tallowy
5.5.9 Rancid
5.5.10 Salty
5.2.11 Stale
5.2.12 Weedy
1.0 OFF SPECIFICATION ACTION
1.1 Refer to Supervisor.
R O C E D U R E  NO : 1.8 REVISION NO : ROO PAGE 2 of 2
APPENDIX IV
Statistical Analysis of the Effects of Animal Feed Quality, Pre-Heat Temperature, 
Packaging Conditions, Storage Temperature and Period of Manufacture on Lipid 
and Cholesterol Oxidation Products in Whole Milk Powder
Effect of animal feed quality, pre-heat, packing and storage temperature on TBARS 
levels after (a) 2 months, (b) 4 months, (c) 6 months storage and (d) 12 months storage.
(a)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality 0.001 N.S. N.S. N.S.
Pre-heat 0.001 0.01 0.01 0.01
Packing 0.05 0.05 N.S. 0.05
StorageT emperature 0.001 0.001 0.05 0.01
(b)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality 0.05 0.05 N.S. N.S.
Pre-heat 0.001 0.001 0.001 0.001
Packing 0.001 N.S. N.S. N.S.
StorageTemperature 0.001 N.S. N.S. N.S.
(c)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality N.S. 0.01 N.S. N.S.
Pre-heat 0.001 0.001 0.01 0.01
Packing 0.001 0.001 0.01 0.01
StorageT emperature 0.001 0.001 0.05 0.01
(d)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality 0.001 0.01 N.S. 0.001
Pre-heat 0.001 0.001 0.05 0.01
Packing 0.001 0.001 0.001 0.01
Storage Temperature 0.001 0.001 0.001 0.001
Effect of animal feed quality, pre-heat, packing and storage temperature on COPs after 
12 months storage.
Effect Period 1 Period 2 Period 3 Overall
Animal feed 0.01 0.01 0.01 0.01
quality
Pre-heat 0.001 0.001 0.001 0.001
Packing 0.001 0.001 0.001 0.001
Storage 0.001 0.001 0.001 0.001
Temperature
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Effect o f animal feed quality and pre-heat treatment on PV and TBARS in fresh whole
milk powder.
Effect Oxidation
index
Period 1 Period 2 Period 3 Overall
Animal Feed PV 0.05 0.05 N.S. N.S.
Quality
Pre-heat 0.001 N.S N.S. N.S.
Animal Feed TBARS N.S. 0.05 N.S. N.S.
Quality
Pre-heat N.S. N.S. N.S. N.S.
Effect o f animal feed quality, pre-heat, packing and storage temperature on PV levels
after (a) 2 months, (b) 4 months, (c) 6 months storage and (d) 12 months storage, 
(a)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality N.S. N.S. N.S. N.S.
Pre-heat 0.01 0.01 N.S. 0.01
Packing 0.001 0.001 0.05 0.01
StorageT emperature 0.01 0.01 0.01 0.01
(b)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality N.S. N.S. N.S. N.S.
Pre-heat 0.001 0.001 0.05 0.01
Packing 0.05 0.001 N.S. 0.05
StorageT emperature 0.001 0.001 N.S. 0.01
(c)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality 0.001 N.S. N.S. N.S.
Pre-heat 0.01 0.01 0.05 0.01
Packing 0.001 0.01 0.001 0.01
StorageTemperature 0.001 0.001 0.001 0.001
(d)
Effect Period 1 Period 2 Period 3 Overall
Animal Feed Quality N.S. 0.01 N.S. N.S.
Pre-heat 0.01 0.001 0.05 0.05
Packing 0.001 N.S. N.S. N.S.
StorageT emperature 0.001 0.05 0.05 0.05
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